Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23428.Concentration of VLDL Particles,AGRP,Agouti-related protein,40058,0.251416376865177,0.00457222702882039,0.242454811888689,0.260377941841665,0
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL27,C-C motif chemokine 27,39868,0.237763103027219,0.00551074862945734,0.226962035713483,0.248564170340956,0
NMR metabolomics,X23428.Concentration of VLDL Particles,CCN1,CCN family member 1,39758,0.351566275606413,0.00655385768433492,0.338720714545116,0.364411836667709,0
NMR metabolomics,X23428.Concentration of VLDL Particles,F7,Coagulation factor VII,39899,0.112193794790377,0.00264559672650985,0.107008425206418,0.117379164374336,0
NMR metabolomics,X23428.Concentration of VLDL Particles,FGFBP1,Fibroblast growth factor-binding protein 1,39913,0.124147209161221,0.00281469962351886,0.118630397899124,0.129664020423318,0
NMR metabolomics,X23428.Concentration of VLDL Particles,LCAT,Phosphatidylcholine-sterol acyltransferase,37445,0.0815766745520272,0.00191926069061839,0.0778149235984152,0.0853384255056393,0
NMR metabolomics,X23428.Concentration of VLDL Particles,LDLR,Low-density lipoprotein receptor,39882,0.398754503352193,0.00375186905331069,0.391400840007704,0.406108166696682,0
NMR metabolomics,X23428.Concentration of VLDL Particles,MFGE8,Lactadherin,39858,0.191618520340696,0.0037866394317458,0.184196707054474,0.199040333626918,0
NMR metabolomics,X23428.Concentration of VLDL Particles,NPY,Pro-neuropeptide Y,40030,0.320467740114167,0.00563712900904819,0.309418967256433,0.331516512971902,0
NMR metabolomics,X23428.Concentration of VLDL Particles,PLA2G7,Platelet-activating factor acetylhydrolase,39858,0.178901723686791,0.00246188754671013,0.174076424095239,0.183727023278343,0
NMR metabolomics,X23428.Concentration of VLDL Particles,PROC,Vitamin K-dependent protein C,39908,0.100344806179962,0.00226725176952231,0.0959009927116982,0.104788619648226,0
NMR metabolomics,X23428.Concentration of VLDL Particles,SMOC1,SPARC-related modular calcium-binding protein 1,40030,0.116201933410433,0.00290644664090461,0.11050529799426,0.121898568826606,0
NMR metabolomics,X23428.Concentration of VLDL Particles,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39931,0.155966099169704,0.00376780987483197,0.148581191815033,0.163351006524375,0
NMR metabolomics,X23428.Concentration of VLDL Particles,TFPI,Tissue factor pathway inhibitor,39843,0.129273424296306,0.00274670113193646,0.123889890077711,0.134656958514902,0
NMR metabolomics,X23428.Concentration of VLDL Particles,RARRES2,Retinoic acid receptor responder protein 2,39949,0.164224079704105,0.00420457888666539,0.155983105086241,0.172465054321969,1.11253692928798e-308
NMR metabolomics,X23428.Concentration of VLDL Particles,HHEX,Hematopoietically-expressed homeobox protein HHEX,37388,0.260055938791587,0.00681171358123846,0.246704980172359,0.273406897410814,5.72501391095328e-303
NMR metabolomics,X23428.Concentration of VLDL Particles,APCS,Serum amyloid P-component,37333,0.115375645527642,0.00310116447318068,0.109297363160208,0.121453927895076,1.76946715660006e-288
NMR metabolomics,X23428.Concentration of VLDL Particles,PTH,Parathyroid hormone,37039,0.254385804071622,0.00712717316316534,0.240416544671818,0.268355063471426,2.00393539239317e-266
NMR metabolomics,X23428.Concentration of VLDL Particles,ERBB3,Receptor tyrosine-protein kinase erbB-3,39809,0.0611872948770039,0.00173118805648009,0.057794166286303,0.0645804234677049,1.61168920078187e-263
NMR metabolomics,X23428.Concentration of VLDL Particles,FURIN,Furin,39913,0.106286574492429,0.00304477412724022,0.100318817203038,0.11225433178182,2.13678937449506e-257
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL23,C-C motif chemokine 23,39931,0.126503432799803,0.00370190966064343,0.119247689864942,0.133759175734664,3.95391993748283e-247
NMR metabolomics,X23428.Concentration of VLDL Particles,CD4,T-cell surface glycoprotein CD4,39839,0.0878906157273428,0.00259795124027683,0.0827986312964002,0.0929826001582854,2.26634743090553e-242
NMR metabolomics,X23428.Concentration of VLDL Particles,GHR,Growth hormone receptor,37124,0.0874314082589381,0.00258179620601951,0.0823710876951399,0.0924917288227364,3.51562234859934e-241
NMR metabolomics,X23428.Concentration of VLDL Particles,VMO1,Vitelline membrane outer layer protein 1 homolog,39788,0.198798250676904,0.00600274429122538,0.187032871866102,0.210563629487705,1.18016341203534e-232
NMR metabolomics,X23428.Concentration of VLDL Particles,PLA2G10,Group 10 secretory phospholipase A2,39749,-0.175636680755451,0.00532623973793958,-0.186076110641813,-0.16519725086909,1.00268928402125e-230
NMR metabolomics,X23428.Concentration of VLDL Particles,PAMR1,Inactive serine protease PAMR1,39858,0.0817001856534991,0.00250057484133103,0.0767990589644903,0.086601312342508,1.00828432986274e-226
NMR metabolomics,X23428.Concentration of VLDL Particles,SMAD1,Mothers against decapentaplegic homolog 1,39477,0.23899848709354,0.00746211078965702,0.224372749945813,0.253624224241268,4.66015166993612e-218
NMR metabolomics,X23428.Concentration of VLDL Particles,CES1,Liver carboxylesterase 1,39854,0.229903077945171,0.00719932140882606,0.215792407983872,0.24401374790647,5.51392555829106e-217
NMR metabolomics,X23428.Concentration of VLDL Particles,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40030,0.0976488175626817,0.00306405716380685,0.0916432655216202,0.103654369603743,3.28770359187103e-216
NMR metabolomics,X23428.Concentration of VLDL Particles,TTR,Transthyretin,37309,0.0719252224714406,0.0022717434000797,0.0674726054072844,0.0763778395355968,2.99822309452347e-212
NMR metabolomics,X23428.Concentration of VLDL Particles,NCS1,Neuronal calcium sensor 1,40030,0.0802012031927306,0.0025434886852391,0.075215965369662,0.0851864410157993,7.78728699289942e-212
NMR metabolomics,X23428.Concentration of VLDL Particles,LPL,Lipoprotein lipase,39868,-0.133903176732338,0.00427483511232269,-0.14228185355249,-0.125524499912185,4.31595746800717e-209
NMR metabolomics,X23428.Concentration of VLDL Particles,CFP,Properdin,37453,0.065357862777754,0.00208984813963135,0.0612617604240766,0.0694539651314315,2.14306643879079e-207
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJB1,DnaJ homolog subfamily B member 1,39788,0.242289507578678,0.00786980137246308,0.22686469688865,0.257714318268705,3.11329322111509e-202
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMP2,Lysosome-associated membrane glycoprotein 2,39383,0.0537688653175714,0.00174591638492044,0.0503468692031274,0.0571908614320155,3.3045192134842e-202
NMR metabolomics,X23428.Concentration of VLDL Particles,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39585,0.235238361305733,0.00766031732591419,0.220224139346941,0.250252583264524,3.60575045766938e-201
NMR metabolomics,X23428.Concentration of VLDL Particles,GCG,Pro-glucagon,39477,0.338374461160504,0.0111137392927039,0.316591532146804,0.360157390174203,7.67470048054168e-198
NMR metabolomics,X23428.Concentration of VLDL Particles,P4HB,Protein disulfide-isomerase,39776,0.106967752071701,0.00352716148223299,0.100054515566524,0.113880988576877,1.88226660110459e-196
NMR metabolomics,X23428.Concentration of VLDL Particles,DEFB4A_DEFB4B,Beta-defensin 4A,39585,0.39577351068257,0.0131410270188954,0.370017097725535,0.421529923639605,8.73130019046114e-194
NMR metabolomics,X23428.Concentration of VLDL Particles,APOM,Apolipoprotein M,39908,0.0726766204192383,0.00241464150254419,0.0679439230742517,0.077409317764225,1.17814592538368e-193
NMR metabolomics,X23428.Concentration of VLDL Particles,BCHE,Cholinesterase,37208,0.0752789165477078,0.00249496715254442,0.0703887809287207,0.0801690521666948,1.59174932707822e-193
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL6,C-X-C motif chemokine 6,40058,0.20872465700611,0.00696141446086209,0.195080284662821,0.2223690293494,2.8107659130381e-192
NMR metabolomics,X23428.Concentration of VLDL Particles,GPR37,Prosaposin receptor GPR37,39585,0.174587088519299,0.00583662329501675,0.163147306861066,0.186026870177532,2.96443212031858e-191
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA4,Kallistatin,37241,0.0623213788556337,0.00211904497244781,0.058168050709636,0.0664747070016314,2.78472040506643e-184
NMR metabolomics,X23428.Concentration of VLDL Particles,FGFBP3,Fibroblast growth factor-binding protein 3,37388,0.0972513380074192,0.00332147529129983,0.0907412464364715,0.103761429578367,8.91527643368246e-183
NMR metabolomics,X23428.Concentration of VLDL Particles,CDKN1A,Cyclin-dependent kinase inhibitor 1,39788,0.282643847693133,0.00968395263959175,0.263663300519533,0.301624394866733,1.75065830384514e-182
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC39A5,Zinc transporter ZIP5,39866,0.139663025995366,0.00479812848327018,0.130258694168156,0.149067357822575,1.48443163823435e-181
NMR metabolomics,X23428.Concentration of VLDL Particles,PROS1,Vitamin K-dependent protein S,37453,0.0647913724935938,0.00222115981111594,0.0604378992638066,0.0691448457233811,1.71085611465422e-181
NMR metabolomics,X23428.Concentration of VLDL Particles,SNCA,Alpha-synuclein,37124,0.306470143857325,0.010519165123796,0.285852580214685,0.327087707499965,6.16365317113868e-181
NMR metabolomics,X23428.Concentration of VLDL Particles,CFH,Complement factor H,36763,0.0618459849237513,0.00213096368189238,0.0576692961072422,0.0660226737402604,1.86143273889987e-179
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA5,Plasma serine protease inhibitor,37283,0.0834559360984282,0.00288686966804207,0.0777976715490658,0.0891142006477907,2.53947305667938e-178
NMR metabolomics,X23428.Concentration of VLDL Particles,CFI,Complement factor I,37453,0.0522853757807182,0.00181150078525128,0.0487348342416257,0.0558359173198108,7.60613520395399e-178
NMR metabolomics,X23428.Concentration of VLDL Particles,KYNU,Kynureninase,40058,0.118089456838636,0.0041332384633643,0.109988309450442,0.12619060422683,3.34196289486641e-175
NMR metabolomics,X23428.Concentration of VLDL Particles,VPS37A,Vacuolar protein sorting-associated protein 37A,39788,0.206076426070545,0.00722879848906669,0.191907981031974,0.220244871109116,2.1808453916063e-174
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPIND1,Heparin cofactor 2,37424,0.0729131399440199,0.00255764367593624,0.0679001583391848,0.0779261215488549,1.16883113644839e-173
NMR metabolomics,X23428.Concentration of VLDL Particles,PRAP1,Proline-rich acidic protein 1,37437,0.104031599251013,0.00365488550632415,0.0968680236586177,0.111195174843408,3.80155477538058e-173
NMR metabolomics,X23428.Concentration of VLDL Particles,IGSF8,Immunoglobulin superfamily member 8,39868,0.0774935349082075,0.00274528687010661,0.0721127726427985,0.0828742971736164,4.02124395481476e-171
NMR metabolomics,X23428.Concentration of VLDL Particles,MEGF9,Multiple epidermal growth factor-like domains protein 9,40002,0.0542000702253286,0.00192874927046339,0.0504197216552204,0.0579804187954369,1.12138265225712e-169
NMR metabolomics,X23428.Concentration of VLDL Particles,CHMP6,Charged multivesicular body protein 6,37437,0.144693846735632,0.00514756704737396,0.134604615322779,0.154783078148485,4.98955490046697e-169
NMR metabolomics,X23428.Concentration of VLDL Particles,SYAP1,Synapse-associated protein 1,37124,0.146240138666961,0.00522586019176738,0.135997452691096,0.156482824642825,1.77555286623961e-167
NMR metabolomics,X23428.Concentration of VLDL Particles,TMPRSS15,Enteropeptidase,39788,0.22602898698717,0.00811808209719364,0.210117546076671,0.24194042789767,1.25797214779918e-166
NMR metabolomics,X23428.Concentration of VLDL Particles,PLAT,Tissue-type plasminogen activator,40002,0.125611275302392,0.00451796341866019,0.116756067001818,0.134466483602966,3.24083933054996e-166
NMR metabolomics,X23428.Concentration of VLDL Particles,SOST,Sclerostin,39846,0.0966167941927275,0.00348170543466918,0.089792651540776,0.103440936844679,1.4315400160925e-165
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINF2,Alpha-2-antiplasmin,37224,0.0340449628651678,0.00122663813580935,0.0316407521189815,0.0364491736113542,6.91941476218097e-165
NMR metabolomics,X23428.Concentration of VLDL Particles,GSTA1,Glutathione S-transferase A1,39841,0.213906679943698,0.00772681693658427,0.198762118747993,0.229051241139403,8.27918889477903e-165
NMR metabolomics,X23428.Concentration of VLDL Particles,APOC1,Apolipoprotein C-I,37424,0.0941261109297981,0.00340542948736263,0.0874514691345674,0.100800752725029,1.20564191914788e-163
NMR metabolomics,X23428.Concentration of VLDL Particles,IGSF9,Protein turtle homolog A,37437,0.20686634808703,0.00748942585502696,0.192187073411177,0.221545622762883,1.95853384801494e-163
NMR metabolomics,X23428.Concentration of VLDL Particles,ERBB2,Receptor tyrosine-protein kinase erbB-2,39913,0.0629468730978971,0.0022848996088431,0.0584684698645646,0.0674252763312295,2.78128125666287e-163
NMR metabolomics,X23428.Concentration of VLDL Particles,ATRN,"Attractin, Isoform 2",37453,0.0408042962354256,0.00148167435530112,0.0379002144990354,0.0437083779718158,1.64437231778371e-162
NMR metabolomics,X23428.Concentration of VLDL Particles,F10,Coagulation factor X,37445,0.0663774339762394,0.00241044524358735,0.0616529612988082,0.0711019066536706,1.73802158950154e-162
NMR metabolomics,X23428.Concentration of VLDL Particles,INHBC,Inhibin beta C chain,39858,0.103592591420142,0.00377550611993426,0.0961925994250708,0.110992583415213,5.2992402308334e-162
NMR metabolomics,X23428.Concentration of VLDL Particles,CPM,Carboxypeptidase M,39955,0.0858023008842554,0.00313915962692018,0.0796495480154918,0.0919550537530189,7.92818103615394e-161
NMR metabolomics,X23428.Concentration of VLDL Particles,FLI1,Friend leukemia integration 1 transcription factor,39477,0.271996609921231,0.010034134729862,0.252329705850702,0.291663513991761,3.62382339296216e-158
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTN3,Contactin-3,39858,0.0804951057595887,0.00297598500233382,0.0746621751550145,0.086328036364163,1.37433729487096e-157
NMR metabolomics,X23428.Concentration of VLDL Particles,KDR,Vascular endothelial growth factor receptor 2,39913,0.0628660542235236,0.00232846709815502,0.0583022587111397,0.0674298497359074,4.79455447766041e-157
NMR metabolomics,X23428.Concentration of VLDL Particles,PCSK9,Proprotein convertase subtilisin/kexin type 9,40052,0.0965230039432527,0.00357576546183447,0.0895145036380571,0.103531504248448,5.13396913284423e-157
NMR metabolomics,X23428.Concentration of VLDL Particles,NRP1,Neuropilin-1,39949,-0.0681709435363719,0.00252530268150871,-0.073120536792129,-0.0632213502806148,5.19042599995167e-157
NMR metabolomics,X23428.Concentration of VLDL Particles,RBP5,Retinol-binding protein 5,39788,0.137464044150855,0.00510699898056985,0.127454326148938,0.147473762152772,4.24608018962214e-156
NMR metabolomics,X23428.Concentration of VLDL Particles,CRIP2,Cysteine-rich protein 2,39749,0.0876352295885893,0.00327495771101825,0.0812163124749935,0.0940541467021851,2.48878574182836e-154
NMR metabolomics,X23428.Concentration of VLDL Particles,GSTA3,Glutathione S-transferase A3,39477,0.186366457271718,0.00697021440841648,0.172704837031222,0.200028077512214,4.9477523072003e-154
NMR metabolomics,X23428.Concentration of VLDL Particles,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39846,0.275472372989887,0.0103372475632262,0.255211367765963,0.29573337821381,4.03916590916887e-153
NMR metabolomics,X23428.Concentration of VLDL Particles,KLKB1,Plasma kallikrein,37187,0.0604381182049396,0.00227822125940505,0.0559728045365057,0.0649034318733735,3.67896095738965e-151
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBP3,Insulin-like growth factor-binding protein 3,39931,0.066493440789101,0.00252619556427269,0.0615420974831265,0.0714447840950755,1.57636909489355e-149
NMR metabolomics,X23428.Concentration of VLDL Particles,SORT1,Sortilin,39846,0.0894416355048257,0.00340192922282628,0.0827738542280862,0.0961094167815652,3.50265323329175e-149
NMR metabolomics,X23428.Concentration of VLDL Particles,DSG2,Desmoglein-2,39858,-0.0640141862782015,0.00243491939850277,-0.0687866282992669,-0.059241744257136,3.60770280352126e-149
NMR metabolomics,X23428.Concentration of VLDL Particles,F9,Coagulation factor IX,39908,0.0435851005512612,0.00165932393900626,0.0403328256308089,0.0468373754717135,6.3498589075313e-149
NMR metabolomics,X23428.Concentration of VLDL Particles,AGR3,Anterior gradient protein 3,39464,0.141105390253146,0.00538140470089822,0.130557837039385,0.151652943466906,2.45984566345727e-148
NMR metabolomics,X23428.Concentration of VLDL Particles,ACY1,Aminoacylase-1,39868,0.146634400171095,0.00563152341151923,0.135596614284518,0.157672186057673,2.01601201211125e-146
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL22,C-C motif chemokine 22,39686,0.119737333353382,0.00459962411215616,0.110722070093556,0.128752596613208,2.54318529947147e-146
NMR metabolomics,X23428.Concentration of VLDL Particles,GRP,Gastrin-releasing peptide,37043,0.123567452768699,0.00474246623104044,0.11427221895586,0.132862686581538,5.5909138579668e-146
NMR metabolomics,X23428.Concentration of VLDL Particles,CDHR2,Cadherin-related family member 2,39788,0.172434966628049,0.00666780313065252,0.15936607249197,0.185503860764128,1.73504145395777e-144
NMR metabolomics,X23428.Concentration of VLDL Particles,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37043,0.0612541706731721,0.00236617709848761,0.0566164635601364,0.0658918777862078,3.58255635120855e-144
NMR metabolomics,X23428.Concentration of VLDL Particles,ELN,Elastin,37437,0.0792262382543003,0.00306159361818428,0.0732255147626591,0.0852269617459415,3.63128239090828e-144
NMR metabolomics,X23428.Concentration of VLDL Particles,CPB2,Carboxypeptidase B2,37424,0.0530707591772133,0.00206051795413794,0.0490321439871029,0.0571093743673237,7.2923129450979e-143
NMR metabolomics,X23428.Concentration of VLDL Particles,FN1,Fibronectin,37453,0.0624855493254232,0.0024310313262935,0.057720727925888,0.0672503707249585,2.6204832427203e-142
NMR metabolomics,X23428.Concentration of VLDL Particles,AFM,Afamin,37453,0.0445093244166752,0.00173210884565575,0.0411143910791899,0.0479042577541604,3.08887643832509e-142
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40058,0.0607481679157111,0.00237299707371368,0.0560970936512323,0.0653992421801899,9.95516824314893e-142
NMR metabolomics,X23428.Concentration of VLDL Particles,ASGR1,Asialoglycoprotein receptor 1,39749,0.0679347934286661,0.00265906696532723,0.0627230221766247,0.0731465646807074,3.98577885696494e-141
NMR metabolomics,X23428.Concentration of VLDL Particles,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37124,0.0501712495704822,0.00197312693885297,0.0463039207703303,0.054038578370634,2.66060298280336e-139
NMR metabolomics,X23428.Concentration of VLDL Particles,UPB1,Beta-ureidopropionase,37437,0.213434079877064,0.00839802373484045,0.196973953356777,0.229894206397351,3.03670993115187e-139
NMR metabolomics,X23428.Concentration of VLDL Particles,LATS1,Serine/threonine-protein kinase LATS1,37056,0.198546893940704,0.0078665829016849,0.183128391453402,0.213965396428007,2.61269548956211e-137
NMR metabolomics,X23428.Concentration of VLDL Particles,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37382,0.324558203332552,0.0128755294290075,0.299322165651697,0.349794241013407,4.73818083517095e-137
NMR metabolomics,X23428.Concentration of VLDL Particles,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39788,0.0691667884377248,0.00275515102662465,0.0637666924255405,0.0745668844499091,1.96648838463117e-136
NMR metabolomics,X23428.Concentration of VLDL Particles,STAB2,Stabilin-2,37437,0.0641795035694053,0.00255925632987428,0.0591633611628518,0.0691956459759589,1.05033496328138e-135
NMR metabolomics,X23428.Concentration of VLDL Particles,AMBP,Protein AMBP,40003,0.0440744367306846,0.00176690866003941,0.0406112957570073,0.0475375777043618,8.66158527086644e-135
NMR metabolomics,X23428.Concentration of VLDL Particles,SMAD2,Mothers against decapentaplegic homolog 2,37368,0.158203492872079,0.00633419763745577,0.145788465502666,0.170618520241492,1.23205185359711e-134
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39477,0.153962432092546,0.00618074704311009,0.14184816788805,0.166076696297042,2.39684339450044e-134
NMR metabolomics,X23428.Concentration of VLDL Particles,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39749,0.168088769518688,0.00677997113058643,0.154800026102739,0.181377512934638,3.66692067075271e-133
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL17,C-X-C motif chemokine 17,40058,0.0972386403515716,0.00392478962901768,0.0895460526786969,0.104931228024446,4.8779656534282e-133
NMR metabolomics,X23428.Concentration of VLDL Particles,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40052,0.0655982787166962,0.00264957338462822,0.0604051148828249,0.0707914425505675,7.41780308237641e-133
NMR metabolomics,X23428.Concentration of VLDL Particles,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40009,0.118291540492811,0.00478445363178986,0.108914011374503,0.127669069611119,1.69142594081033e-132
NMR metabolomics,X23428.Concentration of VLDL Particles,GUSB,Beta-glucuronidase,39919,0.13256240410794,0.00536862611199418,0.122039896928432,0.143084911287449,3.74986201742032e-132
NMR metabolomics,X23428.Concentration of VLDL Particles,FGFR2,Fibroblast growth factor receptor 2,39913,0.0486578794169281,0.00197400262062451,0.0447888342805041,0.0525269245533522,1.03865890958547e-131
NMR metabolomics,X23428.Concentration of VLDL Particles,SMAD5,Mothers against decapentaplegic homolog 5,39788,0.0462148121350749,0.00187786394174671,0.0425341988092514,0.0498954254608985,2.74227474302756e-131
NMR metabolomics,X23428.Concentration of VLDL Particles,PRCP,Lysosomal Pro-X carboxypeptidase,39948,0.0697616723667079,0.00284066047438334,0.0641939778369165,0.0753293668964992,8.9303857363247e-131
NMR metabolomics,X23428.Concentration of VLDL Particles,SNAPIN,SNARE-associated protein Snapin,37411,0.130315662727946,0.00530030874223178,0.119927057593171,0.14070426786272,1.25783680551694e-130
NMR metabolomics,X23428.Concentration of VLDL Particles,PSRC1,Proline/serine-rich coiled-coil protein 1,39477,0.13251616498894,0.0054156914368497,0.121901409772715,0.143130920205165,8.68629046794111e-130
NMR metabolomics,X23428.Concentration of VLDL Particles,ADH1B,All-trans-retinol dehydrogenase,37124,0.169557625840992,0.00693018566978477,0.155974461928214,0.183140789753771,2.41683952378781e-129
NMR metabolomics,X23428.Concentration of VLDL Particles,ENO3,Beta-enolase,37043,0.134756053352289,0.00551199191863341,0.123952549191767,0.14555955751281,3.89945577254488e-129
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPTL2,Angiopoietin-related protein 2,39877,0.0877989555789741,0.00360397970875313,0.080735155349818,0.0948627558081303,9.50084490553862e-129
NMR metabolomics,X23428.Concentration of VLDL Particles,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39788,0.0872099047323241,0.00358618125805779,0.0801809894665308,0.0942388199981173,2.71041069791002e-128
NMR metabolomics,X23428.Concentration of VLDL Particles,NT5E,5'-nucleotidase,39913,0.12290895481194,0.00506454662117147,0.112982443434444,0.132835466189436,8.37773326003579e-128
NMR metabolomics,X23428.Concentration of VLDL Particles,GGT1,Glutathione hydrolase 1 proenzyme,39826,0.110366483063477,0.00455031897043476,0.101447857881425,0.119285108245529,1.19163597041164e-127
NMR metabolomics,X23428.Concentration of VLDL Particles,LAT2,Linker for activation of T-cells family member 2,39788,0.275805443761909,0.0114085221191437,0.253444740408387,0.298166147115431,7.70973714143392e-127
NMR metabolomics,X23428.Concentration of VLDL Particles,NUMB,Protein numb homolog,37056,0.187518039459965,0.00774468432890924,0.172338458175303,0.202697620744627,9.37423741418934e-127
NMR metabolomics,X23428.Concentration of VLDL Particles,FTCD,Formimidoyltransferase-cyclodeaminase,37368,0.186088543504876,0.00772715778898725,0.170943314238461,0.201233772771291,1.65951633684228e-125
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL17,C-C motif chemokine 17,39836,0.198501780873701,0.00825913761115356,0.18231387115584,0.214689690591562,2.0367575998703e-125
NMR metabolomics,X23428.Concentration of VLDL Particles,FCN2,Ficolin-2,39810,0.0889150429136598,0.00371168771177657,0.0816401349985777,0.0961899508287419,1.27703869333954e-124
NMR metabolomics,X23428.Concentration of VLDL Particles,NAA80,N-alpha-acetyltransferase 80,37039,0.264815305549612,0.0110631770551284,0.24313147852156,0.286499132577664,5.52956581258705e-124
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINF1,Pigment epithelium-derived factor,37254,0.0559860795362602,0.0023418770328621,0.0513960005518505,0.0605761585206699,1.00545854029103e-123
NMR metabolomics,X23428.Concentration of VLDL Particles,ADIPOQ,Adiponectin,37453,-0.144157984632204,0.006052814214247,-0.156021500492128,-0.13229446877228,7.25124870994394e-123
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL13,C-X-C motif chemokine 13,40009,0.127882374693979,0.00538946458445842,0.11731902410844,0.138445725279517,2.27153554149056e-122
NMR metabolomics,X23428.Concentration of VLDL Particles,HEG1,Protein HEG homolog 1,37124,0.0589252956169133,0.0024816114201528,0.0540613372334138,0.0637892540004128,4.3109078790156e-122
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37437,0.0635588969875576,0.00267843629394395,0.0583091618514274,0.0688086321236877,5.31520951510168e-122
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBP2,Insulin-like growth factor-binding protein 2,40012,-0.134832632085517,0.0056940254657857,-0.145992921998457,-0.123672342172577,6.91454674257509e-122
NMR metabolomics,X23428.Concentration of VLDL Particles,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37382,0.0643346335692108,0.00271287171318102,0.059017405011376,0.0696518621270456,7.70139986601135e-122
NMR metabolomics,X23428.Concentration of VLDL Particles,MLN,Promotilin,39866,0.192951791854091,0.00815579179465957,0.176966439936558,0.208937143771624,1.17842732385211e-121
NMR metabolomics,X23428.Concentration of VLDL Particles,YTHDF3,YTH domain-containing family protein 3,39587,0.184005484092856,0.00781155726862301,0.168694831846355,0.199316136339357,1.33727188295144e-120
NMR metabolomics,X23428.Concentration of VLDL Particles,AP1G2,AP-1 complex subunit gamma-like 2,37368,0.171865041222786,0.00732209591744305,0.157513733224598,0.186216349220974,1.9034568856715e-119
NMR metabolomics,X23428.Concentration of VLDL Particles,DTYMK,Thymidylate kinase,37437,0.147485121905037,0.00628434042200958,0.135167814677898,0.159802429132176,2.00210170732549e-119
NMR metabolomics,X23428.Concentration of VLDL Particles,RTBDN,Retbindin,39788,0.0629608125464604,0.00268960021501693,0.0576891961250272,0.0682324289678936,3.52978033353636e-119
NMR metabolomics,X23428.Concentration of VLDL Particles,MME,Neprilysin,39788,0.168637604363531,0.00721800434636296,0.154490315844659,0.182784892882402,9.89752953360467e-119
NMR metabolomics,X23428.Concentration of VLDL Particles,EEF1D,Elongation factor 1-delta,37437,0.194851494251035,0.00835556325648242,0.17847459026833,0.211228398233741,5.70674591619307e-118
NMR metabolomics,X23428.Concentration of VLDL Particles,NOS3,"Nitric oxide synthase, endothelial",39489,0.108830989409096,0.00467630172588286,0.0996654380263651,0.117996540791826,8.33651914236493e-118
NMR metabolomics,X23428.Concentration of VLDL Particles,IL16,Pro-interleukin-16,40058,0.0875270711608868,0.00377456795412149,0.0801289179708087,0.0949252243509649,4.74579869831623e-117
NMR metabolomics,X23428.Concentration of VLDL Particles,SNAP29,Synaptosomal-associated protein 29,39913,0.193951827446349,0.00837473838705049,0.17753734020773,0.210366314684968,9.56698872067118e-117
NMR metabolomics,X23428.Concentration of VLDL Particles,F13B,Coagulation factor XIII B chain,37380,0.0542046100121253,0.00233817507338407,0.0496217868682925,0.0587874331559581,1.26967188314806e-116
NMR metabolomics,X23428.Concentration of VLDL Particles,CDHR5,Cadherin-related family member 5,39868,0.0820221377619441,0.00355503345508607,0.0750542721899754,0.0889900033339128,6.80989032882483e-116
NMR metabolomics,X23428.Concentration of VLDL Particles,NOMO1,Nodal modulator 1,39858,0.0501154697172134,0.00217527990764631,0.0458519210982266,0.0543790183362002,1.44340640219551e-115
NMR metabolomics,X23428.Concentration of VLDL Particles,ERP44,Endoplasmic reticulum resident protein 44,39758,0.0547544761554555,0.00238645634857201,0.0500770217122544,0.0594319305986566,1.22652942475116e-114
NMR metabolomics,X23428.Concentration of VLDL Particles,CANT1,Soluble calcium-activated nucleotidase 1,39816,0.0417660167236801,0.00182604166172077,0.0381869750667074,0.0453450583806528,5.90442275805738e-114
NMR metabolomics,X23428.Concentration of VLDL Particles,SCLY,Selenocysteine lyase,39984,0.103160421285144,0.00451187108174009,0.0943171539649338,0.112003688605355,6.78672840460785e-114
NMR metabolomics,X23428.Concentration of VLDL Particles,NPPC,C-type natriuretic peptide,39866,0.0955955282426013,0.00418926860905091,0.0873845617688615,0.103806494716341,1.89925146608119e-113
NMR metabolomics,X23428.Concentration of VLDL Particles,ABL1,Tyrosine-protein kinase ABL1,39788,0.143163926645573,0.00627763026145604,0.130859771333119,0.155468081958027,2.62589337518109e-113
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL16,C-C motif chemokine 16,40052,0.108975074943204,0.00478389249259593,0.0995986456577161,0.118351504228692,4.35040870790719e-113
NMR metabolomics,X23428.Concentration of VLDL Particles,SORD,Sorbitol dehydrogenase,39963,0.142616577616335,0.00628441607452745,0.130299122110261,0.154934033122409,2.96138142555023e-112
NMR metabolomics,X23428.Concentration of VLDL Particles,DCXR,L-xylulose reductase,39913,0.112201862142863,0.00494564983879941,0.102508388458816,0.12189533582691,3.47553582608765e-112
NMR metabolomics,X23428.Concentration of VLDL Particles,YES1,Tyrosine-protein kinase Yes,39788,0.237320545927766,0.0104693209786432,0.216800676809625,0.257840415045906,5.42234240202589e-112
NMR metabolomics,X23428.Concentration of VLDL Particles,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39683,0.0962852653428036,0.00426705065661198,0.0879218460558441,0.104648684629763,5.38310672138584e-111
NMR metabolomics,X23428.Concentration of VLDL Particles,DPY30,Protein dpy-30 homolog,39979,0.12261589187336,0.00543652422752754,0.111960304387406,0.133271479359314,6.33442939981631e-111
NMR metabolomics,X23428.Concentration of VLDL Particles,DKK1,Dickkopf-related protein 1,40009,0.122955969099304,0.00548031293008188,0.112214555756343,0.133697382442264,8.31859770873976e-110
NMR metabolomics,X23428.Concentration of VLDL Particles,MYH9,Myosin-9,37437,0.228232423598209,0.0102179986629265,0.208205146218873,0.248259700977546,1.4649581671926e-108
NMR metabolomics,X23428.Concentration of VLDL Particles,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37382,0.0530301774651999,0.00238037671095594,0.0483646391117263,0.0576957158186735,5.23571261216333e-108
NMR metabolomics,X23428.Concentration of VLDL Particles,COL4A1,Collagen alpha-1(IV) chain,39868,-0.0797130988072145,0.00358550936547695,-0.0867406971635493,-0.0726855004508797,7.18676928566104e-108
NMR metabolomics,X23428.Concentration of VLDL Particles,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37388,0.084171287472829,0.0037830308900771,0.0767565469282779,0.0915860280173801,9.62135708870719e-108
NMR metabolomics,X23428.Concentration of VLDL Particles,FUOM,Fucose mutarotase,37124,0.129312827041305,0.00582908034733594,0.117887829560526,0.140737824522083,4.28787980749795e-107
NMR metabolomics,X23428.Concentration of VLDL Particles,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39477,0.126658530114858,0.00573124531838885,0.115425289290816,0.1378917709389,1.3625065188615e-106
NMR metabolomics,X23428.Concentration of VLDL Particles,GLA,Alpha-galactosidase A,37088,0.0766740217779941,0.00346903146213799,0.0698747201122037,0.0834733234437846,2.48974350537103e-106
NMR metabolomics,X23428.Concentration of VLDL Particles,IL18R1,Interleukin-18 receptor 1,40058,0.0657164327521991,0.00298802862253671,0.0598598966520271,0.071572968852371,1.16997291104722e-105
NMR metabolomics,X23428.Concentration of VLDL Particles,FYB1,FYN-binding protein 1,39836,0.185165574555862,0.00842665573213075,0.168649329320886,0.201681819790839,1.86131247110533e-105
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39788,0.0879415066111779,0.00401120577306139,0.0800795432959776,0.0958034699263783,5.45079492853145e-105
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP20,Centrosomal protein 20,39477,0.148413927089992,0.00678490674969149,0.135115509860596,0.161712344319387,1.68831747721407e-104
NMR metabolomics,X23428.Concentration of VLDL Particles,LECT2,Leukocyte cell-derived chemotaxin-2,37437,0.129608540451516,0.00592289338401671,0.117999669418844,0.141217411484189,2.3942914596329e-104
NMR metabolomics,X23428.Concentration of VLDL Particles,EHBP1,EH domain-binding protein 1,37437,0.150178023551316,0.00688961421596207,0.136674379688031,0.163681667414602,1.44125792304681e-103
NMR metabolomics,X23428.Concentration of VLDL Particles,MAPK9,Mitogen-activated protein kinase 9,39866,0.0867184586991451,0.00398772537385829,0.0789025169663829,0.0945344004319074,2.33354186684313e-103
NMR metabolomics,X23428.Concentration of VLDL Particles,AGRN,Agrin,39931,0.0649480365044717,0.00299684348811519,0.0590742232677659,0.0708218497411774,1.10446463290709e-102
NMR metabolomics,X23428.Concentration of VLDL Particles,F11R,Junctional adhesion molecule A,39858,0.112571598366644,0.00519712570197108,0.102385231990781,0.122757964742508,1.43793525541405e-102
NMR metabolomics,X23428.Concentration of VLDL Particles,KHK,Ketohexokinase,37043,0.128796213757396,0.0059384035977662,0.117156942705775,0.140435484809018,1.60929186889146e-102
NMR metabolomics,X23428.Concentration of VLDL Particles,NOTCH3,Neurogenic locus notch homolog protein 3,40052,-0.0675162740495109,0.00312170286402983,-0.0736348116630093,-0.0613977364360124,2.73163634933949e-102
NMR metabolomics,X23428.Concentration of VLDL Particles,SARG,Specifically androgen-regulated gene protein,37390,0.217718623014038,0.0100541952569659,0.198012400310385,0.237424845717692,2.97476915779357e-102
NMR metabolomics,X23428.Concentration of VLDL Particles,IPCEF1,Interactor protein for cytohesin exchange factors 1,39720,0.177707217814366,0.00823214635889645,0.161572210950929,0.193842224677803,6.93477948381908e-102
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL5,C-X-C motif chemokine 5,39805,0.225281592873411,0.0104611120159543,0.20477781332214,0.245785372424681,2.02314877773872e-101
NMR metabolomics,X23428.Concentration of VLDL Particles,SKAP1,Src kinase-associated phosphoprotein 1,39713,0.142532443960032,0.00662075258230965,0.129555768898706,0.155509119021359,2.38840716419035e-101
NMR metabolomics,X23428.Concentration of VLDL Particles,HBEGF,Proheparin-binding EGF-like growth factor,39984,0.14290682095724,0.00665592196928145,0.129861213897448,0.155952428017031,7.53879155601836e-101
NMR metabolomics,X23428.Concentration of VLDL Particles,GPD1,Glycerol-3-phosphate dehydrogenase,37368,0.10336496969705,0.00480939096891329,0.0939385633979799,0.11279137599612,8.87745658125071e-101
NMR metabolomics,X23428.Concentration of VLDL Particles,HAVCR1,Hepatitis A virus cellular receptor 1,40003,0.118255553313539,0.00551164071965001,0.107452737503025,0.129058369124053,1.02840661942832e-100
NMR metabolomics,X23428.Concentration of VLDL Particles,IL13RA1,Interleukin-13 receptor subunit alpha-1,39597,0.0445774287812143,0.00207790153764952,0.0405047417674212,0.0486501157950074,1.17596562267656e-100
NMR metabolomics,X23428.Concentration of VLDL Particles,ACE2,Angiotensin-converting enzyme 2,39585,0.0984044369368953,0.00458825529982145,0.0894114565492453,0.107397417324545,1.33829148269027e-100
NMR metabolomics,X23428.Concentration of VLDL Particles,BTD,Biotinidase,37453,0.0404263486834349,0.00188717700851261,0.0367274817467502,0.0441252156201196,3.7740049982944e-100
NMR metabolomics,X23428.Concentration of VLDL Particles,ACP5,Tartrate-resistant acid phosphatase type 5,39919,0.0649391096859796,0.00304877201854322,0.0589635165296349,0.0709147028423243,2.66868998643434e-99
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39805,0.0524275899989495,0.00246303331537797,0.0476000447008087,0.0572551352970903,3.67144622856338e-99
NMR metabolomics,X23428.Concentration of VLDL Particles,MTSS1,Protein MTSS 1,37382,0.215887320052441,0.0101521750557747,0.195989056943123,0.23578558316176,9.80490593249938e-99
NMR metabolomics,X23428.Concentration of VLDL Particles,SEMA3F,Semaphorin-3F,39868,0.049631187742345,0.00234540483902946,0.0450341942578473,0.0542281812268427,4.79025934646365e-98
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGA5,Integrin alpha-5,39858,0.0481709126667427,0.00227933236288814,0.0437034212354819,0.0526384040980035,8.41769894170114e-98
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM20A,Pseudokinase FAM20A,37437,0.0548578270850688,0.00259476236391179,0.0497720928518017,0.0599435613183359,1.22230776229354e-97
NMR metabolomics,X23428.Concentration of VLDL Particles,COL18A1,Collagen alpha-1(XVIII) chain,39893,0.043835967571553,0.00207723053378064,0.0397645957253429,0.0479073394177631,1.57356078225586e-97
NMR metabolomics,X23428.Concentration of VLDL Particles,NPL,N-acetylneuraminate lyase,37437,0.0853235622758722,0.0040419595543619,0.0774013215493229,0.0932458030024215,2.36987226098855e-97
NMR metabolomics,X23428.Concentration of VLDL Particles,DAB2,Disabled homolog 2,40030,0.216170407777405,0.0102562429032083,0.196068171687117,0.236272643867693,2.62575339176232e-97
NMR metabolomics,X23428.Concentration of VLDL Particles,VEGFC,Vascular endothelial growth factor C,39913,0.107691709646068,0.005111892992626,0.0976723993805212,0.117711019911615,3.29939465958479e-97
NMR metabolomics,X23428.Concentration of VLDL Particles,TJAP1,Tight junction-associated protein 1,39913,0.160814487831256,0.00763973907075215,0.145840599252582,0.17578837640993,4.69335949381817e-97
NMR metabolomics,X23428.Concentration of VLDL Particles,CD63,CD63 antigen,39720,0.0991340763366129,0.00473625073898699,0.0898510248881984,0.108417127785027,5.53829670442944e-96
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL10,C-X-C motif chemokine 10,39931,0.126822736725313,0.00606077919175608,0.114943609509471,0.138701863941155,5.9948494112491e-96
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASE4,Ribonuclease 4,37051,0.0499534742947636,0.00238858260575757,0.0452718523874787,0.0546350962020484,1.42581359066253e-95
NMR metabolomics,X23428.Concentration of VLDL Particles,TARBP2,RISC-loading complex subunit TARBP2,39489,0.152816782120613,0.0073170352129696,0.138475393103193,0.167158171138034,1.47266012381283e-95
NMR metabolomics,X23428.Concentration of VLDL Particles,PBLD,Phenazine biosynthesis-like domain-containing protein,39489,0.0988510248194398,0.00473968552861078,0.0895612411833627,0.108140808455517,2.65921382658023e-95
NMR metabolomics,X23428.Concentration of VLDL Particles,PLIN1,Perilipin-1,39489,0.0663180918878102,0.00318184412698828,0.0600816773989132,0.0725545063767072,3.48996303283465e-95
NMR metabolomics,X23428.Concentration of VLDL Particles,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39585,0.104547172104592,0.00502346375373537,0.0947011831472707,0.114393161061913,6.4207663398327e-95
NMR metabolomics,X23428.Concentration of VLDL Particles,LEP,Leptin,39868,0.129624738584987,0.00622976334744013,0.117414402424004,0.141835074745969,6.67662799061149e-95
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37043,0.162438425403787,0.00779587831816685,0.14715850390018,0.177718346907394,6.79452937689747e-95
NMR metabolomics,X23428.Concentration of VLDL Particles,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37411,0.187037255642303,0.00899053647350459,0.169415804154234,0.204658707130372,1.1977488809312e-94
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL5,C-C motif chemokine 5,39931,0.192918827638051,0.0092868621531352,0.174716577817906,0.211121077458196,1.31695757164755e-94
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37366,0.155874541976405,0.00754553413667688,0.141085295068519,0.170663788884292,2.28842879719837e-93
NMR metabolomics,X23428.Concentration of VLDL Particles,SELPLG,P-selectin glycoprotein ligand 1,39866,0.0526915409568679,0.00255734979710646,0.0476791353545393,0.0577039465591966,4.07268006598731e-93
NMR metabolomics,X23428.Concentration of VLDL Particles,EZR,Ezrin,40009,0.0455321320204013,0.00221050291180949,0.0411995463132547,0.0498647177275479,4.47424631154547e-93
NMR metabolomics,X23428.Concentration of VLDL Particles,IGF2R,Cation-independent mannose-6-phosphate receptor,39858,0.0444486429873997,0.00216010827326776,0.0402148307717949,0.0486824552030045,7.00695494321061e-93
NMR metabolomics,X23428.Concentration of VLDL Particles,NUCB2,Nucleobindin-2,39995,0.0707678379276072,0.00344928161985462,0.0640072459526921,0.0775284299025223,2.29921849566467e-92
NMR metabolomics,X23428.Concentration of VLDL Particles,GP1BA,Platelet glycoprotein Ib alpha chain,39817,0.061403188599904,0.00299684811016912,0.0555293663039725,0.0672770108958355,4.10254741167817e-92
NMR metabolomics,X23428.Concentration of VLDL Particles,SELP,P-selectin,39931,0.10805345070371,0.00527927292144128,0.0977060757776851,0.118400825629735,6.22195192665431e-92
NMR metabolomics,X23428.Concentration of VLDL Particles,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37114,0.0893895823910089,0.00436483758384703,0.0808345007266687,0.0979446640553491,8.59272967565542e-92
NMR metabolomics,X23428.Concentration of VLDL Particles,CRHBP,Corticotropin-releasing factor-binding protein,39862,0.0526890336108897,0.00257954468155867,0.0476331260350347,0.0577449411867447,1.44968271503024e-91
NMR metabolomics,X23428.Concentration of VLDL Particles,HMOX2,Heme oxygenase 2,39489,0.0887507618478225,0.00434799835303281,0.0802286850758782,0.0972728386197668,2.0346571177544e-91
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC1B,C-type lectin domain family 1 member B,40009,0.180310984415455,0.00886370812707065,0.162938116486396,0.197683852344513,7.40866319066141e-91
NMR metabolomics,X23428.Concentration of VLDL Particles,CD6,T-cell differentiation antigen CD6,40040,0.0980582717737959,0.00482371096333343,0.0886037982856624,0.107512745261929,9.78101008349301e-91
NMR metabolomics,X23428.Concentration of VLDL Particles,TPD52L2,Tumor protein D54,37124,0.204237206468477,0.0100517196138543,0.184535836025323,0.223938576911632,2.0795586644012e-90
NMR metabolomics,X23428.Concentration of VLDL Particles,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37169,0.211487454735109,0.0104205739154792,0.19106312986077,0.231911779609448,3.26966186331505e-90
NMR metabolomics,X23428.Concentration of VLDL Particles,GCC1,GRIP and coiled-coil domain-containing protein 1,37388,0.202508551521042,0.00999296935453045,0.182922331586162,0.222094771455922,5.63139483897177e-90
NMR metabolomics,X23428.Concentration of VLDL Particles,CCN2,CCN family member 2,39880,0.108880384995125,0.00538106299461641,0.0983335015256767,0.119427268464573,6.51775092474162e-90
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPTL3,Angiopoietin-related protein 3,39892,0.0655320435393523,0.00324318363889419,0.0591754036071197,0.0718886834715849,1.12933783762548e-89
NMR metabolomics,X23428.Concentration of VLDL Particles,TXLNA,Alpha-taxilin,39749,0.165795218722167,0.00821446586633092,0.149694865624159,0.181895571820176,1.81052673940263e-89
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB11FIP3,Rab11 family-interacting protein 3,37437,0.199758265943918,0.00990662753107596,0.180341275983009,0.219175255904827,4.0622544236215e-89
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40058,0.0534551168615119,0.0026544185513808,0.0482524565008055,0.0586577772222183,4.20188473381889e-89
NMR metabolomics,X23428.Concentration of VLDL Particles,TCTN3,Tectonic-3,37437,0.0546813818441303,0.00271329236785122,0.0493633288031419,0.0599994348851187,5.03646706488784e-89
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJA2,DnaJ homolog subfamily A member 2,40009,0.152413518502054,0.00757849570486937,0.13755966692051,0.167267370083598,7.18087467082805e-89
NMR metabolomics,X23428.Concentration of VLDL Particles,F2,Prothrombin,37453,0.0272252965146817,0.00135255587616045,0.0245742869974072,0.0298763060319562,8.09326037949919e-89
NMR metabolomics,X23428.Concentration of VLDL Particles,MINK1,Misshapen-like kinase 1,37388,0.171769232107846,0.00855915371115916,0.154993290833974,0.188545173381718,2.6699560668352e-88
NMR metabolomics,X23428.Concentration of VLDL Particles,CD99L2,CD99 antigen-like protein 2,39858,0.0444428108668233,0.00221781252120929,0.0400958983252531,0.0487897234083935,3.03758658517608e-88
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39913,0.0641844400650727,0.00320800374263308,0.0578967527295118,0.0704721274006335,5.57492193087529e-88
NMR metabolomics,X23428.Concentration of VLDL Particles,C9,Complement component C9,37445,-0.0977660736205648,0.00488318434663089,-0.107337114939961,-0.0881950323011682,6.66774135130565e-88
NMR metabolomics,X23428.Concentration of VLDL Particles,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39477,0.152863072127004,0.00764243531327914,0.137883898912977,0.167842245341031,6.67093431329145e-88
NMR metabolomics,X23428.Concentration of VLDL Particles,PLXNA4,Plexin-A4,39866,0.149371943492733,0.00747155490904606,0.134727695871002,0.164016191114463,7.60525814291056e-88
NMR metabolomics,X23428.Concentration of VLDL Particles,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37124,0.0902217312245802,0.00451143052971685,0.0813793273863352,0.0990641350628253,1.10716300614799e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,PDLIM7,PDZ and LIM domain protein 7,39931,0.232200778079981,0.011629458658366,0.209407039109584,0.254994517050379,1.23914026363802e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,BANK1,B-cell scaffold protein with ankyrin repeats,39866,0.195192406046589,0.00978205490359601,0.176019578435541,0.214365233657638,1.59628213048509e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39866,0.18012932940044,0.00902773040932396,0.162434977798165,0.197823681002715,1.63536005753129e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,SDC4,Syndecan-4,39868,0.083016876267244,0.00417624485588285,0.0748314363497136,0.0912023161847743,6.98497532270128e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,KAZN,Kazrin,37382,0.190962974687388,0.00959810518547314,0.172150688523861,0.209775260850915,7.68074721534775e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,MTSS2,Protein MTSS 2,37368,0.18266763028914,0.00918354368710643,0.164667884662412,0.200667375915869,8.51091662386777e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,BTN3A2,Butyrophilin subfamily 3 member A2,39866,0.0672299829892457,0.00338491733217409,0.0605955450181844,0.0738644209603069,9.67118915805734e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,AXIN1,Axin-1,39866,0.174291659025723,0.00878251811092662,0.157077923528307,0.19150539452314,1.32833662852933e-86
NMR metabolomics,X23428.Concentration of VLDL Particles,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37411,0.153989242783069,0.00778712120431283,0.138726485222616,0.169252000343522,7.91855395364583e-86
NMR metabolomics,X23428.Concentration of VLDL Particles,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37021,0.124674208844172,0.00630384331393121,0.112318675948867,0.137029741739477,8.16141805460698e-86
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF41,E3 ubiquitin-protein ligase NRDP1,39477,0.12187415012637,0.00619308533003317,0.109735702879505,0.134012597373235,3.50098275866891e-85
NMR metabolomics,X23428.Concentration of VLDL Particles,THOP1,Thimet oligopeptidase,39798,0.0551095495585137,0.00280139417951826,0.0496188169666579,0.0606002821503695,3.81338144440016e-85
NMR metabolomics,X23428.Concentration of VLDL Particles,PLTP,Phospholipid transfer protein,39976,-0.0650852815903297,0.00330874770379219,-0.0715704270897624,-0.058600136090897,3.82852660376315e-85
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP6V1G1,V-type proton ATPase subunit G 1,37043,0.131449464617844,0.00668956587308141,0.118337915506604,0.144561013729083,9.40466049847915e-85
NMR metabolomics,X23428.Concentration of VLDL Particles,ARF6,ADP-ribosylation factor 6,37382,0.192527340313448,0.00980543334649335,0.173308690954321,0.211745989672575,1.17393525411629e-84
NMR metabolomics,X23428.Concentration of VLDL Particles,DAAM1,Disheveled-associated activator of morphogenesis 1,37124,0.14958564632713,0.00761778931191272,0.134654779275781,0.164516513378478,1.19904097635679e-84
NMR metabolomics,X23428.Concentration of VLDL Particles,OTUD7B,OTU domain-containing protein 7B,37411,0.11592558117766,0.00591097158679468,0.104340076867542,0.127511085487777,1.80645952930962e-84
NMR metabolomics,X23428.Concentration of VLDL Particles,ATG16L1,Autophagy-related protein 16-1,37382,0.154970770880234,0.00792817605812976,0.1394315458063,0.170509995954169,6.29432934681986e-84
NMR metabolomics,X23428.Concentration of VLDL Particles,THPO,Thrombopoietin,39585,0.0684903757980369,0.00351469004915467,0.0616015833016938,0.0753791682943801,1.37053707003617e-83
NMR metabolomics,X23428.Concentration of VLDL Particles,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39788,0.175314322619087,0.00900295631964439,0.157668528232584,0.19296011700559,1.73711235046755e-83
NMR metabolomics,X23428.Concentration of VLDL Particles,CREG1,Protein CREG1,39660,0.0671643194094414,0.00346771126677371,0.060367605326565,0.0739610334923179,1.28989477724242e-82
NMR metabolomics,X23428.Concentration of VLDL Particles,AP3S2,AP-3 complex subunit sigma-2,37388,0.0840731375536805,0.00433972203684772,0.075567282361459,0.092578992745902,1.70575342790243e-82
NMR metabolomics,X23428.Concentration of VLDL Particles,MVK,Mevalonate kinase,39587,0.140980122421538,0.0072893508216707,0.126692994811064,0.155267250032013,2.21217608788517e-82
NMR metabolomics,X23428.Concentration of VLDL Particles,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39749,0.095173813170386,0.00492632736369494,0.0855182115375439,0.104829414803228,3.22869284656808e-82
NMR metabolomics,X23428.Concentration of VLDL Particles,CMIP,C-Maf-inducing protein,37368,0.147545829278317,0.00764482525855114,0.132561971771557,0.162529686785077,6.76604574058784e-82
NMR metabolomics,X23428.Concentration of VLDL Particles,ZBTB16,Zinc finger and BTB domain-containing protein 16,39477,0.125870063496724,0.00653914261581684,0.113053343969723,0.138686783023725,1.27405569315966e-81
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK10,Kallikrein-10,39856,0.0697709612304978,0.00363204346594886,0.062652156037238,0.0768897664237575,2.51945656327723e-81
NMR metabolomics,X23428.Concentration of VLDL Particles,LEFTY2,Left-right determination factor 2,40011,0.0944467142821854,0.00491758544798412,0.0848082468041365,0.104085181760234,2.6591681623786e-81
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL3,C-X-C motif chemokine 3,39859,0.167405021402113,0.00873157021593614,0.150291143778878,0.184518899025348,5.09430851726582e-81
NMR metabolomics,X23428.Concentration of VLDL Particles,PHACTR2,Phosphatase and actin regulator 2,37411,0.202679318645541,0.0105642100619858,0.181973466924049,0.223385170367033,5.77883194924422e-81
NMR metabolomics,X23428.Concentration of VLDL Particles,CIRBP,Cold-inducible RNA-binding protein,37382,0.170620695363765,0.00889346141570141,0.153189510988991,0.18805187973854,5.86461273024973e-81
NMR metabolomics,X23428.Concentration of VLDL Particles,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39419,0.0962000135489885,0.00502593477744724,0.0863491813851919,0.106050845712785,9.78195542083765e-81
NMR metabolomics,X23428.Concentration of VLDL Particles,SUGP1,SURP and G-patch domain-containing protein 1,37382,0.0709380836001566,0.00370326069280929,0.0636796926422504,0.0781964745580628,1.01639085742691e-80
NMR metabolomics,X23428.Concentration of VLDL Particles,FETUB,Fetuin-B,39908,0.059217721285464,0.00310212362344352,0.0531375589835147,0.0652978835874133,2.39978554822783e-80
NMR metabolomics,X23428.Concentration of VLDL Particles,CSNK2A1,Casein kinase II subunit alpha,37411,-0.0791450573557197,0.00414297970040355,-0.0872652975685107,-0.0710248171429288,2.67856186144389e-80
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBP1,Insulin-like growth factor-binding protein 1,40017,-0.215695983486913,0.0113257161134771,-0.237894387069328,-0.193497579904498,5.45206481972425e-80
NMR metabolomics,X23428.Concentration of VLDL Particles,CES2,Cocaine esterase,39788,0.0950992929988101,0.00499466272411957,0.0853097540595357,0.104888831938084,6.11489925179766e-80
NMR metabolomics,X23428.Concentration of VLDL Particles,PDGFB,Platelet-derived growth factor subunit B,39931,0.150051342414061,0.0078975660468142,0.134572112962306,0.165530571865817,1.2781810935876e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,CKB,Creatine kinase B-type,37437,-0.101839763190679,0.0053612598499512,-0.112347832496584,-0.0913316938847751,1.98570760014975e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37358,0.191395211354846,0.0100765599485516,0.171645153855685,0.211145268854007,2.06547149595667e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,GOLM2,Protein GOLM2,40009,0.038686606847172,0.00204071805531537,0.0346867994587538,0.0426864142355901,2.78472514709904e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,RBPMS2,RNA-binding protein with multiple splicing 2,37043,0.180078155148469,0.00948975549830824,0.161478234371785,0.198678075925153,3.05147226337168e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,PLXNB3,Plexin-B3,39812,0.0831782786191596,0.00439110399598236,0.0745717147870342,0.091784842451285,3.76262461758121e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,GH1,Somatotropin,39846,-0.315000981710833,0.0166317826217662,-0.347599275649495,-0.282402687772171,3.94342310888935e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS1,Galectin-1,39868,0.0584885730879772,0.00308928704409298,0.052433570481555,0.0645435756943995,4.47809372753072e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINC1,Antithrombin-III,37424,0.025423916905159,0.00134329391993308,0.0227910608220902,0.0280567729882278,7.13636173037168e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,ERBIN,Erbin,39788,0.179107452983611,0.00948138783017871,0.16052393283646,0.197690973130761,9.90752799158682e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,NFE2,Transcription factor NF-E2 45 kDa subunit,37043,0.129820120591923,0.00686614375787687,0.116362478826484,0.143277762357362,1.08846391466723e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,DPP4,Dipeptidyl peptidase 4,39575,0.0521573382925291,0.00276417000729858,0.0467395650782239,0.0575751115068343,1.51038192608012e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,NCK2,Cytoplasmic protein NCK2,39931,0.184730900826127,0.00979260327642834,0.165537398404327,0.203924403247926,1.57872894960918e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,BCR,Breakpoint cluster region protein,39866,0.159666725257595,0.00846948500107161,0.143066534655494,0.176266915859695,1.99880874928706e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,AAMDC,Mth938 domain-containing protein,37043,0.0929133200647186,0.00492475298458002,0.0832608042149418,0.102565835914495,2.30497939427305e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP85,Centrosomal protein of 85 kDa,39477,0.11095355403405,0.00588917342288013,0.0994107741252046,0.122496333942895,2.60508501594014e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37437,0.123494939093506,0.00654990651567437,0.110657122322784,0.136332755864228,2.6940650862436e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,GHRL,Appetite-regulating hormone,39868,0.133050757583371,0.00707142901432049,0.119190756715303,0.146910758451439,3.94003524512218e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFB1,Transforming growth factor beta-1 proprotein,40040,0.0666349845036708,0.00354770712932236,0.0596814785301989,0.0735884904771426,7.05890225056621e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39788,0.0484847034220915,0.00258526078554716,0.043417592282419,0.0535518145617639,1.22384008064021e-77
NMR metabolomics,X23428.Concentration of VLDL Particles,C4BPB,C4b-binding protein beta chain,39913,0.0685741106500519,0.00365842244525232,0.0614036026573573,0.0757446186427465,1.45228608318079e-77
NMR metabolomics,X23428.Concentration of VLDL Particles,DOK2,Docking protein 2,39868,0.211918754294248,0.0113083131212612,0.189754460576576,0.23408304801192,1.57401986779955e-77
NMR metabolomics,X23428.Concentration of VLDL Particles,USO1,General vesicular transport factor p115,39788,0.154811015454543,0.00828316586880244,0.138576010351691,0.171046020557396,3.99830262543985e-77
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39913,0.163132245609622,0.00873271238708739,0.14601612933093,0.180248361888313,4.66841357852407e-77
NMR metabolomics,X23428.Concentration of VLDL Particles,PAK4,Serine/threonine-protein kinase PAK 4,39489,0.10581086293032,0.00567124308539912,0.0946952264829382,0.116926499377703,7.5018503955584e-77
NMR metabolomics,X23428.Concentration of VLDL Particles,C1S,Complement C1s subcomponent,37453,0.0360681826403531,0.00193215507820426,0.0322811586870728,0.0398552065936335,8.31029467764174e-77
NMR metabolomics,X23428.Concentration of VLDL Particles,BECN1,Beclin-1,37043,0.104109282964284,0.00557675778084695,0.0931788377138243,0.115039728214744,8.71538754539859e-77
NMR metabolomics,X23428.Concentration of VLDL Particles,GPC5,Glypican-5,39749,0.0959461045228028,0.00515939476839689,0.0858336907767449,0.106058518268861,2.22029345609037e-76
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT18,"Keratin, type I cytoskeletal 18",39788,0.139539585458974,0.00750713395238773,0.124825602912294,0.154253568005654,2.59489572996588e-76
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINH1,Serpin H1,37169,0.220034197715465,0.0118405245267964,0.196826769642944,0.243241625787986,4.03007560174903e-76
NMR metabolomics,X23428.Concentration of VLDL Particles,TNIP1,TNFAIP3-interacting protein 1,37388,0.15071220709866,0.00814185830705352,0.134754164816835,0.166670249380484,1.44553741893233e-75
NMR metabolomics,X23428.Concentration of VLDL Particles,SLA2,Src-like-adapter 2,37411,0.179766945125313,0.00972569481433013,0.160704583289226,0.1988293069614,2.35089486413008e-75
NMR metabolomics,X23428.Concentration of VLDL Particles,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39931,-0.0652814720205808,0.00354571144475353,-0.0722310664522977,-0.0583318775888639,6.26976950114391e-75
NMR metabolomics,X23428.Concentration of VLDL Particles,PDGFC,Platelet-derived growth factor C,39477,0.0494171326432502,0.00269038596578521,0.0441439761503112,0.0546902891361893,1.44258242374373e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37043,0.0972108231270929,0.00528771565626932,0.086846900440805,0.107574745813381,1.49608425216018e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,SNAP23,Synaptosomal-associated protein 23,39868,0.147211208625977,0.00802061347997478,0.131490806205226,0.162931611046727,1.77584052694945e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,CA5A,"Carbonic anhydrase 5A, mitochondrial",39585,0.154375401143098,0.00841382965101863,0.137884295027102,0.170866507259095,2.05207100999429e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,SEC31A,Protein transport protein Sec31A,37043,0.130401597973729,0.00710163086084027,0.116482401486482,0.144320794460976,2.22423454529237e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,PLSCR3,Phospholipid scramblase 3,37373,0.100901075524604,0.00549754169232815,0.0901258938076409,0.111676257241567,2.4551805260296e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,ZFYVE19,Abscission/NoCut checkpoint regulator,37382,0.1539771007974,0.00839589002103016,0.137521156356181,0.17043304523862,3.16799706110019e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39763,0.176561930468439,0.00964123420655393,0.157665111423593,0.195458749513285,3.75173862122676e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1R9B,Neurabin-2,40058,0.159900610426713,0.00873393508778302,0.142782097654658,0.177019123198768,3.99474413505484e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39885,0.0450019083027595,0.00246118065315014,0.0401779942225852,0.0498258223829338,6.18336964665478e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,CST3,Cystatin-C,39897,0.0447629643675433,0.00245078467534176,0.0399594264038735,0.0495665023312132,8.83327635238188e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGEF12,Rho guanine nucleotide exchange factor 12,39866,0.174824074159412,0.00957927784125264,0.156048689590557,0.193599458728268,1.14977168524844e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,MXRA8,Matrix remodeling-associated protein 8,37124,-0.0507360390936231,0.00277741701634054,-0.0561797764456506,-0.0452923017415957,1.20140718455404e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP10,Stromelysin-2,39857,-0.0987039899615231,0.00541445272842358,-0.109316317309233,-0.0880916626138129,1.66209397083542e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,HJV,Hemojuvelin,37411,0.0746822749192161,0.00409596972573791,0.0666541742567698,0.0827103755816624,2.12089271260987e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,CLIP2,CAP-Gly domain-containing linker protein 2,39866,0.190139629091402,0.0104398582342457,0.16967750695228,0.210601751230524,2.24608073189874e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,GFRA1,GDNF family receptor alpha-1,40011,0.0451739060987579,0.00248167031078945,0.0403098322896106,0.0500379799079053,2.63795516785404e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,CTBS,Di-N-acetylchitobiase,37296,0.0463913762224688,0.00254770455045197,0.041397875303583,0.0513848771413547,3.31116998795775e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,STC1,Stanniocalcin-1,40009,0.0703495648483063,0.00386765956112919,0.0627689521084931,0.0779301775881195,3.37964029865743e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,IRAK1,Interleukin-1 receptor-associated kinase 1,39587,0.117957819098709,0.00649500937040997,0.105227600732705,0.130688037464712,5.81300498992646e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC4G,C-type lectin domain family 4 member G,39866,0.0555738434098433,0.00306056620712026,0.0495751336438876,0.061572553175799,5.98358985506343e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL13,C-C motif chemokine 13,40024,0.115111420905638,0.00634426271196782,0.102676665990181,0.127546175821095,7.53752029994803e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,AHSG,Alpha-2-HS-glycoprotein,37445,0.0446775994978053,0.00246086392295014,0.039854306208823,0.0495008927867875,8.44823802825812e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,SRPK2,SRSF protein kinase 2,39866,0.140577478606577,0.00775433996737525,0.125378972270522,0.155775984942633,1.00623366823112e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,FOXO1,Forkhead box protein O1,39866,0.143735319145244,0.00792862212975662,0.128195219770921,0.159275418519567,1.01008386724036e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,STAT5B,Signal transducer and activator of transcription 5B,39788,0.230420327760935,0.0127127578052699,0.205503322462606,0.255337333059264,1.08452856858685e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,PCBP2,Poly(rC)-binding protein 2,37411,0.121450733546373,0.00669639779980026,0.108325793858765,0.134575673233982,1.17987429953003e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMP4,Metalloproteinase inhibitor 4,39858,-0.0655765124030729,0.00361956752090835,-0.0726708647440533,-0.0584821600620926,1.2394016013735e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP5,Fatty acid-binding protein 5,39972,0.113989027871792,0.00629212525763409,0.101656462366829,0.126321593376755,1.24886544147461e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,ASAH2,Neutral ceramidase,39749,0.087598415483089,0.00483572770848616,0.0781203891744562,0.0970764417917219,1.30791170747239e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF21,Fibroblast growth factor 21,40011,0.198922957091793,0.0110004496985897,0.177362075682557,0.220483838501029,2.23675990215104e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,CMC1,COX assembly mitochondrial protein homolog,37437,0.151085636800805,0.00836138353557223,0.134697325071083,0.167473948530527,3.87450222228292e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,GDF2,Growth/differentiation factor 2,39868,0.0587361406297359,0.00325516919994355,0.0523560089978466,0.0651162722616253,4.55255279607654e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,DAG1,Dystroglycan,39931,0.0807526608134443,0.00447898570003968,0.0719738488413666,0.0895314727855221,5.87397953837697e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39788,0.0635622459771792,0.00352839038285304,0.0566466008267872,0.0704778911275711,7.73412073699844e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40058,0.16547914434277,0.00919022955197159,0.147466294420906,0.183491994264635,8.7558891203233e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,BPIFB1,BPI fold-containing family B member 1,39786,-0.105213919193394,0.00584591504823532,-0.116671912687936,-0.0937559256988531,1.03895818855686e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,NHLRC3,NHL repeat-containing protein 3,36838,0.0528631982993562,0.00294575651936586,0.0470895155213991,0.0586368810773133,3.75730782906262e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH2,Cadherin-2,39868,0.0580056970263944,0.00323727193117385,0.0516606440412937,0.0643507500114951,4.21459159363521e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,DCTN1,Dynactin subunit 1,40030,0.107494405093796,0.00600155175397092,0.0957313636560125,0.119257446531579,4.69125585397561e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37382,0.179087911267566,0.0100033957127214,0.159481255670632,0.1986945668645,7.37119099742589e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP4,"Fatty acid-binding protein, adipocyte",40052,0.0800087097105171,0.00448084974990238,0.0712262442007084,0.0887911752203257,1.24060100620078e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,NFX1,Transcriptional repressor NF-X1,37021,0.111243977464743,0.00622611003604309,0.0990408017940989,0.123447153135388,1.44116054430037e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,SHBG,Sex hormone-binding globulin,37445,-0.0848149787587069,0.00476118673748344,-0.0941469047641745,-0.0754830527532394,3.46279644976458e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37437,0.10507360291432,0.00590525995228525,0.0934992934078411,0.116647912420799,4.96699038695175e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,FKBPL,FK506-binding protein-like,37382,0.0979191777728699,0.00550312035425898,0.0871330618785223,0.108705293667218,4.98871926656722e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,PENK,Proenkephalin-A,37124,0.0478832072078958,0.00269157454722326,0.0426077210953382,0.0531586933204534,5.47859475418579e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJB6,DnaJ homolog subfamily B member 6,37013,0.140635750206948,0.00790534851418013,0.125141267119154,0.156130233294741,5.57273686888116e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,NFKBIE,NF-kappa-B inhibitor epsilon,39477,0.0808504356795089,0.00455218389059377,0.0719281552539451,0.0897727161050726,6.91542456182844e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,PPY,Pancreatic prohormone,39826,0.163930287243857,0.0092475823512763,0.145805025835356,0.182055548652359,1.2093711165032e-69
NMR metabolomics,X23428.Concentration of VLDL Particles,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37021,0.122755563912383,0.00692359165245365,0.109185324273574,0.136325803551192,1.57856596025721e-69
NMR metabolomics,X23428.Concentration of VLDL Particles,AHNAK,Neuroblast differentiation-associated protein AHNAK,37043,0.0511640708537666,0.00288581845966156,0.0455078666728299,0.0568202750347032,1.58906554359838e-69
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSO,Cathepsin O,40058,0.048911316734083,0.0027625175315369,0.0434967823722706,0.0543258510958953,1.72108374671126e-69
NMR metabolomics,X23428.Concentration of VLDL Particles,PLG,Plasminogen,37162,0.0370301859619637,0.00208976460243358,0.0329342473411939,0.0411261245827335,1.85004502001455e-69
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF4B,Eukaryotic translation initiation factor 4B,39749,0.0945555994739579,0.00536134494499463,0.0840473633817684,0.105063835566147,5.85884424716091e-69
NMR metabolomics,X23428.Concentration of VLDL Particles,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37411,0.126209040690083,0.00715727924978458,0.112180773360505,0.14023730801966,7.96324617943096e-69
NMR metabolomics,X23428.Concentration of VLDL Particles,RAPGEF2,Rap guanine nucleotide exchange factor 2,37169,0.0870483633419482,0.00495090173805696,0.0773445959353566,0.0967521307485399,1.99391873917728e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,GFER,FAD-linked sulfhydryl oxidase ALR,39477,0.105051809707037,0.00598604480119298,0.093319161896699,0.116784457517376,2.71453393768066e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39887,0.0382995920444972,0.00218310081979833,0.0340207144376925,0.0425784696513019,2.88768598961573e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,PAXX,Protein PAXX,37124,0.0745861435253842,0.00424794428154459,0.0662601727335568,0.0829121143172116,3.04065692754144e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMP3,Metalloproteinase inhibitor 3,39931,0.209798206445651,0.0119646090150135,0.186347572776225,0.233248840115078,3.34631880145583e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,BID,BH3-interacting domain death agonist,39866,0.106897480344899,0.00610263150723347,0.0949363225907214,0.118858638099077,4.61376775612419e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,HAO1,Hydroxyacid oxidase 1,40030,0.208508332386744,0.0119063752195083,0.185171836956508,0.23184482781698,4.89615595920333e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1R2,Interleukin-1 receptor type 2,39830,0.0316841315067905,0.00181025083644483,0.0281360398673586,0.0352322231462223,5.8921029243475e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39788,0.0711992770205925,0.00407056045036452,0.063220978537878,0.0791775755033069,7.19122045896977e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,HYOU1,Hypoxia up-regulated protein 1,40052,0.0346965033869702,0.00198383080646328,0.0308081950063022,0.0385848117676383,7.22319678661557e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,RILPL2,RILP-like protein 2,37437,0.159555523383492,0.00911771154664753,0.141684808752063,0.177426238014922,8.00827612408045e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,HCLS1,Hematopoietic lineage cell-specific protein,40058,0.0904215810209754,0.00517202060911305,0.0802844206271138,0.100558741414837,8.11807274212138e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGEF1,Rho guanine nucleotide exchange factor 1,37388,0.146616569501593,0.00838559823351167,0.13018079696391,0.163052342039276,1.04557473135059e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,CD2AP,CD2-associated protein,39868,0.101965491128446,0.00584703923567182,0.0905052942265297,0.113425688030363,1.75919320553425e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,IKBKG,NF-kappa-B essential modulator,39866,0.14815084112358,0.00850304340535057,0.131484876049093,0.164816806198067,2.2977774670536e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,PDCD5,Programmed cell death protein 5,40009,0.0932223671157094,0.00535380929055898,0.0827289009062138,0.103715833325205,2.73706067018533e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,SMOC2,SPARC-related modular calcium-binding protein 2,39931,0.060709415010408,0.00350517293983242,0.0538392760483364,0.0675795539724795,1.33811153945996e-66
NMR metabolomics,X23428.Concentration of VLDL Particles,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39749,0.151400995119463,0.00874116321334927,0.134268315221298,0.168533675017627,1.3474708997256e-66
NMR metabolomics,X23428.Concentration of VLDL Particles,SUSD1,Sushi domain-containing protein 1,39585,0.077712494085418,0.00449467777816221,0.06890292564022,0.0865220625306159,2.30158865738605e-66
NMR metabolomics,X23428.Concentration of VLDL Particles,VAMP8,Vesicle-associated membrane protein 8,37056,0.141558250296003,0.00818413239814071,0.125517350795647,0.157599149796358,2.6784988892525e-66
NMR metabolomics,X23428.Concentration of VLDL Particles,STK11,Serine/threonine-protein kinase STK11,39585,0.116856923168558,0.00677556054239297,0.103576824505468,0.130137021831648,4.78673620194606e-66
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A4,Protein S100-A4,39913,0.0905245590818824,0.00525336313160143,0.0802279673439436,0.100821150819821,6.01306605328902e-66
NMR metabolomics,X23428.Concentration of VLDL Particles,TACC3,Transforming acidic coiled-coil-containing protein 3,39788,0.186254912357564,0.0108162844724489,0.165054994791564,0.207454829923564,7.43343417385772e-66
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39713,0.178137273532712,0.0103494944076445,0.157852264493729,0.198422282571696,8.52313011763389e-66
NMR metabolomics,X23428.Concentration of VLDL Particles,RTN4R,Reticulon-4 receptor,40030,0.0526746049556872,0.00306078022242666,0.0466754757197309,0.0586737341916434,8.67836526202022e-66
NMR metabolomics,X23428.Concentration of VLDL Particles,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39585,0.154267393237362,0.00896630759578423,0.136693430349625,0.171841356125099,9.69366769923734e-66
NMR metabolomics,X23428.Concentration of VLDL Particles,LAT,Linker for activation of T-cells family member 1,40058,0.120478059669569,0.00700431703541702,0.106749598280151,0.134206521058986,1.00841582619495e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,BACH1,Transcription regulator protein BACH1,39866,0.117676261799811,0.00684328216997523,0.104263428746659,0.131089094852962,1.10883548407186e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,NT5C1A,Cytosolic 5'-nucleotidase 1A,37388,0.0486993250898835,0.0028329585932919,0.0431467262470314,0.0542519239327356,1.55776955127846e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,TIA1,Nucleolysin TIA-1 isoform p40,39374,0.195117504421968,0.0113598977937412,0.172852104746235,0.2173829040977,1.61996376083089e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37169,0.168519899931014,0.00981552015727458,0.149281480422755,0.187758319439272,2.29945181883318e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,MPHOSPH8,M-phase phosphoprotein 8,39585,0.120355475834486,0.00701782749700857,0.106600533940349,0.134110417728622,2.46927348417507e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37437,0.120966265138182,0.00705140436869306,0.107145512575544,0.134787017700821,2.8115808202178e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL16,C-X-C motif chemokine 16,40034,0.0367783673590478,0.00214705112436518,0.0325701471552921,0.0409865875628036,3.34830709826887e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,NIT2,Omega-amidase NIT2,37377,0.119210268255278,0.00696464401040725,0.105559565994879,0.132860970515676,5.4050043934772e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINE1,Plasminogen activator inhibitor 1,40052,0.10679252564944,0.00625226791699923,0.0945380805321215,0.119046970766759,7.65115057527583e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,TBC1D23,TBC1 domain family member 23,39788,0.14210454312495,0.00832573041135591,0.125786111518692,0.158422974731207,9.64448991544593e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,SDCCAG8,Serologically defined colon cancer antigen 8,37368,0.180726670688437,0.010581887503287,0.159986171181995,0.20146717019488,1.01769567779171e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,HGF,Hepatocyte growth factor,40058,0.0534785814557611,0.00313704792996974,0.0473299675130204,0.0596271953985018,1.33634205094318e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,PHLDB1,Pleckstrin homology-like domain family B member 1,37382,0.0838849050958238,0.00492624146496461,0.0742294718244932,0.0935403383671545,2.37532394622161e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,MPRIP,Myosin phosphatase Rho-interacting protein,37338,0.0706412719684137,0.00414927652972332,0.062508689970156,0.0787738539666714,2.51900288364538e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,CRELD2,Protein disulfide isomerase CRELD2,39908,0.081751768575756,0.00480730924230427,0.0723294424608397,0.0911740946906724,2.72292841282215e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,CES3,Carboxylesterase 3,39788,0.108233095872311,0.00636544146267149,0.0957568306054748,0.120709361139147,2.86639202452875e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,SCAMP3,Secretory carrier-associated membrane protein 3,39788,0.132876857801926,0.00781626788208822,0.117556972753033,0.148196742850819,3.02407490195953e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,CD36,Platelet glycoprotein 4,37056,0.0719640135690558,0.00423052509761716,0.0636721843777262,0.0802558427603855,3.30505814925305e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,VEGFA,Vascular endothelial growth factor A,39993,0.089293533027897,0.00526293327021982,0.0789781838182661,0.0996088822375278,5.21649523419327e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGAP45,Rho GTPase-activating protein 45,37124,0.129995333723061,0.00765738990491416,0.11498684950943,0.145003817936693,5.8025371462372e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,BIRC2,Baculoviral IAP repeat-containing protein 2,39477,0.0998357036159464,0.00589195223922385,0.0882874772270677,0.111383930004825,7.86455676805765e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37382,0.160602671321879,0.00947485974893836,0.14203194621396,0.179173396429798,8.69986307924971e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39866,0.15851952254626,0.00936922326937939,0.140155844938277,0.176883200154244,1.16138188642288e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,SCPEP1,Retinoid-inducible serine carboxypeptidase,36995,0.0795647377696745,0.00469830441147684,0.0703560611231799,0.0887734144161691,1.17901226402361e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS9,Galectin-9,39859,0.0491616021701078,0.00290972527065569,0.0434585406396227,0.054864663700593,1.72087427389063e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,NPDC1,Neural proliferation differentiation and control protein 1,39868,0.046023907302352,0.00272443937064513,0.0406840061358876,0.0513638084688165,1.7967789328359e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,TANK,TRAF family member-associated NF-kappa-B activator,39587,0.110475376586746,0.00654375690349567,0.0976496130558947,0.123301140117598,2.18541406863603e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,PGF,Placenta growth factor,40058,0.0399447777355578,0.00237593061866141,0.0352879537229814,0.0446016017481342,6.77230873222578e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39913,0.11293365794169,0.00671953995874458,0.0997633596225506,0.126103956260829,7.501982331007e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,CNPY4,Protein canopy homolog 4,39788,0.117610093689305,0.00699764938660504,0.103894700891559,0.131325486487051,7.53282068037975e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,GIGYF2,GRB10-interacting GYF protein 2,37411,0.11908404887682,0.00708616842053325,0.105195158772575,0.132972938981065,9.65142298854532e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,AP3B1,AP-3 complex subunit beta-1,37382,0.119224880467264,0.00710116698040244,0.105306593185675,0.133143167748852,1.25386114413302e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP43,Centrosomal protein 43,39476,0.108483717387706,0.00646841241608962,0.0958056290521701,0.121161805723241,1.39578026251165e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,HEXIM1,Protein HEXIM1,39866,0.126358916416496,0.00753888540861842,0.111582701015604,0.141135131817388,1.60678748162844e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA11,Annexin A11,39829,0.103472522079065,0.00617374140169077,0.0913719889317513,0.115573055226379,1.63423843319535e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,DNMBP,Dynamin-binding protein,39749,0.0960584640743528,0.00573392544416043,0.0848199702037984,0.107296957944907,1.85956513382443e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,CDNF,Cerebral dopamine neurotrophic factor,39788,0.0489067354280736,0.00291956236111239,0.0431843932002934,0.0546290776558539,1.89303388513813e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,SCARA5,Scavenger receptor class A member 5,40009,0.0451761819604046,0.00269702875214171,0.0398900056062068,0.0504623583146023,1.89406325275875e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,YOD1,Ubiquitin thioesterase OTU1,37021,0.0951661661141879,0.00568097182429089,0.0840314613385777,0.106300870889798,2.42906250654581e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,SKAP2,Src kinase-associated phosphoprotein 2,39931,0.160879612005505,0.00961801302712975,0.142028306472331,0.179730917538679,2.8056271870135e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,VNN1,Pantetheinase,37445,0.112088849992814,0.00670088745563324,0.0989551105797726,0.125222589405855,3.46030309840598e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,PDLIM5,PDZ and LIM domain protein 5,37411,0.185219740660399,0.0110746881436597,0.163513351898826,0.206926129421972,3.63996617717074e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,SIAE,Sialate O-acetylesterase,39875,0.0729001109309167,0.00436322411961499,0.0643481916564713,0.0814520302053621,3.85738792218367e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP5IF1,"ATPase inhibitor, mitochondrial",39931,0.169922744336405,0.0101723979131174,0.149984844426695,0.189860644246115,4.07329191217675e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,RGCC,Regulator of cell cycle RGCC,37411,0.117118705883549,0.00700660378078115,0.103385762473218,0.130851649293881,4.22922579331587e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHA1,Ephrin type-A receptor 1,39904,0.0515161706025673,0.00308520120605732,0.0454691762386949,0.0575631649664396,4.5400974711195e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40009,0.0863345258679079,0.00517153630423734,0.0761983147116027,0.0964707370242131,4.78480736128921e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37388,0.107159125442458,0.00642171699976689,0.0945725601229152,0.119745690762001,6.76793621107664e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,MYDGF,Myeloid-derived growth factor,37437,0.156027136599671,0.0093626841202797,0.137676275723923,0.174377997475419,9.69141765862152e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,F11,Coagulation factor XI,37249,0.0482146520302989,0.00289434110834312,0.0425417434579464,0.0538875606026514,1.10001051420986e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,ISM1,Isthmin-1,39866,0.0612587304437588,0.00368245691856092,0.0540411148833794,0.0684763460041382,1.2731163995338e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,VSNL1,Visinin-like protein 1,37388,0.058084401832415,0.00349506152416304,0.0512340812450554,0.0649347224197745,2.06099836401996e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,MAMDC4,Apical endosomal glycoprotein,37368,0.0855866067578707,0.00515602251045259,0.0754808026373836,0.0956924108783577,2.84668604038725e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37411,0.10084726554164,0.00608378091521231,0.0889230549478241,0.112771476135456,4.12053395254702e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,CDC27,Cell division cycle protein 27 homolog,39477,0.0938833807409078,0.00566897296334154,0.0827721937327584,0.104994567749057,4.42914032822526e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,PON2,Serum paraoxonase/arylesterase 2,39585,0.0527054964771147,0.00318277118721987,0.0464672649501637,0.0589437280040656,4.48682928971352e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,MITD1,MIT domain-containing protein 1,39749,0.148698086257253,0.00898720992442319,0.131083154805384,0.166313017709122,5.58060427933874e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,TBCC,Tubulin-specific chaperone C,39749,0.124266690294762,0.00751862518540122,0.109530184931375,0.139003195658148,7.44606087238461e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,AKT1S1,Proline-rich AKT1 substrate 1,39489,0.102671994489301,0.00621911860651505,0.0904825220205315,0.114861466958071,1.03040391081562e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,LYN,Tyrosine-protein kinase Lyn,39788,0.129256052224446,0.00783240356934249,0.113904541228535,0.144607563220358,1.1180312215127e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,DLK1,Protein delta homolog 1,40052,0.0849960746653002,0.00515513562710479,0.0748920088361748,0.0951001404944256,1.40272424628863e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,IST1,IST1 homolog,37287,0.152477933948242,0.0092404765329099,0.134366599943738,0.170589267952745,1.4209452263874e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,C3,Complement C3,36816,0.0703053000819803,0.00426400685858888,0.0619478466391461,0.0786627535248145,1.84302716814794e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,SH2B3,SH2B adapter protein 3,39477,0.150057625794149,0.00910999375296147,0.132202038038344,0.167913213549953,1.89294519021708e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,SPOCK1,Testican-1,39749,0.0386174648423974,0.00234748476344512,0.034016394706045,0.0432185349787498,2.61813801634479e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,LZTFL1,Leucine zipper transcription factor-like protein 1,37124,0.109889743243561,0.00667819325674227,0.0968004844603457,0.122979002026775,3.04876435634194e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,EGFR,Epidermal growth factor receptor,40052,0.0243584983664637,0.00148267284514151,0.0214524595899863,0.027264537142941,3.65082687296148e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39858,0.0370095999602204,0.00225263437358,0.0325944365880036,0.0414247633324372,3.65845448522137e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,CD300LG,CMRF35-like molecule 9,39858,-0.0556001714543741,0.00338595414674421,-0.0622366415819928,-0.0489637013267555,4.20898937284865e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37411,0.118664183876097,0.0072228915239942,0.104507316489068,0.132821051263125,4.51969705795517e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT5,"Keratin, type II cytoskeletal 5",39489,0.0766039798424809,0.00466616425824873,0.0674582978963134,0.0857496617886484,4.60519653297859e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,COMMD1,COMM domain-containing protein 1,37043,0.0940901878283206,0.0057290626250576,0.0828612250832077,0.105319150573433,5.13233051164991e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,SNCG,Gamma-synuclein,39749,0.0985387727711495,0.0060089694899984,0.0867611925707526,0.110316352971546,6.07798252779988e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,OGFR,Opioid growth factor receptor,39788,0.0495814243246386,0.00302450231401229,0.0436533997891745,0.0555094488601027,6.6109694964258e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39477,0.128966463183043,0.00786769182931642,0.113545787197583,0.144387139168503,6.9082583183981e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37043,0.0695031118136719,0.00423817530825054,0.0611962882095009,0.077809935417843,7.56219948367257e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,COCH,Cochlin,37437,0.0692915978406685,0.00422752033012807,0.0610056579936175,0.0775775376877195,8.36868935274078e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37382,0.135199075728272,0.00825065033277633,0.119027801076031,0.151370350380514,8.99208490616685e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,EREG,Proepiregulin,39713,0.120797666856012,0.00738357633877784,0.106325857232007,0.135269476480016,1.13170656111965e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,METAP2,Methionine aminopeptidase 2,40011,0.087249323982094,0.00533887688139878,0.0767851252945524,0.0977135226696356,1.48396584190654e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,MAX,Protein max,39489,0.159207402422713,0.00974242142686859,0.14011225642605,0.178302548419375,1.55372153841396e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,GIT1,ARF GTPase-activating protein GIT1,37056,0.147825486478144,0.00904451465086214,0.130098237762454,0.165552735193833,1.83387807367136e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39788,0.0678919729124317,0.00415768885998307,0.0597429027468649,0.0760410430779985,1.85829830360805e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39788,0.115937352177508,0.00710270831198911,0.10201604388601,0.129858660469007,2.0562237948826e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,TXNDC5,Thioredoxin domain-containing protein 5,40009,0.103373516499824,0.00633562553196346,0.090955690457176,0.115791342542473,2.25827829860137e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,DUSP13,Dual specificity protein phosphatase 13 isoform A,37368,0.0634962097673318,0.00388892697018667,0.0558739129057659,0.0711185066288977,2.32927398062152e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,SYTL4,Synaptotagmin-like protein 4,37437,0.109068341979805,0.00668204068457543,0.0959715422380367,0.122165141721572,2.50069850698337e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,HS1BP3,HCLS1-binding protein 3,37043,0.138094351398981,0.00846586410183317,0.121501257759388,0.154687445038574,3.08575049434985e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,WASF1,Wiskott-Aldrich syndrome protein family member 1,39585,0.141926396478278,0.00871175787817069,0.124851351037064,0.159001441919493,3.46925772742289e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,HDGFL2,Hepatoma-derived growth factor-related protein 2,37388,0.0944852346377905,0.00579927271664574,0.0831186601131649,0.105851809162416,4.06717627047049e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,ARSB,Arylsulfatase B,39788,0.0832462371906784,0.00511428214707909,0.0732222441824034,0.0932702301989535,4.29486122474143e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,SETMAR,Histone-lysine N-methyltransferase SETMAR,39699,0.0448168597739371,0.00275359439342756,0.0394198147628191,0.0502139047850551,4.42243683424347e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39868,0.125450158586381,0.0077120172980501,0.110334604682203,0.140565712490559,5.04587694136615e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,ANG,Angiogenin,39843,0.0508013662452257,0.00312330614011771,0.044679686210595,0.0569230462798564,5.18491169209132e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM21,E3 ubiquitin-protein ligase TRIM21,39866,0.112886456251914,0.00694269804996707,0.0992787680739783,0.126494144429849,5.65624457068648e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37411,0.160507471335541,0.00987239548745432,0.14115757618013,0.179857366490951,7.0416273373401e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37043,0.105050821247927,0.00646945694076562,0.0923706856440261,0.117730956851827,1.00827896277531e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,SEMA4D,Semaphorin-4D,40009,0.044913285014228,0.00276853490740903,0.0394869565957063,0.0503396134327497,1.01384634411155e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF19,Fibroblast growth factor 19,39931,0.114711754980845,0.00707479807373444,0.100845150756326,0.128578359205365,1.17002359374964e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1RN,Interleukin-1 receptor antagonist protein,39820,0.0801462569930168,0.00494856070165825,0.0704470780177666,0.089845435968267,1.57886821736401e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39977,0.154392925121501,0.0095360217413391,0.135702322508476,0.173083527734525,1.70291145989905e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,QDPR,Dihydropteridine reductase,39790,0.0649934967421035,0.00401756279874744,0.0571190736565585,0.0728679198276485,2.12735325475998e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,DBNL,Drebrin-like protein,39931,0.13911525113691,0.00860409165257236,0.122251231497868,0.155979270775952,2.42751970267308e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,CD22,B-cell receptor CD22,40058,0.0599440774223778,0.00370763366196839,0.0526771154449198,0.0672110393998359,2.43681293120062e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,FAP,Prolyl endopeptidase FAP,40052,0.0407810456522018,0.00252329214228355,0.0358353930533261,0.0457266982510776,2.67879484857848e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39868,-0.138418303094866,0.00856886691171076,-0.155213282241819,-0.121623323947913,3.09054506414733e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,C2,Complement C2,39908,0.0352931104056525,0.00218555163877825,0.0310094291936471,0.0395767916176579,3.35194563881857e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37411,0.120166099622171,0.00743798164680519,0.105587655594433,0.13474454364991,3.61301398317941e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,PALM2,Paralemmin-2,37388,0.0565338336136081,0.00350325902080702,0.0496674459328264,0.0634002212943899,4.83911255723737e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,ESM1,Endothelial cell-specific molecule 1,39862,-0.0507350635300282,0.00315014779127701,-0.0569093532009312,-0.0445607738591253,6.64414944446045e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,MASP1,Mannan-binding lectin serine protease 1,39713,0.035034332951013,0.00217837515276028,0.0307647176516028,0.0393039482504231,9.64476138944886e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39868,0.0417336489753512,0.00259535426919677,0.0366467546077255,0.0468205433429768,9.95804054940387e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39587,0.0621898207411539,0.00386763355776988,0.0546092589679249,0.0697703825143828,1.02371825552231e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39908,0.129183367777302,0.00803695151914304,0.113430942799781,0.144935792754822,1.10054028086815e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,RABEP1,Rab GTPase-binding effector protein 1,37124,0.116077895923181,0.00721609660545801,0.101934346576483,0.130221445269878,1.12306126022162e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,NAGK,N-acetyl-D-glucosamine kinase,37026,0.0855779791945418,0.00532000041445622,0.0751507783822076,0.096005180006876,1.13136181734502e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,AZI2,5-azacytidine-induced protein 2,37411,0.0825146312512164,0.00513219067560029,0.0724555375270399,0.092573724975393,1.24392561051306e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37368,0.12455344210888,0.00775630540809077,0.109351083509022,0.139755800708738,1.70051929129391e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSD,Cathepsin D,38721,0.0583196229121542,0.00363349455009246,0.051197973593973,0.0654412722303354,1.72297707565351e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,CRKL,Crk-like protein,39881,0.15880527205588,0.00989847128201343,0.139404268343134,0.178206275768627,1.7818686723976e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,FST,Follistatin,39908,0.076294513828826,0.00475566038537861,0.066973419473484,0.0856156081841681,1.79378276284896e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,SULT2A1,Bile salt sulfotransferase,39866,0.0826393562894173,0.00516162340009286,0.0725225744252353,0.0927561381535993,3.01108548347563e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,GTPBP2,GTP-binding protein 2,37039,0.120048248234681,0.00749565093513053,0.105356772401825,0.134739724067537,3.43570053943934e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,SNX15,Sorting nexin-15,37124,0.0797497158826452,0.00499044096529125,0.0699684515906743,0.089530980174616,5.93804164243321e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,GP1BB,Platelet glycoprotein Ib beta chain,37021,0.100254164044016,0.00627903831325269,0.0879472489500406,0.112561079137991,7.47251048851234e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37382,0.217949843374091,0.0136638002539766,0.191168794876297,0.244730891871885,9.24398049724891e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM13A,Protein FAM13A,37382,0.100048014147714,0.00627727519263073,0.0877445547701577,0.11235147352527,1.12972915518022e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,A1BG,Alpha-1B-glycoprotein,37453,0.0252111174658144,0.00158207139455231,0.0221102575324919,0.0283119773991369,1.16992023221261e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,TREM2,Triggering receptor expressed on myeloid cells 2,39862,0.0759766345346031,0.00477498287277719,0.0666176681039598,0.0853356009652464,1.43414613286114e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,IGSF3,Immunoglobulin superfamily member 3,39788,0.0521038288773865,0.00327992051002249,0.0456751846777424,0.0585324730770305,2.15734652925608e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,LSP1,Lymphocyte-specific protein 1,39866,0.0593138579583117,0.00373677271025369,0.0519897834462145,0.066637932470409,2.61980384654629e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,GORASP2,Golgi reassembly-stacking protein 2,37382,0.0697063617539876,0.00439274515798847,0.0610965812443302,0.078316142263645,3.36329073891658e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,CCDC80,Coiled-coil domain-containing protein 80,39868,0.0478278433913915,0.0030195748822683,0.0419094766221456,0.0537462101606374,4.44588893157403e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39841,0.0898984191915065,0.00567647921622706,0.0787725199277015,0.101024318455312,4.61361406640085e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,AMN,Protein amnionless,39587,0.0697853292611683,0.00440796626779804,0.0611457153762842,0.0784249431460525,5.09694088856168e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,PSIP1,PC4 and SFRS1-interacting protein,39866,0.0923523381488102,0.00584257578443021,0.080900889611327,0.103803786686293,7.38985690449131e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,LBR,Delta(14)-sterol reductase LBR,40009,0.0975781179646268,0.00617677509982572,0.0854716387689684,0.109684597160285,8.4599544065306e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,TOP2B,DNA topoisomerase 2-beta,37056,0.11653332564975,0.00737403275586217,0.10208022144826,0.13098642985124,9.58772612427246e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,DIABLO,"Diablo homolog, mitochondrial",39818,0.160451473430204,0.0101626828246434,0.140532615093903,0.180370331766505,9.8915751820079e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,DDHD2,Phospholipase DDHD2,37411,0.0975222990498229,0.00617920715180186,0.0854110530322913,0.109633545067355,1.28707585509983e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,CD40,Tumor necrosis factor receptor superfamily member 5,39859,0.0734704309249906,0.00466083097565601,0.0643352022127048,0.0826056596372763,1.45547903699987e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,CNST,Consortin,39868,0.157026039032433,0.00998847101630533,0.137448635840474,0.176603442224391,2.82518177112448e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,ORM1,Alpha-1-acid glycoprotein 1,37389,0.0289376212860281,0.00183968421107774,0.0253318402323157,0.0325434023397405,2.9220569330781e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,APPL2,DCC-interacting protein 13-beta,37124,0.16462702241042,0.0104722456889549,0.144101420860068,0.185152623960772,3.4537103193395e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,GPKOW,G-patch domain and KOW motifs-containing protein,39489,0.03943240007846,0.00251591401971383,0.0345012085998209,0.0443635915570991,6.04352307063589e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,OPHN1,Oligophrenin-1,37388,0.156778725451417,0.0100035277679715,0.137171811026193,0.176385639876641,7.09835268396922e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37368,0.105597126882698,0.00673794549412087,0.0923907537142207,0.118803500051174,7.14702239520067e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,TAX1BP1,Tax1-binding protein 1,37388,0.0915528763926556,0.00584526119778151,0.0800961644450038,0.103009588340307,8.23225277065242e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,BRAP,BRCA1-associated protein,37249,0.159850288075658,0.0102076166924684,0.13984335935842,0.179857216792897,8.70080384153104e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,STAMBP,STAM-binding protein,39713,0.0932588477972154,0.00596010711317006,0.0815770378554021,0.104940657739029,8.92022615241835e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKG1,cGMP-dependent protein kinase 1,37124,0.183608365461403,0.0117258331458962,0.160625732495447,0.20659099842736,8.99139506124075e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1R2,Protein phosphatase inhibitor 2,39868,0.116732900238443,0.00746735004368137,0.102096894152827,0.131368906324058,1.11029317114371e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP7,Matrilysin,39563,0.0714109116606938,0.00457803346565753,0.0624379660680051,0.0803838572533826,1.90595865346776e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,MARS1,"Methionine--tRNA ligase, cytoplasmic",37088,0.124907280172951,0.008002623444716,0.109222138221308,0.140592422124595,1.95375362975323e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,C19orf12,Protein C19orf12,39489,0.0934364209164122,0.00600371898299485,0.0816691317097423,0.105203710123082,3.30826218424294e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,CRELD1,Protein disulfide isomerase CRELD1,37124,0.0536877218130259,0.00344782748760549,0.0469299799373191,0.0604454636887326,3.43103891623456e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,PKD2,Polycystin-2,37021,0.0860485013420274,0.00552662422527938,0.0752163178604798,0.096880684823575,3.54931988882156e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,CHMP1A,Charged multivesicular body protein 1a,39749,0.114546786889761,0.00737307100631971,0.100095567717374,0.128998006062147,4.95538867584502e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,VASP,Vasodilator-stimulated phosphoprotein,37445,0.105051059525418,0.00675889331015145,0.0918036286375213,0.118298490413315,5.20400241763026e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,TWF2,Twinfilin-2,37437,0.12137934877554,0.00782789404864243,0.106036676440201,0.136722021110879,9.12690686348984e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS8,Galectin-8,40009,0.0876068925603629,0.00565927494546795,0.0765147136672457,0.0986990714534801,1.1461183008314e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,SPART,Spartin,37124,0.111998766901494,0.00723234823220563,0.097823364366371,0.126174169436617,1.27379396042158e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,STAT2,Signal transducer and activator of transcription 2,37056,0.112961590335436,0.00730365962453512,0.0986464174713471,0.127276763199525,1.72148404513095e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,MED18,Mediator of RNA polymerase II transcription subunit 18,39477,0.109934301768685,0.00711507349466076,0.0959887577191494,0.12387984581822,1.84954938825566e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM5,Tripartite motif-containing protein 5,39866,0.123187053026513,0.00798152767011684,0.107543258793084,0.138830847259942,2.34192158338662e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,EGLN1,Egl nine homolog 1,39866,0.0760927865838917,0.00493308611568288,0.0664239377971532,0.0857616353706301,2.68820870542659e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP2,Microtubule-associated protein 2,37388,0.0658198736329008,0.00426664420735438,0.0574572509864862,0.0741824962793154,3.07701752145781e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,GYS1,"Glycogen [starch] synthase, muscle",39585,0.132941833976199,0.00864177752418263,0.116003950028801,0.149879717923597,5.12866651922628e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,DOK1,Docking protein 1,37388,0.195704805148928,0.0127183388587102,0.170776860985856,0.220632749312,5.56804829917418e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,VWA1,von Willebrand factor A domain-containing protein 1,40011,0.0607151518658784,0.00395092871400449,0.0529713315864296,0.0684589721453272,6.42255610971667e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,CD207,C-type lectin domain family 4 member K,39496,0.0535590353459106,0.0034869024576977,0.0467247065288231,0.0603933641629981,7.37521146554656e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,BAG4,BAG family molecular chaperone regulator 4,37056,0.0710942012631811,0.00462870702552748,0.0620219354931472,0.0801664670332149,8.76179522042397e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,MUC13,Mucin-13,39489,0.0718048157368331,0.0046843079777268,0.0626235721004886,0.0809860593731776,1.18590335065014e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL18,C-C motif chemokine 18,39715,0.100057839745646,0.00653547791348995,0.087248303035206,0.112867376456087,1.55862515968655e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,CFHR5,Complement factor H-related protein 5,37267,0.0586049739584781,0.00382558497547521,0.0511068274065467,0.0661031205104095,1.583862055982e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPING1,Plasma protease C1 inhibitor,37424,0.0266665348612607,0.00174333270436035,0.0232496027607144,0.0300834669618069,2.21341118892427e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,GMPR,GMP reductase 1,40058,0.0701599745509324,0.00459075047273526,0.0611621036243713,0.0791578454774935,2.3054623351378e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39477,0.0816788390918637,0.00534400017193589,0.0712045987548693,0.092153079428858,2.33120381968246e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,MAVS,Mitochondrial antiviral-signaling protein,39477,0.130908932716436,0.00856867944375911,0.114114321006668,0.147703544426204,2.57601660053079e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,PACS2,Phosphofurin acidic cluster sorting protein 2,37021,0.0886009600557587,0.0057979653987944,0.0772369478741217,0.0999649722373957,2.8573482303735e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,MOCS2,Molybdopterin synthase catalytic subunit,37124,0.0963376886924053,0.00630796143695489,0.0839740842759738,0.108701293108837,3.24634835595135e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,MPI,Mannose-6-phosphate isomerase,39788,0.121804804908964,0.00799841144804704,0.106127918470792,0.137481691347137,5.3065815277646e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37124,0.0907321898022894,0.00595482913682483,0.0790607246941128,0.102403654910466,5.55300687900905e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,SH3GLB2,Endophilin-B2,37388,0.0934464216319448,0.00613354594282206,0.0814246715840135,0.105468171679876,5.56475361237091e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,OGA,Protein O-GlcNAcase,37382,0.100503616159511,0.00659971130652024,0.087568181998731,0.11343905032029,6.16800131049386e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,EVI5,Ecotropic viral integration site 5 protein homolog,37056,0.128649156260858,0.00845011786595697,0.112086925243582,0.145211387278133,6.70532009766916e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,TDRKH,Tudor and KH domain-containing protein,39489,0.119952762034355,0.00788921209651225,0.104489906325191,0.135415617743519,7.73570539483276e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,NUDT5,ADP-sugar pyrophosphatase,39858,0.0725943517058424,0.00477546809604604,0.0632344342375921,0.0819542691740926,7.95355447483503e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,RBM17,Splicing factor 45,37411,0.107939148595014,0.00709779543907755,0.0940274695344218,0.121850827655606,8.44731154566029e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39866,0.0864605854609578,0.00569334829501813,0.0753016228027223,0.0976195481191934,1.00031196918119e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL7,C-C motif chemokine 7,39866,0.0818579607835486,0.0053908348637664,0.0712919244505665,0.0924239971165307,1.02454033106677e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,FIS1,Mitochondrial fission 1 protein,39855,0.109975463071077,0.00724318827946453,0.095778814043327,0.124172112098828,1.04627613614479e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,MTDH,Protein LYRIC,37056,0.130133550247051,0.00858376801577957,0.113309364936123,0.146957735557979,1.75379824524591e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,WASHC3,WASH complex subunit 3,37388,0.106507341975651,0.00702670988857139,0.0927349905940507,0.120279693357251,1.7884417393807e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,PXN,Paxillin,39489,0.0724117049981373,0.00478217364449057,0.0630386446549358,0.0817847653413388,1.98200039264257e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,KIFBP,KIF-binding protein,39788,0.116377561178796,0.00769163693446878,0.101301952787237,0.131453169570355,2.32191170315364e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,CASC3,Protein CASC3,37039,0.0588670291578988,0.00388951238367646,0.0512435848858929,0.0664904734299046,2.57549251591528e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,PMVK,Phosphomevalonate kinase,39480,0.154975312033896,0.0102729567143782,0.134840316873715,0.175110307194077,4.60039846151788e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,MGLL,Monoglyceride lipase,39908,0.121923764130695,0.00808397282392991,0.106079177395792,0.137768350865598,4.74922719336492e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,NUDC,Nuclear migration protein nudC,40058,0.0898190183005906,0.00595592635959653,0.0781454026357813,0.1014926339654,4.82442166092176e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB27B,Ras-related protein Rab-27B,37437,0.114511910455548,0.00759495103894089,0.0996258064192242,0.129398014491872,5.8959902102854e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,YJU2,Splicing factor YJU2,37368,0.0453574360246791,0.00300952956304346,0.0394587580811139,0.0512561139682443,6.48780444424894e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNLR1,Interferon lambda receptor 1,39866,0.0521060181225554,0.00345994729641386,0.0453245214215842,0.0588875148235266,6.647220841489e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,ICA1,Islet cell autoantigen 1,39587,0.111754380855396,0.00742482552427776,0.097201722827812,0.126307038882981,7.63224474056325e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,PARP1,Poly [ADP-ribose] polymerase 1,39866,0.0761943305071269,0.0050641275015783,0.0662686406040335,0.0861200204102204,8.17495917840662e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,F12,Coagulation factor XII,37453,0.0578448080626592,0.00384337392363485,0.0503117951723349,0.0653778209529835,8.78155159866475e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,CD69,Early activation antigen CD69,39785,0.122281268851959,0.00813206425338197,0.10634242291533,0.138220114788587,9.38082985244545e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,ATOX1,Copper transport protein ATOX1,39913,0.101277515596417,0.0067421888214285,0.088062825506417,0.114492205686417,1.1735287942207e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,HTRA2,"Serine protease HTRA2, mitochondrial",39913,0.085541724019763,0.0056959471874389,0.0743776675323828,0.0967057805071433,1.23553959640236e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37169,0.0692804890229611,0.00461191868550515,0.060241128399371,0.0783198496465512,1.36722922680569e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,KYAT1,Kynurenine--oxoglutarate transaminase 1,39850,0.078588205460941,0.00524273028593959,0.0683124541004994,0.0888639568213826,1.88058764514323e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,SCRG1,Scrapie-responsive protein 1,37437,0.0366984822956145,0.00244883919982981,0.0318987574639481,0.0414982071272809,2.28769582486063e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,GRAP2,GRB2-related adapter protein 2,39868,0.177850239883282,0.0118865788870312,0.154552545264701,0.201147934501864,2.83235435412323e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,EGF,Pro-epidermal growth factor,39808,0.143584041035641,0.00959694084634904,0.124774036976797,0.162394045094485,2.87597796996253e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,DGKA,Diacylglycerol kinase alpha,37056,0.0760348017142762,0.00508223399675886,0.0660736230806288,0.0859959803479235,3.40842050844929e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,IL7,Interleukin-7,39866,0.0901861341004266,0.00603334973639597,0.0783607686170905,0.102011499583763,3.50286147955847e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,CETN3,Centrin-3,37382,0.109408631424424,0.00732515391505209,0.0950513297509223,0.123765933097927,4.81247064129217e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,KITLG,Kit ligand,39868,-0.0511871336438269,0.00342933679905945,-0.0579086337699835,-0.0444656335176704,4.82792574148235e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,BGLAP,Osteocalcin,37437,0.119596747086754,0.00800917525165989,0.103898763593501,0.135294730580008,5.05276133323114e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39866,0.100986745472808,0.00677518335154881,0.0877073861037724,0.114266104841844,6.57153930717432e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL4,C-C motif chemokine 4,39882,0.0860273298972418,0.00577161262012004,0.0747149691618066,0.0973396906326771,6.58003625668878e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,MFAP5,Microfibrillar-associated protein 5,40052,0.0555088816480296,0.00372498891200699,0.0482079033804959,0.0628098599155633,6.87303589372214e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,IRAK4,Interleukin-1 receptor-associated kinase 4,39866,0.144428935220712,0.00969603389823258,0.125424708780176,0.163433161661248,7.58525207250164e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,CRADD,Death domain-containing protein CRADD,39713,0.10518847892975,0.00707159285498547,0.0913281569339785,0.119048800925522,1.03960593354402e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,FLT4,Vascular endothelial growth factor receptor 3,39913,0.0468198755186515,0.00314998885179932,0.0406458973691248,0.0529938536681782,1.21605677575147e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK13,Kallikrein-13,39490,0.0581264596834408,0.00391102863900709,0.0504608435509869,0.0657920758158947,1.26531112025374e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39506,0.1084624331937,0.00731074757126442,0.0941333679540213,0.122791498433378,1.85783524802202e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,FNDC1,Fibronectin type III domain-containing protein 1,37388,0.0633527186422751,0.00426889306178821,0.0549856882411702,0.07171974904338,1.95996139353785e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39477,0.0621865114882536,0.00419653710035991,0.0539612987715481,0.070411724204959,2.40557238210929e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,SNAP25,Synaptosomal-associated protein 25,36991,0.0648734055830605,0.00437822429882064,0.056292085957372,0.0734547252087489,2.8305972603905e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRD1,Adhesion G-protein coupled receptor D1,37124,0.0533998044565943,0.00360631583245357,0.0463314254249853,0.0604681834882033,3.24646387020482e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,GAS6,Growth arrest-specific protein 6,39947,-0.0349895396134852,0.00236576185228007,-0.0396264328439541,-0.0303526463830162,3.57692376201737e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,PDGFA,Platelet-derived growth factor subunit A,40052,0.0983515931003218,0.00665160996973593,0.0853144375596394,0.111388748641004,3.76561322798075e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39866,0.126714057179243,0.00857012166158371,0.109916618722539,0.143511495635947,3.82974792691488e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,IDUA,Alpha-L-iduronidase,40030,0.0627951112402498,0.00424831191562621,0.0544684198856224,0.0711218025948771,4.05245209424516e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,PPIB,Peptidyl-prolyl cis-trans isomerase B,39837,0.131600095078497,0.00891396114162418,0.114128731240914,0.149071458916081,5.3072348421553e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,SPRY2,Protein sprouty homolog 2,39587,0.126454480609242,0.00857670088891637,0.109644146866966,0.143264814351518,7.13205429501249e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,MSTN,Growth/differentiation factor 8,39585,0.0707924126113014,0.0048046500832323,0.0613752984481661,0.0802095267744367,8.23126808291014e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1RL2,Interleukin-1 receptor-like 2,39587,0.0541727360086438,0.00367854614682949,0.046962785560858,0.0613826864564296,9.17933303525088e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,MOG,Myelin-oligodendrocyte glycoprotein,40030,0.0433201837843198,0.00294326679885244,0.037551380858569,0.0490889867100706,1.01484382491379e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39477,0.106530060513696,0.00724600748652389,0.0923278858401088,0.120732235187282,1.32413496993465e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37043,0.062582768905885,0.00425916164408009,0.0542348120834881,0.070930725728282,1.71036200694551e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39858,0.0632786711533602,0.00431054700403561,0.0548299990254504,0.07172734328127,1.79053508545998e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39477,0.0690296622434466,0.00470719891555513,0.0598035523689585,0.0782557721179346,2.27498819677104e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM172A,Cotranscriptional regulator FAM172A,37043,0.0839568226908562,0.00572740392148666,0.0727311110047424,0.0951825343769701,2.83729797567875e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL11,Eotaxin,40058,0.0517422634866894,0.00353309420269992,0.0448173988493976,0.0586671281239813,2.94905905848389e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,LPP,Lipoma-preferred partner,37021,0.0913460998412939,0.00623307849180636,0.0791292659973534,0.103562933685234,2.99953947685039e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,ASPSCR1,Tether containing UBX domain for GLUT4,37411,0.0920838797859983,0.00628487064718622,0.0797655333175133,0.104402226254483,3.07255444234995e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,STK24,Serine/threonine-protein kinase 24,39489,0.0843018248957653,0.00575938169383751,0.0730134367758438,0.0955902130156869,3.3843995904824e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,SH2D1A,SH2 domain-containing protein 1A,39866,0.0766109813378357,0.0052349001280138,0.0663505770869286,0.0868713855887427,3.45703161684096e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36846,0.0446392238262658,0.00305086130934364,0.0386595356599523,0.0506189119925793,4.2562894229617e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37388,0.132914914875941,0.00909028536180207,0.115097955566809,0.150731874185073,4.75234051680852e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,MAPKAPK2,MAP kinase-activated protein kinase 2,37169,0.0994626541012237,0.00680284313782033,0.0861290815510958,0.112796226651352,4.88088801181961e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37124,0.116698792652128,0.00798431905029481,0.101049527313551,0.132348057990706,5.24278565867134e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39749,0.106376646482769,0.00728580513558014,0.0920964684170315,0.120656824548506,5.69812200631401e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,RWDD1,RWD domain-containing protein 1,40009,0.086193165786745,0.00591099891315759,0.0746076079169561,0.0977787236565339,7.38443985117661e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37124,0.0374565148895905,0.00257218073155935,0.0324150406557341,0.0424979891234468,1.13981790402357e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,PPBP,Platelet basic protein,37371,0.114758255526491,0.00788657065651856,0.0993005770397143,0.130215934013267,1.31638205676818e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39788,0.119521665678372,0.00822500449997368,0.103400656858423,0.13564267449832,1.54150659455322e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39429,0.116555056226732,0.0080432194260505,0.100790346151673,0.132319766301791,2.80110473505362e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39885,0.039266280551919,0.00271575268500551,0.0339434052893082,0.0445891558145298,4.37074752772754e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,SPARC,SPARC,39913,0.0944741992701389,0.00653445941711435,0.0816666588125947,0.107281739727683,4.42010341664964e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,HNMT,Histamine N-methyltransferase,39669,0.0619249502378818,0.0042839078569595,0.0535284908382412,0.0703214096375225,4.63580006515041e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37124,0.0782518292875129,0.00541180191876112,0.0676446975267411,0.0888589610482847,4.97552253017716e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,FGFBP2,Fibroblast growth factor-binding protein 2,37437,0.0664277930250877,0.00460140195251904,0.0574090451981503,0.075446540852025,6.78915942990207e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,BLMH,Bleomycin hydrolase,40052,0.0427429676719959,0.00296393338267111,0.0369336582419605,0.0485522771020313,7.44622151060722e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37453,0.0349308379420444,0.00242230777203706,0.0301831147088518,0.0396785611752371,8.51712079275597e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,AFP,Alpha-fetoprotein,39699,0.0901699533789576,0.00626293389024261,0.0778946029540821,0.102445303803833,1.05927162894287e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,XIAP,E3 ubiquitin-protein ligase XIAP,37056,0.0783389541851224,0.00543802764031512,0.0676804200101048,0.0889974883601401,1.07564976154874e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,DRG2,Developmentally-regulated GTP-binding protein 2,39788,0.0754663304178079,0.00524552206825851,0.0651851071640213,0.0857475536715946,1.22748612655556e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37382,0.0674544467774558,0.00468765142183482,0.0582666499906595,0.076642243564252,1.32407164769159e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40030,0.0847531755906514,0.00589574049309589,0.0731975242241835,0.0963088269571194,1.43170903696392e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,SFRP1,Secreted frizzled-related protein 1,39689,0.0566069965943381,0.00393898267041626,0.0488865905603222,0.0643274026283539,1.54506428142114e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS3,Galectin-3,39901,0.039303465235998,0.00273511456879178,0.0339426406811661,0.0446642897908299,1.55382877142881e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP7,Caspase-7,37388,0.112453707506881,0.00782684987039139,0.0971130817609142,0.127794333252848,1.81360805243612e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39866,0.128129240160429,0.00892684433173178,0.110632625270234,0.145625855050623,1.97407428462525e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,TMED8,Protein TMED8,37382,0.137907325076175,0.00960571646996919,0.119080120795035,0.156734529357315,2.11787604642538e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,TALDO1,Transaldolase,37415,0.0593948192565324,0.00414595988549581,0.0512687378809606,0.0675209006321042,3.27521471781236e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,DTNB,Dystrobrevin beta,37348,0.0583961247565978,0.00407691706520068,0.0504053673088045,0.0663868822043911,3.39925025460667e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,GP5,Platelet glycoprotein V,37124,0.048069623188287,0.0033566439065857,0.041490601131379,0.054648645245195,3.58627751137456e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39587,0.073892502244754,0.00517431614043821,0.0637508426094951,0.0840341618800129,5.60157101407731e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,ELAC1,Zinc phosphodiesterase ELAC protein 1,37411,0.113266659731455,0.00792873268273543,0.0977263436732937,0.128806975789617,5.80145147854946e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,DPT,Dermatopontin,40052,0.0354486105561503,0.00248299559869017,0.0305819391827176,0.0403152819295831,5.82425704439202e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,RRAS,Ras-related protein R-Ras,37039,0.174629949136317,0.0122268625102642,0.150665298616199,0.198594599656434,6.19385680101109e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,SMAD3,Mothers against decapentaplegic homolog 3,37368,0.0675483108729556,0.00473239184971116,0.0582728228475217,0.0768237988983894,6.88917060063353e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37437,0.116205130625625,0.00814236147986318,0.100246102125093,0.132164159126157,7.05279446896779e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,CD226,CD226 antigen,37056,0.055506121687077,0.00389179783244006,0.0478781979354945,0.0631340454386595,8.22451792917904e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,TMEM106A,Transmembrane protein 106A,37368,0.0941739546971548,0.00660747724281842,0.0812232993012307,0.107124610093079,9.26381269888134e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,GOLGA3,Golgin subfamily A member 3,37411,0.102634898227349,0.00720451776906733,0.0885140433999772,0.116755753054721,1.01614467994078e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,NACC1,Nucleus accumbens-associated protein 1,37368,0.0726834025534196,0.00510289105348637,0.0626817360885863,0.0826850690182529,1.05267831016458e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,GPRC5C,G-protein coupled receptor family C group 5 member C,37368,0.0753317845083691,0.00529046468310682,0.0649624737294797,0.0857010952872585,1.12022631011119e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM40,E3 ubiquitin ligase TRIM40,37039,0.0960253822297447,0.00674695640257488,0.0828013476806979,0.109249416778791,1.25558279670743e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,PF4,Platelet factor 4,37385,0.127492906283138,0.00896196486758692,0.109927455142668,0.145058357423609,1.34724621282236e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF5,E3 ubiquitin-protein ligase RNF5,37043,0.0968511675769743,0.00681253059121945,0.0834986076181842,0.110203727535764,1.56752691352169e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,CETN2,Centrin-2,39489,0.0890254925010571,0.00627182788389491,0.076732709848623,0.101318275153491,1.89841885936293e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSL,Cathepsin L1,39868,0.0313921008958709,0.00221183643580162,0.0270569014816998,0.0357273003100421,1.91572897439431e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,SPON2,Spondin-2,39775,-0.044042253522406,0.00310498804691929,-0.0501280300943679,-0.0379564769504442,2.16485559231756e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,AGXT,Serine--pyruvate aminotransferase,39868,0.102232463407914,0.00721124570827191,0.0880984218197013,0.116366504996127,2.39855735318471e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,NSFL1C,NSFL1 cofactor p47,40009,0.0852570137756679,0.00601941665900917,0.07345895712401,0.0970550704273259,2.86985023383918e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINB6,Serpin B6,39970,0.0789876933199691,0.00557690170138498,0.0680569659852545,0.0899184206546836,2.88639430883272e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,STXBP1,Syntaxin-binding protein 1,37411,0.102629557112477,0.00725364014810468,0.088412422422192,0.116846691802762,3.98526159215187e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,ROBO2,Roundabout homolog 2,40009,0.0297742835341788,0.00210605428377418,0.0256464171379814,0.0339021499303762,4.14625595017706e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP6AP2,Renin receptor,39477,0.0533428927111339,0.00377475664636235,0.0459443696842637,0.0607414157380042,4.60521876681804e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM58,E3 ubiquitin-protein ligase TRIM58,37368,0.112004766336675,0.00792443346897079,0.0964728767374927,0.127536655935858,4.90030463294864e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,CTF1,Cardiotrophin-1,39585,0.111006317749876,0.00786617116126994,0.0955886222737871,0.126424013225965,6.03605797803127e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,F2R,Proteinase-activated receptor 1,39908,0.0763332490132362,0.00541113568036696,0.0657274230797169,0.0869390749467554,6.4075888692431e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB6A,Ras-related protein Rab-6A,39866,0.0603577687378743,0.00428408604308108,0.0519609600934354,0.0687545773823132,8.24074912638436e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL8,C-C motif chemokine 8,40003,0.0786237328369827,0.00558996575507143,0.0676673999570426,0.0895800657169227,1.14136643571195e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,SMNDC1,Survival of motor neuron-related-splicing factor 30,37382,0.0778876753835779,0.00553783660468952,0.0670335156383865,0.0887418351287694,1.29172299104051e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,EHD3,EH domain-containing protein 3,37043,0.153211242679082,0.0108928822695032,0.131861193430855,0.174561291927308,1.30438959569567e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,ERP29,Endoplasmic reticulum resident protein 29,37124,0.155792935271564,0.0110843352909179,0.134067638101365,0.177518232441764,1.4931024634384e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,UBXN1,UBX domain-containing protein 1,37124,0.090532361643745,0.00644202567660349,0.0779059913176021,0.103158731969888,1.53172797304998e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,CLUL1,Clusterin-like protein 1,39840,-0.0587798987618101,0.00418581772097757,-0.0669841014949261,-0.0505756960286941,1.57239584353949e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,DLG4,Disks large homolog 4,37388,0.0934611190046113,0.00665350475340832,0.080420249687931,0.106501988321292,1.65307503133164e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,VAV3,Guanine nucleotide exchange factor VAV3,36991,0.129573947245728,0.00922558871950304,0.111491793355502,0.147656101135954,1.73287292505887e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,FARSA,Phenylalanine--tRNA ligase alpha subunit,37039,0.0892840768720081,0.00636782297480753,0.0768031438413853,0.101765009902631,2.41001538170294e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,ST13,Hsc70-interacting protein,37124,0.0719202614459906,0.00513035584345906,0.0618647639928108,0.0819757588991703,2.4855824759594e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,NID1,Nidogen-1,39892,0.0487429615744902,0.00348095351541143,0.0419202926842838,0.0555656304646966,2.73393479869015e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39788,0.0710321436025895,0.00507393887086429,0.0610872234156955,0.0809770637894835,2.87553494282897e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,NUB1,NEDD8 ultimate buster 1,39866,0.109144287229437,0.00780226228410666,0.0938518531525879,0.124436721306286,3.32251777756382e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39489,0.145997442684421,0.0104403568794444,0.12553434320071,0.166460542168132,3.6052010663811e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,BAG6,Large proline-rich protein BAG6,39585,0.047918069873905,0.003427209833007,0.0412007386012112,0.0546354011465987,3.70811921302051e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39758,0.0969794966721852,0.00693821572247912,0.0833805938561261,0.110578399488244,3.89802322219336e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,TP53,Cellular tumor antigen p53,39477,0.0572006953764699,0.00409255867314414,0.0491792803771074,0.0652221103758324,3.98562123650396e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,TBCB,Tubulin-folding cofactor B,39749,0.131281551311246,0.00939504856339052,0.112867256127001,0.149695846495491,4.12769621979951e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39477,0.110403775836364,0.00790512421438187,0.0949097323761757,0.125897819296553,4.62025154251273e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,MESD,LRP chaperone MESD,39858,0.157889874332437,0.0113125703207922,0.135717236503685,0.18006251216119,5.16457573578769e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,BPIFB2,BPI fold-containing family B member 2,37405,0.0794007384592949,0.0056960189718364,0.0682365412744955,0.0905649356440942,7.30141111629387e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,PON3,Serum paraoxonase/lactonase 3,39931,-0.0363007896996009,0.00260855413421331,-0.041413555802659,-0.0311880235965428,9.08117737419079e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,STX8,Syntaxin-8,39866,0.0628493920831443,0.00451698553033245,0.0539961004436927,0.0717026837225958,9.36355035911828e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,PDIA4,Protein disulfide-isomerase A4,37437,0.0793625068118658,0.00570080443975363,0.0681889301099487,0.0905360835137829,9.3984583255176e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL24,C-C motif chemokine 24,39908,0.106233960299653,0.00763720152126386,0.0912650453179761,0.12120287528133,9.8735115504684e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP3R1,Calcineurin subunit B type 1,39749,0.0534880451240612,0.00384988915973182,0.0459422623709868,0.0610338278771355,1.24998897811342e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPT1,Angiopoietin-1,39794,0.108576833970281,0.0078163066028905,0.0932568730286154,0.123896794911946,1.28874163814647e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,NUDT16,U8 snoRNA-decapping enzyme,37366,0.113912354087524,0.00819715690521824,0.0978459265532966,0.129978781621752,1.32601923247954e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,NEXN,Nexilin,37445,0.0886978201729608,0.00638533293580693,0.0761825676187792,0.101213072727142,1.42859153898034e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,PRDX6,Peroxiredoxin-6,40030,-0.0760494244225216,0.00547816391335304,-0.0867866256926936,-0.0653122231523496,1.44243744233358e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,TRAF2,TNF receptor-associated factor 2,39866,0.0912664069409951,0.0065789968419401,0.0783715731307926,0.104161240751198,1.66288141702283e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39979,0.0739034908934871,0.00533096035170762,0.0634548086041401,0.084352173182834,1.8829813559463e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,HPSE,Heparanase,37306,0.120869889678929,0.00872660662341256,0.10376574069704,0.137974038660818,2.49779045549027e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,HARS1,"Histidine--tRNA ligase, cytoplasmic",39858,0.0995838513627869,0.00719562995015741,0.0854804166604784,0.113687286065095,2.6158914371998e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39866,0.129045090319217,0.00932810271829048,0.110762008991368,0.147328171647066,2.81963103862404e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37368,0.0620361788519122,0.00448910512616944,0.0532375328046201,0.0708348248992043,3.83295580506048e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,SDHB,Succinate dehydrogenase,37382,0.0899922027557209,0.00651426603482004,0.0772242413274737,0.102760164183968,4.08164868676041e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37411,0.0603245957762517,0.0043676408886641,0.0517640196344701,0.0688851719180334,4.24223663438051e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,HSPB1,Heat shock protein beta-1,39617,0.089043115389671,0.00645141677668513,0.0763983385073682,0.101687892271974,4.40839496951452e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC3B,Tetranectin,37138,0.0270995115478425,0.00196339881676617,0.0232512498669808,0.0309477732287042,4.88860792023009e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,CACYBP,Calcyclin-binding protein,37088,0.132892702323683,0.00963200275392758,0.114013976925985,0.151771427721381,5.27321815180081e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,BST2,Bone marrow stromal antigen 2,40009,0.067969387217197,0.00493213568232153,0.0583024012798468,0.0776363731545472,5.81123885169484e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,FOXJ3,Forkhead box protein J3,37056,0.0574455299478206,0.00416750200782125,0.049277226012491,0.0656138338831503,6.29429671254135e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,APOL1,Apolipoprotein L1,37445,0.0784617082969652,0.00569374129016277,0.0673019753682461,0.0896214412256842,6.50403777611246e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,MARCO,Macrophage receptor MARCO,39868,0.0334427297860529,0.00242890387217022,0.0286820781965993,0.0382033813755065,6.90769260360015e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,ATXN2L,Ataxin-2-like protein,37411,0.0613774678649646,0.00445830962685242,0.0526391809963339,0.0701157547335953,7.81865932299925e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,SELE,E-selectin,40052,0.0634492465174503,0.00461474148403444,0.0544043532087428,0.0724941398261578,8.94850298499786e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,OCLN,Occludin,37411,0.0547350825596047,0.00398302949812549,0.0469283447432787,0.0625418203759307,1.09810553147835e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,MIA,Melanoma-derived growth regulatory protein,39913,0.0460375649929496,0.00335211200103861,0.0394674254709139,0.0526077045149853,1.1088115841074e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,GASK1A,Golgi-associated kinase 1A,37021,0.054607781116308,0.00397685275656674,0.0468131497134372,0.0624024125191788,1.29451633790176e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39788,0.120794704105295,0.00880647009044145,0.10353402272803,0.138055385482561,1.41013525991831e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39932,0.142607219318215,0.0103994324926704,0.122224331632581,0.162990107003849,1.47382370703001e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39931,0.153303617116748,0.0111806851671783,0.131389474189079,0.175217760044418,1.50455209123474e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,MSR1,Macrophage scavenger receptor types I and II,40009,0.0580401070800762,0.0042330592037825,0.0497433110406625,0.0663369031194899,1.50712832049289e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,IGBP1,Immunoglobulin-binding protein 1,37411,0.0767885275352249,0.00560167033901378,0.0658092536707579,0.0877678013996919,1.74235368490073e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37437,0.0790809081696009,0.00577934726796431,0.0677533875243909,0.090408428814811,2.43656332499938e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,CFB,Complement factor B,37220,0.0418489048884574,0.00306146834411958,0.035848426933983,0.0478493828429318,2.96904544402506e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,KCTD5,BTB/POZ domain-containing protein KCTD5,37165,0.055400488109256,0.0040620552335257,0.0474388598515456,0.0633621163669663,4.53031483066949e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINE2,Glia-derived nexin,37437,0.08165116166764,0.00598845995838017,0.0699137801492148,0.0933885431860651,4.70702663509285e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,VPS4B,Vacuolar protein sorting-associated protein 4B,37368,0.119436658589275,0.00878858837110134,0.102211025381917,0.136662291796634,8.64354855724866e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39908,0.0966129961474393,0.00711300543741149,0.0826715054901128,0.110554486804766,8.64714539368513e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37437,0.112290146493074,0.00826323624515404,0.0960942034525725,0.128486089533576,8.71489593768033e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,COMT,Catechol O-methyltransferase,39403,0.107143735935407,0.00789119756698113,0.0916769887041245,0.122610483166691,9.40522973435185e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37124,0.0531148814266416,0.00391362055128527,0.0454441851461224,0.0607855777071607,1.11675708280248e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,SUGT1,Protein SGT1 homolog,39477,0.101868972761432,0.007515413654786,0.0871387619980514,0.116599183524813,1.27829759716407e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39477,0.0546021388251781,0.00403064747425254,0.0467020697756432,0.0625022078747131,1.42237594418785e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPTL7,Angiopoietin-related protein 7,40030,0.0467224841851692,0.00345314432274597,0.0399543213125871,0.0534906470577513,1.73964043798812e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36709,0.137450019571456,0.0101527290096128,0.117550670712615,0.157349368430297,1.78949166710055e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,OTUD6B,Deubiquitinase OTUD6B,37382,0.0732066692496585,0.00541741909312262,0.0625885278271382,0.0838248106721789,2.42426698151429e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,LACTB2,Endoribonuclease LACTB2,39868,0.0833656435810253,0.00617247284549004,0.0712675968038649,0.0954636903581858,2.4266976115894e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,CERT,Ceramide transfer protein,39489,0.0770699516143442,0.00570873471282939,0.0658808315771986,0.0882590716514898,2.65198367905194e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,CD164,Sialomucin core protein 24,39858,0.0327757655101208,0.00242921527082577,0.0280145035793023,0.0375370274409393,2.91782344515359e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,XPNPEP2,Xaa-Pro aminopeptidase 2,39913,0.123695304682009,0.0091791281205235,0.105704213565783,0.141686395798235,3.63922651836221e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37411,0.124511814165402,0.00924103900082984,0.106399377723776,0.142624250607028,4.10337029849351e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39469,0.0735407127016002,0.00546076657375878,0.062837610217033,0.0842438151861674,4.1437201190512e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39477,0.122773505892904,0.00911953715143343,0.104899213076094,0.140647798709714,4.3946803123677e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39866,0.102073473618425,0.00759509619497839,0.0871870850762679,0.116959862160583,5.92541531861999e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37043,0.127635447619413,0.00949394200641427,0.109027321286841,0.146243573951985,6.22067866741839e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,FUS,RNA-binding protein FUS,39455,0.0488983961243047,0.0036397132227592,0.0417645582076966,0.0560322340409127,6.3949253693495e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,LRP11,Low-density lipoprotein receptor-related protein 11,39868,0.0433275444353069,0.00322547316570338,0.0370056170305283,0.0496494718400856,6.45952815796214e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37368,0.0447044368816962,0.00332636295273606,0.0381847654943335,0.0512241082690588,6.50395112830763e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39788,0.0290474150406761,0.00216416041697485,0.0248056606234054,0.0332891694579468,7.49052191143677e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,C1R,Complement C1r subcomponent,37453,0.0241110435308038,0.00179567547344399,0.0205915196028536,0.027630567458754,7.61890576751015e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,GMPR2,GMP reductase 2,37124,0.0835742445850473,0.00622481868296214,0.0713735999664415,0.0957748892036531,7.8681424251254e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRR,Receptor-type tyrosine-protein phosphatase R,37388,0.044488327157807,0.00331382350796469,0.0379932330821962,0.0509834212334178,7.86888038470251e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37043,0.120915497488059,0.00901517987186154,0.103245744939211,0.138585250036908,9.4572541983899e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL1,Growth-regulated alpha protein,39839,0.117928151019451,0.00880037698295308,0.100679412132863,0.135176889906039,9.98437436666116e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,TST,Thiosulfate sulfurtransferase,39455,0.0949431535700499,0.00708558681182385,0.0810554034188751,0.108830903721225,1.02272865209554e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,TBC1D5,TBC1 domain family member 5,39866,0.0966211152292191,0.00721941131976613,0.0824710690424775,0.110771161415961,1.24828871145469e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37043,0.0585571711013391,0.00437481808601947,0.0499825276527409,0.0671318145499372,1.36087031069219e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,CD244,Natural killer cell receptor 2B4,40058,0.0330820392045157,0.00247500645886694,0.0282310265451365,0.0379330518638949,1.5572809721779e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,NIT1,Deaminated glutathione amidase,37043,0.0584286960453227,0.00436990502715021,0.0498636821921082,0.0669937098985371,1.64639600137479e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRF5,Adhesion G protein-coupled receptor F5,37437,0.0353843000113319,0.00264864772853546,0.0301929504634024,0.0405756495592614,1.87995479338007e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,ASGR2,Asialoglycoprotein receptor 2,37445,0.0313718795905331,0.00235133272228692,0.0267632674548507,0.0359804917262154,2.36080829450516e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37043,0.0951578062898819,0.00713283993150765,0.0811774400241269,0.109138172555637,2.44677613771262e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,ELOA,Elongin-A,39788,0.0632011801553934,0.00474215994834581,0.0539065466566356,0.0724958136541512,2.63280896248303e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,MYO9B,Unconventional myosin-IXb,39587,0.0815916368954801,0.00612705869246236,0.0695826018582539,0.0936006719327064,3.06107623395821e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,SUOX,"Sulfite oxidase, mitochondrial",37411,0.0774953043857081,0.00582504330493699,0.0660782195080316,0.0889123892633846,3.92608938292074e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39866,0.150951977076119,0.0113550993896292,0.128695982272446,0.173207971879793,4.1058732719305e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,APP,Amyloid-beta precursor protein,39829,0.0820023984411292,0.00616909393499973,0.0699109743285297,0.0940938225537286,4.18213648457925e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,STIP1,Stress-induced-phosphoprotein 1,39826,0.0797487210113152,0.00600378106704273,0.0679813101199115,0.091516131902719,4.73397968803148e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,HSPA1A,Heat shock 70 kDa protein 1A,39904,0.0879605369539715,0.00662308969048269,0.0749792811606254,0.100941792747318,4.8615199646205e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,ASS1,Argininosuccinate synthase,37021,0.0987439706257791,0.00743210753331878,0.0841770398604743,0.113310901391084,5.04267483031217e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,LRRC59,Leucine-rich repeat-containing protein 59,37437,0.057543355525392,0.00433264067183522,0.049051379808595,0.066035331242189,5.27443593427339e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,PRSS8,Prostasin,39805,0.0493085989616462,0.00371831318136978,0.0420207051261614,0.056596492797131,6.3391519324392e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,CHM,Rab proteins geranylgeranyltransferase component A 1,37039,0.0754690854831547,0.00569196244974225,0.0643128390816599,0.0866253318846495,7.21379628587656e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,FAS,Tumor necrosis factor receptor superfamily member 6,40002,0.0391752899563497,0.00295942771845553,0.0333748116281768,0.0449757682845225,8.59652096626922e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,TPK1,Thiamin pyrophosphokinase 1,37437,0.0338736396724704,0.00255914751563863,0.0288577105418187,0.0388895688031221,9.54486732602996e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37411,0.058621548761446,0.00442914692043472,0.049940420797394,0.0673026767254981,9.66810734971606e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39998,0.0369058755098278,0.00279721760593275,0.0314233290021996,0.042388422017456,1.52671861070772e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,BIN2,Bridging integrator 2,39858,0.109568028663562,0.00831588391211499,0.0932688961958163,0.125867161131307,1.94195487956152e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,RP2,Protein XRP2,39788,0.0510478284809125,0.00387569948430084,0.0434514574916828,0.0586441994701421,2.06410121708131e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39477,0.0833352253620595,0.00632733418936477,0.0709336503509045,0.0957368003732144,2.09961677939523e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,IL18,Interleukin-18,39795,0.055607556184308,0.00422294236762127,0.0473305891437703,0.0638845232248457,2.15459968384242e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,SCARF1,Scavenger receptor class F member 1,40052,0.0522157177081363,0.00396697959947441,0.0444404376931665,0.0599909977231061,2.29464161072723e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,LAP3,Cytosol aminopeptidase,39587,0.0593451016599842,0.00450957760691903,0.0505063295504229,0.0681838737695455,2.41294683536719e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,BCL2L1,Bcl-2-like protein 1,37388,0.122365364023197,0.00929699259724175,0.104143258532603,0.140587469513791,2.53825254599243e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,PNMA1,Paraneoplastic antigen Ma1,37043,0.0694859825983892,0.0052878899433096,0.0591217183095024,0.079850246887276,3.39778450648245e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,DNM3,Dynamin-3,37411,0.0669390338956694,0.00509694341004911,0.0569490248119731,0.0769290429793656,3.68622555056864e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,ESYT2,Extended synaptotagmin-2,37388,0.100457348370906,0.00764981072582982,0.0854637193482798,0.115450977393533,3.74625488901701e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,PCDH9,Protocadherin-9,37382,0.040498892878343,0.00308838575691728,0.0344456567947852,0.0465521289619009,4.78223432266744e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,CRYBB1,Beta-crystallin B1,37437,0.0808400568947682,0.00617665154095737,0.0687338198744918,0.0929462939150447,6.6303623578915e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,JAM3,Junctional adhesion molecule C,37124,0.0614897317253188,0.00470063819867036,0.0522764808559249,0.0707029825947127,7.34108808324674e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,DFFA,DNA fragmentation factor subunit alpha,40058,0.0821198748512444,0.00628318611190268,0.0698048300719151,0.0944349196305736,7.70438387889333e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,SRP14,Signal recognition particle 14 kDa protein,39788,0.0722481191479943,0.00553722542716502,0.0613951573107508,0.0831010809852377,1.0342109016048e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,SFTPA2,Pulmonary surfactant-associated protein A2,39477,0.0596062213899851,0.00457007138125271,0.0506488814827298,0.0685635612972405,1.11325619364632e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,YWHAQ,14-3-3 protein theta,37124,0.0899510317335524,0.0068979289860783,0.0764310909208389,0.103470972546266,1.24696188454025e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,GLB1,Beta-galactosidase,39749,0.0509489333414952,0.00391149660378293,0.0432823999980806,0.0586154666849097,1.3823646970217e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,DTD1,D-aminoacyl-tRNA deacylase 1,37124,0.10669779453808,0.00819605840408455,0.0906335200660747,0.122762069010086,1.66000978647269e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,RFC4,Replication factor C subunit 4,37368,0.0258279092261299,0.00198454955564536,0.021938192097065,0.0297176263551948,1.72425882103534e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJB14,DnaJ homolog subfamily B member 14,37382,0.0785610262735288,0.00603645910146781,0.0667295664346519,0.0903924861124057,1.72493075916365e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,SEPTIN9,Septin-9,39788,0.0341993652410224,0.00262916294929199,0.0290462058604101,0.0393525246216347,1.73740302630463e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINB9,Serpin B9,39749,0.0403462748187183,0.00310207707168708,0.0342662037582116,0.046426345879225,1.77314371346434e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB1BP2,Integrin beta-1-binding protein 2,39585,0.135512929276296,0.0104276097595101,0.115074814147656,0.155951044404936,2.04396303557493e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,CD5,T-cell surface glycoprotein CD5,40003,0.0395918614514123,0.00304736201885212,0.0336190318944622,0.0455646910083625,2.1113542800088e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,CYB5R2,NADH-cytochrome b5 reductase 2,37220,0.0671970189213397,0.00518028610283394,0.0570436581597852,0.0773503796828943,3.01380518391819e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,PYY,Peptide YY,37021,0.11132816677381,0.00859012976758749,0.0944915124293387,0.128164821118282,3.53060884049806e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGEF10,Rho guanine nucleotide exchange factor 10,37411,0.112675554306179,0.00869926399972188,0.0956249968667244,0.129726111745634,3.83917183037994e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,GRPEL1,"GrpE protein homolog 1, mitochondrial",39788,0.0737034410360748,0.00569346176462051,0.0625442559774186,0.084862626094731,3.89098296427963e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,TADA3,Transcriptional adapter 3,37368,0.0476437052238583,0.00367925854208083,0.0404323584813799,0.0548550519663368,3.99893790258325e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL26,C-C motif chemokine 26,39866,0.102605014036842,0.00793002538236344,0.0870621642874098,0.118147863786274,4.22055108606499e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,AKT2,RAC-beta serine/threonine-protein kinase,37411,0.15279181240182,0.0118060154336968,0.129652022151774,0.175931602651865,4.39144905561177e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,AP2B1,AP-2 complex subunit beta,37039,0.0590287633430486,0.00456090938855773,0.0500893809414755,0.0679681457446218,4.42937950283145e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,GMFG,Glia maturation factor gamma,37437,0.0865048562272469,0.00668548818918432,0.0734012993764456,0.0996084130780482,4.53994323921269e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,CFHR4,Complement factor H-related protein 4,37409,0.0864564650156648,0.0066853845376318,0.0733531113219065,0.0995598187094232,4.97504743847184e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,SCGB3A2,Secretoglobin family 3A member 2,39908,-0.0924271899263224,0.00715326494258675,-0.106447589213792,-0.0784067906388523,5.30268848848579e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37368,0.129493001416192,0.0100319531615904,0.109830373219475,0.14915562961291,6.79006196007371e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,STX4,Syntaxin-4,39788,0.0709771856908977,0.00550188972763663,0.0601934818247299,0.0817608895570655,6.92102689516891e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,GP6,Platelet glycoprotein VI,39836,0.10609081450415,0.0082255844859877,0.0899686689116137,0.122212960096685,7.1694588084844e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP2,Caspase-2,39866,0.0816009629595024,0.00633372468751618,0.0691868625719707,0.0940150633470341,8.58427588450442e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,AKT3,RAC-gamma serine/threonine-protein kinase,39391,0.0695872717252968,0.00541111347408444,0.0589814893160913,0.0801930541345023,1.17536528047125e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,DCTD,Deoxycytidylate deaminase,37124,0.114426163971389,0.00889729391525759,0.0969874678974842,0.131864860045294,1.25534313443402e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37169,0.0801064808001977,0.00623163313801649,0.0678924798496853,0.09232048175071,1.35247730548814e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,CEMIP2,Cell surface hyaluronidase,37056,0.0382401623634998,0.00297604276399652,0.0324071185460666,0.0440732061809329,1.45688254709015e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39749,0.112917315789292,0.00880708792245208,0.0956554234612861,0.130179208117298,1.91312808035373e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37124,0.124610355660882,0.00972306428013101,0.105553149671825,0.143667561649939,2.22390803349532e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,CIAPIN1,Anamorsin,39913,0.0750451962829728,0.00585896612334891,0.0635616226812089,0.0865287698847367,2.23654042410794e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,GNPDA2,Glucosamine-6-phosphate isomerase 2,37124,0.0440222640365503,0.00343756975151993,0.0372846273235712,0.0507599007495293,2.5174331874985e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,CBLN4,Cerebellin-4,40030,0.036783236827421,0.00287562319968425,0.0311470153560399,0.0424194582988021,2.77681313381718e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGA2,Integrin alpha-2,37124,0.0399842440465462,0.00312492327851092,0.0338593944206648,0.0461090936724276,2.89349537666583e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,INPP1,Inositol polyphosphate 1-phosphatase,39788,0.0640263044912727,0.00501019690147299,0.0542063185643856,0.0738462904181597,3.26375864684187e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,THTPA,Thiamine-triphosphatase,37345,0.104852878301506,0.00820294899303784,0.088775098275152,0.12093065832786,3.3825157446398e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,FHIT,Bis(5'-adenosyl)-triphosphatase,39489,0.0881183094139433,0.00689850278683555,0.0745972439517456,0.101639374876141,3.53548547789337e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,BRSK2,Serine/threonine-protein kinase BRSK2,37411,0.0457623747312064,0.00358144225749735,0.0387427479065116,0.0527820015559013,3.5820632233978e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,CD1C,T-cell surface glycoprotein CD1c,39913,0.0277838796504589,0.00217665008894122,0.0235176454761341,0.0320501138247836,3.92130878672884e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,GPI,Glucose-6-phosphate isomerase,37445,0.0562585594237408,0.0044094475041678,0.0476160423155719,0.0649010765319097,4.55327927232747e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,PTX3,Pentraxin-related protein PTX3,39866,-0.0587393871185641,0.00460727294782337,-0.0677696420962979,-0.0497091321408303,4.76479315192965e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSS,Cathepsin S,36543,0.0289262597597273,0.00226818977810569,0.0244806077946402,0.0333719117248144,5.06150447958272e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,AIF1,Allograft inflammatory factor 1,39477,0.0623703560063457,0.00489377522215962,0.0527785565709129,0.0719621554417786,5.09301706461254e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,MEGF10,Multiple epidermal growth factor-like domains protein 10,39862,0.0473906010169398,0.00371918899408084,0.0401009905885414,0.0546802114453383,5.21390746952589e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,DBN1,Drebrin,37056,0.0620343755948932,0.00487296893810142,0.0524833564762144,0.071585394713572,6.61335794812865e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,RABGAP1L,Rab GTPase-activating protein 1-like,39587,0.0702948922557695,0.00552485083702019,0.0594661846152099,0.0811235998963291,6.66400482364059e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,PALM,Paralemmin-1,37299,0.0335884469628614,0.00264260857958914,0.0284089341468667,0.0387679597788562,8.43693458666511e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,IGF1R,Insulin-like growth factor 1 receptor,39788,0.0255973035357922,0.00201547545660751,0.0216469716408414,0.0295476354307429,8.87240477533325e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39699,0.0474606844164112,0.00373778069770907,0.0401346342489015,0.054786734583921,9.21595138864481e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,PRDX5,"Peroxiredoxin-5, mitochondrial",40058,0.0814492045590431,0.00641674916943466,0.0688723761869512,0.0940260329311351,9.64765734871495e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,CDCP1,CUB domain-containing protein 1,39749,0.0587648830857849,0.00462960710699237,0.0496908531560799,0.06783891301549,9.71602133148979e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,PRSS2,Trypsin-2,39931,0.0604194493429137,0.00476197751993384,0.0510859734038433,0.069752925281984,1.03526630594543e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,RELT,Tumor necrosis factor receptor superfamily member 19L,39858,0.0312927363326909,0.002466365230055,0.0264586604817831,0.0361268121835987,1.03842378356129e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,NECAP2,Adaptin ear-binding coat-associated protein 2,37021,0.0765926222476683,0.00604072708134961,0.0647527971682231,0.0884324473271135,1.25984125993755e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,PLPBP,Pyridoxal phosphate homeostasis protein,39868,0.0799283869327357,0.00631307368879839,0.0675547625026909,0.0923020113627805,1.46028209483085e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGAL,Integrin alpha-L,37056,0.0503444365109706,0.00397460356393751,0.042554213525653,0.0581346594962881,1.47913165997359e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINB1,Leukocyte elastase inhibitor,39811,0.105098595678745,0.00830486358349747,0.0888210630550901,0.1213761283024,1.57147278244621e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,CA13,Carbonic anhydrase 13,39657,0.123820554441979,0.00978567995340268,0.10464062173331,0.143000487150649,1.61437136831644e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,GLOD4,Glyoxalase domain-containing protein 4,39832,0.0419612296618939,0.00332120398282734,0.0354516698555523,0.0484707894682355,2.03913919670271e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,VGF,Neurosecretory protein VGF,37411,0.0343132441638789,0.00271625703133477,0.0289893803824627,0.039637107945295,2.23939420693027e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,TMSB10,Thymosin beta-10,39858,0.0904703019739185,0.00716639080783141,0.076424175990569,0.104516427957268,2.31377655408801e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37437,0.115743553681546,0.00916664509754827,0.0977769292903513,0.13371017807274,2.41092874841062e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,MATN2,Matrilin-2,39885,0.0348220786692334,0.00275912007331126,0.0294142033255433,0.0402299540129235,2.41719339832293e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,BAG3,BAG family molecular chaperone regulator 3,39720,0.0462982911158695,0.00366980563761143,0.0391054720661511,0.0534911101655879,2.57528445935985e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM24,Transcription intermediary factor 1-alpha,37135,0.0763273102497269,0.00604936165533102,0.0644705614052781,0.0881840590941757,2.7343004926013e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP10,Caspase-10,39489,0.083540386689053,0.00662502748012017,0.0705553328280174,0.0965254405500885,2.7999744958333e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37437,0.0885581199475546,0.0070246239652793,0.0747898569756071,0.102326382919502,3.09036190078989e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP3,Caspase-3,40052,0.103898463043885,0.00825380855865581,0.0877209982689194,0.12007592781885,3.63346767481687e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37027,0.042677455420998,0.00338877546326344,0.0360354555130016,0.0493194553289943,3.69186873840456e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39866,0.140853582964994,0.0112026181470478,0.118896451396781,0.162810714533208,4.38662567317999e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39749,0.0629968705836456,0.00501542262735406,0.0531666422340316,0.0728270989332595,5.15381838600135e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,JPT2,Jupiter microtubule associated homolog 2,37382,0.103115513212494,0.00820775614702955,0.0870283111643157,0.119202715260672,5.3458910680423e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,FGA,Fibrinogen alpha chain,37149,0.0359303220550756,0.0028608822107422,0.0303229929220209,0.0415376511881303,5.66548837858914e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB33A,Ras-related protein Rab-33A,37021,0.0782827639735423,0.00624933552046732,0.0660340663534263,0.0905314615936582,8.54677722269329e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,CNDP1,Beta-Ala-His dipeptidase,39931,0.0528624904138587,0.00422526917331942,0.0445809628341527,0.0611440179935648,9.53410242472048e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,SCG2,Secretogranin-2,39949,0.0360932271362891,0.00288568142796515,0.0304372915374774,0.0417491627351008,9.93507385858132e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF4E,Eukaryotic translation initiation factor 4E,37056,0.106039822576669,0.00847777531749962,0.08942338295437,0.122656262198969,1.07597711875929e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,IMPACT,Protein IMPACT,37388,0.0643602422366979,0.00514675943812798,0.054272593737967,0.0744478907354287,1.10394261203592e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,CD83,CD83 antigen,39866,0.0380070394484017,0.00304179372426795,0.0320451237488365,0.0439689551479668,1.16689547568932e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,PLA2G4A,Cytosolic phospholipase A2,39931,0.102230840599584,0.00818312025595378,0.086191924897915,0.118269756301254,1.19523492073531e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,ALDH1A1,Retinal dehydrogenase 1,39858,0.0608894507406185,0.00487506453440178,0.051334324253191,0.070444577228046,1.24153391675203e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37437,0.0859247330533193,0.00687917303646164,0.0724415539018544,0.0994079122047841,1.31893527075853e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36764,0.0575123700549041,0.00460674558460005,0.048483148709088,0.0665415914007202,1.45770476583931e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,CD72,B-cell differentiation antigen CD72,37124,0.0481127222212266,0.00385864852850998,0.040549771105347,0.0556756733371061,1.74626718819119e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,CRYZL1,Quinone oxidoreductase-like protein 1,37043,0.107032272021644,0.00858396455087685,0.0902077015019255,0.123856842541363,1.74982654773018e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37056,0.093138270822985,0.00747069627275983,0.0784957061283757,0.107780835517594,1.78663581056048e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,NT5C3A,Cytosolic 5'-nucleotidase 3A,39829,0.102094894383042,0.0081994228286916,0.0860240256388064,0.118165763127277,2.0049372787867e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,CALB2,Calretinin,39489,0.0336563851595797,0.00270471965927133,0.0283551346274079,0.0389576356917516,2.22944388758929e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,ICAM1,Intercellular adhesion molecule 1,39822,0.0328147888447192,0.0026376644761123,0.0276449664715391,0.0379846112178993,2.28772382693407e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,SCARB2,Lysosome membrane protein 2,39486,0.0332051549520492,0.00266959103366126,0.0279727565260732,0.0384375533780253,2.38053809538966e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,DBI,Acyl-CoA-binding protein,39793,0.0922657235257506,0.00741846303714352,0.0777255359729493,0.106805911078552,2.39201116355023e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37437,0.0461021513908958,0.00370971581391101,0.0388311083956302,0.0533731943861613,2.8855279993478e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,PTGDS,Prostaglandin-H2 D-isomerase,39762,0.0326722756014046,0.00263169147654358,0.0275141603073791,0.03783039089543,3.1581941163333e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39749,0.0662233809503036,0.00533482936931669,0.0557671153864429,0.0766796465141643,3.21961580491191e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,SMTN,Smoothelin,37342,0.111038893160867,0.00895821965228599,0.0934807826423869,0.128597003679348,4.30853141658745e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,TSC22D1,TSC22 domain family protein 1,37411,0.0780166211959483,0.00629824696809221,0.0656720571384876,0.090361185253409,4.75398396822351e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,FXYD5,FXYD domain-containing ion transport regulator 5,39587,0.0751202498987281,0.00606838631651192,0.0632262127183648,0.0870142870790915,4.94693664818243e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL3,C-C motif chemokine 3,39866,0.0720216832015635,0.00582100942759312,0.060612504723481,0.083430861679646,5.30791766756066e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,GIPC3,PDZ domain-containing protein GIPC3,37382,0.113851738985441,0.00920618685498244,0.0958076127496753,0.131895865221206,6.09999647050787e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37124,0.0696811365385013,0.00563922571535484,0.0586282541364059,0.0807340189405968,6.9878013251162e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,ANKRD54,Ankyrin repeat domain-containing protein 54,39477,0.0646191875979832,0.00524200391694742,0.0543448599207663,0.0748935152752002,9.3809209764556e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,NRGN,Neurogranin,37445,0.105030036442732,0.00852101923375689,0.0883288387445688,0.121731234140896,1.00604869336924e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,TP53I3,Quinone oxidoreductase PIG3,36874,0.0612987630847614,0.00497293742892474,0.0515518057240689,0.0710457204454539,1.01897902203463e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,FADD,FAS-associated death domain protein,39868,0.0878440024728862,0.00713136487642981,0.0738665273150837,0.101821477630689,1.04107221682337e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,ACVRL1,Serine/threonine-protein kinase receptor R3,39720,0.0265334019112371,0.00215514615225325,0.0223093154528207,0.0307574883696534,1.12899786842052e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,MICALL2,MICAL-like protein 2,37039,0.0778703402234269,0.00632707544286775,0.0654692723554061,0.0902714080914477,1.27893636613321e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP170,Centrosomal protein of 170 kDa,37043,0.0879843699920564,0.0071617944652443,0.0739472528401775,0.102021487143935,1.67865682131119e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39956,0.0316296096668221,0.00257923886681837,0.0265743014878581,0.0366849178457861,2.03436066271535e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,PCDH7,Protocadherin-7,37382,0.0382677628256219,0.00312305020032188,0.032146584432991,0.0443889412182528,2.45209514325327e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,PSME1,Proteasome activator complex subunit 1,39738,0.0419040899031806,0.0034306296232661,0.0351800558415791,0.0486281239647822,3.69310722469045e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,PPCDC,Phosphopantothenoylcysteine decarboxylase,40009,0.0534591622951904,0.00438085900922735,0.0448726786371048,0.062045645953276,4.23869977750617e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,REEP4,Receptor expression-enhancing protein 4,37411,0.070728154402379,0.00579612584140095,0.0593677477532332,0.0820885610515249,4.5399550158598e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGAP25,Rho GTPase-activating protein 25,39477,0.0683242918115903,0.00560283570920754,0.0573427338215435,0.079305849801637,4.74439479541154e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB2B,Ras-related protein Rab-2B,37368,0.0711080107295245,0.00582894711729553,0.0596832743796253,0.0825327470794238,4.74577479525876e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,TXNDC9,Thioredoxin domain-containing protein 9,37388,0.0607720422796905,0.00499742583430343,0.0509770876444558,0.0705669969149252,7.56057676569452e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,DXO,Decapping and exoribonuclease protein,37388,0.0513612505527864,0.00422815761853302,0.0430740616204617,0.0596484394851111,8.87445453996588e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,COL15A1,Collagen alpha-1(XV) chain,37437,0.0282146262666878,0.00232279811986642,0.0236619419517497,0.032767310581626,8.92654282908467e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,MZT1,Mitotic-spindle organizing protein 1,39477,0.0600492997175111,0.00495290889574079,0.0503415982818592,0.0697570011531631,1.11603020795227e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,FUT8,"Alpha-(1,6)-fucosyltransferase",39749,0.0649553784411549,0.00535830274921934,0.054453105052685,0.0754576518296248,1.13203363501471e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,LRRN1,Leucine-rich repeat neuronal protein 1,39587,0.0439458415264305,0.00362675050724708,0.0368374105322262,0.0510542725206347,1.2102913746061e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,BMPER,BMP-binding endothelial regulator protein,37124,0.0253135002432846,0.00208925279260914,0.0212185647697707,0.0294084357167985,1.30680534826523e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,FRMD4B,FERM domain-containing protein 4B,37021,0.0793232050889699,0.00654735840192271,0.0664903826212013,0.0921560275567384,1.32295830192034e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39788,0.0366180691967455,0.00302678840998468,0.0306855639131755,0.0425505744803154,1.51856107993181e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,ARL13B,ADP-ribosylation factor-like protein 13B,37021,0.0781015236477821,0.00646337945836434,0.065433299909388,0.0907697473861762,1.93590085806742e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,CDC37,Hsp90 co-chaperone Cdc37,39913,0.0938511017474036,0.00777271177179042,0.0786165866746944,0.109085616820113,2.01219357132221e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMA4,Laminin subunit alpha-4,39931,0.037671215262269,0.00312044908730926,0.0315551350511429,0.0437872954733952,2.06210939817297e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,UROD,Uroporphyrinogen decarboxylase,37124,0.0779085984637842,0.00645151243565642,0.0652636340898976,0.0905535628376708,2.1165304216713e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37388,0.0430837868614982,0.00357251389674172,0.0360816596238844,0.050085914099112,2.5523009695886e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA3,Annexin A3,39985,0.0780477546063855,0.00647733251609684,0.0653521828748357,0.0907433263379353,2.71676791990985e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,GBP1,Guanylate-binding protein 1,37376,0.0712361687878931,0.00590977507473537,0.0596530096414118,0.0828193279343744,2.73866660392083e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37368,0.0421817540653815,0.00350246185725892,0.035316928825154,0.0490465793056089,3.10709786236735e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,BDNF,Brain-derived neurotrophic factor,37437,0.0922641378988795,0.00766619094215358,0.0772384036522585,0.107289872145501,3.42384027329309e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,BTC,Probetacellulin,39477,0.0826195882845453,0.00687037300619799,0.0691536571923973,0.0960855193766934,3.65766187467272e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGA6,Integrin alpha-6,39866,0.0591597631960781,0.00492066893109428,0.0495152520911333,0.0688042743010228,3.75104787599518e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,GGACT,Gamma-glutamylaminecyclotransferase,37437,0.0795180888571905,0.00663144231754694,0.0665204619147985,0.0925157157995825,5.8060900036556e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,ABRAXAS2,BRISC complex subunit Abraxas 2,37021,0.0743586866968007,0.00621108772022153,0.0621849547651665,0.0865324186284349,7.38450937906585e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37085,0.0429000763161431,0.00358688763449326,0.0358697765525363,0.0499303760797499,8.47114053464709e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,FOXO3,Forkhead box protein O3,39477,0.108106389706823,0.00906452406197108,0.0903399225453593,0.125872856868286,1.19624123225461e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,BLNK,B-cell linker protein,37056,0.043395364352882,0.00363936485418363,0.0362622092386821,0.050528519467082,1.30676501139138e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,MCFD2,Multiple coagulation factor deficiency protein 2,39788,0.0495460576011243,0.00415851928788733,0.0413953597968652,0.0576967554053835,1.37055028357787e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,CHRDL1,Chordin-like protein 1,39908,0.0338692323880989,0.0028442194170698,0.0282945623306421,0.0394439024455557,1.47289205735229e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,MIF,Macrophage migration inhibitory factor,39826,0.0752370656055595,0.00633014212749643,0.0628299870356665,0.0876441441754525,1.92866814642876e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,CDC26,Anaphase-promoting complex subunit CDC26,37362,0.0785305670092031,0.00661297345933589,0.0655691390289048,0.0914919949895015,2.30676033075162e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,CD274,Programmed cell death 1 ligand 1,39749,0.0368971862969985,0.00311571829457655,0.0307903784396285,0.0430039941543685,3.22376455986571e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,RGS10,Regulator of G-protein signaling 10,37411,0.0659866400117555,0.00557050781476547,0.0550684446948152,0.0769048353286959,3.2654528999197e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,GSR,"Glutathione reductase, mitochondrial",37403,0.0247956183794191,0.00209412330111785,0.0206911367092281,0.0289001000496101,3.47050916424462e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,SLAMF6,SLAM family member 6,39477,0.0414436298093806,0.00350383614871692,0.0345761109578954,0.0483111486608658,3.83315631432452e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,LARP1,La-related protein 1,37368,0.0704479537545374,0.00595941198417396,0.0587675062655565,0.0821284012435184,4.36050551529011e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,GGH,Gamma-glutamyl hydrolase,39573,0.0372498858786038,0.00315297429025896,0.0310700562696962,0.0434297154875113,4.50596649456422e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,PRSS27,Serine protease 27,39818,0.044018750004843,0.00372757387324588,0.036712705213281,0.0513247947964049,4.77097641556666e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSZ,Cathepsin Z,39865,0.0339800195215119,0.00287927312741919,0.0283366441917703,0.0396233948512536,5.19853248248379e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,FSHB,Follitropin subunit beta,37043,0.0716355291378864,0.00607526852272732,0.0597280028333409,0.083543055442432,6.2586300431192e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,EGFL7,Epidermal growth factor-like protein 7,39477,0.0431021214519126,0.00365946868639116,0.035929562826586,0.0502746800772393,6.89456564110274e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,CD40LG,CD40 ligand,40058,0.0849737705622831,0.00721825489255965,0.0708259909728661,0.0991215501517,7.33252360192869e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37021,0.0443005381138937,0.00376660657056886,0.0369179892355788,0.0516830869922087,8.89952295639446e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,ARFIP1,Arfaptin-1,37411,0.0756658926503279,0.0064401716415591,0.063043156232872,0.0882886290677837,1.01776024448032e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,SLMAP,Sarcolemmal membrane-associated protein,37382,0.0913971656380049,0.00779167998682462,0.0761254728638287,0.106668858412181,1.27146973492205e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,GGCT,Gamma-glutamylcyclotransferase,37430,0.052313099908378,0.00447553640479114,0.0435410485549874,0.0610851512617686,2.05966205737675e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,DYNLT1,Dynein light chain Tctex-type 1,37039,0.086824482506624,0.00743043699023553,0.0722608260057624,0.101388139007486,2.17247440993149e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37056,0.062135723235719,0.00534212347570389,0.0516651612233394,0.0726062852480986,4.05336724072491e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,CD46,Membrane cofactor protein,39777,0.0305996187345847,0.00263284264729304,0.0254392471458904,0.0357599903232791,4.24059227216795e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,SIT1,Signaling threshold-regulating transmembrane adapter 1,39587,0.0590120572072675,0.00508024725882061,0.0490547725799791,0.0689693418345559,4.57771353096701e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,GRK5,G protein-coupled receptor kinase 5,39585,0.0571204985241381,0.00492208998710677,0.0474732021494088,0.0667677948988673,5.20392575242939e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,ATXN3,Ataxin-3,37388,0.0661945777765472,0.00570276023366771,0.0550171677185585,0.0773719878345359,5.29630844746425e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,CCDC134,Coiled-coil domain-containing protein 134,37368,0.0525025061618095,0.00452428935919775,0.0436348990177819,0.0613701133058371,5.47836053763336e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,CPXM2,Inactive carboxypeptidase-like protein X2,37437,0.0258603663747515,0.00222932134860286,0.0214908965314899,0.0302298362180131,5.75997441667234e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,LTBP3,Latent-transforming growth factor beta-binding protein 3,39477,0.0591468370426298,0.00510577229740845,0.0491395233397092,0.0691541507455503,6.62064714013178e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,HSPB6,Heat shock protein beta-6,40030,0.0401129586383355,0.00347955276412243,0.0332930352206555,0.0469328820560155,1.25309092212205e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,DDT,D-dopachrome decarboxylase,37437,0.0429622266989331,0.00373136997587413,0.0356487415462198,0.0502757118516464,1.5580419853423e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37043,0.0566909449220644,0.00493514949466332,0.0470180519125243,0.0663638379316046,2.13491682882964e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,RBKS,Ribokinase,39504,0.0527795508441622,0.004600463081045,0.043762643205314,0.0617964584830104,2.39372566534502e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,ACRBP,Acrosin-binding protein,37368,0.0409681357939621,0.00357019610093287,0.0339705514361337,0.0479657201517906,2.43401824892425e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,CPXM1,Probable carboxypeptidase X1,39913,0.0722173230366858,0.00630630926776531,0.0598569568718658,0.0845776892015058,3.02532095746221e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,ASPN,Asporin,37437,0.0286900251233109,0.00250645641384307,0.0237773705521785,0.0336026796944433,3.36980955407614e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,IMMT,MICOS complex subunit MIC60,37368,0.0466994755903069,0.00408049733951615,0.0387017008048552,0.0546972503757585,3.44907348336243e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,ANPEP,Aminopeptidase N,39891,0.0296533723578698,0.00259326004391633,0.0245705826717938,0.0347361620439458,3.66804893530712e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,PTP4A3,Protein tyrosine phosphatase type IVA 3,37056,0.0550033948274523,0.0048123564785563,0.0455711761294819,0.0644356135254226,4.12086415821617e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,RGMB,RGM domain family member B,40009,0.0270229894331711,0.00236592370383789,0.0223857789736489,0.0316601998926934,4.24861960905137e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,GZMA,Granzyme A,40058,0.0358292055483433,0.00313762331958859,0.0296794638419497,0.0419789472547369,4.36970082201418e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,PEBP1,Phosphatidylethanolamine-binding protein 1,39858,0.0610825976753131,0.00535114874900686,0.0505943461272597,0.0715708492233666,4.6078154340437e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM3C,Protein FAM3C,39846,0.0306650979621957,0.00268651776201197,0.0253995231486522,0.0359306727757391,4.63067056950926e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,CPPED1,Serine/threonine-protein phosphatase CPPED1,40009,0.0694214043817623,0.00608789251562906,0.0574891350511294,0.0813536737123953,5.25031697341626e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL25,C-C motif chemokine 25,40058,0.0527451496261484,0.00462593638145387,0.0436783143184988,0.061811984933798,5.31495240001908e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS3BP,Galectin-3-binding protein,37453,0.0319666228820755,0.00280304677665517,0.0264726511998314,0.0374605945643196,5.45063550028952e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,MEP1A,Meprin A subunit alpha,37382,0.075890571367337,0.00666008833974547,0.0628367982214359,0.0889443445132381,6.07661647912221e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASEH2A,Ribonuclease H2 subunit A,37411,0.0522191859912145,0.00458603477631923,0.0432305578296288,0.0612078141528002,6.67070828466461e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37026,0.0844101941917159,0.0074159190991151,0.0698749927574503,0.0989453956259815,7.06606663027483e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39477,0.0693335900034931,0.00609458377317879,0.0573882058080626,0.0812789741989235,7.1974876380958e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,STXBP3,Syntaxin-binding protein 3,39477,0.0465781230818759,0.00410378289702655,0.0385347086037039,0.054621537560048,9.69353439287486e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,PARK7,Parkinson disease protein 7,39858,0.0552662937545579,0.00487060854215614,0.0457199010119319,0.064812686497184,9.98236729884549e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,ENAH,Protein enabled homolog,39587,0.0505370624824699,0.00445475266405958,0.0418057472609132,0.0592683777040267,1.03003614863726e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF2,Fibroblast growth factor 2,39866,0.0701335263615347,0.00618555113831969,0.0580098461304281,0.0822572065926412,1.10051604561307e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,ZNRD2,Protein ZNRD2,37382,0.0716691730277375,0.00632024213207525,0.05928149844887,0.0840568476066049,1.13676739561579e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,MDK,Midkine,39843,0.0532366723973822,0.00469853585141385,0.044027542128611,0.0624458026661534,1.20266794470474e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,IFT20,Intraflagellar transport protein 20 homolog,37039,0.0459408248601717,0.00405410767460517,0.0379947738179456,0.0538868759023978,1.25022047294364e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,ACAN,Aggrecan core protein,39730,0.0296195705147959,0.00261514419415744,0.0244938878942473,0.0347452531353445,1.26515409895023e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,ESAM,Endothelial cell-selective adhesion molecule,40052,0.032832419496395,0.00290288945021869,0.0271427561739663,0.0385220828188236,1.50699397582719e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,PDZD2,PDZ domain-containing protein 2,37021,0.0630956082999809,0.00558664962050044,0.0521457750438,0.0740454415561618,1.91918773670624e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,NFAT5,Nuclear factor of activated T-cells 5,37056,0.0907161486434601,0.00804038742775192,0.0749569892850664,0.106475308001854,2.18136983246674e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,ABHD14B,Protein ABHD14B,39687,0.0601972250511858,0.00534111092760069,0.0497286476330885,0.0706658024692832,2.3730562954924e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,PAEP,Glycodelin,39749,-0.151588883502492,0.0134525618044296,-0.177955904639174,-0.12522186236581,2.42857247269501e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,PARD3,Partitioning defective 3 homolog,37169,0.0774618843839325,0.00687537885708273,0.0639861418240503,0.0909376269438146,2.60485397296289e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,DNM1,Dynamin-1,37382,0.120109795210742,0.010667892433887,0.0992007260403231,0.14101886438116,2.82253842294163e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,RAD23B,UV excision repair protein RAD23 homolog B,39477,0.0492685590787491,0.00437880486016936,0.0406861015528171,0.057851016604681,2.94727258103831e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,CEBPB,CCAAT/enhancer-binding protein beta,39585,0.0390503744068884,0.00347103353594693,0.0322471486764324,0.0458536001373444,2.98339059403904e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB6,Integrin beta-6,39587,0.0309748468836092,0.00275363196372589,0.0255777282347064,0.0363719655325119,3.03865679957068e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39866,0.0866460957337938,0.00771723189250611,0.0715203212244818,0.101771870243106,3.83505355819374e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39845,0.0252855133076806,0.00225296949226264,0.0208696931028458,0.0297013335125154,4.03141944567796e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,APOE,Apolipoprotein E,37453,0.0756180196981556,0.00674572807206801,0.0623963926769023,0.0888396467194089,4.89589264830993e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,TTF2,Transcription termination factor 2,37039,0.0513269496524076,0.00458028603769011,0.042349589018535,0.0603043102862802,5.1501189564835e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,TBCA,Tubulin-specific chaperone A,37124,0.0900088285318665,0.00804494197983107,0.0742407422513976,0.105776914812335,6.27245242448227e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,MTIF3,"Translation initiation factor IF-3, mitochondrial",37382,0.0911860241739469,0.00815078408643849,0.0752104873645274,0.107161560983366,6.29715307042252e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,WAS,Wiskott-Aldrich syndrome protein,39587,0.0699563781071017,0.00625976175530287,0.0576872450667081,0.0822255111474954,6.90020095502228e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,GET3,ATPase GET3,37437,0.0581810464474851,0.00520491790980372,0.0479794073442698,0.0683826855507004,6.97827939185737e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37382,0.079683195539378,0.00714370369262426,0.0656815363018344,0.0936848547769216,9.10660450208253e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39749,0.0460173885702245,0.00412785347177467,0.0379267957655461,0.0541079813749028,9.36049060861403e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL11,C-X-C motif chemokine 11,40009,0.0805322860318061,0.00722608985255383,0.0663691499208006,0.0946954221428116,9.67993423996533e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,PPL,Periplakin,37056,0.0332840406688218,0.00298789847940171,0.0274277596491945,0.0391403216884492,1.08029807542139e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,LGMN,Legumain,39931,0.0371142077106449,0.00333456094591486,0.0305784682566518,0.043649947164638,1.13892270254316e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37382,0.0674544328114735,0.00605849386558312,0.0555797848349306,0.0793290807880164,1.14359853149633e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,TFPI2,Tissue factor pathway inhibitor 2,39864,0.0414499170397727,0.00372561603628184,0.0341477096086603,0.0487521244708851,1.1987398489374e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,SCRN1,Secernin-1,39866,0.0580788135751792,0.00522067305837802,0.0478462943807582,0.0683113327696001,1.2104924497561e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,CPA1,Carboxypeptidase A1,40052,0.0610706139141071,0.00549263337099384,0.0503050525069592,0.0718361753212551,1.29241913071543e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,SRC,Proto-oncogene tyrosine-protein kinase Src,39887,0.123968714378044,0.0111522431029551,0.102110317896252,0.145827110859836,1.3336760230352e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,WDR46,WD repeat-containing protein 46,37368,0.0372503664955436,0.00335533919458927,0.0306739016741486,0.0438268313169385,1.63281950797988e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNAR1,Interferon alpha/beta receptor 1,37382,0.0263475700217328,0.00237337018942369,0.0216957644504624,0.0309993755930032,1.64117428294404e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,GIP,Gastric inhibitory polypeptide,37043,0.0448097401296194,0.00405117059655763,0.0368694457603665,0.0527500344988724,2.58496495264966e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39788,-0.0203452718695943,0.00184035605652663,-0.0239523697403865,-0.0167381739988021,2.62584905513086e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMP1,Metalloproteinase inhibitor 1,39698,0.0282847306109569,0.00256376159855598,0.0232597578777872,0.0333097033441267,3.37367402291825e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJC9,DnaJ homolog subfamily C member 9,37382,0.0779485131279545,0.0070636840722252,0.0641036923463931,0.0917933339095159,3.41320572126666e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39489,0.0659292256278684,0.00597729879690263,0.0542137199859392,0.0776447312697975,3.4818675430522e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK6,Kallikrein-6,39889,0.0302928123502935,0.00274775382747919,0.0249072148484342,0.0356784098521527,3.67223060049025e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINT2,Kunitz-type protease inhibitor 2,39931,0.0420567994492268,0.0038156427146519,0.034578139728509,0.0495354591699445,3.76707967050328e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,CTRB1,Chymotrypsinogen B,39858,0.0545576992945045,0.0049623941530271,0.0448314067545714,0.0642839918344376,5.13198628422649e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMP1,Lysosome-associated membrane glycoprotein 1,37097,0.0289439895593201,0.00263256423588489,0.0237841636569857,0.0341038154616545,5.36181308431887e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBP4,Insulin-like growth factor-binding protein 4,39585,0.0403717818422179,0.00367807148253083,0.0331627617364574,0.0475808019479783,6.27164290023383e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,HPGDS,Hematopoietic prostaglandin D synthase,39477,0.0378645177813092,0.00345147881771143,0.0310996192985948,0.0446294162640236,6.69655618453668e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,MEP1B,Meprin A subunit beta,39868,0.117297508977662,0.0106936592874489,0.0963379367742625,0.138257081181062,6.77915474496678e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,CD84,SLAM family member 5,39866,0.03166545789809,0.00289134279410486,0.0259984260216445,0.0373324897745356,8.17488209147634e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,VCAM1,Vascular cell adhesion protein 1,39908,-0.027126797342042,0.00247698916229708,-0.0319816961001443,-0.0222718985839397,8.19666805875505e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,CCT5,T-complex protein 1 subunit epsilon,39477,0.0455447014639218,0.0041596382835945,0.0373918104280766,0.053697592499767,8.4604388030065e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,IL10RB,Interleukin-10 receptor subunit beta,39931,0.0284588304641722,0.00260284938403356,0.0233572456714664,0.0335604152568779,9.95742734355319e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,SORCS2,VPS10 domain-containing receptor SorCS2,39477,0.0346575805040412,0.00317615243926723,0.0284323217230774,0.040882839285005,1.2733974954907e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJB2,DnaJ homolog subfamily B member 2,37124,0.0540962535073562,0.00496065435784459,0.0443733709659808,0.0638191360487316,1.42723815805809e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39587,0.072994313738525,0.00671810351274503,0.0598268308535448,0.0861617966235053,2.11015240901569e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,CALCA,Calcitonin,39713,0.061518077487025,0.00566350519445773,0.0504176073058878,0.0726185476681621,2.17919541532597e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,CGA,Glycoprotein hormones alpha chain,39858,0.0891351947072214,0.00821431466681734,0.0730351379602594,0.105235251454183,2.45068447174007e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39585,0.0893928885891593,0.00824096768070401,0.0732405919349794,0.105545185243339,2.56431576068631e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,PTGR1,Prostaglandin reductase 1,37437,0.0803102905468973,0.00740318502404456,0.06580004789977,0.0948205331940247,2.63580797681951e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,IMPA1,Inositol monophosphatase 1,39749,0.0616624592707348,0.00569978771555011,0.0504908753482566,0.072834043193213,3.50384718564589e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37124,0.0672795263081408,0.00622248768086917,0.0550834504536372,0.0794756021626443,3.9050719067345e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,TAFA5,Chemokine-like protein TAFA-5,39788,0.0342011782988475,0.00316440126615862,0.0279989518171766,0.0404034047805183,3.91394024501576e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,MDH1,"Malate dehydrogenase, cytoplasmic",37397,0.0404845315020166,0.00374475438281443,0.0331448129117003,0.0478242500923329,3.94063597371328e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37306,0.0306063200416178,0.00283103566261904,0.0250574901428844,0.0361551499403511,3.94741207275989e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,RILP,Rab-interacting lysosomal protein,39984,0.0595548533349407,0.00551174126193568,0.0487518404615468,0.0703578662083347,4.03314404976856e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,TNF,Tumor necrosis factor,39555,0.0381435872184617,0.00353127859657984,0.0312222811691652,0.0450648932677582,4.21099350095891e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,ENO2,Gamma-enolase,40009,0.0663659683735332,0.00614703503204806,0.054317779710719,0.0784141570363474,4.42806995985629e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,CORO1A,Coronin-1A,39520,0.0897549650527832,0.00831543608029122,0.0734567103354124,0.106053219770154,4.58655804232854e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL19,C-C motif chemokine 19,40009,0.115862937605598,0.0107421472667611,0.0948083289627466,0.13691754624845,4.96499545823108e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,DMD,Dystrophin,37043,0.0518917861896155,0.00481395381796563,0.0424564367064029,0.0613271356728282,5.57647481829774e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,NPC2,NPC intracellular cholesterol transporter 2,37268,0.0298221980627653,0.00276749710572071,0.0243979037355527,0.0352464923899779,5.77076270195979e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,AMOT,Angiomotin,37124,0.0414282377102251,0.00384605274386095,0.0338899743322577,0.0489665010881926,6.05755498651963e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39866,0.0606341882736164,0.00565236496391415,0.0495555529443446,0.0717128236028881,9.35066003999987e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,NGRN,Neugrin,37388,0.021279534333591,0.00198511003340608,0.0173887186681151,0.0251703499990669,1.05447911433737e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,ITPA,Inosine triphosphate pyrophosphatase,37021,0.0677117633087368,0.00631672803542225,0.0553309763593092,0.0800925502581644,1.06329216789765e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,DYNLT3,Dynein light chain Tctex-type 3,37368,0.0435463654407632,0.00407038269253475,0.035568415363395,0.0515243155181313,1.32412671543897e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37124,0.089151765682003,0.00833708258478841,0.0728110838158177,0.105492447548188,1.40233563171895e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37382,0.0476185004301499,0.00445835105054435,0.038880132371083,0.0563568684892168,1.59792903396437e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,MRI1,Methylthioribose-1-phosphate isomerase,37039,0.0670341836152571,0.00627695896759579,0.0547313440387694,0.0793370231917449,1.631174236255e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,DNER,Delta and Notch-like epidermal growth factor-related receptor,39821,0.025131548812031,0.00235610046112614,0.0205135919082238,0.0297495057158382,1.79141889795967e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,PIGR,Polymeric immunoglobulin receptor,39677,0.0360072038274458,0.00337820516135529,0.0293859217111894,0.0426284859437021,1.95287901325703e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA4,Annexin A4,39783,0.0716491420259483,0.00672675841307612,0.0584646955363191,0.0848335885155775,2.10857058557262e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,ADD1,Alpha-adducin,37124,0.0682753310467773,0.00642219701697052,0.0556878248935151,0.0808628372000395,2.72355726395628e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMP3,Lysosome-associated membrane glycoprotein 3,40040,0.0495118434858998,0.00465935434321587,0.0403795089731967,0.0586441779986029,2.74429007710849e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,FMNL1,Formin-like protein 1,39489,0.0601002497268866,0.0056579793521248,0.049010610196722,0.0711898892570512,2.88743071643832e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,ALCAM,CD166 antigen,40052,0.0191271934994385,0.00180298970073914,0.0155933336859898,0.0226610533128872,3.31343155126342e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,CLU,Clusterin,37453,0.0314490887800938,0.00296497240556539,0.0256377428651856,0.037260434695002,3.50417249296349e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37056,0.0446454681649426,0.00421773261494844,0.0363787122396436,0.0529122240902415,4.44111876831923e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39587,0.0409317728719408,0.00386826148504125,0.0333499803612599,0.0485135653826216,4.4461111133844e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,OPLAH,5-oxoprolinase,37043,0.068219918131437,0.00644743203122464,0.0555829513502367,0.0808568849126373,4.64599882853468e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,PTN,Pleiotrophin,39585,0.0494568286171759,0.00468226570615585,0.0402795878331105,0.0586340694012414,5.42878537732126e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,VWC2,Brorin,39684,0.0377441314294119,0.00357983657013686,0.0307276517519437,0.0447606111068802,6.63168858196358e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,AK2,"Adenylate kinase 2, mitochondrial",37388,0.104704733957016,0.00992809343631517,0.0852456708218384,0.124163797092194,6.65911921275024e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,BMP6,Bone morphogenetic protein 6,39568,0.0409511832804332,0.00388634324252008,0.0333339505250938,0.0485684160357725,7.10062105191025e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,THBD,Thrombomodulin,39868,0.0265898994229256,0.00252518273433278,0.0216405412636333,0.0315392575822178,7.64176291411644e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,LONP1,"Lon protease homolog, mitochondrial",37043,0.0855391038449097,0.00812137893699224,0.0696212011284049,0.101457006561415,7.74246145737056e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37411,0.0894362267070673,0.00849356887107769,0.0727888317197551,0.10608362169438,7.91590403513729e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,PER3,Period circadian protein homolog 3,37056,0.115232994122315,0.0109439947162311,0.0937827644785018,0.136683223766128,8.01014545506334e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37021,0.027087082305149,0.00257545387558695,0.0220391927089985,0.0321349719012994,9.08820906451463e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,PSAP,Prosaposin,37347,0.02735383883356,0.00260143118809626,0.0222550337048914,0.0324526439622287,9.27610874454942e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,TREML2,Trem-like transcript 2 protein,39858,0.0323260495821936,0.00307787089060054,0.0262934226366166,0.0383586765277707,1.01750142175891e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB10,Ras-related protein Rab-10,37437,0.0523039712290769,0.00497873231536872,0.0425456558909543,0.0620622865671996,1.02288847644813e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,EPPK1,Epiplakin,37043,0.072729036903419,0.00693437687113321,0.0591376582359979,0.0863204155708401,1.23492023553611e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37056,0.0436851168244237,0.00417305122293491,0.0355059364274713,0.0518642972213762,1.51947832459472e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,POMC,Pro-opiomelanocortin,37043,0.0690385179874474,0.00659801329097854,0.0561064119371295,0.0819706240377653,1.59911589826672e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,ASAH1,Acid ceramidase,37340,0.0460069743686845,0.00439771392781344,0.0373874550701702,0.0546264936671989,1.62415107198767e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,FLT3LG,Fms-related tyrosine kinase 3 ligand,40058,0.0323501168959302,0.00309354994465375,0.0262867590044089,0.0384134747874516,1.63613127073131e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,BAP18,Chromatin complexes subunit BAP18,37388,0.0632925271927317,0.00606085936088327,0.0514132428454005,0.0751718115400629,1.97426405819132e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,CLTA,Clathrin light chain A,39585,0.045033720824669,0.00432734230809514,0.0365521299008025,0.0535153117485355,2.78932612992121e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37388,0.0749657382704587,0.0072029218014208,0.060848011539674,0.0890834650012435,2.84899377345787e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,HRG,Histidine-rich glycoprotein,37380,0.0306020347531321,0.00294705647731656,0.0248258040575916,0.0363782654486725,3.64839818891575e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,IL12A_IL12B,Interleukin-12,39788,0.0710670166514127,0.00684942204019617,0.0576421494526282,0.0844918838501972,3.84957747031185e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,RASSF2,Ras association domain-containing protein 2,39477,0.0530956481087683,0.00511892901729735,0.0430625472348655,0.0631287489826712,3.9947589415209e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,NID2,Nidogen-2,39858,0.0700088946834955,0.00675065641524467,0.056777608109616,0.083240181257375,4.04934302022023e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC27A4,Long-chain fatty acid transport protein 4,39489,0.0651437335158859,0.00628335277258378,0.0528283620816217,0.0774591049501501,4.19599381813797e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,TREH,Trehalase,37437,0.0726098942158086,0.00701009413759124,0.0588701097061298,0.0863496787254875,4.77608488489315e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,C5,Complement C5,37453,0.0146651859910524,0.00141653341289047,0.0118887805017871,0.0174415914803177,5.03082664205234e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,AKR1B1,Aldo-keto reductase family 1 member B1,39477,0.0739188347241657,0.00714517749315316,0.0599142868375855,0.0879233826107459,5.29482721067409e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,COLEC12,Collectin-12,39862,0.0237883086969414,0.00230692775789121,0.0192667302914747,0.0283098871024082,7.46416918914638e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,UNC79,Protein unc-79 homolog,36962,0.0543083852038357,0.0052702495212751,0.0439786961421365,0.0646380742655349,8.34393986165718e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,C1RL,Complement C1r subcomponent-like protein,37432,0.0184250799870888,0.00179138187056516,0.0149139715207811,0.0219361884533965,1.01055890141177e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,SNX9,Sorting nexin-9,39868,0.0661309221696106,0.0064403844380975,0.0535077686709395,0.0787540756682817,1.16936237763791e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM3B,Protein FAM3B,39788,0.0342129948923047,0.0033389637545748,0.0276686259333381,0.0407573638512713,1.4611469907126e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,XG,Glycoprotein Xg,39985,0.0286306518118944,0.00279442523123416,0.0231535783586754,0.0341077252651134,1.47246771321243e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,MCEMP1,Mast cell-expressed membrane protein 1,37056,0.0860189906060288,0.00840137552900473,0.0695522945691795,0.102485686642878,1.64298990725233e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,FBP1,"Fructose-1,6-bisphosphatase 1",39868,0.0691027739493326,0.00675409539233408,0.0558647469803578,0.0823408009183074,1.70908408307405e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,FXN,"Frataxin, mitochondrial",40030,0.0696569982167335,0.0068206838536856,0.0562884578635097,0.0830255385699573,2.06514055322965e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39788,0.0663544987691913,0.00650639696830258,0.0536019607113183,0.0791070368270644,2.39593045683422e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,DSCAM,Down syndrome cell adhesion molecule,37411,0.0334825310089385,0.00328255242843249,0.0270487282492109,0.0399163337686662,2.42398830287431e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,OXT,Oxytocin-neurophysin 1,40009,0.131267333146964,0.0128762188482396,0.106029944204414,0.156504722089514,2.48482498367175e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,CPB1,Carboxypeptidase B,40052,0.0543310533832313,0.00533695276679866,0.043870625960306,0.0647914808061567,2.87719308940575e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,DKK4,Dickkopf-related protein 4,39718,0.0428781983383745,0.00421474998653485,0.0346172883647662,0.0511391083119828,3.09477976263011e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,XRCC4,DNA repair protein XRCC4,39489,0.0349372700465867,0.00345142420392425,0.0281724786068952,0.0417020614862783,5.20306078109184e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37169,0.0788283626727061,0.00779771798176548,0.0635448354284458,0.0941118899169665,6.13925844052421e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,PECAM1,Platelet endothelial cell adhesion molecule,39858,0.0281535669756169,0.00278940541898417,0.0226863323544079,0.0336208015968259,6.99209412276326e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37056,0.0450844099770074,0.0044686643947232,0.0363258277633499,0.0538429921906648,7.5400869212942e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37031,0.0263009386521038,0.00260771975811529,0.0211898079261978,0.0314120693780098,7.79186254777182e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,GDNF,Glial cell line-derived neurotrophic factor,39489,0.0358313762618243,0.00355951144895815,0.0288547338218663,0.0428080187017823,9.19097403191776e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,CCN4,CCN family member 4,40030,0.0374246079352747,0.00372253667286474,0.0301284360564598,0.0447207798140896,1.04061361640139e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,TREML1,Trem-like transcript 1 protein,37445,0.0496139174802556,0.0049353829508271,0.0399405668966345,0.0592872680638768,1.08164830747494e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,ING1,Inhibitor of growth protein 1,39453,0.041941614939798,0.00418043197832985,0.0337479682622714,0.0501352616173245,1.28928996351444e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,PPM1F,Protein phosphatase 1F,37437,0.0496806121919488,0.00495466274962013,0.0399694732026933,0.0593917511812042,1.40042503970123e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,ARAF,Serine/threonine-protein kinase A-Raf,37169,0.0624321123170026,0.0062271378923934,0.0502269220479115,0.0746373025860937,1.42322275881891e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,FGL1,Fibrinogen-like protein 1,37445,-0.0577923191675662,0.00576561330944278,-0.0690929212540741,-0.0464917170810584,1.44925499527934e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,CXADR,Coxsackievirus and adenovirus receptor,39866,0.0470337851917547,0.00470661350340247,0.0378088227250858,0.0562587476584235,1.91346494759121e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,NBN,Nibrin,39587,0.0477606064047671,0.00478727882485174,0.0383775399080577,0.0571436729014765,2.26513641555546e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,NTRK2,BDNF/NT-3 growth factors receptor,39868,0.0236720381969173,0.00237322636823515,0.0190205145151764,0.0283235618786582,2.30319815735323e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37437,0.0300650153107215,0.00301354380908666,0.0241584694449117,0.0359715611765314,2.32146113955009e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,PKN3,Serine/threonine-protein kinase N3,37169,0.0705592827323117,0.00707393949069293,0.0566943613305535,0.0844242041340698,2.3793595459802e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINK2,Serine protease inhibitor Kazal-type 2,37124,0.0338575605632833,0.0033959376968292,0.0272015226774981,0.0405135984490685,2.49092337078769e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,EFNA4,Ephrin-A4,39720,0.0256345777610927,0.00257371447856885,0.0205900973830978,0.0306790581390877,2.66592237954372e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,IL6R,Interleukin-6 receptor subunit alpha,39805,0.0311519731302954,0.00312916196406151,0.0250188156807349,0.037285130579856,2.79391050960648e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF23,Fibroblast growth factor 23,40008,0.0539878504586016,0.00542695331959696,0.0433510219521916,0.0646246789650116,2.99868200945717e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,ARSA,Arylsulfatase A,39858,0.0415054880653529,0.00417892901574443,0.0333147871944938,0.0496961889362119,3.52305166724812e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,TLR3,Toll-like receptor 3,40058,0.0561676842022011,0.00566117431759015,0.0450717825397244,0.0672635858646778,3.90526736274683e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,KLF4,Krueppel-like factor 4,36991,0.0363678055408027,0.00367032958455891,0.0291739595550673,0.0435616515265382,4.6021716167019e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,KIF22,Kinesin-like protein KIF22,37021,0.11188231237304,0.0113066004642953,0.0897213754630209,0.134043249283058,5.24869449015644e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,APOA2,Apolipoprotein A-II,37445,-0.0437976566884907,0.00443309316839506,-0.052486519298545,-0.0351087940784364,6.09184649652256e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,CD302,CD302 antigen,39788,0.0266850248224955,0.00270223259020812,0.0213886489456875,0.0319814006993034,6.20760032234796e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,SWAP70,Switch-associated protein 70,37382,0.0329669069066772,0.00334408751598346,0.0264124953753496,0.0395213184380048,7.53802576476574e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,NOTCH1,Neurogenic locus notch homolog protein 1,40052,0.0143504720525167,0.00145632575788238,0.0114960735670672,0.0172048705379661,7.64580070527514e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,ADM,Pro-adrenomedullin,40030,0.0240499566951057,0.0024461980074132,0.0192554086005758,0.0288445047896356,9.53507746655603e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37382,0.0385500925918333,0.00394266095717042,0.0308224771157793,0.0462777080678873,1.66682987272289e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,KLRD1,Natural killer cells antigen CD94,40058,0.0414609582062322,0.00424416566866249,0.0331423934956537,0.0497795229168107,1.76577994867353e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,PMM2,Phosphomannomutase 2,37021,0.0547040550771867,0.00561186995477716,0.0437047899658235,0.06570332018855,2.24133983825252e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL2,C-C motif chemokine 2,39720,0.0467910210050063,0.00480508613112455,0.0373730521880022,0.0562089898220105,2.40233456114503e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP12,Macrophage metalloelastase,39900,0.0454434707411493,0.00466865346343101,0.0362929099528245,0.0545940315294741,2.49581362462417e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,ACYP1,Acylphosphatase-1,37073,0.0594239667812221,0.00611704255431777,0.0474345633747593,0.0714133701876849,3.10401415509095e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,ADA,Adenosine deaminase,40058,0.0313550896148961,0.00323023583919476,0.0250238273700744,0.0376863518597178,3.24396358627883e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJC21,DnaJ homolog subfamily C member 21,37388,0.0347420712737766,0.00358181429577425,0.0277217152540591,0.0417624272934941,3.57527981875637e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFA,Protransforming growth factor alpha,39866,0.0412789884331649,0.00426236667527682,0.0329247497496223,0.0496332271167075,4.03470611500781e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,TCL1A,T-cell leukemia/lymphoma protein 1A,39730,0.0854686833212352,0.00882559202321996,0.0681705229557241,0.102766843686746,4.05275200875494e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL20,C-C motif chemokine 20,40058,0.0757051537763109,0.00782620156784701,0.0603657987033308,0.0910445088492911,4.49275881914929e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37056,0.0636059160506712,0.0065790161168597,0.0507110444616262,0.0765007876397163,4.87924223961112e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,TPP1,Tripeptidyl-peptidase 1,39767,0.0416999173016716,0.00432410521209968,0.0332246710859563,0.050175163517387,6.00835790799607e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,MTUS1,Microtubule-associated tumor suppressor 1,37169,0.0501250544163201,0.00519829259511429,0.0399364009298961,0.0603137079027441,6.2317139465878e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,PAGR1,PAXIP1-associated glutamate-rich protein 1,37043,0.0389968683410499,0.00404687171268919,0.0310649997841791,0.0469287368979208,6.63369284162303e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,STK4,Serine/threonine-protein kinase 4,39868,0.0779141235202507,0.00810584414941545,0.0620266689873965,0.093801578053105,8.1418621071753e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS7_LGALS7B,Galectin-7,39822,0.0363142476478896,0.00378088877618385,0.0289037056465693,0.0437247896492099,8.74881858569102e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,PVR,Poliovirus receptor,40009,0.0331654604602988,0.00345754117065996,0.0263886797658053,0.0399422411547924,9.85212567199102e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,NPHS1,Nephrin,37056,0.0306063107147244,0.00319253907521456,0.0243489341273039,0.036863687302145,1.068921203555e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,BRK1,Protein BRICK1,39489,0.0394374898684712,0.00413552863125351,0.0313318537512143,0.0475431259857281,1.69416439372882e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,PRG2,Bone marrow proteoglycan,37437,-0.0449943792262654,0.00471865970038899,-0.0542429522390279,-0.035745806213503,1.74293916470978e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC4A,C-type lectin domain family 4 member A,39866,-0.030717432593765,0.00322819027639634,-0.0370446855355019,-0.0243901796520282,2.06276172815487e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,COX6B1,Cytochrome c oxidase subunit 6B1,37437,0.0283395748613518,0.00297822292259296,0.0225022579330696,0.034176891789634,2.10665705134811e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,GRN,Progranulin,39787,0.021812414007685,0.00229569834861842,0.0173128452443929,0.0263119827709771,2.35832542260223e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,SLIT2,Slit homolog 2 protein,39489,0.0454934832290072,0.00479407123274437,0.0360971036128282,0.0548898628451861,2.64846362321158e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,TSNAX,Translin-associated protein X,37021,0.0347215233805952,0.00365838132507156,0.027551095983455,0.0418919507777355,2.67803259359225e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,SH3BP1,SH3 domain-binding protein 1,37382,0.0423912780211593,0.0044691969910073,0.033631651918785,0.0511509041235336,2.81683697392628e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,BRDT,Bromodomain testis-specific protein,37021,0.0322835093592107,0.00341047958081487,0.0255989693808136,0.0389680493376078,3.39669005919033e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37388,0.0426417501156684,0.00450495254840805,0.0338120431207886,0.0514714571105481,3.39686750840668e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,CD34,Hematopoietic progenitor cell antigen CD34,39945,0.021106450059251,0.00223361358198502,0.0167285674385603,0.0254843326799416,3.86388940674796e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,AMOTL2,Angiomotin-like protein 2,37333,0.0425387041378166,0.00451061274014325,0.0336979031671358,0.0513795051084974,4.72539360067305e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGAP1,Rho GTPase-activating protein 1,39477,0.0411104194541101,0.00436195523713221,0.0325609871893309,0.0496598517188892,4.90234924211545e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPTL1,Angiopoietin-related protein 1,39617,0.0255537796191805,0.00271879117308227,0.0202249489199393,0.0308826103184218,6.25198040077432e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,ATG4A,Cysteine protease ATG4A,39477,0.0513618994227068,0.00547307127170604,0.040634679730163,0.0620891191152506,7.17568655548876e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39477,0.0410810360119508,0.00437935852571892,0.0324974933015417,0.0496645787223598,7.44242788221106e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,EFCAB2,Dynein regulatory complex protein 8,37169,0.0305875888763168,0.00326053700933609,0.0241969363380181,0.0369782414146155,7.56753846456873e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37039,0.0459757796464071,0.00490512405226961,0.0363617365039586,0.0555898227888555,8.18243943640561e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37437,0.0538112599812887,0.00574589030205641,0.0425493149892581,0.0650732049733192,8.77060879694561e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,FRZB,Secreted frizzled-related protein 3,39695,0.0229544130097217,0.00245221733763015,0.0181480670279666,0.0277607589914768,8.96434765876452e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39713,0.0638274771747595,0.00682555763598236,0.0504493842082341,0.077205570141285,9.79459274598847e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37411,0.0409736955769943,0.00438078593756844,0.0323873551393601,0.0495600360146284,9.83265202275674e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37437,0.0260551814478529,0.00278577044595412,0.0205950713737828,0.031515291521923,9.83857186588763e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,GNAS,Neuroendocrine secretory protein 55,37411,0.0785222060859079,0.00841996263585164,0.0620190793196387,0.0950253328521772,1.27068815883712e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,ROBO1,Roundabout homolog 1,39885,0.0204432520462499,0.00219346484023258,0.0161440609593941,0.0247424431331058,1.31080253632971e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39477,0.0512346180017531,0.00550984400352156,0.0404353237548509,0.0620339122486553,1.60555947472578e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,PKD1,Polycystin-1,37437,0.0226525566019469,0.00243832604728684,0.0178734375492647,0.0274316756546291,1.77080327921636e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,SNRPB2,U2 small nuclear ribonucleoprotein B'',37388,0.0349385324168101,0.00376957556255107,0.02755016431421,0.0423269005194102,2.1680485365164e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,CD74,HLA class II histocompatibility antigen gamma chain,40009,0.0290177534160595,0.00314762892242778,0.022848400728101,0.035187106104018,3.36345041592345e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,DCTN6,Dynactin subunit 6,39489,0.0608194274571065,0.00659898399675476,0.0478854188234672,0.0737534360907458,3.45348485106829e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,BPIFA2,BPI fold-containing family A member 2,36593,-0.0934207022261424,0.0101339466007624,-0.113283237563637,-0.0735581668886481,3.47822565251969e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,IL17RB,Interleukin-17 receptor B,39644,-0.0461159601151541,0.0050045945058783,-0.0559249653466755,-0.0363069548836326,3.5062278181383e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,VIT,Vitrin,37437,0.0313007935255688,0.00342333014744415,0.0245910664365783,0.0380105206145593,6.90206242710536e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,STX16,Syntaxin-16,39477,0.0495283637245561,0.00541891349211652,0.0389072932800077,0.0601494341691044,7.0051930091055e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,VAMP5,Vesicle-associated membrane protein 5,39585,0.0449047105691538,0.00491482008661407,0.0352716631993902,0.0545377579389173,7.21632697878708e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,IL17D,Interleukin-17D,39587,0.0287072000353757,0.00314895048314929,0.0225352570884031,0.0348791429823483,8.68405222401587e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,ACP6,Lysophosphatidic acid phosphatase type 6,40011,0.0552930493527715,0.00607414970305395,0.0433877159347857,0.0671983827707572,9.79282406150881e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,FCN1,Ficolin-1,37430,0.047597382586935,0.005241028402238,0.0373249669185485,0.0578697982553215,1.21481588095162e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,CYTL1,Cytokine-like protein 1,37437,0.0193205662674718,0.00213013332445778,0.0151455049515345,0.023495627583409,1.35000963691085e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,CCS,Copper chaperone for superoxide dismutase,39749,0.0398269365180933,0.0043926570185717,0.0312173287616928,0.0484365442744939,1.36729635325076e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,PVALB,Parvalbumin alpha,39971,0.0959978339572684,0.0106118620805027,0.075198584279483,0.116797083635054,1.64483129291177e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39749,0.0290726937898749,0.00322269390421823,0.0227562137376072,0.0353891738421427,2.06850490898252e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMB1,Laminin subunit beta-1,37043,0.0255301911226498,0.00282948556332127,0.0199843994185402,0.0310759828267595,2.08220269608853e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,SV2A,Synaptic vesicle glycoprotein 2A,37039,0.0516275329942794,0.00572430652604609,0.040407892203229,0.0628471737853297,2.15742133623182e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,MENT,Protein MENT,37124,-0.0186616931367336,0.00207130025564508,-0.022721441637798,-0.0146019446356693,2.34639813773899e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37411,0.0555572682368128,0.00616762651992892,0.0434687202577521,0.0676458162158735,2.3779043638653e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,IDS,Iduronate 2-sulfatase,40058,0.00753607946231192,0.000836993266866395,0.00589557265925378,0.00917658626537005,2.41938354314149e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,CELA3A,Chymotrypsin-like elastase family member 3A,40034,0.046655547269733,0.00518259317424916,0.0364976646482047,0.0568134298912614,2.45057126328697e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,SPAG1,Sperm-associated antigen 1,37411,0.0489174242856781,0.0054334357075511,0.038267890298878,0.0595669582724783,2.48465823710701e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QA,Complement C1q subcomponent subunit A,39971,-0.0191479109460536,0.00213318621751668,-0.0233289559323863,-0.0149668659597209,3.10644677137546e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,IL6ST,Interleukin-6 receptor subunit beta,39868,0.0146542322212059,0.001633763937775,0.0114520549031669,0.0178564095392449,3.29916983533015e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,SOD1,Superoxide dismutase [Cu-Zn],39487,0.040377961843015,0.00450341592161961,0.0315512666366406,0.0492046570493894,3.41489079954784e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA9,Serpin A9,39715,0.0606581609793935,0.00676559541908835,0.0473975939579803,0.0739187280008067,3.42189998382245e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,CBS,Cystathionine beta-synthase,37043,0.0425205401166997,0.00474458950455778,0.0332211446877665,0.051819935545633,3.61567584675499e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,ABCA2,ATP-binding cassette sub-family A member 2,37021,0.0306966286140118,0.00342885494717639,0.023976072917546,0.0374171843104775,3.93815411303612e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,ELOB,Elongin-B,37021,0.0327913297031524,0.00366338674507054,0.0256110916828142,0.0399715677234907,3.98618866952012e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,PEPD,Xaa-Pro dipeptidase,37445,0.0213988083136674,0.00239354946107255,0.0167074513699652,0.0260901652573696,4.38007916353077e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A13,Protein S100-A13,37056,0.0288960328546327,0.00324127412227727,0.0225431355749693,0.0352489301342962,5.51096595275774e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,FCRL1,Fc receptor-like protein 1,39868,0.036354461390412,0.00408031531123573,0.02835704338039,0.0443518794004341,5.65740898533658e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK7,Kallikrein-7,36818,0.0324152295647329,0.00363851179664,0.0252837464433185,0.0395467126861473,5.83368802419823e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA6,Corticosteroid-binding globulin,37453,0.0146101465964693,0.00164015048945928,0.0113954516371291,0.0178248415558095,5.8584609603617e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINI1,Neuroserpin,37088,0.0255160146698722,0.00287032479080906,0.0198901780798864,0.0311418512598579,6.91897246924422e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,ZHX2,Zinc fingers and homeoboxes protein 2,37388,0.0257838707837828,0.00290292157409282,0.0200941444985608,0.0314735970690047,7.382591135324e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB1,Integrin beta-1,39862,0.017942884886802,0.00202066846555398,0.0139823746943162,0.0219033950792878,7.4051350598607e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL14,C-C motif chemokine 14,39843,0.0320925314413585,0.00361744542525433,0.02500233840786,0.0391827244748569,7.96066557363377e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,PRDX1,Peroxiredoxin-1,39434,-0.0748690836112901,0.00844478565075643,-0.0914208634867727,-0.0583173037358075,8.41203057363848e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,ERMAP,Erythroid membrane-associated protein,37056,0.0367660041453463,0.00415550274058561,0.0286212187737985,0.0449107895168941,1.00726704425281e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39682,0.0262344781714767,0.0029668169532106,0.020419516943184,0.0320494393997695,1.03189641981427e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39453,0.0390157815270438,0.00441749394469324,0.030357493395445,0.0476740696586425,1.13492654405354e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39858,0.0308412498641903,0.0034967394651529,0.0239876405124906,0.0376948592158899,1.26075126952077e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,HPCAL1,Hippocalcin-like protein 1,40058,0.0607460748162506,0.00689500785670713,0.0472318594171046,0.0742602902153965,1.37438883030032e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40030,0.0243159190776059,0.00276524602734692,0.0188960368640059,0.0297358012912058,1.59481903858217e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,PQBP1,Polyglutamine-binding protein 1,39477,0.044733648216564,0.00508792481020614,0.03476131558856,0.054705980844568,1.61841452477235e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,SCRIB,Protein scribble homolog,37043,0.0736190428328581,0.00839931557524271,0.0571563843053824,0.0900817013603338,2.09621211862322e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,BOLA2_BOLA2B,BolA-like protein 2,37043,0.0446589635135592,0.00510856483549349,0.0346461764359919,0.0546717505911264,2.56518391496369e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,TEK,Angiopoietin-1 receptor,39913,0.0176052272543301,0.00201529199954834,0.0136552549352154,0.0215551995734449,2.65410118450162e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,AMIGO2,Amphoterin-induced protein 2,39788,0.0182661892750199,0.00209156465086702,0.0141667225593206,0.0223656559907193,2.71642938810161e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,KLB,Beta-klotho,39489,-0.0597373766668324,0.00684294070677707,-0.0731495404521154,-0.0463252128815493,2.80599849071066e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBP6,Insulin-like growth factor-binding protein 6,39825,0.0224048677581757,0.00256746917063685,0.0173726281837274,0.0274371073326239,2.88393654180018e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,XCL1,Lymphotactin,40030,0.0444984840208236,0.00509998058216028,0.0345025220797895,0.0544944459618578,2.91149460053331e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,PZP,Pregnancy zone protein,37453,0.0446964911379877,0.00512938973589663,0.0346428872556303,0.0547500950203451,3.2749458120528e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,ENTR1,Endosome-associated-trafficking regulator 1,37043,0.04855841022659,0.00557371342642157,0.0376339319108037,0.0594828885423763,3.33720904044293e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,MAGED1,Melanoma-associated antigen D1,39477,0.0392026364539609,0.00450352176983964,0.0303757337850752,0.0480295391228466,3.49239709811566e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37382,0.0831119710768363,0.00955239638200871,0.0643892741680992,0.101834667985573,3.6777429104809e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,ECI2,Enoyl-CoA delta isomerase 2,37021,0.0502428908835142,0.00577559485804321,0.0389227249617495,0.0615630568052789,3.73643912425744e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37043,0.0405562518295476,0.00467893457021512,0.031385540071926,0.0497269635871692,4.91344396008454e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37043,0.073855164812464,0.00852284341225713,0.05715039172444,0.090559937900488,5.01241235277836e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,TCOF1,Treacle protein,37437,0.0245665231868711,0.00283559800572314,0.0190087510956537,0.0301242952780884,5.08200068804086e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,SLITRK2,SLIT and NTRK-like protein 2,40030,0.0310723715599773,0.00358961686301864,0.0240367225084608,0.0381080206114939,5.33155111676751e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,NPPB,Natriuretic peptides B,39585,-0.101978788437517,0.0117820325397033,-0.125071572215336,-0.0788860046596991,5.37913248420795e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,JAM2,Junctional adhesion molecule B,40009,0.0201004837057264,0.00233156537298307,0.0155306155746796,0.0246703518367733,7.24275908257982e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,TSPYL1,Testis-specific Y-encoded-like protein 1,37056,0.0326882970076974,0.00379309491841983,0.0252538309675946,0.0401227630478003,7.59240902729821e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL15,C-C motif chemokine 15,40052,0.034699217466924,0.00403225273296323,0.0267960021103161,0.042602432823532,8.29247963084174e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,EPCAM,Epithelial cell adhesion molecule,39867,-0.0759696301561219,0.00884017398231023,-0.09329637116145,-0.0586428891507939,9.19021560977527e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,PTGES2,Prostaglandin E synthase 2,36961,0.0445509421202937,0.00518653005107225,0.0343853432201921,0.0547165410203953,9.6941785177292e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39868,0.0507202807627233,0.00590811671352204,0.0391403720042201,0.0623001895212265,9.92098423442474e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,DENR,Density-regulated protein,37056,0.0462764014136174,0.00539311056776292,0.0357059047008021,0.0568468981264327,1.0479063698681e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,CD101,Immunoglobulin superfamily member 2,37382,0.0336894642328253,0.00392821577479438,0.0259901613142283,0.0413887671514223,1.08555479222324e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,ECE1,Endothelin-converting enzyme 1,39489,0.0278674735916024,0.00325023828888375,0.0214970065453902,0.0342379406378145,1.09221352128894e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,CRIM1,Cysteine-rich motor neuron 1 protein,39931,-0.0160483341738399,0.00187409937656237,-0.0197215689519022,-0.0123750993957777,1.19568987827595e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,IL12B,Interleukin-12 subunit beta,40058,0.04161584348566,0.00486555664413222,0.0320793524631608,0.0511523345081591,1.30345108872292e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37411,0.0472589542800111,0.00552784185330415,0.036424384247535,0.0580935243124872,1.37029375842903e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,INSR,Insulin receptor,37056,0.0132688295948726,0.00155205891598232,0.0102267941195473,0.016310865070198,1.37495590469036e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39914,-0.0238834954529801,0.00279614383492757,-0.0293639373694381,-0.0184030535365221,1.44125600910764e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,CCN5,CCN family member 5,39858,0.030552470106452,0.00357811135807318,0.0235393718446286,0.0375655683682755,1.47776180184804e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39858,0.0286529061967334,0.00335727993834219,0.0220726375175827,0.0352331748758841,1.53158708353288e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,BOLA1,BolA-like protein 1,36991,0.0436530635137834,0.00511745793238209,0.0336228459663145,0.0536832810612523,1.61940313360413e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSF,Cathepsin F,39913,0.0320461068371166,0.0037628857828305,0.0246708507027688,0.0394213629714644,1.79052305244519e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,SPRR3,Small proline-rich protein 3,37388,0.0519282914453595,0.00610653262832378,0.0399594874938449,0.0638970953968741,2.02692486306389e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37021,0.0519609097674307,0.0061220209314663,0.0399617487417567,0.0639600707931046,2.33467600183237e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,ERI1,3'-5' exoribonuclease 1,37169,0.0264649911094171,0.00311828515175296,0.0203531522119813,0.0325768300068529,2.3422306816081e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,C7,Complement component C7,37149,-0.0253698798941518,0.00299075176380214,-0.031231753351204,-0.0195080064370996,2.42944620538989e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP8,Caspase-8,39984,0.0486137415402284,0.00573470882055884,0.0373737122519331,0.0598537708285237,2.50600762574273e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,NCAN,Neurocan core protein,40009,0.0288653036055847,0.00341367614294363,0.0221744983654152,0.0355561088457542,3.00642368862367e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRC,Receptor-type tyrosine-protein phosphatase C,37437,0.0175581971820065,0.002076353242594,0.0134885448265223,0.0216278495374907,3.04023146139615e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,NADK,NAD kinase,39868,0.041961908890923,0.00496342746931385,0.0322335910510679,0.0516902267307781,3.04894147714497e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39868,0.0383905266800098,0.00454108616706826,0.029489997792556,0.0472910555674636,3.05361811509691e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,EDF1,Endothelial differentiation-related factor 1,37411,0.0541106422112691,0.00641925575827543,0.0415289009250493,0.066692383497489,3.82142604393726e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,COL24A1,Collagen alpha-1(XXIV) chain,37382,0.043450384473275,0.00516402633814932,0.0333288928505023,0.0535718760960476,4.35532599632021e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL8,Interleukin-8,39750,0.0516422369580097,0.0061466072538413,0.0395948867404807,0.0636895871755386,4.76697696706746e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,CHCHD6,MICOS complex subunit MIC25,37368,0.0227152418989053,0.00270775927439381,0.0174080337210934,0.0280224500767172,5.38832047444778e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,C8B,Complement component C8 beta chain,37453,0.0236856741611062,0.00282631997103019,0.0181460870178871,0.0292252613043254,5.78900923190193e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,COL6A3,Collagen alpha-3(VI) chain,40052,0.024929925491541,0.00297784609159296,0.0190933471520188,0.0307665038310632,6.13350127142073e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,C7orf50,Uncharacterized protein C7orf50,37388,0.0170912069687584,0.00204335851352192,0.0130862242822554,0.0210961896552614,6.63626266473924e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,SCT,Secretin,37039,0.0344425750679093,0.00411893111484724,0.0263694700828087,0.0425156800530099,6.78023468378136e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,IL5RA,Interleukin-5 receptor subunit alpha,39866,-0.0421326472937771,0.00504491533368863,-0.0520206813478069,-0.0322446132397474,7.2859114323714e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39587,0.046409936355821,0.00555747648158927,0.035517282451906,0.0573025902597359,7.33334383709962e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,PDIA3,Protein disulfide-isomerase A3,37124,0.0196984561401582,0.00236211652908998,0.0150687077431418,0.0243282045371745,8.20339655630318e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,GFAP,Glial fibrillary acidic protein,39453,0.0338525771646519,0.0040652699580517,0.0258846480468705,0.0418205062824332,8.95391565960886e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA2,Annexin A2,36879,0.0540132655606607,0.00648859841302607,0.0412956126711296,0.0667309184501918,9.32100469123885e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,DCTN2,Dynactin subunit 2,39788,0.0734843620915277,0.00883032929939342,0.0561769166647166,0.0907918075183388,9.35805295784469e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,LY75,Lymphocyte antigen 75,39866,0.0298936725029878,0.0035925947251723,0.02285218684165,0.0369351581643255,9.42556731555123e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,YAP1,Transcriptional coactivator YAP1,37388,0.0197269423898266,0.00237758640351089,0.0150668730389453,0.0243870117407079,1.16761206901215e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39713,0.0745538559604555,0.00898827176536262,0.0569368433003448,0.0921708686205663,1.17651587144742e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,HIP1R,Huntingtin-interacting protein 1-related protein,37365,0.0323454926817622,0.0039072019870972,0.0246873767870517,0.0400036085764727,1.36451295069634e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,NAA10,N-alpha-acetyltransferase 10,37021,0.0389449449654759,0.00472028457099432,0.029693187206327,0.0481967027246247,1.72563432018513e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,SYT1,Synaptotagmin-1,37388,0.0284754509066337,0.00345164503564672,0.0217102266367661,0.0352406751765013,1.73192250424111e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,CLSTN3,Calsyntenin-3,37388,0.0232323995176543,0.00281939999618815,0.0177063755251255,0.0287584235101831,1.87637725820287e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,AGER,Advanced glycosylation end product-specific receptor,39817,0.0303100181171971,0.00368154633076879,0.0230941873088903,0.0375258489255039,1.9665076913386e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37043,0.0248651383040968,0.0030215896517817,0.0189428225866047,0.0307874540215889,2.0612709158562e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,AMFR,E3 ubiquitin-protein ligase AMFR,39489,0.0494682157348052,0.00601477059218057,0.0376792653741313,0.0612571660954791,2.11376101582461e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,ACOT13,Acyl-coenzyme A thioesterase 13,37382,0.0875971128665304,0.0106509045776701,0.0667213398942971,0.108472885838764,2.13987130685656e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,HLA_E,,39866,0.0209172493153054,0.00254552629670627,0.0159280177737611,0.0259064808568496,2.23997964775084e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,CSTB,Cystatin-B,39619,0.0324257035533683,0.00394908931025675,0.0246854885052651,0.0401659186014716,2.36341120553541e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,STX6,Syntaxin-6,39477,0.0520967796719732,0.00634555168811198,0.0396594983632737,0.0645340609806727,2.38396904562234e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,CD59,CD59 glycoprotein,39173,0.016147082111711,0.00196680428378886,0.0122921457154848,0.0200020185079372,2.39070952946398e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,HGFAC,Hepatocyte growth factor activator,37318,0.0216617843971776,0.00263831184599357,0.0164906931790302,0.026832875615325,2.40256222744039e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP6,Gastrotropin,39564,0.0412675469498037,0.00503271864263907,0.0314034184102312,0.0511316754893763,2.59140595376508e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,C2orf69,UPF0565 protein C2orf69,37039,0.0446674552789555,0.00545178567071545,0.0339819553643532,0.0553529551935577,2.77739582430876e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,CR1,Complement receptor type 1,37420,0.0271869585686133,0.00332205244510127,0.0206757357762148,0.0336981813610118,2.99433163335171e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,BSG,Basigin,40040,0.0147787058113566,0.00180840862801509,0.011234224900447,0.0183231867222662,3.24980770031844e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP1,Interstitial collagenase,39314,0.0696771449575027,0.00852706415977389,0.0529640992043459,0.0863901907106596,3.28551984220523e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,NEK7,Serine/threonine-protein kinase Nek7,37169,0.0563573445643918,0.00689648180254901,0.0428402402313958,0.0698744488973879,3.30830752815557e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,CSNK1D,Casein kinase I isoform delta,37056,0.0492565282270323,0.00603278813308494,0.0374322634861859,0.0610807929678788,3.51018823112292e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,CHAD,Chondroadherin,37124,0.0382839435808678,0.00469980325186564,0.0290723292072111,0.0474955579545245,4.10081021929472e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINK6,Serine protease inhibitor Kazal-type 6,40030,0.0409504390798574,0.00502830391423767,0.0310949634079515,0.0508059147517632,4.10146181999466e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,CD300E,CMRF35-like molecule 2,39991,0.0290911010889596,0.00357833184723281,0.0220775706683833,0.0361046315095359,4.60991651237425e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,TF,Serotransferrin,37453,0.0165413285219492,0.0020359358806059,0.0125508941959616,0.0205317628479368,4.87012920944054e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,RARRES1,Retinoic acid receptor responder protein 1,39477,0.0255993181206967,0.00315176900929621,0.0194218508624761,0.0317767853789173,4.9174718684773e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37056,0.0457758522485454,0.00563910885858506,0.0347231988857186,0.0568285056113721,5.17533946801042e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,CAPG,Macrophage-capping protein,39739,0.0438057957465984,0.00540182578616267,0.0332182172057196,0.0543933742874772,5.45372771544929e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,NXPH3,Neurexophilin-3,37056,0.0224566307036915,0.00277191265586489,0.0170236818981963,0.0278895795091867,5.90346860981654e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,HEPH,Hephaestin,37437,0.0198490901389329,0.00245224641222709,0.0150426871709678,0.024655493106898,6.24916960858004e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,TPMT,Thiopurine S-methyltransferase,39477,0.0546563247537649,0.00677085917429012,0.0413854407721562,0.0679272087353735,7.39844697649446e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,GLRX,Glutaredoxin-1,39771,0.0420838549250982,0.00521418079596045,0.0318640605650157,0.0523036492851807,7.46462299729043e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,MANSC1,MANSC domain-containing protein 1,39913,-0.0202753405524425,0.00251440361686939,-0.0252035716415066,-0.0153471094633785,7.92162563840602e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,DMP1,Dentin matrix acidic phosphoprotein 1,37043,-0.0453168034766224,0.00563570152462434,-0.0563627784648861,-0.0342708284883586,9.66522843990892e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39749,-0.0826547109422888,0.0102869964326424,-0.102817223950268,-0.0624921979343097,1.00208647490704e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP6V1F,V-type proton ATPase subunit F,39453,0.0493489761945023,0.00615330929210318,0.0372884899819801,0.0614094624070245,1.13291875718251e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,NPTX1,Neuronal pentraxin-1,39858,0.0304613044286474,0.00379927255823679,0.0230147302145033,0.0379078786427915,1.15170292852851e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,CD14,Monocyte differentiation antigen CD14,39564,0.0305697586643547,0.00381855308730734,0.0230853946132323,0.0380541227154771,1.27167013924296e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37382,-0.0246731204950299,0.00308180714208234,-0.0307134624935113,-0.0186327784965485,1.2806303226017e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,GPNMB,Transmembrane glycoprotein NMB,39444,0.0210005642934874,0.00262672600493953,0.015852181323806,0.0261489472631689,1.38654881972191e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP9,Caspase-9,37056,0.04711116910829,0.00590977120150044,0.0355280175533491,0.0586943206632309,1.69255410014195e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,WFDC1,WAP four-disulfide core domain protein 1,37123,0.0388338942493787,0.00489784812272258,0.0292341119288425,0.048433676569915,2.38955246274953e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,NECTIN2,Nectin-2,39846,0.020730938007215,0.00262296542441642,0.0155899257753589,0.0258719502390712,2.88463876311154e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,PRSS53,Serine protease 53,37388,0.0274720574401254,0.00347744811776978,0.0206562591292967,0.0342878557509542,3.0018874352034e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,BGN,Biglycan,39448,-0.0875022366175825,0.011097490010012,-0.109253317037206,-0.0657511561979589,3.35614023417316e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,NXPH1,Neurexophilin-1,39489,0.0275033487692608,0.0034910198358643,0.0206609498909668,0.0343457476475549,3.53558275064577e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,APOB,Apolipoprotein B-100,37445,0.0166124817487576,0.00211198822555707,0.0124729848266657,0.0207519786708494,3.94310874921465e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,AGT,Angiotensinogen,37445,0.0164310646438865,0.00209015747842793,0.0123343559861678,0.0205277733016052,4.09132804260521e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,SF3B4,Splicing factor 3B subunit 4,39788,0.0533818387206566,0.0067936122721587,0.0400663586672256,0.0666973187740877,4.16270682526234e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,CD300LF,CMRF35-like molecule 1,40030,0.0435867873714108,0.00555430078225445,0.0327003578381921,0.0544732169046295,4.51204016204025e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,GC,Vitamin D-binding protein,37453,0.0189200442523305,0.00241082035714303,0.0141948363523301,0.0236452521523308,4.54303782708175e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37411,0.049203286486643,0.0062711007411824,0.0369119290339255,0.0614946439393605,4.6142645586411e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,COL2A1,Collagen alpha-1(II) chain,37043,0.0587030686294884,0.00749244537790907,0.0440178756887866,0.0733882615701902,5.04753482459779e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,PLA2G15,Phospholipase A2 group XV,39913,0.0192882076188266,0.00246251859322593,0.0144616711761038,0.0241147440615495,5.0715123217617e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37056,0.0266566468343065,0.00340447128971885,0.0199838831064576,0.0333294105621555,5.25413515144775e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,REG4,Regenerating islet-derived protein 4,39885,0.034207160812349,0.0043704124399358,0.0256411524300748,0.0427731691946231,5.3075722417197e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,MCAM,Cell surface glycoprotein MUC18,39931,-0.0238027418676558,0.00304132553625966,-0.0297637399187248,-0.0178417438165869,5.32983248551205e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,C2CD2L,Phospholipid transfer protein C2CD2L,39453,0.0304297480238115,0.00389019655705119,0.0228049627719912,0.0380545332756319,5.52343773577077e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,TSHB,Thyrotropin subunit beta,39868,0.0544157320774446,0.00696399827291111,0.0407662954625388,0.0680651686923504,5.88883883322095e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,SCGB3A1,Secretoglobin family 3A member 1,37124,-0.0178093660272792,0.00228272896337377,-0.0222835147954918,-0.0133352172590666,6.55858789946448e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,CARHSP1,Calcium-regulated heat-stable protein 1,39489,0.0366647928114783,0.00470256159653268,0.0274477720822743,0.0458818135406824,6.74987218213868e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSE,Cathepsin E,37124,0.0382958743238984,0.00492672794383363,0.0286394875539845,0.0479522610938123,8.22216531207185e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,FOLR2,Folate receptor beta,40009,-0.0207835881080216,0.00268129584944409,-0.026038927972932,-0.0155282482431112,9.63316302188994e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,CRYM,Ketimine reductase mu-crystallin,36991,0.0552538045403684,0.00714666878258917,0.0412463337264936,0.0692612753542432,1.14085230372592e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,THBS4,Thrombospondin-4,39892,0.032086590770218,0.00415893293024012,0.0239350822269473,0.0402380993134886,1.27970141569861e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,CA9,Carbonic anhydrase 9,40030,-0.0310620746402024,0.00402669709156396,-0.0389544009396678,-0.0231697483407371,1.28980322345673e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,HDGF,Hepatoma-derived growth factor,40014,0.0673511984135755,0.00873415363334797,0.0502322572922135,0.0844701395349375,1.31826854432987e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37043,0.0556633343571626,0.0072475209279002,0.0414581933384782,0.069868475375847,1.69848845976097e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37382,0.0848609310169288,0.0110617459483383,0.0631799089581858,0.106541953075672,1.81500575231254e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39931,0.0294936381437616,0.00385912218185071,0.0219297586673342,0.037057517620189,2.2489732632125e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,CFHR2,Complement factor H-related protein 2,37364,0.040110573949974,0.00525646708920985,0.0298078984551226,0.0504132494448253,2.49075315930915e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,CD28,T-cell-specific surface glycoprotein CD28,39477,0.0249312011367899,0.00327708437903769,0.018508115753876,0.0313542865197037,2.94801163232789e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39477,0.0572832855505102,0.00753184327734587,0.0425208727269123,0.0720456983741082,2.99975767947085e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNGR2,Interferon gamma receptor 2,39749,0.0367544967615225,0.00484683378578264,0.0272547025413885,0.0462542909816564,3.5574004806948e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,MAN2B2,Epididymis-specific alpha-mannosidase,37437,0.0416148388331178,0.00548927421934229,0.0308558613632069,0.0523738163030287,3.64773785288779e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39453,0.0330838827499761,0.00436750451289895,0.0245235739046942,0.0416441915952581,3.79212420661084e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,LRRC25,Leucine-rich repeat-containing protein 25,39788,0.0273607362158841,0.00361475300857919,0.0202758203190689,0.0344456521126993,3.96084213247248e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,DEFB103A_DEFB103B,Beta-defensin 103,37000,0.0283069969582051,0.00374991972453609,0.0209571542981144,0.0356568396182959,4.68582467142957e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,STX7,Syntaxin-7,37056,0.0347064506830224,0.00460817060438607,0.0256744362984257,0.0437384650676191,5.34165290682346e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,INSL3,Insulin-like 3,37388,0.0508889609893811,0.00675992799924609,0.0376395021108588,0.0641384198679034,5.47645850051619e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJB8,DnaJ homolog subfamily B member 8,39585,0.0398983302596685,0.00530412026565947,0.029502254538976,0.0502944059803611,5.67952793671079e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,MERTK,Tyrosine-protein kinase Mer,40058,0.0176949661333473,0.00235797097914403,0.013073343014225,0.0223165892524696,6.4950815945119e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,DAPK2,Death-associated protein kinase 2,37056,0.0372419995799015,0.00497004845383036,0.027500704610394,0.046983294549409,7.14423178978554e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGAV,Integrin alpha-V,40030,0.0115271225945015,0.0015387643105403,0.00851114454584254,0.0145431006431605,7.17913475852403e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,COMP,Cartilage oligomeric matrix protein,39729,0.0233270804216035,0.00311698465430209,0.0172177904991714,0.0294363703440356,7.59502037721515e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,GLO1,Lactoylglutathione lyase,39585,0.0403104604896909,0.00538846873171089,0.0297490617755376,0.0508718592038443,7.77263219466486e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,PDCD1,Programmed cell death protein 1,39998,0.0284118284255302,0.00380837597773043,0.0209474115091786,0.0358762453418819,9.06777331223326e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,CD200R1,Cell surface glycoprotein CD200 receptor 1,39809,0.0239683839170068,0.00321812247216233,0.0176608638715687,0.030275903962445,9.96541883411865e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37388,0.0429852777650568,0.005772183964323,0.0316717971949837,0.0542987583351299,1.01283967746574e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,GM2A,Ganglioside GM2 activator,37178,0.025086179611508,0.00336893734006837,0.0184830624249739,0.031689296798042,1.01876858604301e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,PRSS22,Brain-specific serine protease 4,37056,0.0232139265829387,0.00313982549411151,0.0170598686144801,0.0293679845513973,1.51765192253879e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,DHPS,Deoxyhypusine synthase,37368,0.0282126616134446,0.00382057958573819,0.0207243256253977,0.0357009976014915,1.62114290431994e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,PCDH1,Protocadherin-1,40018,0.0142769945890228,0.00193460118328051,0.010485176269793,0.0180688129082526,1.66216238707016e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,TMPRSS11D,Transmembrane protease serine 11D,37357,0.0249039092011828,0.00337453005460319,0.0182898302941605,0.031517988108205,1.6758533907492e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,STAM,Signal transducing adapter molecule 1,37368,0.0249619837919624,0.00339489952798271,0.0183079807171162,0.0316159868668085,2.05278034757707e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37437,0.0233153862391494,0.00317605629683567,0.0170903158973515,0.0295404565809474,2.24080296556389e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRG2,Adhesion G-protein coupled receptor G2,39868,0.0182996534723378,0.00249577386936233,0.0134079366883876,0.0231913702562879,2.37129508297887e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,GPR15L,Protein GPR15L,37382,0.0419392606780134,0.00572689948270382,0.0307145376919139,0.0531639836641129,2.55805725407156e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39477,0.0349125766986618,0.00476880568135111,0.0255657175632136,0.0442594358341099,2.58063353107569e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,NFASC,Neurofascin,40058,0.0188284033051859,0.00257638292830649,0.0137786927657052,0.0238781138446666,2.83625753656978e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,CPA2,Carboxypeptidase A2,39933,0.0437839417140492,0.0059968326703204,0.0320301496802212,0.0555377337478772,2.98611331117061e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,IDO1,"Indoleamine 2,3-dioxygenase 1",37043,0.043170495060043,0.00591566599616701,0.0315757897075556,0.0547652004125303,3.09578705363174e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,SFTPD,Pulmonary surfactant-associated protein D,39868,0.0446697124538495,0.00613099390292691,0.0326529644041127,0.0566864605035862,3.34460861409023e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40009,-0.0302095251208115,0.00414792408107286,-0.0383394563197143,-0.0220795939219087,3.41415495195678e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,IGHMBP2,DNA-binding protein SMUBP-2,37021,0.0383120603065712,0.00526283926656717,0.0279968953440996,0.0486272252690429,3.53465217611497e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,PODXL,Podocalyxin,39788,0.0101932461591471,0.00140085240692205,0.0074475754415799,0.0129389168767143,3.5866465733197e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,PRELP,Prolargin,39862,0.0150124427833817,0.00206337625554362,0.0109682253225162,0.0190566602442472,3.60689103085525e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,LCP1,Plastin-2,37437,0.0317491951927564,0.00437386074107282,0.0231764281402537,0.0403219622452592,4.1161011202988e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,SGSH,N-sulphoglucosamine sulphohydrolase,37265,0.0373186676551296,0.00514669535674628,0.0272311447559069,0.0474061905543523,4.36393734973351e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,MCTS1,Malignant T-cell-amplified sequence 1,37382,0.0168677105195326,0.00232714583641693,0.0123065046801555,0.0214289163589098,4.45125342491312e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINB8,Serpin B8,40058,0.0370786929211997,0.00512233310257481,0.0270389200401531,0.0471184658022464,4.73560020765198e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,LACRT,Extracellular glycoprotein lacritin,37339,0.0325445672076008,0.0044992031297591,0.023726129073273,0.0413630053419287,4.96447184269974e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,UMOD,Uromodulin,40012,-0.0354600911631626,0.00490571222479291,-0.0450752871237567,-0.0258448952025685,5.1085594605946e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,PPM1A,Protein phosphatase 1A,39477,0.0205352547510713,0.00284226136835919,0.0149644224690873,0.0261060870330553,5.24373193155002e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37382,0.069673640010103,0.00964247303174972,0.0507743928678736,0.0885728871523324,5.25222007935935e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37043,0.0286080778943949,0.00397331833822694,0.0208203739514701,0.0363957818373197,6.34539863144049e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,CD86,T-lymphocyte activation antigen CD86,37382,0.0196720116466851,0.00273446512655022,0.0143124599986467,0.0250315632947236,6.61837976716959e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,CILP,Cartilage intermediate layer protein 1,37437,0.0360178601616794,0.00501067291462659,0.0261969412490113,0.0458387790743475,6.90663493876391e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,TXN,Thioredoxin,37289,0.0288663007264481,0.00402520602971237,0.0209768969082119,0.0367557045446844,7.81282617114125e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39749,0.0258959468105297,0.00361337452462822,0.0188137327422584,0.032978160878801,8.02081168142914e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,ZBTB17,Zinc finger and BTB domain-containing protein 17,39585,0.0270092855419447,0.00377674167450749,0.01960687185991,0.0344116992239794,8.96297517116951e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRG1,Adhesion G-protein coupled receptor G1,39788,-0.0362164260317897,0.0050657568096261,-0.0461453093786568,-0.0262875426849225,9.1033511252866e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,PLXNB2,Plexin-B2,39984,0.0157139480347923,0.00219822169016929,0.0114054335220605,0.0200224625475241,9.15038259223306e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39755,0.0160126733490201,0.00224090797134646,0.011620493725181,0.0204048529728591,9.3482017511505e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1B,Interleukin-1 beta,39478,0.0370047219753471,0.00519010561159193,0.0268321149766269,0.0471773289740673,1.04874345980143e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,DGKZ,Diacylglycerol kinase zeta,39587,0.0238301659644789,0.00334886925158798,0.0172663822313664,0.0303939496975913,1.1599796548691e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,LETM1,Mitochondrial proton/calcium exchanger protein,37411,0.0347792022279671,0.00488741652397699,0.0251998658409722,0.044358538614962,1.16628609463905e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37388,0.0577738045619553,0.00812071558415012,0.041857202017021,0.0736904071068895,1.18077130960233e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSH,Pro-cathepsin H,39546,0.0478290032372428,0.0067333222484446,0.0346316916302914,0.0610263148441942,1.27021388774751e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINI2,Serpin I2,37382,0.0377258841411066,0.00534229439181653,0.0272549871331462,0.048196781149067,1.72464315057685e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,SFRP4,Secreted frizzled-related protein 4,37124,0.0273332671720982,0.00387294538959539,0.0197422942084913,0.0349242401357052,1.77964244387732e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39749,0.0191575727786402,0.00271654574293494,0.0138331431224877,0.0244820024347927,1.83393393028947e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,SMARCA2,Probable global transcription activator SNF2L2,39489,0.0483438141412401,0.00685708517014039,0.0349039272077649,0.0617837010747153,1.86141515596867e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,NFIC,Nuclear factor 1 C-type,37411,0.0275588898387265,0.0039121156514671,0.019891143161851,0.035226636515602,1.95114839087458e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39788,0.0377623288720948,0.00536474205698106,0.027247434440412,0.0482772233037777,2.01548992771412e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,GOT1,"Aspartate aminotransferase, cytoplasmic",37437,0.0276308796092795,0.00392839794242143,0.0199312196421335,0.0353305395764255,2.1086813983471e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,LTA,Lymphotoxin-alpha,39866,0.025825488394589,0.00367274979792288,0.0186268987906601,0.0330240779985179,2.12358507334456e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,DDR1,Epithelial discoidin domain-containing receptor 1,40009,0.0152257208924766,0.00216739271945052,0.0109776311623536,0.0194738106225996,2.22766946055359e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTSL4,ADAMTS-like protein 4,37043,0.0158414352428691,0.00225468029584857,0.0114222618630059,0.0202606086227323,2.22941593091331e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,FCRL2,Fc receptor-like protein 2,39990,0.0302287340107301,0.00430594740147022,0.0217890771038485,0.0386683909176117,2.30333945512146e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,CCN3,CCN family member 3,40042,0.0211501136564914,0.00301316402583348,0.0152443121658578,0.027055915147125,2.31939222392323e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,DSG4,Desmoglein-4,39725,0.0319826828452537,0.00457511366974733,0.0230154600525489,0.0409499056379584,2.84668562424223e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHB4,Ephrin type-B receptor 4,40052,-0.0152594822075092,0.00218663517766908,-0.0195452871557406,-0.0109736772592778,3.09864787840072e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,NPTXR,Neuronal pentraxin receptor,39868,0.0220156552814065,0.00316351234357859,0.0158151710879925,0.0282161394748206,3.55372241489906e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,NRCAM,Neuronal cell adhesion molecule,39868,0.01790245146864,0.00257556783856656,0.0128543385050495,0.0229505644322305,3.77039590487325e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39885,0.0204757063570247,0.00295834187673392,0.0146773562786262,0.0262740564354232,4.64333961433051e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,LXN,Latexin,39682,-0.0430033257025451,0.00622441992705496,-0.0552031887595729,-0.0308034626455174,5.07375842319821e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39862,0.0190745178687806,0.00276123310247414,0.0136625009879313,0.0244865347496299,5.10156763523379e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,TPR,Nucleoprotein TPR,37021,0.0303634569338857,0.00439721389070023,0.0217449177081132,0.0389819961596581,5.24491458017456e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,PNLIP,Pancreatic triacylglycerol lipase,37445,0.0394361539120976,0.00571219259223887,0.0282402564313094,0.0506320513928858,5.28568624909747e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,CRYGD,Gamma-crystallin D,37388,0.0620210223374201,0.0089861276266921,0.0444082121891036,0.0796338324857366,5.36109904841034e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,WASF3,Wiskott-Aldrich syndrome protein family member 3,39489,0.0539516310246109,0.00782299771196252,0.0386185555091643,0.0692847065400574,5.53262727792668e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37043,0.0449903795071953,0.00653885069667256,0.0321742321417171,0.0578065268726735,6.23488951694164e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,SMS,Spermine synthase,36991,0.0411238538683667,0.00597966769212336,0.0294037051918049,0.0528440025449285,6.37671585261221e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39866,0.0236305810923251,0.00343817768687,0.0168917528260599,0.0303694093585903,6.51877938780142e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,IL31RA,Interleukin-31 receptor subunit alpha,37015,0.0256319071823987,0.00372961208590917,0.0183218674940167,0.0329419468707806,6.5910403469317e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,EFHD1,EF-hand domain-containing protein D1,37411,0.0221135987405761,0.00321867705947673,0.0158049917040017,0.0284222057771504,6.6817294665423e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,PRTG,Protogenin,40030,0.0159018476037311,0.00231701914319962,0.0113604900830599,0.0204432051244024,6.98475418332088e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,FES,Tyrosine-protein kinase Fes/Fps,39477,0.0302366538836945,0.00440872852664862,0.0215955459714632,0.0388777617959258,7.22685520070356e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,SORBS1,Sorbin and SH3 domain-containing protein 1,37411,0.024169748541966,0.00353331623199879,0.0172444487272484,0.0310950483566836,8.22871137403322e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,SNX2,Sorting nexin-2,37368,0.0514209186210144,0.00751854109963844,0.036684578065723,0.0661572591763057,8.30532374861447e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40058,0.0230457508706814,0.00337628152777577,0.0164282390762409,0.0296632626651219,9.05520331396174e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,RPE,Ribulose-phosphate 3-epimerase,37169,0.0452711505893082,0.00663456270721135,0.0322674076831739,0.0582748934954424,9.26723852226711e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,SOD2,"Superoxide dismutase [Mn], mitochondrial",39858,0.0236814900080526,0.0034723855140214,0.0168756144005707,0.0304873656155345,9.43341290543999e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,SNX5,Sorting nexin-5,37043,0.0192518600773511,0.00283823660120749,0.0136889163389845,0.0248148038157178,1.22696865853951e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37056,0.0288510956991757,0.00425537702619549,0.0205105567278326,0.0371916346705189,1.25361740754957e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39904,0.0320194637483139,0.0047251210189466,0.0227582265511785,0.0412807009454492,1.27466495570816e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,COPB2,Coatomer subunit beta',37021,0.0270567516887862,0.0039938626084179,0.0192287809762871,0.0348847224012853,1.30071336858988e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CST5,Cystatin-D,39559,0.0342253017113314,0.00505466853666635,0.0243181513794653,0.0441324520431974,1.32405701989422e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,APRT,Adenine phosphoribosyltransferase,39738,0.0303069847931536,0.00448114109669088,0.0215239482436394,0.0390900213426677,1.39659098257382e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA7,Thyroxine-binding globulin,37453,0.0116926906750949,0.00173051056531268,0.00830088996708206,0.0150844913831078,1.46830219138969e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CD300A,CMRF35-like molecule 8,37124,0.0182073968329678,0.00269886532014951,0.0129176208054748,0.0234971728604609,1.57938112046802e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,KIF1C,Kinesin-like protein KIF1C,37021,0.0230177342230748,0.00341767860443684,0.0163190841583786,0.0297163842877711,1.70852754019102e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,RPL14,60S ribosomal protein L14,37043,0.0253901881860844,0.00377009132755594,0.0180008091840748,0.0327795671880941,1.71155637849354e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB1BP1,Integrin beta-1-binding protein 1,39477,0.0254151803544046,0.00377830906561824,0.0180096945857929,0.0328206661230163,1.79703357953246e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF149,E3 ubiquitin-protein ligase RNF149,37043,0.0184607299198923,0.00274440405877946,0.0130816979646846,0.0238397618751001,1.80739440486266e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,DDX58,Antiviral innate immune response receptor RIG-I,39477,0.0357562941425627,0.00531852490649743,0.0253319853258278,0.0461806029592977,1.84225900584827e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39931,0.0266000360703467,0.00395706062922093,0.0188441972370737,0.0343558749036197,1.85061753720805e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,RSPO3,R-spondin-3,40030,0.0168243040293202,0.0025081719952837,0.0119082869185641,0.0217403211400762,2.04138278389045e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37043,0.0232332126810631,0.00346664796152795,0.0164385826764683,0.0300278426856579,2.14056052519402e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,MDM1,Nuclear protein MDM1,37039,0.0195459924549234,0.00292017469759399,0.0138224500476392,0.0252695348622076,2.268173944404e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,SDC1,Syndecan-1,39868,0.0246982648240016,0.00369668032500252,0.0174527713869966,0.0319437582610065,2.44805746688441e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,ENSA,Alpha-endosulfine,37368,0.0327152795620856,0.00490061783428412,0.0231100686068887,0.0423204905172825,2.55583586694619e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,LRG1,Leucine-rich alpha-2-glycoprotein,37453,-0.0158147966812842,0.00237147261614195,-0.0204628830089224,-0.011166710353646,2.67930733944405e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,NELL2,Protein kinase C-binding protein NELL2,39931,0.0174536202674647,0.00262094027415187,0.012316577330127,0.0225906632048023,2.84058687130264e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37368,0.022726746639991,0.0034129389827705,0.0160373862337608,0.0294161070462212,2.86364048431889e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,DSC2,Desmocollin-2,39673,-0.0205669254578793,0.0030991617671714,-0.0266412825215353,-0.0144925683942234,3.32139401377589e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CBLIF,Cobalamin binding intrinsic factor,39846,0.0423138385676374,0.00638343621444245,0.0298023035873302,0.0548253735479446,3.49509309320276e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,GIMAP8,GTPase IMAP family member 8,36962,0.0306067477070064,0.00463412474856364,0.0215238631998217,0.0396896322141911,4.13852537014967e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP9,Fatty acid-binding protein 9,39866,0.0339538006841205,0.0051463988711727,0.023866858896622,0.044040742471619,4.31019359571373e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,SLITRK6,SLIT and NTRK-like protein 6,39585,-0.0204013903064713,0.00309481513217689,-0.026467227965538,-0.0143355526474046,4.47393422494513e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40058,0.0221328896372349,0.00335893368481998,0.0155493796149877,0.0287163996594821,4.55651804558882e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,FCRL3,Fc receptor-like protein 3,39587,0.0319034863159739,0.00485231531895033,0.0223929482908313,0.0414140243411166,5.02194555321791e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,DIPK2B,Divergent protein kinase domain 2B,37124,0.017403881534665,0.00264682815921187,0.0122160983426097,0.0225916647267203,5.03490587128654e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37437,0.0330918568228639,0.00503474323803667,0.023223760076312,0.0429599535694158,5.12152288594898e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,NAP1L4,Nucleosome assembly protein 1-like 4,37362,0.0248777086427939,0.00378937701677423,0.0174505296899164,0.0323048875956714,5.38920188573188e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CD8A,T-cell surface glycoprotein CD8 alpha chain,40009,0.0287767077745063,0.00438459688245541,0.0201828978848937,0.0373705176641189,5.42916971154122e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,LYPD3,Ly6/PLAUR domain-containing protein 3,39794,0.0210479770396989,0.00320824207244244,0.0147598225777117,0.0273361315016861,5.5244953237917e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39489,0.0184579607212578,0.00281880215100339,0.0129331085052911,0.0239828129372244,6.00680026658707e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,S100P,Protein S100-P,39585,0.0320934932706099,0.00490711979811376,0.0224755384663069,0.0417114480749128,6.33361584920478e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39931,0.0159665390773263,0.00244638569771671,0.0111716231098016,0.0207614550448511,6.93006511498855e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40030,0.0153017095421698,0.00234551982626798,0.0107044906826846,0.019898928401655,7.05817803105013e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,RANBP1,Ran-specific GTPase-activating protein,37043,0.0317962754615193,0.00487494364191091,0.0222413859233739,0.0413511649996647,7.17216891525398e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37368,0.0325343267961498,0.00498942019917063,0.0227550632057753,0.0423135903865242,7.24866753876849e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CKAP4,Cytoskeleton-associated protein 4,39991,0.0154179520088558,0.00236498613877472,0.0107825791768573,0.0200533248408542,7.27536659239397e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA12,Serpin A12,39405,0.071633037457516,0.0109877375076606,0.0500970719425012,0.0931690029725308,7.27829097401303e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39587,0.0217340916573569,0.00333594566063427,0.0151956381625137,0.0282725451522,7.48370124683709e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,LMNB2,Lamin-B2,37388,0.0166044176412139,0.0025520721040492,0.0116023563172774,0.0216064789651503,7.97622989977291e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFBR2,TGF-beta receptor type-2,39913,0.0180213763534237,0.00277485731287187,0.0125826560201948,0.0234600966866525,8.57437959398618e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMG3,Proteasome assembly chaperone 3,39866,0.0300145590326664,0.00462340567239182,0.0209526839147784,0.0390764341505544,8.72701975077535e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSC,Dipeptidyl peptidase 1,39856,0.0257968335716722,0.00398109307669788,0.0179938911413443,0.033599776002,9.45051100851283e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CLPS,Colipase,39836,0.0416745510766853,0.00644267233717181,0.0290469132958286,0.0543021888575421,1.01843550760584e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,POSTN,Periostin,37437,-0.0223361774796712,0.00346569213540444,-0.0291289340650639,-0.0155434208942785,1.19552163442074e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,ULBP2,UL16-binding protein 2,39749,0.0218757156987374,0.0034014244811168,0.0152089237157484,0.0285425076817263,1.30096502506183e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,REPS1,RalBP1-associated Eps domain-containing protein 1,37056,0.0230640072826413,0.00358589641261562,0.0160356503139147,0.0300923642513679,1.30393110539701e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39858,0.028501997920805,0.00444678526309909,0.0197862988051308,0.0372176970364792,1.50010633552264e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,EFNA1,Ephrin-A1,39826,0.015700812257887,0.00245317650325812,0.0108925863115011,0.020509038204273,1.59502921983196e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF3R,Granulocyte colony-stimulating factor receptor,37056,0.0187005152462235,0.00292463337424222,0.0129682338327087,0.0244327966597382,1.66892675611312e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,BCL2,Apoptosis regulator Bcl-2,37382,0.0301790280340142,0.00472141284321452,0.0209250588613137,0.0394329972067147,1.69160536471042e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,NAGA,Alpha-N-acetylgalactosaminidase,37037,0.0359465214357901,0.00563306956026348,0.0249057050976737,0.0469873377739066,1.81423002081173e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CD80,T-lymphocyte activation antigen CD80,37437,0.0199251299899186,0.00312774937828379,0.0137947412084824,0.0260555187713548,1.94569637725806e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,AFAP1,Actin filament-associated protein 1,37124,0.0504409732114585,0.00791882437756511,0.0349200774314309,0.0659618689914861,1.9557978246047e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,BTN2A1,Butyrophilin subfamily 2 member A1,39931,0.014761389027007,0.00232435659669041,0.0102056500974938,0.0193171279565202,2.20033662574102e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39585,-0.0180648499837396,0.00285079463693815,-0.0236524074721383,-0.0124772924953408,2.41006707104693e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,SEZ6L,Seizure 6-like protein,39913,0.0158809596035985,0.00250786710698171,0.0109655400739143,0.0207963791332826,2.47702151901044e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,AK1,Adenylate kinase isoenzyme 1,39868,0.0368847608509651,0.00582878953981083,0.0254603333529358,0.0483091883489943,2.54910381407409e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,LUZP2,Leucine zipper protein 2,37368,0.0257860417942374,0.00407718974025767,0.0177947499033324,0.0337773336851425,2.62117043636789e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A12,Protein S100-A12,39615,0.0440084202229027,0.00696041352654341,0.0303660097108776,0.0576508307349278,2.63998555037598e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,DGCR6,Protein DGCR6,36991,0.0254693181740127,0.00404046163896364,0.0175500133616439,0.0333886229863814,3.00180180687793e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37169,0.0223045076465367,0.00354569949656954,0.0153549366332604,0.029254078659813,3.26182398128114e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,PDGFRB,Platelet-derived growth factor receptor beta,40052,0.0203868165718989,0.00324630289511413,0.0140240628974752,0.0267495702463226,3.471827165158e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37039,0.0318386834599352,0.00507716761538148,0.0218874349337875,0.0417899319860829,3.70049392773562e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39585,0.0330674730761238,0.0052798101989377,0.0227190450862059,0.0434159010660417,3.87443382413026e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,AHCY,Adenosylhomocysteinase,39868,0.0394596165268896,0.00630776046522608,0.0270964060150465,0.0518228270387327,4.05724292914819e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,FGR,Tyrosine-protein kinase Fgr,39489,0.0327120902940101,0.00524823223982514,0.0224255551039528,0.0429986254840673,4.69406053441396e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,MYOM3,Myomesin-3,37124,-0.0544112217341072,0.00874113947229947,-0.0715438550998142,-0.0372785883684003,4.9692458893073e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,BCAN,Brevican core protein,39749,0.0192555423497138,0.00310119777157755,0.0131771947174218,0.0253338899820058,5.4624887659135e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,LEPR,Leptin receptor,39868,-0.0178341085640667,0.00287625600278122,-0.0234715703295179,-0.0121966467986155,5.76795262292513e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CPQ,Carboxypeptidase Q,37430,0.0217369868166111,0.00352029287309637,0.0148372127853422,0.02863676084788,6.81509709814787e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,B4GALT1,"Beta-1,4-galactosyltransferase 1",39931,0.0154394911228235,0.0025019030673697,0.0105357611107789,0.0203432211348681,6.94431502246239e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,TINAGL1,Tubulointerstitial nephritis antigen-like,39844,0.0127677055952667,0.00207032177108221,0.00870987492394552,0.0168255362665878,7.12646036409417e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,SLAMF7,SLAM family member 7,39866,-0.0330669719036294,0.00536950520176209,-0.0435912020990831,-0.0225427417081757,7.52904804776834e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CSDE1,Cold shock domain-containing protein E1,37021,0.0687790985347634,0.011195461342936,0.0468359943026089,0.090722202766918,8.30601990102766e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,IL34,Interleukin-34,39456,0.0204272453801639,0.00332851759023086,0.0139033509033114,0.0269511398570164,8.61063642068098e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,GCLM,Glutamate--cysteine ligase regulatory subunit,37021,0.0253338264841629,0.00413156439846237,0.0172359602631767,0.0334316927051491,8.93902471130649e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,RCOR1,REST corepressor 1,39585,0.0256119282823666,0.0041875252304556,0.0174043788306736,0.0338194777340596,9.80733675893447e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,GRSF1,G-rich sequence factor 1,36874,0.0462009779055175,0.00755937938091789,0.0313845943189185,0.0610173614921166,1.013648482274e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39866,0.0249682506066409,0.00409246440482504,0.0169470203731838,0.0329894808400979,1.07812366534527e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,MILR1,Allergin-1,39587,-0.0280974057306925,0.0046077560026883,-0.0371286074959616,-0.0190662039654234,1.10017988948902e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CDA,Cytidine deaminase,37422,0.0263727125356975,0.00432625142236536,0.0178932597478614,0.0348521653235336,1.11724027543626e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,RABEPK,Rab9 effector protein with kelch motifs,39477,0.0340963632047224,0.00559725047569107,0.0231257522723679,0.0450669741370769,1.1439000623721e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,LTBP2,Latent-transforming growth factor beta-binding protein 2,40052,-0.0174722190221012,0.00287059100131398,-0.0230985773846766,-0.0118458606595258,1.17912633406044e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QL2,Complement C1q-like protein 2,37056,0.0238096323473197,0.00391920646017029,0.0161279876853859,0.0314912770092534,1.27306898931404e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,FCRL5,Fc receptor-like protein 5,39858,-0.0315577090106572,0.00520106996393385,-0.0417518061399676,-0.0213636118813469,1.3280968384437e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,SCN4B,Sodium channel subunit beta-4,37043,0.0234112765672216,0.00386252274923084,0.0158407319787291,0.030981821155714,1.3885167111567e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39866,-0.0218380264536123,0.00361182094920105,-0.0289171955140464,-0.0147588573931782,1.51535178141805e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,MRC1,Macrophage mannose receptor 1,37445,0.0154799370232697,0.00256914534667927,0.0104444121437783,0.020515461902761,1.73133982079569e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37056,0.0184120001906598,0.00305631488800312,0.0124216230101737,0.0244023773711459,1.74418570393598e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,DPP10,Inactive dipeptidyl peptidase 10,39866,0.0194107860164553,0.00322381989549028,0.0130920990212943,0.0257294730116162,1.77073941714055e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,ICOSLG,ICOS ligand,39788,0.0105637554415709,0.00175728362999768,0.00711947952677547,0.0140080313563664,1.87927784364775e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,MUC2,Mucin-2,37437,0.0505401984422006,0.00841078806243889,0.0340550538398204,0.0670253430445809,1.91481702427574e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CLC,Galectin-10,39841,-0.0372030281533502,0.00619873292520132,-0.0493525446867448,-0.0250535116199557,1.99463446475826e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CIT,Citron Rho-interacting kinase,37039,0.025339608141873,0.00423097392909967,0.0170468992408377,0.0336323170429084,2.16536731155168e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39842,0.0352386213967416,0.00589272018882945,0.0236888898266359,0.0467883529668473,2.27854384931509e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CRTAC1,Cartilage acidic protein 1,40052,0.0167507395247571,0.00280296921324959,0.0112569198667879,0.0222445591827263,2.33378474948451e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37043,0.0155657148788612,0.00260813399188651,0.0104537722547636,0.0206776575029587,2.46130919706334e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,SLITRK1,SLIT and NTRK-like protein 1,37056,0.0177562901499292,0.00298258589646383,0.0119104217928601,0.0236021585069983,2.69429281654715e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,GART,Trifunctional purine biosynthetic protein adenosine-3,37411,0.0148334940711425,0.00249483452083683,0.0099436184103023,0.0197233697319827,2.82080052745089e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,HSPA2,Heat shock-related 70 kDa protein 2,37368,0.0187599073457728,0.00315534543426265,0.012575430294618,0.0249443843969276,2.82524045004681e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36962,-0.0168835622207956,0.00284857554539545,-0.0224667702897706,-0.0113003541518205,3.16237926543272e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40052,0.0125220194906424,0.00211302854881673,0.00838048353496157,0.0166635554463232,3.16506551920308e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,FEN1,Flap endonuclease 1,39477,0.0344213503253018,0.00580909126695594,0.0230355314420682,0.0458071692085355,3.18036991610329e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39585,0.0201456825445221,0.00341266857261119,0.0134568521422042,0.0268345129468401,3.63843758479739e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,SPTLC1,Serine palmitoyltransferase 1,37388,0.0196843827103202,0.00333668624315046,0.0131444776737453,0.0262242877468951,3.7358722411473e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,BAX,Apoptosis regulator BAX,39456,0.0502432253794962,0.00851936919533005,0.0335452617566493,0.0669411890023431,3.76614295978551e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40058,0.0188440642704239,0.00319606247966076,0.0125797818102889,0.025108346730559,3.79764917899593e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,GSTT2B,Glutathione S-transferase theta-2B,37388,0.131480736759077,0.0223098158789569,0.0877534976363211,0.175207975881832,3.8732654951519e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,APLP1,Amyloid-like protein 1,39868,-0.0280845223602828,0.00476608201691731,-0.0374260431134408,-0.0187430016071249,3.87841847337233e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,LIPF,Gastric triacylglycerol lipase,37043,0.0328600630012683,0.00558061505478007,0.0219220574938994,0.0437980685086372,3.99806142632919e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,GAS2,Growth arrest-specific protein 2,37169,0.0290601700055236,0.00493992531366432,0.0193779163907416,0.0387424236203057,4.13287929071912e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP6V1G2,V-type proton ATPase subunit G 2,37021,0.0540852743132673,0.00921552422605638,0.0360228468301968,0.0721477017963378,4.49173534806897e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,LTB,Lymphotoxin-beta,37368,0.0187040722927436,0.00318765743105938,0.0124562637278672,0.02495188085762,4.52359074229756e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39749,0.0385523481039857,0.00657649882733941,0.0256624104024004,0.0514422858055709,4.65997695561022e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,KIAA0319,Dyslexia-associated protein KIAA0319,37388,0.0165363577767349,0.00282752553498979,0.0109944077281549,0.0220783078253149,5.07939419856544e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,AREG,Amphiregulin,39788,-0.0253461803935032,0.00435888038935999,-0.0338895859566488,-0.0168027748303576,6.18550058789782e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,LTA4H,Leukotriene A-4 hydrolase,40030,0.0316481664012868,0.00545848798420432,0.0209495299522463,0.0423468028503273,6.83727056063415e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,NINJ1,Ninjurin-1,39477,0.0304507164419589,0.00525555678134889,0.0201498251505151,0.0407516077334027,7.0051488862288e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,FASLG,Tumor necrosis factor ligand superfamily member 6,40058,0.019786754349279,0.00341552085723761,0.0130923334690933,0.0264811752294647,7.03440179333607e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,MST1,Hepatocyte growth factor-like protein,37271,0.0339748668693579,0.00588922474045767,0.0224319863780608,0.0455177473606549,8.15097075455953e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CLMP,CXADR-like membrane protein,40030,0.010989874925813,0.00190683362205617,0.0072524810265829,0.0147272688250431,8.39296808424126e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,DCTPP1,dCTP pyrophosphatase 1,39868,0.0169845817270979,0.00295074629817322,0.0112011189826784,0.0227680444715174,8.76919897773017e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A11,Protein S100-A11,39703,0.0242518800586424,0.00422803394158956,0.0159649335331269,0.032538826584158,9.87244111895136e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CFC1,Cryptic protein,39477,0.0248217966849081,0.00434758402751636,0.0163005319909761,0.0333430613788402,1.1548287844321e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CD276,CD276 antigen,39862,-0.0186809937847731,0.00327565193462331,-0.0251012715766348,-0.0122607159929114,1.19806512483088e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CABP2,Calcium-binding protein 2,37039,0.0350048869937694,0.00614333044304698,0.0229639593253973,0.0470458146621415,1.2379329500184e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,BRD1,Bromodomain-containing protein 1,37169,-0.0163284293003886,0.00287030358745512,-0.0219542243318007,-0.0107026342689766,1.30670320201599e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPT2,Angiopoietin-2,40030,-0.0201540132724026,0.00354719314276556,-0.0271065118322231,-0.0132015147125821,1.35675703138302e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP3,Stromelysin-1,39858,-0.0251165335749206,0.00443830096297885,-0.0338156034623591,-0.016417463687482,1.54828650773508e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,RBP2,Retinol-binding protein 2,39788,-0.0402778062350504,0.00712305152147865,-0.0542389872171485,-0.0263166252529522,1.58916391160957e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,SEMA4C,Semaphorin-4C,39788,0.0149060755290668,0.00264091164061384,0.00972988871346368,0.0200822623446699,1.68688818903141e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,IGSF21,Immunoglobulin superfamily member 21,37043,0.0207993698199919,0.00368851782523422,0.0135698748825328,0.028028864757451,1.74603963482259e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1R1,Interleukin-1 receptor type 1,39826,-0.0117593099901845,0.0020927029275627,-0.0158610077282074,-0.00765761225216158,1.95051669254742e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKD2,Serine/threonine-protein kinase D2,37021,0.0239940628845303,0.00427319586794322,0.0156185989833616,0.032369526785699,2.00521296411769e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,ZBP1,Z-DNA-binding protein 1,37056,0.0216073211920377,0.00385022991353551,0.0140608705615081,0.0291537718225673,2.04080921476483e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CA7,Carbonic anhydrase 7,37169,-0.017615774493233,0.00314108960923566,-0.0237723101273348,-0.0114592388591311,2.08545093530283e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,IL12RB1,Interleukin-12 receptor subunit beta-1,39587,0.0192475499288071,0.00343345338426384,0.01251798129565,0.0259771185619642,2.10673205262268e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,HYAL1,Hyaluronidase-1,39747,0.011878703094719,0.00212295710303156,0.00771770717277715,0.0160396990166608,2.23803301185941e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,VIPR1,Vasoactive intestinal polypeptide receptor 1,37043,-0.0135519792522572,0.00242286150900615,-0.0183007878099092,-0.00880317069460509,2.27125447702521e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,GPC1,Glypican-1,40030,0.0150991364907845,0.00269988191284686,0.00980736794160467,0.0203909050399643,2.27423596906364e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,NEFL,Neurofilament light polypeptide,39438,0.0226033315394005,0.00404509419500404,0.0146749469171926,0.0305317161616084,2.33765402555119e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,ODAM,Odontogenic ameloblast-associated protein,39456,0.0265748625432428,0.00476484524997567,0.0172357658532904,0.0359139592331951,2.48370368944969e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37056,0.0162770013154146,0.00292629789626847,0.0105414574387284,0.0220125451921007,2.71391365944814e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,SPON1,Spondin-1,39885,0.0164571255472609,0.00296503659243505,0.0106456538260882,0.0222685972684336,2.89544482737144e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37043,-0.0181015738049326,0.00326463443250205,-0.0245002572926366,-0.0117028903172286,3.00039215271981e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40034,0.0137115421483331,0.00247457411182943,0.00886137688914742,0.0185617074075188,3.05494887890593e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CWC15,Spliceosome-associated protein CWC15 homolog,37324,0.0316361412582234,0.00571770634390313,0.0204294368241733,0.0428428456922735,3.20653491908104e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39908,0.0459949641251781,0.00834698496956559,0.0296348735848295,0.0623550546655266,3.63595647578633e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH5,Cadherin-5,40052,-0.0155897585209118,0.00283986059622394,-0.0211558852895107,-0.0100236317523129,4.08852640096241e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASE3,Eosinophil cationic protein,39791,0.0549399281284339,0.0100113971609445,0.0353175896929826,0.0745622665638851,4.13325613884746e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37169,0.0367370920989668,0.00669481079746554,0.0236152629359343,0.0498589212619992,4.15356168448151e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,NTF3,Neurotrophin-3,39866,0.0171825974071239,0.0031330572759935,0.0110418051461766,0.0233233896680711,4.21421428775263e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,MUC16,Mucin-16,39788,0.0948169616677329,0.0173442653459763,0.0608222015896194,0.128811721745846,4.65224425970965e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CD300C,CMRF35-like molecule 6,40009,0.0168576018255652,0.00309671956201379,0.0107880314840182,0.0229271721671122,5.29473601367738e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,IL22RA1,Interleukin-22 receptor subunit alpha-1,39587,0.02179289786318,0.00401018516935955,0.0139329349312353,0.0296528607951247,5.58034467618667e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CGREF1,Cell growth regulator with EF hand domain protein 1,39868,0.0211100836576112,0.00389714653512294,0.0134716764487702,0.0287484908664522,6.15492380721352e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,ICAM5,Intercellular adhesion molecule 5,39868,0.0222122930749425,0.00410757928460597,0.0141614376771148,0.0302631484727702,6.47779130137917e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,FLT1,Vascular endothelial growth factor receptor 1,39755,0.0116152003778925,0.0021559492501082,0.00738953984768041,0.0158408609081046,7.24570152304446e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CALB1,Calbindin,39788,0.0210463015745501,0.00390699336313175,0.0133885945828119,0.0287040085662883,7.27301304417698e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,GNLY,Granulysin,39858,0.0255452541649418,0.00474405802124821,0.0162469004432953,0.0348436078865882,7.35962087095673e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,MZB1,Marginal zone B- and B1-cell-specific protein,39908,-0.024604205128185,0.00457747590308303,-0.0335760578982278,-0.0156323523581423,7.76270422714433e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,NME3,Nucleoside diphosphate kinase 3,39885,0.0119125804706011,0.00221836181765844,0.00756459130799051,0.0162605696332116,7.98387467941837e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37437,0.0133925906372456,0.00249474246576517,0.00850289540434586,0.0182822858701453,8.07782235776543e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,SELENOP,Selenoprotein P,37453,0.0110401248276198,0.00207459831301366,0.00697391213411298,0.0151063375211265,1.04507914005712e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,NTF4,Neurotrophin-4,39477,0.0197090156972253,0.00370397172128488,0.0124492311235069,0.0269688002709436,1.04594799854594e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH17,Cadherin-17,39868,-0.0328620476185554,0.00618399838818738,-0.0449826844594026,-0.0207414107777081,1.08654372634387e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,LYZL2,Lysozyme-like protein 2,36962,0.0179243062757396,0.00337273427058078,0.0113137471054012,0.0245348654460779,1.08719855067914e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,NCAM1,Neural cell adhesion molecule 1,39931,0.0148224614626462,0.0027904387930576,0.00935320142825333,0.0202917214970391,1.09948767678415e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,GAST,Gastrin,37388,0.05757476332636,0.0108426696330913,0.0363231308455011,0.0788263958072189,1.11349211227823e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,PRUNE2,Protein prune homolog 2,37169,0.0140921262768846,0.00265898473148309,0.00888051620317777,0.0193037363505915,1.17770892901068e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,ECM1,Extracellular matrix protein 1,37106,0.0179223524181106,0.00338284685084668,0.0112919725904511,0.0245527322457701,1.18947768186932e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,TSPAN8,Tetraspanin-8,37382,0.0483848621003613,0.00914940509682756,0.0304520281105792,0.0663176960901433,1.25376984265395e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40040,0.0176839474399957,0.00334680954417648,0.0111242007334098,0.0242436941465816,1.2815589768482e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,MTPN,Myotrophin,39585,0.0159539080142541,0.00302342758463866,0.0100279899483623,0.0218798260801459,1.33231368530313e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,NFYA,Nuclear transcription factor Y subunit alpha,37021,0.0186578843698447,0.00353783264145489,0.0117237323925931,0.0255920363470963,1.35730921923302e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CHGB,Secretogranin-1,39952,0.0193337186520921,0.00367290802013192,0.0121348189326336,0.0265326183715507,1.42864125086336e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA3,Alpha-1-antichymotrypsin,37407,0.00709403617198449,0.00135089884616104,0.00444627443350885,0.00974179791046013,1.53277028603688e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CPA4,Carboxypeptidase A4,36868,0.0213515848064954,0.0040698829841542,0.0133746141575532,0.0293285554554376,1.57671777558791e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,ITM2A,Integral membrane protein 2A,39866,-0.0288317482807039,0.0055022797364792,-0.0396162165642032,-0.0180472799972047,1.62645396759856e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,IL32,Interleukin-32,39866,-0.020867770633626,0.00398554493453785,-0.0286794387053202,-0.0130561025619318,1.66291963591984e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,LEO1,RNA polymerase-associated protein LEO1,37411,0.0136713016917931,0.00261098923722786,0.00855376278682651,0.0187888405967597,1.66492106160779e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37382,0.0410792482888537,0.00785287110793712,0.025687620917297,0.0564708756604105,1.71009448763477e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,COL28A1,Collagen alpha-1(XXVIII) chain,37039,0.0377464080245863,0.00724384038471385,0.0235484808705472,0.0519443351786255,1.90837071394479e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,RBFOX3,RNA binding protein fox-1 homolog 3,37411,0.017994317761845,0.00345368529855609,0.0112250945766751,0.024763540947015,1.91426372380254e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CST1,Cystatin-SN,35640,0.0491181951018341,0.00942884187307121,0.0306376650306146,0.0675987251730537,1.92695820128652e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,SFTPA1,Pulmonary surfactant-associated protein A1,39477,0.0280367800653833,0.00538542528341444,0.017481346509891,0.0385922136208756,1.95351264263798e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,SEL1L,Protein sel-1 homolog 1,37043,0.0151778355803557,0.00292032230796468,0.0094540038567449,0.0209016673039665,2.05207517434834e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,PFDN2,Prefoldin subunit 2,39489,0.0269891559272501,0.00519553761799629,0.0168059021959773,0.0371724096585228,2.07648456277243e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,SAA4,Serum amyloid A-4 protein,37453,0.015983963494898,0.00308101612645347,0.00994517188704916,0.0220227551027468,2.15752622777938e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,AARSD1,Alanyl-tRNA editing protein Aarsd1,39788,0.0263943596446936,0.00508874138318683,0.0164204265336474,0.0363682927557397,2.16542446664357e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,MSLN,Mesothelin,39766,0.0253162207058765,0.00489370071679088,0.0157245673009664,0.0349078741107866,2.32880855546139e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37056,0.0204539390285026,0.00396591812705299,0.0126807394994787,0.0282271385575264,2.53990252041115e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHB6,Ephrin type-B receptor 6,39713,0.0145125402807673,0.00281735535529038,0.00899052378439819,0.0200345567771365,2.62036641079631e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CD55,Complement decay-accelerating factor,39315,0.0121605478857699,0.00236550302935844,0.00752416194822733,0.0167969338233124,2.76927599804912e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,GBP4,Guanylate-binding protein 4,39489,0.0233839588266001,0.00455026562123769,0.0144654382089742,0.0323024794442259,2.79485121118474e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39749,0.0334261016927955,0.00653179855841453,0.020623776518303,0.0462284268672879,3.1331741305937e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,WFDC2,WAP four-disulfide core domain protein 2,39017,0.0170328097753226,0.00333841107895488,0.0104895240605711,0.0235760954900742,3.40015899263272e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37043,0.0290053952550853,0.00568765643900186,0.0178575886346416,0.0401532018755289,3.44895535888754e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP2,"Fatty acid-binding protein, intestinal",39868,-0.0369385098617271,0.00724634777142224,-0.0511413514937147,-0.0227356682297395,3.48026977552029e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,NEO1,Neogenin,37411,0.0102585865295578,0.00201647795975093,0.00630628972844593,0.0142108833306696,3.67901135600023e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,PDGFRA,Platelet-derived growth factor receptor alpha,39868,-0.0132843981778534,0.00261249938912207,-0.0184048969805326,-0.0081638993751741,3.71896791265673e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40003,0.0142986825952771,0.00281785426430208,0.00877568823724503,0.0198216769533092,3.93210449477246e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNGR1,Interferon gamma receptor 1,39931,0.00953604175198406,0.00188011429850522,0.00585101772691383,0.0132210657770543,3.97925685725066e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMTOR5,Ragulator complex protein LAMTOR5,37368,0.0195654715160961,0.00386210892613861,0.0119957380208644,0.0271352050113278,4.11607506337828e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,EGFLAM,Pikachurin,37382,0.0144883954430725,0.00286184123599353,0.00887918662052514,0.0200976042656198,4.18985586608225e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,TPPP3,Tubulin polymerization-promoting protein family member 3,39489,0.0183068441075252,0.00361849754514836,0.0112145889190344,0.0253990992960159,4.2570547110161e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,TDO2,"Tryptophan 2,3-dioxygenase",37039,0.0185061838892174,0.00365776224909718,0.011336969880987,0.0256753978974479,4.26176390489078e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39749,0.0149339390861312,0.0029542555115562,0.00914359828348103,0.0207242798887813,4.35038070958428e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37021,0.0225247286929788,0.00445626104636828,0.013790457042097,0.0312590003438607,4.37027881606975e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CNPY2,Protein canopy homolog 2,39585,0.0283570731572573,0.00561655028296656,0.0173486346026429,0.0393655117118718,4.49465967599957e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,TYRO3,Tyrosine-protein kinase receptor TYRO3,39868,0.0132326959746675,0.0026218310840412,0.00809390704994675,0.0183714848993882,4.53438264062934e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CRISP3,Cysteine-rich secretory protein 3,37325,-0.0126537040832202,0.00250872810198428,-0.0175708111631094,-0.007736597003331,4.62141604400044e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39846,0.0148110557727123,0.00294287287476297,0.00904302493817691,0.0205790866072477,4.88474295200215e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTN2,Contactin-2,40030,0.0207511478678387,0.00412685150936272,0.0126625189094877,0.0288397768261896,5.00078603829083e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,EDN1,Endothelin-1,37043,0.013167667775967,0.00261863766196393,0.00803513795851767,0.0183001975934163,5.00977446092405e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,FSTL1,Follistatin-related protein 1,37043,-0.0107370060862281,0.00213743290936824,-0.0149263745885898,-0.00654763758386632,5.14508479646628e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,INSL5,Insulin-like peptide INSL5,37382,0.0453467598546788,0.00904958691694356,0.0276095694974695,0.0630839502118882,5.48547515251317e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL9,C-X-C motif chemokine 9,39931,0.0303861131006174,0.00606959498497829,0.0184897069300599,0.0422825192711748,5.6078351405205e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,QPCT,Glutaminyl-peptide cyclotransferase,39862,0.0123331486252477,0.00246370336242155,0.00750429003490141,0.0171620072155939,5.61811521602463e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFB2,Transforming growth factor beta-2 proprotein,37368,0.024557198178646,0.00490979229932625,0.0149340052719665,0.0341803910853254,5.75472828978272e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CA12,Carbonic anhydrase 12,39788,-0.0148336613952161,0.00297053883556157,-0.0206559175129168,-0.0090114052775154,5.98930387633974e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39985,0.0130166291366133,0.00261153418425335,0.00789802213547673,0.0181352361377499,6.28364885766588e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,LAG3,Lymphocyte activation gene 3 protein,39788,-0.0188638133674484,0.00378802725175008,-0.0262883467808786,-0.0114392799540183,6.42988583316762e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,TPM3,Tropomyosin alpha-3 chain,37021,-0.02063915790978,0.00414824898301657,-0.0287697259164925,-0.0125085899030675,6.59387068203762e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,DUSP3,Dual specificity protein phosphatase 3,39489,0.0391411407483623,0.00789773909298687,0.023661572126108,0.0546207093706165,7.2715019054364e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,MNDA,Myeloid cell nuclear differentiation antigen,39841,0.0448875328578698,0.00907093131603278,0.0271085074784456,0.0626665582372941,7.55474003620399e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,GALNT7,N-acetylgalactosaminyltransferase 7,39788,0.00955491727613243,0.0019309164302563,0.00577032107283007,0.0133395134794348,7.5595890974116e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39809,-0.0300595139509631,0.0061080560100499,-0.0420313037306609,-0.0180877241712653,8.68338637210447e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37382,0.0177553948516508,0.00361025927887545,0.0106792866650549,0.0248315030382467,8.84428859936309e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC5A,C-type lectin domain family 5 member A,39818,-0.0129842476160154,0.00264200742125855,-0.0181625821616822,-0.00780591307034865,8.98748323419653e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,ARID4B,AT-rich interactive domain-containing protein 4B,39489,0.0185539778719006,0.00377664128279661,0.0111517609576193,0.025956194786182,9.06818071307478e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,HMOX1,Heme oxygenase 1,39691,-0.0217624126625117,0.00443477553997973,-0.030454572720872,-0.0130702526041515,9.32958248689774e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB37,Ras-related protein Rab-37,39587,0.0379888657499886,0.00776139609108119,0.0227765294114695,0.0532012020885078,9.94864332414238e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,GLYR1,Putative oxidoreductase GLYR1,37368,0.0272695593713139,0.0055717300009036,0.0163489685695428,0.0381901501730849,9.980970230664e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASE6,Ribonuclease K6,37386,0.0126084123669924,0.00257858472522289,0.00755438630555554,0.0176624384284293,1.02168700552362e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,LBP,Lipopolysaccharide-binding protein,39931,-0.0262028857157401,0.00539549473359125,-0.036778055393579,-0.0156277160379013,1.20640850363926e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,PCSK7,Proprotein convertase subtilisin/kexin type 7,37368,0.0199517094828669,0.00414178637987436,0.0118338081783131,0.0280696107874206,1.47185954259309e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,FOLH1,Glutamate carboxypeptidase 2,37056,0.0492280037602315,0.0102388158754828,0.0291599246442853,0.0692960828761777,1.54146606005941e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF2,Granulocyte-macrophage colony-stimulating factor,37021,0.0157433118371776,0.00328099706020299,0.00931255759917971,0.0221740660751754,1.61749088182061e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,PCDHB15,Protocadherin beta-15,37368,-0.0177878816150562,0.00370892723535164,-0.0250573789963454,-0.010518384233767,1.63622398714877e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,TOR1AIP1,Torsin-1A-interacting protein 1,37043,0.022523542969835,0.00470644813813608,0.0132989046190883,0.0317481813205817,1.72260123940795e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,AHNAK2,Protein AHNAK2,37043,0.0130762611345662,0.00273596331001863,0.00771377304692965,0.0184387492222027,1.77717348686278e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,DSG3,Desmoglein-3,39964,0.0148160180266056,0.00310553909455753,0.00872916140127282,0.0209028746519383,1.85071340291212e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,VSIG10,V-set and immunoglobulin domain-containing protein 10,37368,0.016175140156123,0.00339759963247538,0.00951584487647129,0.0228344354357748,1.94870825501212e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP3,"Fatty acid-binding protein, heart",37437,0.0217721720508728,0.00457593323786256,0.0128033429046622,0.0307410011970835,1.97559351398966e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSB,Cathepsin B,39847,-0.0226668863077422,0.00478222176334217,-0.0320400409638929,-0.0132937316515916,2.15746955115331e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,MYOM2,Myomesin-2,37021,-0.0228123132900784,0.00481584332619816,-0.0322513662094268,-0.01337326037073,2.19246324623832e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,FGFR4,Fibroblast growth factor receptor 4,37124,0.023237653993628,0.00492716512922308,0.0135804103403508,0.0328948976469053,2.42700626664251e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP1,"Fatty acid-binding protein, liver",39862,0.0410988345924493,0.0087200944479776,0.0240074494744132,0.0581902197104854,2.46008695285883e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CTRC,Chymotrypsin-C,39856,0.0269525512446783,0.00575060971058912,0.0156813562119236,0.0382237462774329,2.79656510952182e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,EBI3_IL27,Interleukin-27,40011,-0.0134208590976325,0.0028676224977282,-0.0190413991931797,-0.0078003190020852,2.89014261102843e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,BRD3,Bromodomain-containing protein 3,37021,0.0202639349221736,0.00433668035347684,0.011764041429359,0.0287638284149882,3.00235586130188e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37039,0.0437736789018182,0.00937088882134526,0.0254067368119815,0.0621406209916549,3.02344731684393e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39868,0.0142664110372142,0.00306180868977025,0.00826526600526447,0.0202675560691639,3.19574948270461e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,PREB,Prolactin regulatory element-binding protein,39587,0.0124083141153168,0.00266493263259905,0.00718504615542267,0.0176315820752109,3.2481811508034e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHX2,Bifunctional epoxide hydrolase 2,39585,0.0266011522208698,0.00572099626890164,0.0153879995338226,0.0378143049079171,3.35054711709926e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CLSTN1,Calsyntenin-1,39489,0.0217602661876064,0.0046876968475913,0.0125723803663275,0.0309481520088854,3.4786645522775e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,BMP10,Bone morphogenetic protein 10,37124,0.0122486140007744,0.00264052692818069,0.00707318122154023,0.0174240467800085,3.53958052860466e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,TDP1,Tyrosyl-DNA phosphodiesterase 1,37368,0.0298179153240165,0.00644806173692671,0.0171797143196401,0.0424561163283928,3.79310875487086e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,BAMBI,BMP and activin membrane-bound inhibitor homolog,39477,0.0129114067531073,0.00279525981940306,0.00743269750707729,0.0183901159991373,3.88603989363542e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,REN,Renin,39868,-0.0282604274704323,0.00613800636414723,-0.0402909199441609,-0.0162299349967038,4.17298397245849e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,MPO,Myeloperoxidase,39858,0.0194056159741419,0.00422103115901646,0.0111323949024697,0.0276788370458142,4.31144463490389e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39869,0.0245660576047453,0.00536747097387394,0.0140458144959524,0.0350863007135382,4.75599923002411e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CD93,Complement component C1q receptor,39238,-0.0130948976601817,0.0028673301918976,-0.018714864836301,-0.00747493048406243,4.98759361727567e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,MRPL46,"39S ribosomal protein L46, mitochondrial",39489,0.0115852247135077,0.00253811100857429,0.00661052713670206,0.0165599222903133,5.0448577698261e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,ARTN,Artemin,39587,0.0189931631995976,0.00417301971248323,0.0108140445631305,0.0271722818360647,5.36843087118403e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,GFRA2,GDNF family receptor alpha-2,39788,0.00878803578359638,0.00194119504685393,0.00498329349176267,0.0125927780754301,6.02243015127615e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37043,0.0152315565264317,0.00336624152401548,0.00863372313936133,0.021829389913502,6.09822049110397e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CCND2,G1/S-specific cyclin-D2,37169,0.0154871732656217,0.0034329903727935,0.00875851213494644,0.0222158343962969,6.49898104202445e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,LRP1,Prolow-density lipoprotein receptor-related protein 1,39788,0.011092387184653,0.00247080515978038,0.00624960907148344,0.0159351652978225,7.19313888390683e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,FCRLB,Fc receptor-like B,39477,0.0241517503022264,0.00539203099819782,0.0135833695457586,0.0347201310586941,7.54701930129874e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39247,0.0256248589211083,0.00572316140265508,0.0144074625719043,0.0368422552703122,7.61022858221549e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,PTK7,Inactive tyrosine-protein kinase 7,39489,0.0160331613505085,0.00358122905093101,0.00901395241068368,0.0230523702903332,7.62349421786599e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF1R,Macrophage colony-stimulating factor 1 receptor,37445,0.0164867304860844,0.00368524617800739,0.00926364797718988,0.0237098129949789,7.74974369075364e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK11,Kallikrein-11,39779,0.0121281098176971,0.00271283293952078,0.00681095725623632,0.0174452623791578,7.85232099931367e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,MEPE,Matrix extracellular phosphoglycoprotein,39862,0.010253307710378,0.00229787793153213,0.005749466964575,0.014757148456181,8.17228642534796e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF16,Fibroblast growth factor 16,37056,0.0201368258505818,0.0045128897924701,0.0112915618573404,0.0289820898438232,8.18439200935629e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,ATXN2,Ataxin-2,36991,0.0463109564227707,0.010385954037651,0.0259544865089748,0.0666674263365667,8.30265210722264e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,MFAP4,Microfibril-associated glycoprotein 4,37124,-0.0132396072303197,0.00297459854905461,-0.0190698203864667,-0.00740939407417267,8.62130626124058e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,INHBB,Inhibin beta B chain,37124,0.0204552491946043,0.00462166572998319,0.0113967843638373,0.0295137140253714,9.67863460460209e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,SCGB1A1,Uteroglobin,39903,0.0225199122566703,0.00509498303790774,0.0125337455023711,0.0325060790109694,9.93406925259202e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTSL2,ADAMTS-like protein 2,37437,0.0130800668523052,0.00296414246784319,0.00727034761533254,0.0188897860892778,1.02845044984409e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,MYL3,Myosin light chain 3,37043,-0.0299668093259164,0.00679121648433297,-0.043277593635209,-0.0166560250166238,1.02955271525282e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,RHOC,Rho-related GTP-binding protein RhoC,39672,0.0484968998421688,0.0109914210908809,0.0269537145040422,0.0700400851802953,1.02978346175974e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,GSN,Gelsolin,37383,0.00767094729319923,0.00174090640755763,0.00425877073438629,0.0110831238520122,1.05962969826413e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39913,0.0104300865571438,0.00237900275708924,0.00576724115324885,0.0150929319610387,1.17138620344993e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,GGT5,Glutathione hydrolase 5 proenzyme,39749,0.00938478022082691,0.0021408004339074,0.0051888113703684,0.0135807490712854,1.1739088593825e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37453,0.00762659093401886,0.00173968117118168,0.00421681583850277,0.011036366029535,1.17447746429789e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40030,0.0134907816617407,0.0030816777601758,0.00745069325179616,0.0195308700716853,1.20669174371544e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,TPSAB1,Tryptase alpha/beta-1,40038,0.0212629963244257,0.0048688490007837,0.0117200522828896,0.0308059403659617,1.26660206981407e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASET2,Ribonuclease T2,39974,0.0103484154936954,0.00237260213125953,0.00569811531642668,0.014998715670964,1.29897857562524e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CX3CL1,Fractalkine,39749,-0.0134500896281757,0.00309227353258551,-0.0195109457520433,-0.00738923350430808,1.37248648413335e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,GZMB,Granzyme B,39866,0.0259058974696074,0.00596605661806019,0.0142124264982095,0.0375993684410054,1.41920487154993e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,IL18BP,Interleukin-18-binding protein,39931,0.0119492753060459,0.00275220912207797,0.00655494542677308,0.0173436051853187,1.42247269086741e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF3,Granulocyte colony-stimulating factor,39587,0.019337541555823,0.00446666070593527,0.0105828865721899,0.0280921965394561,1.50504794260506e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,LRRC38,Leucine-rich repeat-containing protein 38,37039,0.0194690996209455,0.00451100396502056,0.0106275318495052,0.0283106673923858,1.60104270388487e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CA2,Carbonic anhydrase 2,39821,0.0272847430905605,0.00632460792988551,0.0148885115479849,0.0396809746331361,1.61246286768697e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,REG3G,Regenerating islet-derived protein 3-gamma,37368,0.015738922513766,0.00365234444392157,0.00858032740367977,0.0228975176238523,1.64956412928917e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,APOD,Apolipoprotein D,36780,-0.017495219849502,0.00405985601486932,-0.0254525376386459,-0.00953790206035814,1.64968621385567e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,VSIG4,V-set and immunoglobulin domain-containing protein 4,39831,-0.0152583927563905,0.00354676830574223,-0.0222100586356453,-0.00830672687713572,1.70226965891766e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CRTAP,Cartilage-associated protein,37039,0.0197040894625959,0.0046161615759197,0.0106564127737932,0.0287517661513985,1.98167388976613e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SSH3,Protein phosphatase Slingshot homolog 3,36962,0.0118295207233809,0.00277430682734139,0.0063918793417918,0.01726716210497,2.02246636269146e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK8,Kallikrein-8,39315,0.013816645145379,0.0032421138142967,0.00746210206935752,0.0201711882214006,2.04156130068011e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37169,0.0255930600651801,0.00602999938055743,0.0137742612792875,0.0374118588510727,2.20773556192048e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36962,0.0269225395177518,0.0063526014802835,0.0144714406163961,0.0393736384191074,2.27029329581237e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CEBPA,CCAAT/enhancer-binding protein alpha,37056,0.0149754995358661,0.00353412937897403,0.00804860595307701,0.0219023931186552,2.27664779698378e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,PRL,Prolactin,40009,-0.0298928319878983,0.00706202568957516,-0.0437344023394657,-0.016051261636331,2.31974177813935e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,IL15RA,Interleukin-15 receptor subunit alpha,39587,0.0135102123709567,0.00319443329079753,0.00724912312099351,0.0197713016209198,2.35746744660095e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC13A1,Solute carrier family 13 member 1,37368,0.0235751705896783,0.00558209094319055,0.0126342723410248,0.0345160688383317,2.42265499591726e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CLGN,Calmegin,37039,0.0172215926085174,0.00407842834399043,0.0092278730542962,0.0252153121627387,2.43115294876368e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37021,0.019946113128843,0.0047273549295938,0.0106804974668392,0.0292117287908469,2.46707519573115e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SAT2,Thialysine N-epsilon-acetyltransferase,37169,0.0280073896708875,0.00664249204517224,0.0149881052623499,0.0410266740794251,2.49875909980997e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39801,0.0728931063886429,0.0173920107093806,0.0388047653982569,0.106981447379029,2.78999003853051e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CRLF1,Cytokine receptor-like factor 1,39931,0.0101797660171617,0.00243051497682199,0.00541595666259065,0.0149435753717329,2.82529984986635e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC4A1,Band 3 anion transport protein,37437,-0.0182093679083745,0.00435232504769194,-0.0267399250018507,-0.00967881081489831,2.88446915411648e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,THBS2,Thrombospondin-2,39858,-0.0140149333454209,0.00335592391769518,-0.0205925442241035,-0.00743732246673837,2.9801933946371e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,RPA2,Replication protein A 32 kDa subunit,37056,0.0124519906037315,0.00298432143703767,0.00660272058713761,0.0183012606203253,3.03245328792367e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39749,0.0149741536269708,0.00359210752955903,0.00793362286903512,0.0220146843849065,3.08064489304713e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,DKK3,Dickkopf-related protein 3,40052,-0.0111560017732752,0.00267633900474096,-0.0164016262225675,-0.00591037732398289,3.08364646226495e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC4M,C-type lectin domain family 4 member M,37410,0.0188253621422536,0.0045187586059383,0.00996859527461451,0.0276821290098927,3.11847845445821e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39674,0.0228515327601575,0.00550692059988029,0.0120579683843922,0.0336450971359229,3.34794989994753e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39788,0.0208258075196955,0.00501933893976604,0.010987903197754,0.0306637118416369,3.35497767856322e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,BMP4,Bone morphogenetic protein 4,39720,-0.0177446325367777,0.00428376156047811,-0.0261408051953148,-0.00934845987824058,3.45619120002781e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CRH,Corticoliberin,39455,0.0334940756984516,0.00810444081797805,0.0176093716952146,0.0493787797016886,3.60234180829403e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,TDGF1,Teratocarcinoma-derived growth factor 1,39489,0.0538346071420228,0.0131707931566348,0.0280198525550187,0.079649361729027,4.3837068821079e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39962,0.0131100081882432,0.00320939369646536,0.00681959654317109,0.0194004198333153,4.43118117992734e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37021,0.0136092914227873,0.00334674482501579,0.00704967156575633,0.0201689112798182,4.80174836943999e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SLURP1,Secreted Ly-6/uPAR-related protein 1,37370,0.0139632046736635,0.00343601462986876,0.00722861599912069,0.0206977933482062,4.8557655459808e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,LY9,T-lymphocyte surface antigen Ly-9,39699,0.010709282175959,0.00263997357537905,0.00553493396821605,0.0158836303837019,5.00336319529907e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,HSBP1,Heat shock factor-binding protein 1,37043,0.0364220388117553,0.00901041191601027,0.0187616314563752,0.0540824461671354,5.32490636836484e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,PLAU,Urokinase-type plasminogen activator,39858,0.0107648560901219,0.0026642993415931,0.00554282938059945,0.0159868827996444,5.36076216759626e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39984,0.0127603627334435,0.00316504208814003,0.00655688024068904,0.0189638452261979,5.56397232918569e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,COL9A1,Collagen alpha-1(IX) chain,39866,0.0163811730506921,0.0040704025207624,0.00840318410999778,0.0243591619913864,5.73688520810917e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CA4,Carbonic anhydrase 4,40052,-0.00878161275233899,0.0021821543397393,-0.013058635258228,-0.00450459024644996,5.7408313640879e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGAM,Integrin alpha-M,39858,-0.0118086028184658,0.00293757605340493,-0.0175662518831394,-0.00605095375379209,5.85031176279721e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SNX18,Sorting nexin-18,37382,0.0169486714088705,0.00422409614339499,0.00866944296781635,0.0252278998499247,6.04337966044601e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,DDC,Aromatic-L-amino-acid decarboxylase,39846,-0.0181463234036515,0.00452775778448496,-0.027020728661242,-0.00927191814606098,6.15662667425722e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,B2M,Beta-2-microglobulin,37453,0.0115252512994914,0.00287582615329311,0.00588863203903686,0.0171618705599458,6.16578125855491e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,VASN,Vasorin,39642,0.0102052997164791,0.00254782954625179,0.00521155380582561,0.0151990456271326,6.21733056763591e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,LHB,Lutropin subunit beta,39477,0.0329471184505551,0.00824469745719386,0.0167875114344551,0.049106725466655,6.46741537878365e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,KIAA1549L,UPF0606 protein KIAA1549L,37169,-0.0102993286202745,0.00258036120263357,-0.0153568365774363,-0.00524182066311276,6.60286327931796e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRH,Receptor-type tyrosine-protein phosphatase H,37382,0.0181543850302525,0.00455740605658936,0.00922186915933739,0.0270869009011677,6.82661343005951e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CD7,T-cell antigen CD7,37037,0.0159257366701881,0.00399881306285778,0.00808806306698689,0.0237634102733894,6.85270575320197e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CAPS,Calcyphosin,37388,0.0321847165105466,0.00812543215381065,0.0162588694890777,0.0481105635320155,7.50237757112551e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,ACTN2,Alpha-actinin-2,37021,-0.0218479257075441,0.0055228402395989,-0.0326726925771579,-0.0110231588379302,7.66397946017581e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC16A1,Monocarboxylate transporter 1,39489,0.0213620397952221,0.00540157723311185,0.0107749484183228,0.0319491311721213,7.69434947313136e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,PPME1,Protein phosphatase methylesterase 1,39788,0.0220558036936067,0.00558643584946666,0.0111063894286521,0.0330052179585614,7.9112777516921e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTN5,Contactin-5,39897,0.0132376317099657,0.00335295142098297,0.00666584692483905,0.0198094164950923,7.91255920288129e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37056,0.0330790945756392,0.00839962815932363,0.0166158233833649,0.0495423657679135,8.25303878871313e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SEPTIN8,Septin-8,37357,0.0117237119116918,0.00297738727279382,0.00588803285701591,0.0175593909663677,8.27196826457583e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,LSM1,U6 snRNA-associated Sm-like protein LSm1,39477,0.0200602437998536,0.005095200779035,0.010073650272945,0.0300468373267622,8.28348911930198e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,ERC2,ERC protein 2,37039,0.0273425699133648,0.00700524832879403,0.0136122831889285,0.0410728566378012,9.541941720647e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,IL17RA,Interleukin-17 receptor A,39858,0.0159976877693096,0.00410430754548309,0.0079532449801628,0.0240421305584565,9.74743934343833e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,NCF2,Neutrophil cytosol factor 2,39843,0.0301299690749286,0.00773030527309591,0.0149785707396606,0.0452813674101966,9.75299074071971e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,LMNB1,Lamin-B1,37348,0.0210968712297201,0.00541518538267258,0.0104831078796819,0.0317106345797584,9.8318357410576e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37021,0.0204529057372774,0.0052505410758691,0.010161845228574,0.0307439662459809,9.85257638644007e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CR2,Complement receptor type 2,39931,0.0164433531491051,0.00422451175185668,0.00816331011546599,0.0247233961827442,9.96714536742746e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,ICAM4,Intercellular adhesion molecule 4,39866,-0.0189476440144523,0.00488204589875403,-0.0285164539760102,-0.00937883405289444,0.000104407692714891
NMR metabolomics,X23428.Concentration of VLDL Particles,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36991,0.0223280433574716,0.00575806749100571,0.0110422310751004,0.0336138556398428,0.000105963633625033
NMR metabolomics,X23428.Concentration of VLDL Particles,MET,Hepatocyte growth factor receptor,39879,0.0070394439990078,0.0018191257597846,0.00347395750982999,0.0106049304881856,0.000109407776945521
NMR metabolomics,X23428.Concentration of VLDL Particles,NECTIN1,Nectin-1,37056,0.0115916216595797,0.00299852956269978,0.00571450371668818,0.0174687396024713,0.000111270637860649
NMR metabolomics,X23428.Concentration of VLDL Particles,IL17C,Interleukin-17C,39587,-0.0238999270250273,0.00618766874163071,-0.0360277577586235,-0.0117720962914311,0.000112678154277198
NMR metabolomics,X23428.Concentration of VLDL Particles,DDX25,ATP-dependent RNA helicase DDX25,37039,-0.0135209031911767,0.00350202201118056,-0.0203848663330906,-0.00665694004926284,0.00011351682602074
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40052,0.00984121585509707,0.00255197467284521,0.00483934549632046,0.0148430862138737,0.000115554932088715
NMR metabolomics,X23428.Concentration of VLDL Particles,GPR158,Probable G-protein coupled receptor 158,37411,0.0128430455845921,0.00333085472662804,0.00631457032040118,0.0193715208487831,0.000115894019446403
NMR metabolomics,X23428.Concentration of VLDL Particles,L1CAM,Neural cell adhesion molecule L1,39913,0.0102500373548849,0.00266442915238061,0.00502775621621893,0.0154723184935509,0.000120039331815003
NMR metabolomics,X23428.Concentration of VLDL Particles,RLN1,Prorelaxin H1,37411,-0.0288924657831711,0.00753093010176936,-0.043653088782639,-0.0141318427837032,0.000125362633581428
NMR metabolomics,X23428.Concentration of VLDL Particles,UNC5D,Netrin receptor UNC5D,37056,0.00952938992956224,0.00248677270824731,0.00465531542139751,0.014403464437727,0.00012767905927868
NMR metabolomics,X23428.Concentration of VLDL Particles,CD27,CD27 antigen,39913,-0.0138948810250313,0.00362635965038235,-0.0210025459397807,-0.00678721611028188,0.000127780162034744
NMR metabolomics,X23428.Concentration of VLDL Particles,CHGA,Chromogranin-A,37437,-0.0279091194519471,0.00731322901266609,-0.0422430483167727,-0.0135751905871216,0.000136095711250861
NMR metabolomics,X23428.Concentration of VLDL Particles,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37021,-0.0145362503959933,0.00381698355841021,-0.0220175381704773,-0.00705496262150931,0.00014055618045606
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC28A1,Sodium/nucleoside cotransporter 1,36962,0.0212406849977322,0.00557868364899533,0.0103064650457013,0.032174904949763,0.000141034256930413
NMR metabolomics,X23428.Concentration of VLDL Particles,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37169,0.0206714025206119,0.0054481792287791,0.00999297123220482,0.0313498338090189,0.000148784901983911
NMR metabolomics,X23428.Concentration of VLDL Particles,PGA4,Pepsin A-4,37445,0.0220333408198929,0.0058078855356688,0.0106498851699821,0.0334167964698038,0.000149066134338355
NMR metabolomics,X23428.Concentration of VLDL Particles,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39931,0.015009858817604,0.00397383794785532,0.00722113643980758,0.0227985811954005,0.000159192698885539
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH1,Cadherin-1,39315,0.0141880894398095,0.00376046551672181,0.00681757702703474,0.0215586018525842,0.000161923778024014
NMR metabolomics,X23428.Concentration of VLDL Particles,CLSPN,Claspin,39453,0.0120650554294603,0.00320697661828055,0.00577938125763043,0.0183507296012902,0.000169090639802435
NMR metabolomics,X23428.Concentration of VLDL Particles,DPP7,Dipeptidyl peptidase 2,39754,0.021030715937368,0.00559831614449538,0.010058016294157,0.0320034155805789,0.00017284245493579
NMR metabolomics,X23428.Concentration of VLDL Particles,CFD,Complement factor D,37453,0.00638390084986131,0.00170550898852871,0.00304110323234503,0.00972669846737758,0.000182508381473122
NMR metabolomics,X23428.Concentration of VLDL Particles,SRPX,Sushi repeat-containing protein SRPX,37437,-0.0118927361835899,0.00318434849496939,-0.0181340592337299,-0.00565141313344992,0.000188672519889388
NMR metabolomics,X23428.Concentration of VLDL Particles,CPTP,Ceramide-1-phosphate transfer protein,37021,-0.0138429686719582,0.00371348320056437,-0.0211213957450643,-0.00656454159885201,0.000193999826761371
NMR metabolomics,X23428.Concentration of VLDL Particles,FOSB,Protein fosB,39489,0.0135305235344296,0.00363778298513789,0.00640046888355934,0.0206605781852999,0.000200361679169772
NMR metabolomics,X23428.Concentration of VLDL Particles,VEGFB,Vascular endothelial growth factor B,37056,0.00983465553782067,0.00265040348421718,0.00463986470875499,0.0150294463668864,0.000207596670386086
NMR metabolomics,X23428.Concentration of VLDL Particles,PEAR1,Platelet endothelial aggregation receptor 1,40052,0.00782536278839095,0.00210931832638494,0.00369109886867647,0.0119596267081054,0.000208033392849391
NMR metabolomics,X23428.Concentration of VLDL Particles,CRNN,Cornulin,39397,0.0223047396923432,0.0060249080519386,0.0104959199105436,0.0341135594741429,0.000214571764981081
NMR metabolomics,X23428.Concentration of VLDL Particles,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37056,0.0206903518349593,0.00559736153911142,0.00971952321830095,0.0316611804516177,0.000219522779365865
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40052,0.0240204354990704,0.00650121178541311,0.0112780603996607,0.0367628105984801,0.000220816888406633
NMR metabolomics,X23428.Concentration of VLDL Particles,VWC2L,von Willebrand factor C domain-containing protein 2-like,37411,0.0164127238378191,0.00444457657531461,0.00770135375020248,0.0251240939254357,0.000222710659085153
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL12,Stromal cell-derived factor 1,39587,0.0137117067809899,0.00371346428282565,0.00643331678665158,0.0209900967753281,0.000222872810881674
NMR metabolomics,X23428.Concentration of VLDL Particles,PSPN,Persephin,39866,0.0323946156504277,0.00877460576735491,0.0151963883464121,0.0495928429544434,0.000223359449633533
NMR metabolomics,X23428.Concentration of VLDL Particles,CALCB,Calcitonin gene-related peptide 2,37388,0.0135559302272184,0.00367601828802515,0.00635093438268905,0.0207609260717477,0.000227205600583752
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM171B,Protein FAM171B,37368,0.00951829917985537,0.00258764546685459,0.00444651406482037,0.0145900842948904,0.0002356471616366
NMR metabolomics,X23428.Concentration of VLDL Particles,PRRT3,Proline-rich transmembrane protein 3,37043,0.0124319313713836,0.00338178353714577,0.00580363563857793,0.0190602271041894,0.000237723570786639
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39858,0.00938964674488944,0.00255851588924539,0.00437495560196847,0.0144043378878104,0.00024337831315484
NMR metabolomics,X23428.Concentration of VLDL Particles,CREBZF,CREB/ATF bZIP transcription factor,36962,-0.00900531311404732,0.00245775178663138,-0.0138225066158448,-0.00418811961224982,0.000249242511155502
NMR metabolomics,X23428.Concentration of VLDL Particles,SATB1,DNA-binding protein SATB1,37411,0.0102270244196092,0.00280125235631068,0.00473656980124027,0.0157174790379781,0.000262331001668125
NMR metabolomics,X23428.Concentration of VLDL Particles,PMS1,PMS1 protein homolog 1,37039,0.016897018682865,0.00464842743349858,0.00778610091320781,0.0260079364525222,0.000279042224613805
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC14A,C-type lectin domain family 14 member A,39858,-0.0101809133333991,0.00281481022757991,-0.0156979413794557,-0.0046638852873425,0.000299059031961564
NMR metabolomics,X23428.Concentration of VLDL Particles,RALY,RNA-binding protein Raly,37368,0.0164361010826087,0.00454562303814284,0.00752667992784878,0.0253455222373687,0.000300502021192644
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK4,Kallikrein-4,40030,-0.0202624401912646,0.00560574395066239,-0.0312496983345629,-0.00927518204796633,0.000301742197650174
NMR metabolomics,X23428.Concentration of VLDL Particles,MYL4,Myosin light chain 4,37043,-0.0174721309976378,0.00484136027131579,-0.0269611971294168,-0.00798306486585884,0.00030860118353243
NMR metabolomics,X23428.Concentration of VLDL Particles,MELTF,Melanotransferrin,37437,0.00976665495783056,0.0027108334256221,0.00445342144361125,0.0150798884720499,0.000315903874748762
NMR metabolomics,X23428.Concentration of VLDL Particles,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37368,0.0226929978074127,0.00630703433345717,0.0103312105138366,0.0350547851009887,0.000321763153679116
NMR metabolomics,X23428.Concentration of VLDL Particles,EXTL1,Exostosin-like 1,37021,0.0160600750173299,0.00446463435464324,0.00730939168222913,0.0248107583524306,0.000322869960929015
NMR metabolomics,X23428.Concentration of VLDL Particles,MYO6,Unconventional myosin-VI,37411,0.0127827815492717,0.00356317047166742,0.00579896742480357,0.0197665956737399,0.000335073470731911
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF1,Macrophage colony-stimulating factor 1,39931,0.0087477210838141,0.00244087443032774,0.00396360720037173,0.0135318349672565,0.000339572070517803
NMR metabolomics,X23428.Concentration of VLDL Particles,COL1A1,Collagen alpha-1(I) chain,40052,-0.00826579449945672,0.00230673640509788,-0.0127869978534486,-0.00374459114546487,0.000340239283489477
NMR metabolomics,X23428.Concentration of VLDL Particles,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39984,-0.0235855427218995,0.00658390883122344,-0.0364900040310975,-0.0106810814127016,0.000341584070586831
NMR metabolomics,X23428.Concentration of VLDL Particles,CA6,Carbonic anhydrase 6,39817,-0.0211388713372271,0.00592226961377426,-0.0327465197802246,-0.00953122289422955,0.000358868142596268
NMR metabolomics,X23428.Concentration of VLDL Particles,PDCD1LG2,Programmed cell death 1 ligand 2,39788,0.0102149423911094,0.00286938074592054,0.00459095612910514,0.0158389286531137,0.000371960964052769
NMR metabolomics,X23428.Concentration of VLDL Particles,DEFB104A_DEFB104B,Beta-defensin 104,36991,0.0193142551332984,0.00544990795914051,0.00863243553338297,0.0299960747332138,0.000395534566585699
NMR metabolomics,X23428.Concentration of VLDL Particles,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37039,0.0120710699195888,0.00340669309389645,0.00539395145555175,0.0187481883836258,0.00039646051079617
NMR metabolomics,X23428.Concentration of VLDL Particles,MANSC4,MANSC domain-containing protein 4,37021,0.0206369064436827,0.00582580886322657,0.00921832107175863,0.0320554918156068,0.000397989330866677
NMR metabolomics,X23428.Concentration of VLDL Particles,UROS,Uroporphyrinogen-III synthase,37039,0.0226775886351111,0.0064050387364042,0.0101237127117588,0.0352314645584633,0.000400616931380384
NMR metabolomics,X23428.Concentration of VLDL Particles,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39788,0.0111835755518229,0.00316896882113994,0.00497239666238867,0.0173947544412572,0.000418167001700254
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINK1,Serine protease inhibitor Kazal-type 1,39858,0.0131795546751913,0.00373804949020112,0.00585297767439713,0.0205061316759855,0.000423412178998678
NMR metabolomics,X23428.Concentration of VLDL Particles,SDK2,Protein sidekick-2,37124,0.0122376925006487,0.00347125363228183,0.00543403538137633,0.0190413496199211,0.000424207535714627
NMR metabolomics,X23428.Concentration of VLDL Particles,ATXN10,Ataxin-10,39489,0.0239751482412523,0.00681339875847377,0.0106208866746437,0.0373294098078609,0.00043469659430728
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB5,Integrin beta-5,39913,0.012400623975356,0.00353716962284263,0.0054677715145845,0.0193334764361276,0.000456472125833223
NMR metabolomics,X23428.Concentration of VLDL Particles,VWF,von Willebrand factor,40052,-0.0238370863752904,0.00680922053609607,-0.0371831586260387,-0.0104910141245421,0.000465274020354829
NMR metabolomics,X23428.Concentration of VLDL Particles,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39489,0.0158955704908283,0.00456264905756566,0.00695277833799964,0.024838362643657,0.000495615347227484
NMR metabolomics,X23428.Concentration of VLDL Particles,SEMA6C,Semaphorin-6C,37056,0.00850965663807013,0.00244656611162292,0.00371438705928921,0.0133049262168511,0.000506412221328847
NMR metabolomics,X23428.Concentration of VLDL Particles,SCP2,Non-specific lipid-transfer protein,39477,0.0252410333578927,0.00726591020699128,0.0109998493521898,0.0394822173635956,0.000514345794712943
NMR metabolomics,X23428.Concentration of VLDL Particles,PDIA5,Protein disulfide-isomerase A5,36962,0.0199687140886178,0.00574962860746487,0.00869944201798661,0.0312379861592489,0.000516252044395222
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSV,Cathepsin L2,39967,0.0132393494392012,0.00381649528264206,0.00575901868522272,0.0207196801931796,0.000523802284431118
NMR metabolomics,X23428.Concentration of VLDL Particles,VSIG2,V-set and immunoglobulin domain-containing protein 2,37368,0.0172681478949057,0.00498302091276732,0.00750142690588173,0.0270348688839296,0.000531092774295385
NMR metabolomics,X23428.Concentration of VLDL Particles,HBQ1,Hemoglobin subunit theta-1,40030,-0.0193619711182297,0.00558761698973098,-0.0303137004181024,-0.00841024181835702,0.000531295965219472
NMR metabolomics,X23428.Concentration of VLDL Particles,DNPEP,Aspartyl aminopeptidase,37388,0.0190405009991591,0.00551954993809062,0.00822218312050147,0.0298588188778167,0.000563030668836113
NMR metabolomics,X23428.Concentration of VLDL Particles,PROCR,Endothelial protein C receptor,37021,-0.0117873121470719,0.00341766708231736,-0.0184859396284139,-0.00508868466572986,0.000564564337059012
NMR metabolomics,X23428.Concentration of VLDL Particles,GLP1R,Glucagon-like peptide 1 receptor,36991,-0.0121926834073492,0.00353714803702129,-0.0191254935599109,-0.00525987325478747,0.000568544366116805
NMR metabolomics,X23428.Concentration of VLDL Particles,GBP2,Guanylate-binding protein 2,39587,0.0190108175334944,0.00552302550625729,0.00818568754123015,0.0298359475257587,0.000578713728763065
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL28,C-C motif chemokine 28,39815,0.0190395676194806,0.00554730016694329,0.00816685929227172,0.0299122759466894,0.000600175004348544
NMR metabolomics,X23428.Concentration of VLDL Particles,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39587,0.0134689808888441,0.00392987493405202,0.0057664260181021,0.021171535759586,0.000611106559087675
NMR metabolomics,X23428.Concentration of VLDL Particles,CSPG4,Chondroitin sulfate proteoglycan 4,37437,-0.0104680053398095,0.00306641990637709,-0.0164781883563086,-0.00445782232331037,0.00064261456604307
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40009,0.0085208847140335,0.00249677444824698,0.00362720679546942,0.0134145626325976,0.000644670180284642
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37411,-0.0117050864306053,0.00343443753900863,-0.0184365840070622,-0.00497358885414835,0.000655946673515904
NMR metabolomics,X23428.Concentration of VLDL Particles,TK1,"Thymidine kinase, cytosolic",37169,0.0146514676605228,0.00430105103262206,0.00622140763658354,0.023081527684462,0.000659996641615177
NMR metabolomics,X23428.Concentration of VLDL Particles,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37411,0.0223497278258952,0.00656585019889787,0.00948066143605534,0.035218794215735,0.000666149166974274
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39913,0.014374717052333,0.00423139232525266,0.0060811880948378,0.0226682460098282,0.000682543426018098
NMR metabolomics,X23428.Concentration of VLDL Particles,SAG,S-arrestin,36991,-0.0168240391016286,0.00495983728699825,-0.0265453201841452,-0.00710275801911199,0.000695752747032984
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF5,Eukaryotic translation initiation factor 5,37021,0.0139632052227899,0.00412300233104629,0.00588212065393922,0.0220442897916407,0.00070956156921526
NMR metabolomics,X23428.Concentration of VLDL Particles,TSC1,Hamartin,37056,0.0241447323865559,0.00714237310530237,0.0101456811001633,0.0381437836729486,0.000725660306255806
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39585,0.0100541715310966,0.00297482581785962,0.00422351292809169,0.0158848301341014,0.000727277586842496
NMR metabolomics,X23428.Concentration of VLDL Particles,LY6D,Lymphocyte antigen 6D,39761,0.0113875581397321,0.00337006732881831,0.00478222617524825,0.017992890104216,0.000729167934985394
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39585,0.0151673516236263,0.00449740650987255,0.00635243486427612,0.0239822683829765,0.000746778248593947
NMR metabolomics,X23428.Concentration of VLDL Particles,EP300,Histone acetyltransferase p300,37056,0.00932449776993968,0.00276596656714411,0.00390320329833723,0.0147457922415421,0.000750689165807842
NMR metabolomics,X23428.Concentration of VLDL Particles,CDHR1,Cadherin-related family member 1,39489,0.0133995625142873,0.00397681810538836,0.00560499902772607,0.0211941260008485,0.000755092077933794
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPTL4,Angiopoietin-related protein 4,39908,-0.0141922862938085,0.00421228775534065,-0.0224483702942762,-0.00593620229334086,0.000755481299657395
NMR metabolomics,X23428.Concentration of VLDL Particles,AGR2,Anterior gradient protein 2 homolog,39364,0.0314228134558069,0.00933247124459669,0.0131311698163974,0.0497144570952164,0.00076164069302099
NMR metabolomics,X23428.Concentration of VLDL Particles,CENPF,Centromere protein F,37169,0.0169484490373995,0.00503726119295838,0.00707541709920109,0.0268214809755979,0.000768667745925161
NMR metabolomics,X23428.Concentration of VLDL Particles,GBA,Lysosomal acid glucosylceramidase,37039,0.016552816919336,0.00492267994360583,0.0069043642298686,0.0262012696088035,0.000774425183597435
NMR metabolomics,X23428.Concentration of VLDL Particles,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39214,0.0118032187945793,0.00351509609958681,0.00491363043938911,0.0186928071497694,0.000787377597707555
NMR metabolomics,X23428.Concentration of VLDL Particles,OLFM4,Olfactomedin-4,36654,0.0384950447168993,0.0114987904513022,0.015957415432347,0.0610326740014516,0.000817062097933003
NMR metabolomics,X23428.Concentration of VLDL Particles,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37368,0.0159292958218009,0.00476185925832919,0.0065960516754757,0.0252625399681261,0.000824519218682952
NMR metabolomics,X23428.Concentration of VLDL Particles,DLL4,Delta-like protein 4,37043,0.0268426931998107,0.00803062158236562,0.0111026748983741,0.0425827115012474,0.000832456605426817
NMR metabolomics,X23428.Concentration of VLDL Particles,LYAR,Cell growth-regulating nucleolar protein,39477,0.016014916071743,0.00480448068368934,0.00659813393171187,0.0254316982117741,0.000860128050690319
NMR metabolomics,X23428.Concentration of VLDL Particles,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37169,0.021832157311836,0.00655798601902834,0.00897850471454049,0.0346858099091316,0.000873653114772484
NMR metabolomics,X23428.Concentration of VLDL Particles,CPVL,Probable serine carboxypeptidase CPVL,39990,0.012449594140684,0.00374734186888715,0.00510480407766521,0.0197943842037028,0.000894942132507205
NMR metabolomics,X23428.Concentration of VLDL Particles,ALPI,Intestinal-type alkaline phosphatase,37056,-0.0373939370771311,0.0113049809575993,-0.0595516997540258,-0.0152361744002364,0.000943035950032026
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINT1,Kunitz-type protease inhibitor 1,39794,0.00800684062496263,0.00242232093426213,0.00325909159380886,0.0127545896561164,0.000950362537260648
NMR metabolomics,X23428.Concentration of VLDL Particles,ABO,Histo-blood group ABO system transferase,37445,0.044240740967738,0.0133953923477581,0.0179857719661321,0.0704957099693438,0.00096011742912778
NMR metabolomics,X23428.Concentration of VLDL Particles,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37056,0.0110753340167467,0.00335614514736052,0.00449728952792011,0.0176533785055733,0.000969354669703975
NMR metabolomics,X23428.Concentration of VLDL Particles,ROBO4,Roundabout homolog 4,37043,-0.005489618550967,0.00166383955843188,-0.00875074408549348,-0.00222849301644052,0.000971598274266408
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA1,Annexin A1,37072,0.0134514241375524,0.00408568089463507,0.00544348958406767,0.0214593586910371,0.000996205188290043
NMR metabolomics,X23428.Concentration of VLDL Particles,WNT9A,Protein Wnt-9a,39587,0.0085865967887435,0.00262014173529977,0.00345111898755596,0.013722074589931,0.00105088028888727
NMR metabolomics,X23428.Concentration of VLDL Particles,DRAXIN,Draxin,39749,0.0127860513100066,0.00392012337476121,0.00510260949547466,0.0204694931245386,0.0011100122126209
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP5PO,"ATP synthase subunit O, mitochondrial",39489,0.0131822025985287,0.00405683978301257,0.00523079662382411,0.0211336085732334,0.00115902456575635
NMR metabolomics,X23428.Concentration of VLDL Particles,LIF,Leukemia inhibitory factor,39489,0.0155169095763269,0.00478263478881683,0.00614294539024592,0.0248908737624079,0.00117934502666282
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF5A,Eukaryotic translation initiation factor 5A-1,39587,0.00909516189137677,0.00280748030989304,0.00359250048398641,0.0145978232987671,0.00119938818632065
NMR metabolomics,X23428.Concentration of VLDL Particles,TMOD4,Tropomodulin-4,36962,-0.0123642730106379,0.00381893795508578,-0.0198493914026061,-0.00487915461866982,0.00120830762081222
NMR metabolomics,X23428.Concentration of VLDL Particles,CLSTN2,Calsyntenin-2,40058,-0.0118776637628725,0.00366956395052363,-0.0190700091058989,-0.00468531841984621,0.00121118871623706
NMR metabolomics,X23428.Concentration of VLDL Particles,CAT,Catalase,37252,0.0159144565546242,0.0049332739821975,0.00624523954951706,0.0255836735597313,0.00125860282130448
NMR metabolomics,X23428.Concentration of VLDL Particles,TACSTD2,Tumor-associated calcium signal transducer 2,38022,-0.00921404218399337,0.00286205402547524,-0.0148236680739248,-0.0036044162940619,0.00128757267250109
NMR metabolomics,X23428.Concentration of VLDL Particles,GZMH,Granzyme H,39585,0.0225914831846131,0.00702247657800813,0.00882742909171717,0.036355537277509,0.00129789494978835
NMR metabolomics,X23428.Concentration of VLDL Particles,NOTCH2,Neurogenic locus notch homolog protein 2,37437,0.00652727472400626,0.00203051347103711,0.00254746832077351,0.010507081127239,0.00130934974818986
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37382,-0.00884485481956371,0.00275537179107116,-0.0142453835300632,-0.00344432610906423,0.00133026283570328
NMR metabolomics,X23428.Concentration of VLDL Particles,SCGB2A2,Mammaglobin-A,37021,-0.00940661524629458,0.00293767073777069,-0.0151644498923251,-0.00364878060026404,0.00136770229554676
NMR metabolomics,X23428.Concentration of VLDL Particles,IL7R,Interleukin-7 receptor subunit alpha,39858,-0.0155134720567632,0.00485018739329704,-0.0250198393476254,-0.00600710476590102,0.00138399016183818
NMR metabolomics,X23428.Concentration of VLDL Particles,RANBP2,E3 SUMO-protein ligase RanBP2,36991,-0.0100174068732025,0.00315166376445345,-0.0161946678515313,-0.00384014589487378,0.00148407936742958
NMR metabolomics,X23428.Concentration of VLDL Particles,LMOD1,Leiomodin-1,37411,-0.0104508795970351,0.0032893367828297,-0.0168979796913813,-0.00400377950268891,0.00149038320089104
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF43,E3 ubiquitin-protein ligase RNF43,37169,0.0174678524715857,0.00550118135109255,0.00668553702344427,0.0282501679197271,0.00150027466249903
NMR metabolomics,X23428.Concentration of VLDL Particles,MRPS16,"28S ribosomal protein S16, mitochondrial",37056,0.00881742446139232,0.00277874168742286,0.00337109075404352,0.0142637581687411,0.0015112916021376
NMR metabolomics,X23428.Concentration of VLDL Particles,CLASP1,CLIP-associating protein 1,36962,0.0217454987596839,0.0068567971120913,0.00830617641998491,0.0351848210993828,0.00152067077361473
NMR metabolomics,X23428.Concentration of VLDL Particles,SIL1,Nucleotide exchange factor SIL1,37043,0.00986700200006039,0.00311323705565459,0.00376505737097739,0.0159689466291434,0.00153118653975641
NMR metabolomics,X23428.Concentration of VLDL Particles,AHSP,Alpha-hemoglobin-stabilizing protein,39836,0.0251261223181705,0.00794827761334295,0.00954749819601828,0.0407047464403227,0.00157412243934533
NMR metabolomics,X23428.Concentration of VLDL Particles,M6PR,Cation-dependent mannose-6-phosphate receptor,37043,0.0121389087499008,0.00384512884541058,0.00460245621289604,0.0196753612869055,0.00159783696267932
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTSL5,ADAMTS-like protein 5,37437,-0.0115337628865754,0.00365938252795153,-0.0187061526413604,-0.00436137313179039,0.00162601804258675
NMR metabolomics,X23428.Concentration of VLDL Particles,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39749,0.0299855048749843,0.00953515697773814,0.0112965971986175,0.048674412551351,0.00166545846773355
NMR metabolomics,X23428.Concentration of VLDL Particles,TMEM25,Transmembrane protein 25,37411,-0.0131319619482857,0.00417921717669327,-0.0213232276146045,-0.00494069628196686,0.00168041153550619
NMR metabolomics,X23428.Concentration of VLDL Particles,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39587,0.0354551669000172,0.0112882846280429,0.0133301290290532,0.0575802047709812,0.00168752189062695
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK15,Kallikrein-15,37351,0.0147394676999538,0.00470393664374292,0.00551975187821772,0.02395918352169,0.00173144719586378
NMR metabolomics,X23428.Concentration of VLDL Particles,NUP50,Nuclear pore complex protein Nup50,37021,-0.00968082102036078,0.00309217420430208,-0.0157414824607929,-0.0036201595799287,0.00174742767089643
NMR metabolomics,X23428.Concentration of VLDL Particles,KIRREL2,Kin of IRRE-like protein 2,39489,0.0114843020988199,0.00368801173844536,0.00425579909146694,0.0187128051061728,0.00184931240934551
NMR metabolomics,X23428.Concentration of VLDL Particles,PCDH12,Protocadherin-12,37411,0.00732272290433209,0.00236334553048014,0.00269056566459101,0.0119548801440732,0.00194929672613165
NMR metabolomics,X23428.Concentration of VLDL Particles,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39862,0.0108707668827376,0.00351361651634532,0.00398407851070079,0.0177574552547745,0.001978866062399
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A14,Protein S100-A14,37411,0.0146346908043937,0.0047710940828364,0.0052833464020344,0.0239860352067531,0.00216380227474702
NMR metabolomics,X23428.Concentration of VLDL Particles,SOX9,Transcription factor SOX-9,37039,0.00774436860510485,0.00252501715281686,0.00279533498558381,0.0126934022246259,0.00216616607268081
NMR metabolomics,X23428.Concentration of VLDL Particles,CA1,Carbonic anhydrase 1,39531,0.0169474823084302,0.00552902456091179,0.0061105941690431,0.0277843704478173,0.00217905421524969
NMR metabolomics,X23428.Concentration of VLDL Particles,CD70,CD70 antigen,39866,0.012058695137524,0.00393433549325147,0.00434739757075113,0.0197699927042969,0.00218040303933298
NMR metabolomics,X23428.Concentration of VLDL Particles,IL10RA,Interleukin-10 receptor subunit alpha,39587,0.0166606371604671,0.00544281377093872,0.00599272216942719,0.027328552151507,0.00220946058573524
NMR metabolomics,X23428.Concentration of VLDL Particles,GGA1,ADP-ribosylation factor-binding protein GGA1,39489,0.0199550082202487,0.0065236691039156,0.00716861677657414,0.0327413996639233,0.0022255491126671
NMR metabolomics,X23428.Concentration of VLDL Particles,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39585,0.00765423360240581,0.00250808860595362,0.00273837993473671,0.0125700872700749,0.00227838211968044
NMR metabolomics,X23428.Concentration of VLDL Particles,SHISA5,Protein shisa-5,37437,0.00651514015936138,0.00213925967900054,0.00232219118852033,0.0107080891302024,0.00232730147906395
NMR metabolomics,X23428.Concentration of VLDL Particles,GPR101,Probable G-protein coupled receptor 101,36991,-0.0178008735555846,0.00584875508539742,-0.0292644335229636,-0.00633731358820565,0.00234280932524251
NMR metabolomics,X23428.Concentration of VLDL Particles,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37021,0.0247928995656241,0.00814883059010026,0.00882119160902761,0.0407646075222206,0.00235076270941179
NMR metabolomics,X23428.Concentration of VLDL Particles,SLAMF1,Signaling lymphocytic activation molecule,39587,-0.0165974420952047,0.0054564093268681,-0.0272920043758662,-0.00590287981454327,0.00235536029267456
NMR metabolomics,X23428.Concentration of VLDL Particles,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39868,0.0086918599702367,0.00286283804627112,0.00308069739954531,0.0143030225409281,0.00240045865590534
NMR metabolomics,X23428.Concentration of VLDL Particles,KLRK1,NKG2-D type II integral membrane protein,37388,0.0125909628465589,0.00414858891544647,0.00445972857228387,0.020722197120834,0.00240993552773368
NMR metabolomics,X23428.Concentration of VLDL Particles,SULT1A1,Sulfotransferase 1A1,40009,-0.0363132986550194,0.0120207871437137,-0.0598740414566983,-0.0127525558533405,0.00252439486919086
NMR metabolomics,X23428.Concentration of VLDL Particles,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40009,0.0199441900000261,0.00660873499957478,0.00699106940085957,0.0328973105991927,0.00254969279846422
NMR metabolomics,X23428.Concentration of VLDL Particles,TNN,Tenascin-N,37437,0.0120770451335266,0.00401109805257046,0.00421529295048855,0.0199387973165647,0.00260947122796199
NMR metabolomics,X23428.Concentration of VLDL Particles,IL6,Interleukin-6,39788,0.0198696570264918,0.00660573651855294,0.006922413450128,0.0328169006028555,0.00263436060210324
NMR metabolomics,X23428.Concentration of VLDL Particles,NELL1,Protein kinase C-binding protein NELL1,39913,0.0114491770996708,0.00380777594518956,0.00398593624709929,0.0189124179522424,0.00264431849145942
NMR metabolomics,X23428.Concentration of VLDL Particles,RBPMS,RNA-binding protein with multiple splicing,37056,0.018232296030688,0.00606831236856204,0.00633840378830636,0.0301261882730696,0.00266509677543916
NMR metabolomics,X23428.Concentration of VLDL Particles,AIF1L,Allograft inflammatory factor 1-like,37043,0.0163862409891163,0.00546898894423759,0.00566702265841064,0.027105459319822,0.00273866323257181
NMR metabolomics,X23428.Concentration of VLDL Particles,HEPACAM2,HEPACAM family member 2,37388,-0.011718841565576,0.00391325679189846,-0.019388824877697,-0.00404885825345505,0.00275255382865565
NMR metabolomics,X23428.Concentration of VLDL Particles,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39812,0.016338904086052,0.0054601031960553,0.00563710182178357,0.0270407063503203,0.00277201647420686
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL21,C-C motif chemokine 21,39931,0.0109066684825669,0.00364696569822216,0.00375861571405152,0.0180547212510824,0.00278838629937028
NMR metabolomics,X23428.Concentration of VLDL Particles,TERF1,Telomeric repeat-binding factor 1,37056,-0.0081625343189622,0.00273123561703084,-0.0135157561283426,-0.00280931250958176,0.00280787014835414
NMR metabolomics,X23428.Concentration of VLDL Particles,SEMA3G,Semaphorin-3G,37124,0.0121988164989394,0.00409372293521742,0.00417511954591322,0.0202225134519655,0.00288880821581439
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP1,Caspase-1,39489,0.0185428466519889,0.00622775010564478,0.00633645644492518,0.0307492368590527,0.00291097833485241
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKCQ,Protein kinase C theta type,39587,0.0120266279168419,0.00404055455331177,0.00410714099235085,0.019946114841333,0.00292022320984089
NMR metabolomics,X23428.Concentration of VLDL Particles,PODXL2,Podocalyxin-like protein 2,39913,0.0076142445207611,0.00256136563437949,0.00259396787737731,0.0126345211641449,0.00295603539682078
NMR metabolomics,X23428.Concentration of VLDL Particles,SAFB2,Scaffold attachment factor B2,37411,0.0076076410844407,0.00255929536828228,0.00259142216260743,0.012623860006274,0.00295853427668346
NMR metabolomics,X23428.Concentration of VLDL Particles,NPTN,Neuroplastin,39477,0.0232471684098651,0.0078245598433687,0.00791103111686247,0.0385833057028678,0.00297234095794643
NMR metabolomics,X23428.Concentration of VLDL Particles,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39788,0.012270256634457,0.00413319382007609,0.00416919674710783,0.0203713165218061,0.00299497161060416
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP152,Centrosomal protein of 152 kDa,36962,0.0116004077038411,0.00390762747310342,0.00394145785655838,0.0192593575511238,0.00299645008122279
NMR metabolomics,X23428.Concentration of VLDL Particles,CST7,Cystatin-F,39882,0.0255174980623708,0.00860012988039371,0.0086612434967991,0.0423737526279424,0.00301061143006446
NMR metabolomics,X23428.Concentration of VLDL Particles,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39749,-0.00777808750658308,0.00262383400287633,-0.0129208021522207,-0.00263537286094548,0.00303726196484519
NMR metabolomics,X23428.Concentration of VLDL Particles,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37453,-0.00528659488173636,0.00178999268750209,-0.00879498054924045,-0.00177820921423227,0.00314815059341088
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39749,0.0165652669232208,0.0056160757128165,0.00555775852610048,0.0275727753203412,0.00318632809981843
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39866,0.00900023861128114,0.00305529460225953,0.00301186119085247,0.0149886160317098,0.00322600922639166
NMR metabolomics,X23428.Concentration of VLDL Particles,FSTL3,Follistatin-related protein 3,39803,0.00818433550560407,0.00279245087295291,0.00271113179461636,0.0136575392165918,0.00338484165886566
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37022,0.0106191882139615,0.00363833568030367,0.00348805028056634,0.0177503261473567,0.0035209640910222
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37437,0.00969239871204664,0.00332344510084151,0.00317844631439728,0.016206351109696,0.00354708864616438
NMR metabolomics,X23428.Concentration of VLDL Particles,NMRK2,Nicotinamide riboside kinase 2,36962,-0.0111296606280186,0.00382253087604696,-0.0186218211450706,-0.00363750011096653,0.00360195218228528
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASE1,Ribonuclease pancreatic,37445,0.00606151230055158,0.00209135094326568,0.00196246445175086,0.0101605601493523,0.0037570578774598
NMR metabolomics,X23428.Concentration of VLDL Particles,IL20RA,Interleukin-20 receptor subunit alpha,39587,0.0122987136975734,0.00424633187658072,0.00397590321947519,0.0206215241756716,0.00378093789767271
NMR metabolomics,X23428.Concentration of VLDL Particles,PKLR,Pyruvate kinase PKLR,39881,-0.0172439255067645,0.00595648833336541,-0.0289186426401607,-0.00556920837336827,0.00379692556108507
NMR metabolomics,X23428.Concentration of VLDL Particles,TSPAN1,Tetraspanin-1,39585,0.0108961431676581,0.00376428513413977,0.00351814430474415,0.0182741420305721,0.00380150110035251
NMR metabolomics,X23428.Concentration of VLDL Particles,RCC1,Regulator of chromosome condensation,37368,0.0136843393753724,0.00472954388845017,0.00441443335401006,0.0229542453967347,0.00381736429753688
NMR metabolomics,X23428.Concentration of VLDL Particles,PLB1,"Phospholipase B1, membrane-associated",37388,0.0161595028068211,0.00559207643515186,0.00519903299392348,0.0271199726197188,0.00386204860279372
NMR metabolomics,X23428.Concentration of VLDL Particles,MYOM1,Myomesin-1,36991,0.0127602247525037,0.00442374874253648,0.00408967721713224,0.0214307722878752,0.00392695436531963
NMR metabolomics,X23428.Concentration of VLDL Particles,NGF,Beta-nerve growth factor,39749,0.00329142559355574,0.00114612418160256,0.00104502219761472,0.00553782898949677,0.0040869657382119
NMR metabolomics,X23428.Concentration of VLDL Particles,SCGN,Secretagogin,39587,-0.0114871890632837,0.00401528324394211,-0.0193571442214103,-0.00361723390515717,0.00423041772479476
NMR metabolomics,X23428.Concentration of VLDL Particles,COL9A2,Collagen alpha-2(IX) chain,37169,0.0123096854250395,0.0043068844958599,0.00386819181315405,0.0207511790369249,0.00426791643115204
NMR metabolomics,X23428.Concentration of VLDL Particles,OBP2B,Odorant-binding protein 2b,39701,-0.0167498049857429,0.00587180392814879,-0.0282585406849145,-0.00524106928657126,0.00434217027289148
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTNAP2,Contactin-associated protein-like 2,39866,0.0108650807132956,0.00381567660099896,0.00338635457533765,0.0183438068512536,0.00441223128827179
NMR metabolomics,X23428.Concentration of VLDL Particles,MSMB,Beta-microseminoprotein,39780,0.0177625986529218,0.00625594139080375,0.00550095352694645,0.0300242437788971,0.00452675346979548
NMR metabolomics,X23428.Concentration of VLDL Particles,CST6,Cystatin-M,39524,0.0123986363107615,0.00436767073856927,0.00383800166316572,0.0209592709583572,0.00453517859354109
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM26,Tripartite motif-containing protein 26,36962,0.0148288645438667,0.00522987722809166,0.0045783051768071,0.0250794239109264,0.00458365023804334
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP6V1D,V-type proton ATPase subunit D,39788,0.00688267641471636,0.0024293065084221,0.00212123565820905,0.0116441171712237,0.00461445017970107
NMR metabolomics,X23428.Concentration of VLDL Particles,FOLR1,Folate receptor alpha,39809,0.00722887928499668,0.00255271337501554,0.00222556106996622,0.0122321975000271,0.00463387681737788
NMR metabolomics,X23428.Concentration of VLDL Particles,TFF3,Trefoil factor 3,39839,0.0127661402396281,0.00451898027693018,0.00390893889684492,0.0216233415824112,0.00473385201199298
NMR metabolomics,X23428.Concentration of VLDL Particles,SSB,Lupus La protein,39489,0.0159332247183664,0.00565383721584694,0.00485170377530641,0.0270147456614264,0.00483655372793229
NMR metabolomics,X23428.Concentration of VLDL Particles,GKN1,Gastrokine-1,39123,0.00736979050333882,0.00261685123811772,0.00224076207662808,0.0124988189300496,0.00486453604981409
NMR metabolomics,X23428.Concentration of VLDL Particles,TNC,Tenascin,39931,-0.0123529055380153,0.00438636584785465,-0.0209501825998104,-0.00375562847622017,0.00486538459408236
NMR metabolomics,X23428.Concentration of VLDL Particles,AKR1C4,Aldo-keto reductase family 1 member C4,39585,0.0138563618957521,0.0049228399571066,0.00420759557982316,0.023505128211681,0.00488820915950958
NMR metabolomics,X23428.Concentration of VLDL Particles,UBAC1,Ubiquitin-associated domain-containing protein 1,39788,0.00901454799887384,0.00320881830753343,0.00272526411610831,0.0153038318816394,0.00497091395776494
NMR metabolomics,X23428.Concentration of VLDL Particles,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39788,0.0100072269803406,0.00357226266046158,0.00300559216583586,0.0170088617948453,0.00509476159709121
NMR metabolomics,X23428.Concentration of VLDL Particles,STX1B,Syntaxin-1B,37039,0.0111136143084353,0.00397171744576057,0.00332904811474454,0.018898180502126,0.00514647040592927
NMR metabolomics,X23428.Concentration of VLDL Particles,STX3,Syntaxin-3,37388,0.00991083655507906,0.00355115779940876,0.00295056726823789,0.0168711058419202,0.00526394529996959
NMR metabolomics,X23428.Concentration of VLDL Particles,OMG,Oligodendrocyte-myelin glycoprotein,39788,0.0168334091488265,0.00605603914331495,0.00496357242792918,0.0287032458697238,0.00544885252688057
NMR metabolomics,X23428.Concentration of VLDL Particles,CELA2A,Chymotrypsin-like elastase family member 2A,37437,0.0153649724811365,0.00553890855577375,0.00450871171181991,0.026221233250453,0.00554460625867473
NMR metabolomics,X23428.Concentration of VLDL Particles,FUCA1,Tissue alpha-L-fucosidase,39928,0.0206977177995804,0.00750208313523182,0.005993634854526,0.0354018007446347,0.0058056675232577
NMR metabolomics,X23428.Concentration of VLDL Particles,STX5,Syntaxin-5,37056,0.010488853500653,0.00380640287563325,0.0030283038644118,0.0179494031368941,0.00586682696849316
NMR metabolomics,X23428.Concentration of VLDL Particles,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37411,0.0106517867600468,0.00389455412261688,0.00301846067971772,0.0182851128403759,0.00624525646834583
NMR metabolomics,X23428.Concentration of VLDL Particles,MYBPC2,"Myosin-binding protein C, fast-type",37043,-0.0216458143680507,0.00794319963312141,-0.0372144856489687,-0.00607714308713278,0.00643717027809668
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37411,0.0121987136948872,0.00450748182995044,0.00336404930818435,0.0210333780815901,0.00681174729842363
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHA2,Ephrin type-A receptor 2,39248,0.00739198434693572,0.0027390234314882,0.00202349842121884,0.0127604702726526,0.00696729801634564
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39881,-0.0122903481557706,0.00455442574618835,-0.0212170226182998,-0.00336367369324148,0.00697151478365259
NMR metabolomics,X23428.Concentration of VLDL Particles,METAP1,Methionine aminopeptidase 1,39489,0.00764735575102198,0.00283900579821753,0.00208290438651562,0.0132118071155283,0.00707447082661468
NMR metabolomics,X23428.Concentration of VLDL Particles,CSH1,Chorionic somatomammotropin hormone 1,37445,0.00873182965083531,0.00325064064936781,0.00236057397807439,0.0151030853235962,0.00723604358736841
NMR metabolomics,X23428.Concentration of VLDL Particles,KIAA1549,UPF0606 protein KIAA1549,37169,0.0172072093524742,0.00641719347506355,0.00462951014134968,0.0297849085635988,0.00734002201883266
NMR metabolomics,X23428.Concentration of VLDL Particles,HIF1A,Hypoxia-inducible factor 1-alpha,37056,0.017142708358769,0.0063934456944081,0.00461155479772914,0.0296738619198089,0.00734292280144664
NMR metabolomics,X23428.Concentration of VLDL Particles,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37445,0.01170775862755,0.00436653039085497,0.00314935906147424,0.0202661581936257,0.00734363426903946
NMR metabolomics,X23428.Concentration of VLDL Particles,IL20,Interleukin-20,39587,0.0121696737707773,0.00454899140521261,0.00325365061656057,0.021085696924994,0.00747515897116334
NMR metabolomics,X23428.Concentration of VLDL Particles,SMPD1,Sphingomyelin phosphodiesterase,39912,-0.01221393210954,0.00457356623086987,-0.0211781219220449,-0.00324974229703502,0.00758036576856835
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHA10,Ephrin type-A receptor 10,39489,0.015916100962549,0.00597459970052866,0.00420588554951285,0.0276263163755852,0.00773057249493355
NMR metabolomics,X23428.Concentration of VLDL Particles,BABAM1,BRISC and BRCA1-A complex member 1,37056,0.00737793785257157,0.00277652899410335,0.00193594102412901,0.0128199346810141,0.00788753402109634
NMR metabolomics,X23428.Concentration of VLDL Particles,TYMP,Thymidine phosphorylase,39764,0.0167596352166002,0.00630903709817211,0.00439392250418286,0.0291253479290175,0.00790472070278475
NMR metabolomics,X23428.Concentration of VLDL Particles,NEDD9,Enhancer of filamentation 1,37056,0.00829066476883137,0.00312227971457638,0.00217099652826167,0.0144103330094011,0.00793273887589153
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK14,Kallikrein-14,40030,0.0111675938951307,0.00420601201058939,0.00292381035437547,0.0194113774358859,0.00793507641561215
NMR metabolomics,X23428.Concentration of VLDL Particles,CHRM1,Muscarinic acetylcholine receptor M1,37039,-0.00904536339249708,0.00343186760228904,-0.0157718238929836,-0.00231890289201056,0.00840629859484939
NMR metabolomics,X23428.Concentration of VLDL Particles,ALPP,"Alkaline phosphatase, placental type",39788,0.0259143937002864,0.00984998376222207,0.00660842552633117,0.0452203618742417,0.00852392527901099
NMR metabolomics,X23428.Concentration of VLDL Particles,CLNS1A,Methylosome subunit pICln,37039,-0.00828025957077776,0.00314753848959442,-0.0144494350103828,-0.00211108413117271,0.00853059372001752
NMR metabolomics,X23428.Concentration of VLDL Particles,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40009,0.011391797371664,0.00433139168848972,0.00290226966222418,0.0198813250811039,0.00854520802843306
NMR metabolomics,X23428.Concentration of VLDL Particles,NCR1,Natural cytotoxicity triggering receptor 1,39835,0.00868833857005617,0.00330567523005794,0.00220921511914261,0.0151674620209697,0.00858924056951114
NMR metabolomics,X23428.Concentration of VLDL Particles,MNAT1,CDK-activating kinase assembly factor MAT1,37169,0.0107409439627547,0.00408673097056031,0.00273095126045647,0.0187509366650529,0.00859243597779602
NMR metabolomics,X23428.Concentration of VLDL Particles,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37056,0.0106526356897691,0.00405826193259572,0.0026984423018815,0.0186068290776567,0.00867677971771885
NMR metabolomics,X23428.Concentration of VLDL Particles,QSOX1,Sulfhydryl oxidase 1,37186,0.0103097843382445,0.00392862409830016,0.0026096811055762,0.0180098875709128,0.0086933036113651
NMR metabolomics,X23428.Concentration of VLDL Particles,TBC1D17,TBC1 domain family member 17,39489,0.0107297365651637,0.00409645356578384,0.0027006875762274,0.0187587855541,0.00882020939462538
NMR metabolomics,X23428.Concentration of VLDL Particles,PADI4,Protein-arginine deiminase type-4,39456,0.0170968753738079,0.00654771621671746,0.00426335158904162,0.0299303991585741,0.00903324880030238
NMR metabolomics,X23428.Concentration of VLDL Particles,APOBR,Apolipoprotein B receptor,37043,-0.0103603729316511,0.00396877044748054,-0.018139163008713,-0.00258158285458925,0.00905190756749163
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40009,-0.0108238905873446,0.00414871696387692,-0.0189553758365434,-0.00269240533814589,0.00908980983735648
NMR metabolomics,X23428.Concentration of VLDL Particles,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37411,0.00624994948530705,0.00239725435095117,0.00155133095744275,0.0109485680131713,0.00914051908858022
NMR metabolomics,X23428.Concentration of VLDL Particles,RPS10,40S ribosomal protein S10,37021,-0.0104253004636805,0.00401504165830931,-0.0182947821139667,-0.0025558188133942,0.0094266885099603
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37437,-0.00958855461157435,0.00370568175009579,-0.0168516908417621,-0.00232541838138661,0.00967702901865372
NMR metabolomics,X23428.Concentration of VLDL Particles,SNU13,NHP2-like protein 1,37021,0.0149481815637974,0.00579027005330868,0.00359925225931243,0.0262971108682825,0.00984496081100219
NMR metabolomics,X23428.Concentration of VLDL Particles,PSAPL1,Proactivator polypeptide-like 1,37382,0.0119627292940584,0.00464724269560733,0.00285413361066806,0.0210713249774488,0.0100590292277163
NMR metabolomics,X23428.Concentration of VLDL Particles,IGLC2,Immunoglobulin lambda constant 2,37422,-0.00585301082588857,0.00227966772041612,-0.0103211595579042,-0.00138486209387298,0.0102545650628389
NMR metabolomics,X23428.Concentration of VLDL Particles,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39835,-0.0173136580111967,0.00677865532714237,-0.0305998224523958,-0.00402749356999769,0.0106541354066826
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37382,0.00509385464851391,0.00199742198106248,0.00117890756563144,0.00900880173139638,0.0107765915080413
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC4D,C-type lectin domain family 4 member D,39866,0.0143457612366023,0.00564310893301093,0.00328526772790083,0.0254062547453037,0.0110258931445591
NMR metabolomics,X23428.Concentration of VLDL Particles,SELL,L-selectin,37453,0.00536234081027563,0.00211437350385856,0.00121816874271285,0.0095065128778384,0.011219386445414
NMR metabolomics,X23428.Concentration of VLDL Particles,MORF4L2,Mortality factor 4-like protein 2,36962,-0.00880656582312938,0.00347768849557728,-0.0156228352744609,-0.0019902963717979,0.0113431359537444
NMR metabolomics,X23428.Concentration of VLDL Particles,TCN1,Transcobalamin-1,37235,0.00808798528661184,0.00319778950268315,0.00182031786135287,0.0143556527118708,0.0114422924413297
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC7A,C-type lectin domain family 7 member A,40058,0.0134852702465032,0.0053329290366672,0.00303272933463547,0.0239378111583709,0.0114586550080336
NMR metabolomics,X23428.Concentration of VLDL Particles,PDRG1,p53 and DNA damage-regulated protein 1,37039,0.0124922806642925,0.00496080058411772,0.0027691115194218,0.0222154498091633,0.0118074292948801
NMR metabolomics,X23428.Concentration of VLDL Particles,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39477,-0.00756577479217045,0.00301236198282298,-0.0134700042785035,-0.00166154530583742,0.0120293621485496
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37437,0.0171828479192477,0.00684778977534774,0.00376117995956615,0.0306045158789293,0.0121101748026062
NMR metabolomics,X23428.Concentration of VLDL Particles,HTR1B,5-hydroxytryptamine receptor 1B,36991,-0.00997119757467552,0.00399747841134147,-0.0178062552609048,-0.00213613988844623,0.0126302241395705
NMR metabolomics,X23428.Concentration of VLDL Particles,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37021,0.011696543560205,0.00469105185933205,0.00250208191591414,0.0208910052044958,0.0126657576466127
NMR metabolomics,X23428.Concentration of VLDL Particles,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39858,0.00587481791710334,0.00236458469540808,0.00124023191410351,0.0105094039201032,0.0129833878501537
NMR metabolomics,X23428.Concentration of VLDL Particles,SEPTIN3,Neuronal-specific septin-3,37411,-0.0176878131551117,0.00712782748441046,-0.0316583550245562,-0.00371727128566719,0.0130945396651997
NMR metabolomics,X23428.Concentration of VLDL Particles,PLXDC2,Plexin domain-containing protein 2,37388,0.00620317942914908,0.00250459389056498,0.00129417540364172,0.0111121834546564,0.0132716952505063
NMR metabolomics,X23428.Concentration of VLDL Particles,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37043,-0.0061325686156107,0.00247863435569021,-0.0109906919527635,-0.00127444527845788,0.0133670181815518
NMR metabolomics,X23428.Concentration of VLDL Particles,CDKL5,Cyclin-dependent kinase-like 5,36991,-0.0121660729025243,0.00491827459140181,-0.0218058911016719,-0.00252625470337674,0.0133867461365876
NMR metabolomics,X23428.Concentration of VLDL Particles,SUSD4,Sushi domain-containing protein 4,37368,0.00962097703541927,0.00389878139403265,0.00197936550311528,0.0172625885677233,0.0136111709068146
NMR metabolomics,X23428.Concentration of VLDL Particles,NDRG1,Protein NDRG1,39489,0.0159076663744117,0.00645190928815172,0.00326192416963431,0.0285534085791891,0.0136900150038167
NMR metabolomics,X23428.Concentration of VLDL Particles,IL22,Interleukin-22,37368,-0.0150681011751395,0.00611340203854044,-0.0270503691706788,-0.00308583317960028,0.013722653076979
NMR metabolomics,X23428.Concentration of VLDL Particles,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37368,0.0104231140343023,0.00423199318408405,0.00212840739349758,0.0187178206751071,0.0137929625948977
NMR metabolomics,X23428.Concentration of VLDL Particles,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36675,0.0112365733536279,0.00456227096024455,0.00229452227154863,0.0201786244357073,0.0137935697810902
NMR metabolomics,X23428.Concentration of VLDL Particles,SHPK,Sedoheptulokinase,37169,-0.00961145863436929,0.00391003521172811,-0.0172751276493564,-0.0019477896193822,0.0139780756870598
NMR metabolomics,X23428.Concentration of VLDL Particles,MYH7B,Myosin-7B,36962,-0.0100798473128128,0.00411949273157329,-0.0181540530666965,-0.00200564155892919,0.0144234790448714
NMR metabolomics,X23428.Concentration of VLDL Particles,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39351,-0.019380905908993,0.0079347492927929,-0.0349330145228671,-0.00382879729511893,0.0145955963747174
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH6,Cadherin-6,39868,-0.0086510874008796,0.00354350150408184,-0.01559635034888,-0.00170582445287919,0.0146413903981466
NMR metabolomics,X23428.Concentration of VLDL Particles,FRMD7,FERM domain-containing protein 7,37039,0.00764237022304015,0.00314171747971962,0.00148460396278969,0.0138001364832906,0.0150063314078035
NMR metabolomics,X23428.Concentration of VLDL Particles,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37139,-0.0145960977389079,0.00601917472212841,-0.0263936801942795,-0.00279851528353618,0.0153244453661609
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS4,Galectin-4,39862,-0.0118681167274627,0.0049139322027344,-0.0214994238448222,-0.00223680961010333,0.0157378146587227
NMR metabolomics,X23428.Concentration of VLDL Particles,CD209,CD209 antigen,39885,0.00872210616871019,0.00362291953257995,0.00162118388485349,0.0158230284525669,0.0160742735815107
NMR metabolomics,X23428.Concentration of VLDL Particles,GRIK2,"Glutamate receptor ionotropic, kainate 2",37411,0.0088446197208702,0.0036851534046312,0.00162171904779304,0.0160675203939473,0.0164054214840655
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF9,Fibroblast growth factor 9,36931,0.00909083959440906,0.00379295380420627,0.00165665013816477,0.0165250290506533,0.0165542396251043
NMR metabolomics,X23428.Concentration of VLDL Particles,CD3D,T-cell surface glycoprotein CD3 delta chain,36991,-0.00771609341549535,0.00322457932026366,-0.0140362688832121,-0.00139591794777856,0.0167297927083423
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1A,Interleukin-1 alpha,39587,0.0119033162154355,0.00497480423384251,0.00215269991710415,0.0216539325137668,0.0167356340059209
NMR metabolomics,X23428.Concentration of VLDL Particles,PXDNL,Peroxidasin-like protein,37368,0.013250122405249,0.00555798932436215,0.00235646332949914,0.0241437814809988,0.0171403670993328
NMR metabolomics,X23428.Concentration of VLDL Particles,DUSP29,Dual specificity phosphatase 29,37039,-0.0147862164686438,0.00621085186470641,-0.0269594861234683,-0.00261294681381919,0.0172935906564379
NMR metabolomics,X23428.Concentration of VLDL Particles,ENO1,Alpha-enolase,39830,0.0175245534961174,0.00736418165970684,0.00309075744309198,0.0319583495491428,0.0173383424600604
NMR metabolomics,X23428.Concentration of VLDL Particles,SBSN,Suprabasin,37420,-0.00754451221892042,0.00317078972953447,-0.013759260088808,-0.00132976434903286,0.0173555611289155
NMR metabolomics,X23428.Concentration of VLDL Particles,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39913,-0.00766649862594144,0.00322287630518727,-0.0139833361841085,-0.00134966106777439,0.0173818839010551
NMR metabolomics,X23428.Concentration of VLDL Particles,TEF,Thyrotroph embryonic factor,37021,0.00941571679634158,0.00396730318837396,0.00163980254712861,0.0171916310455545,0.0176428155501833
NMR metabolomics,X23428.Concentration of VLDL Particles,CD99,CD99 antigen,39858,0.00423085476597674,0.00178359683470336,0.000735004969958149,0.00772670456199533,0.0176994743836088
NMR metabolomics,X23428.Concentration of VLDL Particles,APOA4,Apolipoprotein A-IV,37453,0.00780507806371744,0.0033073719842804,0.00132262897452785,0.014287527152907,0.0182937499482889
NMR metabolomics,X23428.Concentration of VLDL Particles,AMBN,Ameloblastin,39587,-0.00626586075546003,0.00265875340192032,-0.0114770174232239,-0.0010547040876962,0.0184507639853479
NMR metabolomics,X23428.Concentration of VLDL Particles,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37368,-0.018314685001814,0.00781924558166921,-0.0336404063418857,-0.00298896366174238,0.0191819390474921
NMR metabolomics,X23428.Concentration of VLDL Particles,MBL2,Mannose-binding protein C,37257,-0.0234896439428344,0.0100393131324142,-0.0431666976823664,-0.00381259020330252,0.0193104292051968
NMR metabolomics,X23428.Concentration of VLDL Particles,CENPJ,Centromere protein J,37169,0.0158502549460976,0.00678046273573438,0.00256054798405825,0.029139961908137,0.0194208697039385
NMR metabolomics,X23428.Concentration of VLDL Particles,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37056,0.00606739069032929,0.00259695464085951,0.000977359594244639,0.0111574217864139,0.0194879822583908
NMR metabolomics,X23428.Concentration of VLDL Particles,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37021,-0.0125864546259276,0.0053900901830158,-0.0231510313846385,-0.00202187786721661,0.0195526142649525
NMR metabolomics,X23428.Concentration of VLDL Particles,PI3,Elafin,39594,0.0115295437426008,0.00493802781214248,0.00185100923080155,0.0212080782544001,0.019563878236215
NMR metabolomics,X23428.Concentration of VLDL Particles,CTHRC1,Collagen triple helix repeat-containing protein 1,37437,0.00585514995856618,0.00250954302869768,0.00093644562231872,0.0107738542948136,0.0196545980864876
NMR metabolomics,X23428.Concentration of VLDL Particles,MAEA,E3 ubiquitin-protein transferase MAEA,39477,0.00870421330787071,0.00373485050065169,0.00138390632659341,0.016024520289148,0.0197903686278638
NMR metabolomics,X23428.Concentration of VLDL Particles,REG1A,Lithostathine-1-alpha,39804,-0.0100501675398821,0.00432919166474399,-0.0185353832027803,-0.00156495187698392,0.020273047303129
NMR metabolomics,X23428.Concentration of VLDL Particles,TCN2,Transcobalamin-2,40012,0.00632066153375583,0.00272706757392231,0.000975609088868103,0.0116657139786436,0.0204753302747746
NMR metabolomics,X23428.Concentration of VLDL Particles,SUMF1,Formylglycine-generating enzyme,37056,0.0148113012560977,0.00639120791419122,0.00228453374428295,0.0273380687679125,0.0204944833528424
NMR metabolomics,X23428.Concentration of VLDL Particles,PNLIPRP2,Pancreatic lipase-related protein 2,39862,0.0633166134003773,0.0273947663929225,0.00962287127024924,0.117010355530505,0.0208307663501605
NMR metabolomics,X23428.Concentration of VLDL Particles,GH2,Growth hormone variant,39477,0.0353975041992693,0.0153185770584349,0.00537309316473693,0.0654219152338017,0.0208592604604509
NMR metabolomics,X23428.Concentration of VLDL Particles,JUN,Transcription factor AP-1,39587,0.0111704685046175,0.00483637564293165,0.00169117224447143,0.0206497647647635,0.0209188966166022
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37388,0.0119286525281003,0.005166588483704,0.0018021391000405,0.0220551659561602,0.020969324010425
NMR metabolomics,X23428.Concentration of VLDL Particles,DCUN1D2,DCN1-like protein 2,36962,-0.0173633091484309,0.00752919654837978,-0.0321205343832552,-0.00260608391360652,0.0211188784880918
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGAP5,Rho GTPase-activating protein 5,36962,0.0159771670857756,0.00693038757709083,0.00239360743467758,0.0295607267368736,0.0211609254040171
NMR metabolomics,X23428.Concentration of VLDL Particles,MRPL52,"39S ribosomal protein L52, mitochondrial",36942,0.00546051401243324,0.00236948721956455,0.000816319062086718,0.0101047089627798,0.0212094501384257
NMR metabolomics,X23428.Concentration of VLDL Particles,VIM,Vimentin,39585,0.0251500479389865,0.0109327221925862,0.00372191244151758,0.0465781834364554,0.021436451694209
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM3D,Protein FAM3D,37382,0.017890405656089,0.00779943520751129,0.00260351264936691,0.0331772986628112,0.0218167999986394
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1RL1,Interleukin-1 receptor-like 1,40002,-0.0100163936476275,0.00436719275711819,-0.0185760914515791,-0.00145669584367584,0.0218289017015832
NMR metabolomics,X23428.Concentration of VLDL Particles,PPM1B,Protein phosphatase 1B,37056,0.0136662918884045,0.00595976675739006,0.00198514904391997,0.025347434732889,0.0218583751542079
NMR metabolomics,X23428.Concentration of VLDL Particles,NCAM2,Neural cell adhesion molecule 2,39858,-0.0056794555572623,0.0024897692852133,-0.0105594033562804,-0.000799507758244229,0.0225545953152417
NMR metabolomics,X23428.Concentration of VLDL Particles,TCL1B,T-cell leukemia/lymphoma protein 1B,39585,0.016651500221906,0.00731261996665855,0.00231876508725521,0.0309842353565567,0.0227941688714608
NMR metabolomics,X23428.Concentration of VLDL Particles,TLR4,Toll-like receptor 4,37056,0.00586707268958663,0.00257741863946884,0.00081533215622771,0.0109188132229455,0.0228418093300351
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNG,Interferon gamma,39587,0.024237492190312,0.0106557611838023,0.00335220027005945,0.0451227841105645,0.0229439166669262
NMR metabolomics,X23428.Concentration of VLDL Particles,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39489,0.0145962752175227,0.00642483936933672,0.00200359005362271,0.0271889603814227,0.0231090643753158
NMR metabolomics,X23428.Concentration of VLDL Particles,VSTM1,V-set and transmembrane domain-containing protein 1,39489,0.0101905811819799,0.00449733846476467,0.00137579779104113,0.0190053645729186,0.0234702801089614
NMR metabolomics,X23428.Concentration of VLDL Particles,MRPL24,"39S ribosomal protein L24, mitochondrial",37021,0.00840408036093067,0.00371312304713869,0.00112635918853884,0.0156818015333225,0.0236306151514117
NMR metabolomics,X23428.Concentration of VLDL Particles,RELB,Transcription factor RelB,37056,0.0104044596291788,0.0045980905450997,0.00139220216078336,0.0194167170975742,0.0236655404773161
NMR metabolomics,X23428.Concentration of VLDL Particles,MYBPC1,"Myosin-binding protein C, slow-type",37437,-0.0144212904709629,0.00637337892997622,-0.0269131131737163,-0.00192946776820949,0.0236675376850734
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39858,-0.00731472380797705,0.00324389719815617,-0.0136727623163632,-0.000956685299590956,0.0241519063939
NMR metabolomics,X23428.Concentration of VLDL Particles,NPR1,Atrial natriuretic peptide receptor 1,37021,-0.00874214045969682,0.00388361735320488,-0.0163540304719784,-0.00113025044741526,0.024400048029842
NMR metabolomics,X23428.Concentration of VLDL Particles,SCN2B,Sodium channel subunit beta-2,37039,-0.00606014479915587,0.00269419969932881,-0.0113407762098403,-0.000779513388471391,0.0245079335573826
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1RAP,Interleukin-1 receptor accessory protein,39858,-0.00897986004736991,0.00399350843650372,-0.0168071365829172,-0.00115258351182262,0.0245506002212309
NMR metabolomics,X23428.Concentration of VLDL Particles,NAPRT,Nicotinate phosphoribosyltransferase,37388,0.00685195660845853,0.00305392811676274,0.000866257499603565,0.0128376557173135,0.0248708133157496
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA5,Annexin A5,39415,0.00632010484358304,0.00281815043548413,0.000796529990034139,0.0118436796971319,0.024933883115016
NMR metabolomics,X23428.Concentration of VLDL Particles,NRTN,Neurturin,39587,0.0102932157341865,0.00462552786394888,0.0012271811208467,0.0193592503475263,0.0260748165855194
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37021,-0.00639306855069565,0.00287664438736573,-0.0120312915499325,-0.00075484555145881,0.0262728854731434
NMR metabolomics,X23428.Concentration of VLDL Particles,OSM,Oncostatin-M,39785,0.0147957361672514,0.00665911111675996,0.00174387837840191,0.0278475939561009,0.0263055133256318
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB39B,Ras-related protein Rab-39B,37021,0.0184251707974202,0.0082991349536678,0.00215886628823131,0.0346914753066091,0.0264268132378668
NMR metabolomics,X23428.Concentration of VLDL Particles,RBM19,Probable RNA-binding protein 19,37021,-0.00986782826036636,0.00444708488423691,-0.0185841146334707,-0.001151541887262,0.0265075869215873
NMR metabolomics,X23428.Concentration of VLDL Particles,SEMA7A,Semaphorin-7A,40002,0.00555897630560841,0.00251096369336206,0.000637487466618767,0.0104804651445981,0.0268508488779078
NMR metabolomics,X23428.Concentration of VLDL Particles,TMEM132A,Transmembrane protein 132A,37043,0.0129503704102063,0.00585035861971621,0.00148366751556257,0.0244170733048501,0.0268731663655073
NMR metabolomics,X23428.Concentration of VLDL Particles,MAPK13,Mitogen-activated protein kinase 13,36962,0.00881621605972501,0.00399399023933419,0.000987995190630007,0.01664443692882,0.0273054560876292
NMR metabolomics,X23428.Concentration of VLDL Particles,PRR4,Proline-rich protein 4,37031,-0.0143745930323641,0.00652636933112762,-0.0271662769213742,-0.00158290914335393,0.0276444088324072
NMR metabolomics,X23428.Concentration of VLDL Particles,CLIC5,Chloride intracellular channel protein 5,37039,-0.00659447320723121,0.0029966772707061,-0.0124679606578152,-0.000720985756647253,0.0277819864182342
NMR metabolomics,X23428.Concentration of VLDL Particles,LY96,Lymphocyte antigen 96,39749,-0.00723481609576098,0.00329385059742771,-0.0136907632667193,-0.000778868924802669,0.0280733201728048
NMR metabolomics,X23428.Concentration of VLDL Particles,DEFA1_DEFA1B,Neutrophil defensin 1,39537,0.0102199123342632,0.00467302052426529,0.00106079210670322,0.0193790325618231,0.0287569913619639
NMR metabolomics,X23428.Concentration of VLDL Particles,ICAM3,Intercellular adhesion molecule 3,40052,-0.00515693762992822,0.00236038102138185,-0.00978328443183664,-0.000530590828019789,0.0289185100644841
NMR metabolomics,X23428.Concentration of VLDL Particles,DDA1,DET1- and DDB1-associated protein 1,37021,0.00809920544670966,0.00371646708190268,0.000814929966180399,0.0153834809272389,0.0293288833909146
NMR metabolomics,X23428.Concentration of VLDL Particles,PCDH17,Protocadherin-17,39868,-0.00707915945233303,0.00325775630572407,-0.0134643618115522,-0.00069395709311385,0.0297936620433336
NMR metabolomics,X23428.Concentration of VLDL Particles,DCUN1D1,DCN1-like protein 1,36991,-0.0152045542340851,0.00699896496735163,-0.0289225255700943,-0.00148658289807591,0.0298433038603871
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37039,-0.00644467588008947,0.00296802757989452,-0.0122620099366827,-0.000627341823496206,0.0299212543482121
NMR metabolomics,X23428.Concentration of VLDL Particles,MYOC,Myocilin,39858,0.00929174319749419,0.00428070686765162,0.000901557736897027,0.0176819286580914,0.0299753578247331
NMR metabolomics,X23428.Concentration of VLDL Particles,ELAVL4,ELAV-like protein 4,36991,0.0170924608900382,0.00788816745161518,0.00163165268487241,0.0325532690952039,0.030264358589393
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC1A,C-type lectin domain family 1 member A,39585,0.00645511175348234,0.00298755995212486,0.000599494247317618,0.0123107292596471,0.0307363950832542
NMR metabolomics,X23428.Concentration of VLDL Particles,TTN,Titin,37021,-0.0138000553528121,0.00639806903820061,-0.0263402706676853,-0.00125984003793887,0.0310307720131043
NMR metabolomics,X23428.Concentration of VLDL Particles,REG3A,Regenerating islet-derived protein 3-alpha,40052,-0.0117757953757909,0.00546972167200688,-0.0224964498529243,-0.00105514089865737,0.0313408091798021
NMR metabolomics,X23428.Concentration of VLDL Particles,GIMAP7,GTPase IMAP family member 7,37124,-0.00655420292952423,0.00304837438145919,-0.0125290167171842,-0.000579389141864226,0.0315680995806532
NMR metabolomics,X23428.Concentration of VLDL Particles,ATRAID,All-trans retinoic acid-induced differentiation factor,37382,0.00544030634698413,0.00253343215940064,0.000474779314558882,0.0104058333794094,0.0317787288474599
NMR metabolomics,X23428.Concentration of VLDL Particles,SCARF2,Scavenger receptor class F member 2,40009,-0.00562835094013519,0.00262202351096404,-0.0107675170216247,-0.000489184858645663,0.0318425649500546
NMR metabolomics,X23428.Concentration of VLDL Particles,LTO1,Protein LTO1 homolog,39587,0.00806384066163505,0.00375958830639791,0.000695047581095147,0.0154326337421749,0.0319782490138526
NMR metabolomics,X23428.Concentration of VLDL Particles,UBE2B,Ubiquitin-conjugating enzyme E2 B,37368,0.00568244076429686,0.0026554764861862,0.000477706851371919,0.0108871746772218,0.0323811179452923
NMR metabolomics,X23428.Concentration of VLDL Particles,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37388,-0.00506400923709243,0.00236835389699797,-0.00970598287520846,-0.000422035598976411,0.0325185507684641
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC39A14,Zinc transporter ZIP14,39489,0.0065035338470166,0.00304170801926141,0.000541786129264229,0.012465281564769,0.0325225450733662
NMR metabolomics,X23428.Concentration of VLDL Particles,COL3A1,Collagen alpha-1(III) chain,37437,-0.00462729202708063,0.00217067712359677,-0.0088818191893303,-0.000372764864830967,0.0330471602957188
NMR metabolomics,X23428.Concentration of VLDL Particles,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39858,0.00822972598631295,0.00387040220881927,0.000643737657027175,0.0158157143155987,0.0334916241387717
NMR metabolomics,X23428.Concentration of VLDL Particles,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37368,0.00967329793424985,0.00456226386394287,0.000731260760921823,0.0186153351075779,0.0340002260635411
NMR metabolomics,X23428.Concentration of VLDL Particles,ERBB4,Receptor tyrosine-protein kinase erbB-4,39913,-0.00470416714014277,0.00221953974948076,-0.00905446504912507,-0.000353869231160473,0.0340691453538371
NMR metabolomics,X23428.Concentration of VLDL Particles,CADPS,Calcium-dependent secretion activator 1,37039,-0.00857870696522539,0.00405037277599475,-0.0165174376061751,-0.000639976324275676,0.0341933710731857
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH15,Cadherin-15,39973,0.0105801157388979,0.0049954816775015,0.000788971650994966,0.0203712598268008,0.0341956683872495
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF31,E3 ubiquitin-protein ligase RNF31,37056,0.00740652696661087,0.0035039251851584,0.000538833603700398,0.0142742203295213,0.0345527745862532
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39931,-0.00847919721208766,0.0040129517722198,-0.0163445826856385,-0.000613811738536842,0.0346197670528774
NMR metabolomics,X23428.Concentration of VLDL Particles,OSBPL2,Oxysterol-binding protein-related protein 2,37388,0.0075710171295471,0.00359777208507399,0.000519383842802079,0.0146226504162921,0.0353652281839553
NMR metabolomics,X23428.Concentration of VLDL Particles,PCNA,Proliferating cell nuclear antigen,36962,0.0125889925908547,0.00598617837202624,0.00085608298168329,0.0243219022000262,0.0354839229097435
NMR metabolomics,X23428.Concentration of VLDL Particles,LPA,Apolipoprotein(a),37186,0.0345334635340696,0.0164366946108856,0.00231754209673381,0.0667493849714055,0.0356598704663502
NMR metabolomics,X23428.Concentration of VLDL Particles,SH3GL3,Endophilin-A3,37083,0.0161500990456705,0.00770577709547489,0.00104677593853972,0.0312534221528013,0.0361150822817988
NMR metabolomics,X23428.Concentration of VLDL Particles,HEBP1,Heme-binding protein 1,39585,-0.0104899684175111,0.00500995691030458,-0.0203094839617081,-0.000670452873314154,0.0362916265859931
NMR metabolomics,X23428.Concentration of VLDL Particles,CD200,OX-2 membrane glycoprotein,39866,0.00501535869793128,0.00239612416517706,0.000318955334184247,0.00971176206167831,0.0363547675664076
NMR metabolomics,X23428.Concentration of VLDL Particles,GHRHR,Growth hormone-releasing hormone receptor,39489,0.0104810994013259,0.00502779262081268,0.000626625864533036,0.0203355729381187,0.0371188747836374
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP290,Centrosomal protein of 290 kDa,37169,0.0100299584513127,0.00484487766891144,0.000533998220246258,0.0195259186823791,0.0384510694737261
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGA11,Integrin alpha-11,39866,-0.00650585258209102,0.0031675070302375,-0.0127141663613565,-0.000297538802825517,0.0399982194438174
NMR metabolomics,X23428.Concentration of VLDL Particles,ADRA2A,Alpha-2A adrenergic receptor,37021,-0.0137549257580972,0.00670250017976043,-0.0268918261104276,-0.000618025405766727,0.0401691705247474
NMR metabolomics,X23428.Concentration of VLDL Particles,MAPT,Microtubule-associated protein tau,39489,0.010044920417492,0.00490454291787909,0.000432016298448978,0.019657824536535,0.0405683516599535
NMR metabolomics,X23428.Concentration of VLDL Particles,WIF1,Wnt inhibitory factor 1,40030,0.00639698208794464,0.00312359529755918,0.00027473530472864,0.0125192288711606,0.0405805419478048
NMR metabolomics,X23428.Concentration of VLDL Particles,FDX2,"Ferredoxin-2, mitochondrial",37021,0.0107906348898495,0.00527162216846845,0.000458255439651325,0.0211230143400477,0.0406848996965426
NMR metabolomics,X23428.Concentration of VLDL Particles,AKAP12,A-kinase anchor protein 12,37124,0.00402654839941896,0.00197045158529443,0.000164463292241889,0.00788863350659604,0.0410261669573444
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC10A,C-type lectin domain family 10 member A,39749,-0.00685922791714767,0.00335906658659021,-0.0134429984268645,-0.000275457407430857,0.041167596217271
NMR metabolomics,X23428.Concentration of VLDL Particles,FMR1,Synaptic functional regulator FMR1,39477,0.00677502915424976,0.00331869629054354,0.000270384424784427,0.0132796738837151,0.0412205970212945
NMR metabolomics,X23428.Concentration of VLDL Particles,LYPD8,Ly6/PLAUR domain-containing protein 8,39477,0.0099780305162561,0.00489413667270419,0.000385522637755882,0.0195705383947563,0.0414895582359209
NMR metabolomics,X23428.Concentration of VLDL Particles,RALB,Ras-related protein Ral-B,37056,0.00557416866346351,0.00273453100939761,0.000214487885044193,0.0109338494418828,0.0415261615841759
NMR metabolomics,X23428.Concentration of VLDL Particles,ICAM2,Intercellular adhesion molecule 2,40052,-0.00594707904817159,0.00291877240084529,-0.0116678729538284,-0.000226285142514817,0.0416134319311976
NMR metabolomics,X23428.Concentration of VLDL Particles,NAMPT,Nicotinamide phosphoribosyltransferase,39477,0.00969807584755576,0.00475980447625179,0.000368859074102239,0.0190272926210093,0.0416173252063978
NMR metabolomics,X23428.Concentration of VLDL Particles,CCNE1,G1/S-specific cyclin-E1,37056,0.0182141445958055,0.008943222200143,0.000685429083525226,0.0357428601080858,0.0417058212335466
NMR metabolomics,X23428.Concentration of VLDL Particles,OPTC,Opticin,39788,0.00833825174040246,0.00411552573172185,0.000271821306227637,0.0164046821745773,0.0427765237694522
NMR metabolomics,X23428.Concentration of VLDL Particles,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37021,0.00491066750583686,0.00242451541797748,0.000158617286600991,0.00966271772507273,0.0428441643428062
NMR metabolomics,X23428.Concentration of VLDL Particles,TAP1,Antigen peptide transporter 1,37169,-0.0111012921355789,0.00549272263241533,-0.0218670284951129,-0.000335555776044822,0.0432903290684587
NMR metabolomics,X23428.Concentration of VLDL Particles,COPE,Coatomer subunit epsilon,39489,0.00889938756223406,0.00440713276378056,0.000261407345224176,0.017537367779244,0.0434715672627884
NMR metabolomics,X23428.Concentration of VLDL Particles,DEFB116,Beta-defensin 116,36991,-0.0145822696969059,0.00722487213092963,-0.0287430190735279,-0.000421520320283801,0.0435758490245434
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMC3,26S proteasome regulatory subunit 6A,36962,-0.00564001731757601,0.00280683406814623,-0.0111414120911426,-0.000138622544009399,0.0445165224071354
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37124,0.00701991471517192,0.00350686019177535,0.000146468739292233,0.0138933606910516,0.0453301949311354
NMR metabolomics,X23428.Concentration of VLDL Particles,CD109,CD109 antigen,39858,-0.00628666222359701,0.0031434440425316,-0.0124478125469589,-0.000125511900235077,0.0455248987636372
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFBR1,TGF-beta receptor type-1,37056,0.00407024169525714,0.00203575226901279,8.01672479920721e-05,0.00806031614252221,0.0455877570729359
NMR metabolomics,X23428.Concentration of VLDL Particles,UXS1,UDP-glucuronic acid decarboxylase 1,39477,0.00972248944694071,0.00487236062467489,0.000172662622577924,0.0192723162713035,0.0460125629588257
NMR metabolomics,X23428.Concentration of VLDL Particles,HDAC8,Histone deacetylase 8,37056,0.0117770582459059,0.00590740858650125,0.000198537416363468,0.0233555790754484,0.0462154368206013
NMR metabolomics,X23428.Concentration of VLDL Particles,IL31,Interleukin-31,37056,-0.0107054832136437,0.00537117337439662,-0.021232983027461,-0.0001779833998263,0.0462670271342502
NMR metabolomics,X23428.Concentration of VLDL Particles,GSTP1,Glutathione S-transferase P,39393,-0.0128672523182577,0.00646578781313371,-0.0255401964319998,-0.000194308204515648,0.0466027358192424
NMR metabolomics,X23428.Concentration of VLDL Particles,FZD8,Frizzled-8,36991,0.00790782091134218,0.00397381190853721,0.000119149570609252,0.0156964922520751,0.0466134338795677
NMR metabolomics,X23428.Concentration of VLDL Particles,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39477,0.0223190334219713,0.0112173287026256,0.000333069164825072,0.0443049976791175,0.0466422430881674
NMR metabolomics,X23428.Concentration of VLDL Particles,ACE,Angiotensin-converting enzyme,37445,-0.00476083999533328,0.00239522237251081,-0.00945547584545446,-6.62041452120926e-05,0.04687155249884
NMR metabolomics,X23428.Concentration of VLDL Particles,HSP90B1,Endoplasmin,39405,0.0124256850993093,0.00627978480950373,0.000117306872682004,0.0247340633259366,0.0478696589395054
NMR metabolomics,X23428.Concentration of VLDL Particles,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36962,0.00937068480375819,0.00475273076048333,5.53325132108592e-05,0.0186860370943055,0.0486714648980167
NMR metabolomics,X23428.Concentration of VLDL Particles,TIE1,Tyrosine-protein kinase receptor Tie-1,40052,0.00751582280922147,0.00382837611072083,1.22056322086348e-05,0.0150194399862343,0.0496414002697999
NMR metabolomics,X23428.Concentration of VLDL Particles,SCARB1,Scavenger receptor class B member 1,39489,0.0103929139703569,0.00530816817513262,-1.10956529029965e-05,0.0207969235936169,0.050258375319475
NMR metabolomics,X23428.Concentration of VLDL Particles,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40052,0.00491708235267747,0.0025122564500401,-6.94028940113542e-06,0.00984110499475607,0.0503367159374341
NMR metabolomics,X23428.Concentration of VLDL Particles,OMD,Osteomodulin,39931,-0.00792099771744472,0.00405262359954304,-0.0158641399725491,2.21445376596408e-05,0.0506552053953998
NMR metabolomics,X23428.Concentration of VLDL Particles,KIF20B,Kinesin-like protein KIF20B,36991,0.0136917599710659,0.00701190956057468,-5.15827676604817e-05,0.0274351027097922,0.0508830635697861
NMR metabolomics,X23428.Concentration of VLDL Particles,SAT1,Diamine acetyltransferase 1,37021,-0.00906011316759782,0.00464658940683637,-0.0181674284049971,4.72020698014681e-05,0.0512162109272908
NMR metabolomics,X23428.Concentration of VLDL Particles,IL2RG,Cytokine receptor common subunit gamma,37368,0.006849608694637,0.00351973921934031,-4.9080175270012e-05,0.013748297564544,0.0516687542616661
NMR metabolomics,X23428.Concentration of VLDL Particles,LPO,Lactoperoxidase,39344,-0.010846297041319,0.00557846732796265,-0.0217800930041257,8.74989214878306e-05,0.0518755770432833
NMR metabolomics,X23428.Concentration of VLDL Particles,MATN3,Matrilin-3,39720,-0.00567767006348364,0.0029214341115826,-0.0114036809221855,4.83407952182593e-05,0.0519791081012055
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJA4,DnaJ homolog subfamily A member 4,37388,-0.0126517653826444,0.00651077220413782,-0.0254128789027546,0.000109348137465701,0.0520121040811643
NMR metabolomics,X23428.Concentration of VLDL Particles,CCDC28A,Coiled-coil domain-containing protein 28A,37039,0.00534231135526485,0.00275285065214704,-5.32759229433452e-05,0.010737898633473,0.0523224063007016
NMR metabolomics,X23428.Concentration of VLDL Particles,VEGFD,Vascular endothelial growth factor D,40024,-0.00637406637497474,0.00330827926134114,-0.0128582937272034,0.000110160977253897,0.0540343599039665
NMR metabolomics,X23428.Concentration of VLDL Particles,RAD51,DNA repair protein RAD51 homolog 1,37169,0.0094793262947712,0.00492243080015967,-0.000168638073541756,0.0191272906630841,0.0541580131534035
NMR metabolomics,X23428.Concentration of VLDL Particles,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39489,0.00886668988643217,0.00460962452198884,-0.000168174176665949,0.0179015539495303,0.0544333308181507
NMR metabolomics,X23428.Concentration of VLDL Particles,CDSN,Corneodesmosin,39992,0.00756739834553812,0.0039411722129809,-0.000157299191904445,0.0152920958829807,0.0548643695338775
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37411,0.0115138619023998,0.00605586626654028,-0.000355635980019104,0.0233833597848188,0.0572873066801935
NMR metabolomics,X23428.Concentration of VLDL Particles,GSAP,Gamma-secretase-activating protein,39477,0.0155775097822459,0.00820144173565884,-0.000497316019645437,0.0316523355841372,0.0575352555361262
NMR metabolomics,X23428.Concentration of VLDL Particles,SUSD2,Sushi domain-containing protein 2,39858,-0.00497576539452018,0.00262563821713625,-0.0101220163001072,0.000170485511066869,0.0581012820571993
NMR metabolomics,X23428.Concentration of VLDL Particles,LIFR,Leukemia inhibitory factor receptor,39866,-0.00428363233119611,0.00227223491491433,-0.00873721276442818,0.000169948102035973,0.059420043082564
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37382,0.00886696127342185,0.00470350140306768,-0.000351901476590796,0.0180858240234345,0.0594265461622072
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASE10,Inactive ribonuclease-like protein 10,37043,-0.00821962618910844,0.00437378102555924,-0.0167922369992046,0.000352984620987661,0.0602262217323362
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37021,0.00858863116443144,0.00458110477615095,-0.000390334196824426,0.0175675965256873,0.0608430949419103
NMR metabolomics,X23428.Concentration of VLDL Particles,CTRL,Chymotrypsin-like protease CTRL-1,37388,-0.0115270099363234,0.00615178474630089,-0.0235845080390731,0.000530488166426341,0.0609841156812324
NMR metabolomics,X23428.Concentration of VLDL Particles,GIPC2,PDZ domain-containing protein GIPC2,37388,0.0050085667627931,0.00268206500109902,-0.000248280639360975,0.0102654141649472,0.0618632701134428
NMR metabolomics,X23428.Concentration of VLDL Particles,H2AP,Huntingtin-interacting protein M,36962,-0.00875816377526474,0.0046911007016263,-0.0179527211504523,0.000436393599922797,0.0619275131281287
NMR metabolomics,X23428.Concentration of VLDL Particles,EDA2R,Tumor necrosis factor receptor superfamily member 27,40030,-0.00618064842243118,0.00331090238426027,-0.0126700170955813,0.000308720250718949,0.0619536888994912
NMR metabolomics,X23428.Concentration of VLDL Particles,SPP1,Osteopontin,40012,-0.00781925016226772,0.00419630639653916,-0.0160440106994845,0.000405510374949031,0.0624290756460062
NMR metabolomics,X23428.Concentration of VLDL Particles,OLR1,Oxidized low-density lipoprotein receptor 1,39721,0.0101512911315442,0.00546887729042523,-0.00056770835768926,0.0208702906207776,0.063444601499143
NMR metabolomics,X23428.Concentration of VLDL Particles,MN1,Transcriptional activator MN1,37039,-0.0102636791067746,0.00553138616920843,-0.0211051959984232,0.000577837784873898,0.0635422159493687
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF12,Fibroblast growth factor 12,37056,0.00811682534746044,0.00438090680745917,-0.000469751995159542,0.0167034026900804,0.0639372294127601
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A3,Protein S100-A3,37368,0.00779137782491997,0.00421537732645327,-0.000470761734928437,0.0160535173847684,0.0645775080376166
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC4C,C-type lectin domain family 4 member C,39866,0.00790032137005218,0.00428464195316986,-0.000497576858160757,0.0162982195982651,0.0652206067930849
NMR metabolomics,X23428.Concentration of VLDL Particles,CDAN1,Codanin-1,37388,0.00388163545619795,0.00210583302303489,-0.000245797268950433,0.00800906818134633,0.0653103082667374
NMR metabolomics,X23428.Concentration of VLDL Particles,MFAP3L,Microfibrillar-associated protein 3-like,37039,-0.0110569254923536,0.00602415355862827,-0.022864266467265,0.000750415482557828,0.0664641949361958
NMR metabolomics,X23428.Concentration of VLDL Particles,TPSG1,Tryptase gamma,37056,0.00461582367092749,0.00251493548853738,-0.000313449886605773,0.00954509722846076,0.0664741711651314
NMR metabolomics,X23428.Concentration of VLDL Particles,IL36G,Interleukin-36 gamma,37021,0.0115590283839457,0.00630594071939993,-0.000800615426078146,0.0239186721939696,0.0668195092883129
NMR metabolomics,X23428.Concentration of VLDL Particles,ADA2,Adenosine deaminase 2,39782,-0.00704717158964491,0.00384604427264057,-0.0145854183640204,0.000491075184730598,0.0669229000483896
NMR metabolomics,X23428.Concentration of VLDL Particles,PTTG1,Securin,37169,0.00713843761244313,0.00389678324045626,-0.000499257538851147,0.0147761327637374,0.0669917006526099
NMR metabolomics,X23428.Concentration of VLDL Particles,CYB5A,Cytochrome b5,36962,0.0122847379472083,0.00671085764540708,-0.000868543037789589,0.0254380189322062,0.0671864885775771
NMR metabolomics,X23428.Concentration of VLDL Particles,MORF4L1,Mortality factor 4-like protein 1,37169,-0.00689181981509588,0.00376611828320112,-0.0142734116501701,0.000489772019978303,0.0672793076797408
NMR metabolomics,X23428.Concentration of VLDL Particles,CD33,Myeloid cell surface antigen CD33,39913,0.013357347954449,0.0073179155766584,-0.000985766575801451,0.0277004624846995,0.0679752351907615
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37056,0.00617569424533875,0.00338893357642438,-0.000466615564453031,0.0128180040551305,0.0684302835543986
NMR metabolomics,X23428.Concentration of VLDL Particles,ESR1,Estrogen receptor,37056,0.0101239316901753,0.00555750973814077,-0.000768787396580617,0.0210166507769312,0.0685281669198245
NMR metabolomics,X23428.Concentration of VLDL Particles,CD248,Endosialin,37437,-0.00673443824684693,0.00370301850776882,-0.0139923545220738,0.000523478028379949,0.0689891894340503
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINK8,Serine protease inhibitor Kazal-type 8,37021,0.0063284432491999,0.00349066331257005,-0.000513256843437392,0.0131701433418372,0.0698603078526215
NMR metabolomics,X23428.Concentration of VLDL Particles,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37169,0.00881469129657758,0.00486236902666491,-0.000715551995685654,0.0183449345888408,0.0698792051460833
NMR metabolomics,X23428.Concentration of VLDL Particles,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36991,-0.00993588573914502,0.0054883079672899,-0.0206929693550332,0.000821197876743186,0.070260778188909
NMR metabolomics,X23428.Concentration of VLDL Particles,VNN2,Vascular non-inflammatory molecule 2,39788,-0.00780839688450644,0.00431382388153332,-0.0162634916923118,0.000646697923298863,0.0703011219084775
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB7,Integrin beta-7,40030,0.00767357212485843,0.00424016470898604,-0.000637150704754212,0.0159842949544711,0.0703555371012879
NMR metabolomics,X23428.Concentration of VLDL Particles,PGM2,Phosphoglucomutase-2,37039,0.0102225035550169,0.00565921398403883,-0.000869555853699177,0.021314562963733,0.0708869748420161
NMR metabolomics,X23428.Concentration of VLDL Particles,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39587,0.00920199022133193,0.00509648973292593,-0.0007871296552029,0.0191911100978668,0.0710070617149303
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37169,0.00728695839660485,0.00403770174822174,-0.000626937029909754,0.0152008538231195,0.07113965664876
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC12A,C-type lectin domain family 12 member A,37056,0.00339046492998899,0.00188337055775719,-0.000300941363215107,0.00708187122319309,0.0718501117049005
NMR metabolomics,X23428.Concentration of VLDL Particles,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39489,0.00916887806194966,0.00509598526290356,-0.000819253053341313,0.0191570091772406,0.0720007040546007
NMR metabolomics,X23428.Concentration of VLDL Particles,HAVCR2,Hepatitis A virus cellular receptor 2,39858,-0.00562794115832661,0.00313406695407998,-0.0117707123883234,0.000514830071670148,0.0725561741275736
NMR metabolomics,X23428.Concentration of VLDL Particles,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37021,-0.00613853046385388,0.00341872903760875,-0.012839239377567,0.000562178449859277,0.0725875769618962
NMR metabolomics,X23428.Concentration of VLDL Particles,NME1,Nucleoside diphosphate kinase A,37056,-0.00366395213112221,0.00204112757798918,-0.00766456218398101,0.000336657921736595,0.0726665740814972
NMR metabolomics,X23428.Concentration of VLDL Particles,NPTX2,Neuronal pentraxin-2,37437,-0.00564438919246168,0.00314661113942588,-0.0118117470257364,0.000522968640813057,0.0728674357736609
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMG4,Proteasome assembly chaperone 4,37056,-0.00924079480428792,0.00518312347340795,-0.0193997168121675,0.000918127203591667,0.0746317219744169
NMR metabolomics,X23428.Concentration of VLDL Particles,TEX33,Testis-expressed protein 33,37169,-0.00659689255968696,0.00370780481664447,-0.0138641900003101,0.000670404880936192,0.0752312873319669
NMR metabolomics,X23428.Concentration of VLDL Particles,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37021,-0.00785753038217085,0.00442556113534968,-0.0165316302074562,0.000816569443114517,0.0758404602629399
NMR metabolomics,X23428.Concentration of VLDL Particles,IL2RA,Interleukin-2 receptor subunit alpha,39732,-0.00647897748536683,0.00366141517137682,-0.0136553512212654,0.000697396250531735,0.0768249626806859
NMR metabolomics,X23428.Concentration of VLDL Particles,IL11,Interleukin-11,39587,0.0102402398503891,0.00579816932987003,-0.00112417203615611,0.0216046517369344,0.0773957806492598
NMR metabolomics,X23428.Concentration of VLDL Particles,CHI3L1,Chitinase-3-like protein 1,39545,0.0123270812633188,0.00701158053501229,-0.0014156165853053,0.0260697791119429,0.0787494754148643
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP164,Centrosomal protein of 164 kDa,39587,0.00988143096773514,0.00564244867175525,-0.00117776842890516,0.0209406303643754,0.0799195195705636
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF5,Fibroblast growth factor 5,39587,0.00540204446611701,0.00308568009420712,-0.000645888518528947,0.011449977450763,0.0800202056725566
NMR metabolomics,X23428.Concentration of VLDL Particles,CRHR1,Corticotropin-releasing factor receptor 1,39585,0.0101076344783056,0.00578595686678302,-0.00123284098058915,0.0214481099372003,0.0806698174557857
NMR metabolomics,X23428.Concentration of VLDL Particles,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36962,0.00429241033898784,0.00245745989986982,-0.000524211064757003,0.00910903174273268,0.0807152851440697
NMR metabolomics,X23428.Concentration of VLDL Particles,DCLRE1C,Protein artemis,36962,-0.00504651201289606,0.00290613075535211,-0.0107425282933862,0.000649504267594081,0.0824979991780401
NMR metabolomics,X23428.Concentration of VLDL Particles,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36962,0.00922819232512847,0.00531613726556729,-0.00119143671538342,0.0196478213656404,0.0826080326968338
NMR metabolomics,X23428.Concentration of VLDL Particles,APOF,Apolipoprotein F,37445,0.00419577697435598,0.00241839838770818,-0.000544283865552046,0.008935837814264,0.0827740486264061
NMR metabolomics,X23428.Concentration of VLDL Particles,RYR1,Ryanodine receptor 1,37021,-0.00549083480257138,0.00316640210221254,-0.0116969829229079,0.000715313317765187,0.0829250507848155
NMR metabolomics,X23428.Concentration of VLDL Particles,SEZ6L2,Seizure 6-like protein 2,39788,0.00386200706774959,0.00224058130121052,-0.000529532282623039,0.00825354641812221,0.0847881052501158
NMR metabolomics,X23428.Concentration of VLDL Particles,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39585,-0.00343743257950626,0.00200246215101057,-0.00736225839548697,0.000487393236474446,0.0860714234647185
NMR metabolomics,X23428.Concentration of VLDL Particles,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37382,-0.0112722057653625,0.00657968427056142,-0.0241683869356628,0.00162397540493792,0.0867017298827611
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH3,Cadherin-3,40009,0.00551613567359167,0.00322809092404903,-0.000810922537544442,0.0118431938847278,0.0875087158699097
NMR metabolomics,X23428.Concentration of VLDL Particles,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37039,-0.00997541213149932,0.00586454162044282,-0.0214699137075672,0.00151908944456859,0.088972122539677
NMR metabolomics,X23428.Concentration of VLDL Particles,DPEP2,Dipeptidase 2,39788,0.00458525181340726,0.00271321626838392,-0.000732652072625213,0.00990315569943974,0.0910534238967028
NMR metabolomics,X23428.Concentration of VLDL Particles,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37021,-0.010662790620931,0.00631873087927962,-0.023047503144319,0.00172192190245705,0.0915330052497983
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH23,Cadherin-23,37388,-0.00423358283224545,0.00250923401021012,-0.00915168149225729,0.000684515827766395,0.0915877098196624
NMR metabolomics,X23428.Concentration of VLDL Particles,BEX3,Protein BEX3,36962,-0.00736621293621587,0.00438283536870303,-0.0159565702588738,0.00122414438644208,0.092845856250103
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBP7,Insulin-like growth factor-binding protein 7,40052,0.00458824835011292,0.00273307035909612,-0.000768569553715476,0.00994506625394131,0.0932124760960228
NMR metabolomics,X23428.Concentration of VLDL Particles,SPESP1,Sperm equatorial segment protein 1,37437,0.00457099507765191,0.00272327423360555,-0.000766622420214969,0.0099086125755188,0.0932740280075463
NMR metabolomics,X23428.Concentration of VLDL Particles,PRTN3,Myeloblastin,39421,-0.00720014342600456,0.00430892172348251,-0.0156456300040303,0.00124534315202116,0.0947447559138887
NMR metabolomics,X23428.Concentration of VLDL Particles,HLA_A,,37411,0.00503172827125332,0.0030159796206659,-0.00087959178525185,0.0109430483277585,0.0952681424938838
NMR metabolomics,X23428.Concentration of VLDL Particles,TFF2,Trefoil factor 2,39908,0.00881414919031441,0.00531621787243825,-0.00160563783966456,0.0192339362202934,0.0973423279905797
NMR metabolomics,X23428.Concentration of VLDL Particles,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37021,0.00718273367976531,0.00433253614704187,-0.00130903716843676,0.0156745045279674,0.097369778543488
NMR metabolomics,X23428.Concentration of VLDL Particles,EDNRB,Endothelin receptor type B,37056,0.00722455849028421,0.00436054738787018,-0.00132211438994134,0.0157712313705098,0.0975835243562145
NMR metabolomics,X23428.Concentration of VLDL Particles,FDX1,"Adrenodoxin, mitochondrial",37021,0.00980563176381223,0.00593983452142225,-0.00183644389817537,0.0214477074257998,0.0987980208819841
NMR metabolomics,X23428.Concentration of VLDL Particles,APOA1,Apolipoprotein A-I,37453,-0.00419755692321067,0.00255255418144195,-0.00920056311883689,0.000805449272415556,0.100105664518567
NMR metabolomics,X23428.Concentration of VLDL Particles,UNG,Uracil-DNA glycosylase,37368,0.00532279458415387,0.00323954250286361,-0.00102670872145881,0.0116722978897665,0.100391758376457
NMR metabolomics,X23428.Concentration of VLDL Particles,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37039,-0.0074032728897817,0.00451305840642761,-0.0162488673663798,0.00144232158681641,0.100943501303265
NMR metabolomics,X23428.Concentration of VLDL Particles,SMPD3,Sphingomyelin phosphodiesterase 3,37056,0.00917735312738609,0.00562030523923275,-0.00183844514151009,0.0201931513962823,0.102515508816781
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC1,Sialoadhesin,39931,0.00628799565619278,0.00389329691839717,-0.00134286630386567,0.0139188576162512,0.106312464041214
NMR metabolomics,X23428.Concentration of VLDL Particles,FCRL6,Fc receptor-like protein 6,39866,-0.00991667282879107,0.00614363382462676,-0.0219581951250595,0.00212484946747739,0.10651720793707
NMR metabolomics,X23428.Concentration of VLDL Particles,MEGF11,Multiple epidermal growth factor-like domains protein 11,37021,0.00477786677412076,0.00296264310010917,-0.00102891370209321,0.0105846472503347,0.106832778400299
NMR metabolomics,X23428.Concentration of VLDL Particles,IL18RAP,Interleukin-18 receptor accessory protein,39639,0.0257172767800798,0.0160021496014735,-0.00564693643880819,0.0570814899989679,0.108049397033166
NMR metabolomics,X23428.Concentration of VLDL Particles,C9orf40,Uncharacterized protein C9orf40,37382,-0.0118653118862303,0.00741224829025222,-0.0263933185351246,0.00266269476266407,0.109451016072858
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36991,0.00855851860938894,0.0053862896403641,-0.0019986090857247,0.0191156463045026,0.112096859932443
NMR metabolomics,X23428.Concentration of VLDL Particles,IGLON5,IgLON family member 5,36962,0.0137136873120497,0.00863601168285836,-0.00321289558635267,0.0306402702104521,0.11231830465718
NMR metabolomics,X23428.Concentration of VLDL Particles,ZNF75D,Zinc finger protein 75D,37169,0.00877602115759851,0.00552760429817879,-0.00205808326683191,0.0196101255820289,0.112384340681198
NMR metabolomics,X23428.Concentration of VLDL Particles,CD5L,CD5 antigen-like,37380,0.00692653017448244,0.0043679577525909,-0.00163466702059573,0.0154877273695606,0.112817279913837
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRE2,Adhesion G protein-coupled receptor E2,39931,-0.00414205995325291,0.00261443544928011,-0.00926635343384192,0.000982233527336104,0.113144283073504
NMR metabolomics,X23428.Concentration of VLDL Particles,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37039,-0.00763187083931288,0.00482533770401792,-0.017089532739188,0.00182579106056224,0.113759385093287
NMR metabolomics,X23428.Concentration of VLDL Particles,ENDOU,Poly(U)-specific endoribonuclease,36430,0.00763206640300144,0.00483794321093202,-0.00185030229042532,0.0171144350964282,0.114695659360664
NMR metabolomics,X23428.Concentration of VLDL Particles,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36931,-0.00773527333734938,0.00493358094315719,-0.0174050919859375,0.00193454531123872,0.116932852371462
NMR metabolomics,X23428.Concentration of VLDL Particles,LEG1,Protein LEG1 homolog,36703,-0.0101991506570752,0.00654244032470816,-0.0230223336935032,0.0026240323793528,0.119039608984398
NMR metabolomics,X23428.Concentration of VLDL Particles,TRPV3,Transient receptor potential cation channel subfamily V member 3,37021,-0.00754538721183925,0.00484099067259159,-0.0170337289301188,0.00194295450644027,0.119104406700973
NMR metabolomics,X23428.Concentration of VLDL Particles,WASL,Neural Wiskott-Aldrich syndrome protein,37056,-0.00876299988729609,0.00562403268985254,-0.0197861039594071,0.00226010418481488,0.119225326638394
NMR metabolomics,X23428.Concentration of VLDL Particles,SHD,SH2 domain-containing adapter protein D,37002,0.0120692300667239,0.00778072063821764,-0.00318098238418263,0.0273194425176305,0.120884732430645
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A16,Protein S100-A16,39456,-0.00895395683501541,0.00578697558728201,-0.0202964289860881,0.00238851531605733,0.121820812016787
NMR metabolomics,X23428.Concentration of VLDL Particles,TCP11,T-complex protein 11 homolog,37169,-0.00853416678712408,0.00556057953583179,-0.0194329026773544,0.00236456910310622,0.124866043276264
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRE5,Adhesion G protein-coupled receptor E5,39962,-0.00425196586139214,0.0027756812114311,-0.0096923010357971,0.00118836931301282,0.12557566750437
NMR metabolomics,X23428.Concentration of VLDL Particles,ESPL1,Separin,36962,-0.00769750308861814,0.00503845547007788,-0.0175728758099708,0.0021778696327345,0.12659862509688
NMR metabolomics,X23428.Concentration of VLDL Particles,AZU1,Azurocidin,39344,0.010865697519198,0.0071449753414247,-0.0031384541499944,0.0248698491883904,0.128343839024397
NMR metabolomics,X23428.Concentration of VLDL Particles,SLAMF8,SLAM family member 8,39477,0.00737205101865426,0.00485000587902425,-0.00213396050423327,0.0168780625415418,0.12852903930015
NMR metabolomics,X23428.Concentration of VLDL Particles,PCARE,Photoreceptor cilium actin regulator,36991,-0.0120942630878227,0.00796156723895633,-0.0276989348761771,0.00351040870053169,0.128766261360846
NMR metabolomics,X23428.Concentration of VLDL Particles,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37039,-0.00668902627599351,0.00441219981263729,-0.0153369379087626,0.00195888535677558,0.129535808104769
NMR metabolomics,X23428.Concentration of VLDL Particles,TAGLN3,Transgelin-3,36962,-0.00848314262269157,0.005600199762704,-0.0194595341575914,0.00249324891220827,0.129848991580043
NMR metabolomics,X23428.Concentration of VLDL Particles,MYH4,Myosin-4,37021,-0.00676829339944713,0.00447006543862563,-0.0155296216591534,0.0019930348602591,0.130015000420454
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRF,Receptor-type tyrosine-protein phosphatase F,40052,0.00403416281407901,0.00266667023495263,-0.00119251084642814,0.00926083647458616,0.130347690921057
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB44,Ras-related protein Rab-44,37368,0.00593924442881526,0.00394526133442176,-0.00179346778665139,0.0136719566442819,0.132241523715627
NMR metabolomics,X23428.Concentration of VLDL Particles,CINP,Cyclin-dependent kinase 2-interacting protein,37169,0.00610672214828298,0.00406085858365942,-0.00185256067568948,0.0140660049722554,0.132656408456004
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRS,Receptor-type tyrosine-protein phosphatase S,40052,-0.0034188219309066,0.00227681719057445,-0.00788138362443252,0.00104373976261932,0.133225250593772
NMR metabolomics,X23428.Concentration of VLDL Particles,AMPD3,AMP deaminase 3,37388,0.00982672453110381,0.00661749666291901,-0.00314356892821746,0.0227970179904251,0.13757745318394
NMR metabolomics,X23428.Concentration of VLDL Particles,AMIGO1,Amphoterin-induced protein 1,37039,0.00688385545969295,0.00466845930481101,-0.00226632477773663,0.0160340356971225,0.14035867460307
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP15,Matrix metalloproteinase-15,37437,0.00681332370260501,0.00462363151649073,-0.00224899406971682,0.0158756414749268,0.140615983394156
NMR metabolomics,X23428.Concentration of VLDL Particles,TBR1,T-box brain protein 1,37039,-0.006633256050238,0.00450572814134651,-0.0154644832072772,0.00219797110680117,0.140995365141656
NMR metabolomics,X23428.Concentration of VLDL Particles,C1GALT1C1,C1GALT1-specific chaperone 1,37021,0.00450424291697168,0.00306255811029179,-0.00149837097920024,0.0105068568131436,0.141383919938932
NMR metabolomics,X23428.Concentration of VLDL Particles,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39866,0.0202800870211747,0.0139053046460728,-0.00697431008512804,0.0475344841274775,0.144738239780273
NMR metabolomics,X23428.Concentration of VLDL Particles,MKI67,Proliferation marker protein Ki-67,37056,0.00534431778007553,0.00367380533331698,-0.00185634067322574,0.0125449762333768,0.145773617782436
NMR metabolomics,X23428.Concentration of VLDL Particles,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37039,0.0104321038803702,0.0071870225881515,-0.00365446039240673,0.0245186681531472,0.146659042079199
NMR metabolomics,X23428.Concentration of VLDL Particles,ENOPH1,Enolase-phosphatase E1,37368,0.00755661470602691,0.00521198481877384,-0.00265887553876981,0.0177721049508236,0.147122578612805
NMR metabolomics,X23428.Concentration of VLDL Particles,CDK1,Cyclin-dependent kinase 1,36962,0.00491053346493333,0.00339002472491849,-0.00173391499590691,0.0115549819257736,0.147494382917337
NMR metabolomics,X23428.Concentration of VLDL Particles,RSPO1,R-spondin-1,39749,0.00475547977389091,0.00329018531907834,-0.00169328345150263,0.0112042429992845,0.148378432515907
NMR metabolomics,X23428.Concentration of VLDL Particles,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37382,-0.0225565740447582,0.0159130893626873,-0.0537462291956252,0.00863308110610886,0.156364060661036
NMR metabolomics,X23428.Concentration of VLDL Particles,ID4,DNA-binding protein inhibitor ID-4,37169,-0.00585492883801316,0.00413352431580284,-0.0139566364969867,0.00224677882096041,0.156667316693632
NMR metabolomics,X23428.Concentration of VLDL Particles,GFRAL,GDNF family receptor alpha-like,36942,-0.008236473215092,0.0058153726129036,-0.0196346035363831,0.00316165710619905,0.156703396218985
NMR metabolomics,X23428.Concentration of VLDL Particles,OSMR,Oncostatin-M-specific receptor subunit beta,39949,0.00265809542897116,0.00188361239283811,-0.00103378486099154,0.00634997571893385,0.158214122783539
NMR metabolomics,X23428.Concentration of VLDL Particles,LCN15,Lipocalin-15,37411,-0.0081609811653045,0.00579116046356514,-0.0195116556738922,0.00318969334328318,0.158795011230852
NMR metabolomics,X23428.Concentration of VLDL Particles,MYL6B,Myosin light chain 6B,37039,-0.012174109539076,0.00864235996922985,-0.0291131350787665,0.00476491600061451,0.158960594540369
NMR metabolomics,X23428.Concentration of VLDL Particles,IL17A,Interleukin-17A,39558,-0.00555461754111281,0.00394616967478143,-0.0132891101036844,0.00217987502145878,0.159270165861891
NMR metabolomics,X23428.Concentration of VLDL Particles,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37169,0.00448949237230917,0.00319988467899706,-0.00178228159852506,0.0107612663431434,0.160635118990891
NMR metabolomics,X23428.Concentration of VLDL Particles,LMOD2,Leiomodin-2,36991,-0.00837313937909277,0.00598792191132882,-0.0201094663252973,0.00336318756711173,0.16203517571799
NMR metabolomics,X23428.Concentration of VLDL Particles,CD177,CD177 antigen,39844,-0.0161948631681784,0.0116289143802046,-0.0389875353533794,0.0065978090170225,0.163748784007901
NMR metabolomics,X23428.Concentration of VLDL Particles,NMI,N-myc-interactor,37311,0.00934885200983676,0.00673651332050095,-0.0038547140983451,0.0225524181180186,0.165224612789842
NMR metabolomics,X23428.Concentration of VLDL Particles,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39885,0.00426612183119827,0.00308484294401787,-0.00178017033907675,0.0103124140014733,0.166705601167198
NMR metabolomics,X23428.Concentration of VLDL Particles,AGBL2,Cytosolic carboxypeptidase 2,36991,0.0117362683743829,0.00855869148159525,-0.0050387669295438,0.0285113036783096,0.170314546219849
NMR metabolomics,X23428.Concentration of VLDL Particles,ART5,Ecto-ADP-ribosyltransferase 5,36991,-0.00785968993424739,0.00575083323432347,-0.0191313230735214,0.0034119432050266,0.171741331243132
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA1,Alpha-1-antitrypsin,37247,-0.00103003759333453,0.000755960689612801,-0.00251172054497562,0.000451645358306562,0.173045897424875
NMR metabolomics,X23428.Concentration of VLDL Particles,SKIV2L,Helicase SKI2W,37021,0.00511475406599396,0.00376630361913794,-0.00226720102751641,0.0124967091595043,0.174477381010397
NMR metabolomics,X23428.Concentration of VLDL Particles,BOC,Brother of CDO,39585,0.00296531800385475,0.00218484963541081,-0.00131698728155043,0.00724762328925993,0.174731322861218
NMR metabolomics,X23428.Concentration of VLDL Particles,NOP56,Nucleolar protein 56,37021,0.0139925778135659,0.0103236019609601,-0.00624168202991584,0.0342268376570476,0.175314405087279
NMR metabolomics,X23428.Concentration of VLDL Particles,PSCA,Prostate stem cell antigen,37382,0.0321420210946545,0.0237152550079382,-0.0143398787209043,0.0786239209102134,0.175334749787435
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINK4,Serine protease inhibitor Kazal-type 4,39866,-0.00779515359949476,0.00578272234900422,-0.019129289403543,0.0035389822045535,0.177675019197177
NMR metabolomics,X23428.Concentration of VLDL Particles,BCAM,Basal cell adhesion molecule,39858,-0.002953150556512,0.00219388475910165,-0.00725316468435124,0.00134686357132723,0.178294885858337
NMR metabolomics,X23428.Concentration of VLDL Particles,SMC3,Structural maintenance of chromosomes protein 3,36962,0.00666140585744521,0.00495390751751684,-0.0030482528768878,0.0163710645917782,0.178752819432433
NMR metabolomics,X23428.Concentration of VLDL Particles,PROK1,Prokineticin-1,39866,0.00808452629813618,0.00603213686072961,-0.00373846194889386,0.0199075145451662,0.180185536398971
NMR metabolomics,X23428.Concentration of VLDL Particles,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39585,0.00397348259446768,0.00296776512526523,-0.00184333705105217,0.00979030223998753,0.180628961488673
NMR metabolomics,X23428.Concentration of VLDL Particles,EPN1,Epsin-1,37169,0.00535622623351638,0.00402176766073102,-0.00252643838151642,0.0132388908485492,0.182945777876509
NMR metabolomics,X23428.Concentration of VLDL Particles,PADI2,Protein-arginine deiminase type-2,39587,0.00706810550251654,0.00531085758551208,-0.00334117536508714,0.0174773863701202,0.183248328383467
NMR metabolomics,X23428.Concentration of VLDL Particles,AXL,Tyrosine-protein kinase receptor UFO,39931,0.00337582965205439,0.00254064858776984,-0.00160384157997449,0.00835550088408328,0.183956753384132
NMR metabolomics,X23428.Concentration of VLDL Particles,PGLYRP4,Peptidoglycan recognition protein 4,37021,0.00774670130647937,0.00584073948770363,-0.00370114808941975,0.0191945507023785,0.18475607627879
NMR metabolomics,X23428.Concentration of VLDL Particles,ENPEP,Glutamyl aminopeptidase,37021,0.00519711106658689,0.00391882503381358,-0.00248378599968774,0.0128780081328615,0.18479940492129
NMR metabolomics,X23428.Concentration of VLDL Particles,SPRR1B,Cornifin-B,37169,0.0108251454077675,0.00818558033784716,-0.00521859205441292,0.0268688828699479,0.186036003971477
NMR metabolomics,X23428.Concentration of VLDL Particles,REG1B,Lithostathine-1-beta,40052,-0.00667483881946106,0.00506450998050465,-0.0166012783812502,0.00325160074232805,0.187534543629266
NMR metabolomics,X23428.Concentration of VLDL Particles,DHODH,Dihydroorotate dehydrogenase,37021,0.00570342233992284,0.00434238328373257,-0.00280764889619301,0.0142144935760387,0.189060535951427
NMR metabolomics,X23428.Concentration of VLDL Particles,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36991,-0.00395415075168907,0.00302626846889084,-0.00988563695071512,0.00197733544733698,0.191368294734346
NMR metabolomics,X23428.Concentration of VLDL Particles,HMBS,Porphobilinogen deaminase,40030,0.00523101933856282,0.00400550074251042,-0.0026197621167576,0.0130818007938832,0.191585112957424
NMR metabolomics,X23428.Concentration of VLDL Particles,PI16,Peptidase inhibitor 16,37445,0.00291079269448234,0.00223001897274216,-0.0014600444920923,0.00728162988105698,0.191820615698263
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37021,-0.00501111608712372,0.00385117662207532,-0.0125594222663913,0.00253719009214391,0.193215887827441
NMR metabolomics,X23428.Concentration of VLDL Particles,ECSCR,Endothelial cell-specific chemotaxis regulator,36991,0.00596618028923799,0.0045872684637537,-0.00302486589971926,0.0149572264781952,0.193419805011219
NMR metabolomics,X23428.Concentration of VLDL Particles,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37169,-0.00794590313312476,0.00611761767296737,-0.0199364337721408,0.00404462750589129,0.194015926588216
NMR metabolomics,X23428.Concentration of VLDL Particles,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36962,-0.0101187971651201,0.00781762058596269,-0.0254413335136069,0.00520373918336679,0.195564717328308
NMR metabolomics,X23428.Concentration of VLDL Particles,SHH,Sonic hedgehog protein,37056,-0.00527879367018174,0.00408044079967045,-0.0132764576375358,0.00271887029717235,0.195797855890724
NMR metabolomics,X23428.Concentration of VLDL Particles,EDDM3B,Epididymal secretory protein E3-beta,37368,0.00621792546100292,0.00480901085271813,-0.00320773581032462,0.0156435867323305,0.196042203343632
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP13,Collagenase 3,39489,-0.00385720146439233,0.00298920661001143,-0.00971604642001473,0.00200164349123008,0.196939115050007
NMR metabolomics,X23428.Concentration of VLDL Particles,AMY2A,Pancreatic alpha-amylase,39246,0.00563980935858534,0.00438641098345429,-0.00295755616898508,0.0142371748861557,0.198551152907291
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37021,-0.00610750741349623,0.00475267748964308,-0.0154227552931967,0.00320774046620421,0.198791603483252
NMR metabolomics,X23428.Concentration of VLDL Particles,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36991,-0.00787595307079902,0.00616161218577848,-0.0199527129549248,0.00420080681332681,0.201191190743143
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT14,"Keratin, type I cytoskeletal 14",39064,0.00344711679878108,0.00270108878158185,-0.00184701721311935,0.00874125081068151,0.201905985111203
NMR metabolomics,X23428.Concentration of VLDL Particles,NLGN2,Neuroligin-2,36991,-0.00559597009205854,0.00440067660063536,-0.0142212962293038,0.00302935604518676,0.203532166275314
NMR metabolomics,X23428.Concentration of VLDL Particles,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37169,0.00423971616416707,0.00334669057639629,-0.00231979736556967,0.0107992296939038,0.205235244005852
NMR metabolomics,X23428.Concentration of VLDL Particles,AOC3,Membrane primary amine oxidase,39931,0.00354749142779428,0.00280065658264802,-0.00194179547419583,0.0090367783297844,0.205293743471312
NMR metabolomics,X23428.Concentration of VLDL Particles,IL15,Interleukin-15,39866,0.0038291807850065,0.00302368059523603,-0.00209723318165612,0.00975559475166912,0.205389324955689
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHA4,Ephrin type-A receptor 4,37124,0.00332305702597147,0.00263113429316069,-0.00183396618862349,0.00848008024056643,0.206620339181687
NMR metabolomics,X23428.Concentration of VLDL Particles,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37039,-0.00568166802443153,0.00451736004525851,-0.0145356937131382,0.00317235766427516,0.208507797755287
NMR metabolomics,X23428.Concentration of VLDL Particles,VCPKMT,Protein-lysine methyltransferase METTL21D,36962,0.0101819900210248,0.00809668670101715,-0.00568751591296883,0.0260514959550184,0.208576885266707
NMR metabolomics,X23428.Concentration of VLDL Particles,CD79B,B-cell antigen receptor complex-associated protein beta chain,40058,-0.00485662671416735,0.00389976524963133,-0.0125001666034448,0.00278691317511006,0.2130160452098
NMR metabolomics,X23428.Concentration of VLDL Particles,FBN2,Fibrillin-2,37039,0.00696846026013721,0.00561805148525378,-0.00404292065096019,0.0179798411712346,0.214860802557819
NMR metabolomics,X23428.Concentration of VLDL Particles,TNR,Tenascin-R,39749,0.00483745786311472,0.00391278190092116,-0.00283159466269075,0.0125065103889202,0.216357217593364
NMR metabolomics,X23428.Concentration of VLDL Particles,IL33,Interleukin-33,39587,0.00449862169439485,0.00364741149998607,-0.00265030484557784,0.0116475482343675,0.217454777583117
NMR metabolomics,X23428.Concentration of VLDL Particles,UPK3BL1,Uroplakin-3b-like protein 1,37149,-0.0062504891088259,0.00506996463315587,-0.0161876197898114,0.00368664157215959,0.217654777199791
NMR metabolomics,X23428.Concentration of VLDL Particles,MAMDC2,MAM domain-containing protein 2,37437,-0.00380160221395332,0.00308557687555734,-0.00984933289004571,0.00224612846213907,0.217949658719905
NMR metabolomics,X23428.Concentration of VLDL Particles,BHLHE40,Class E basic helix-loop-helix protein 40,36991,-0.00820089747860716,0.00666602597947785,-0.0212663083983837,0.00486451344116942,0.218624472619723
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJA1,DnaJ homolog subfamily A member 1,36962,-0.00531383577284602,0.00432523951599517,-0.0137913052241966,0.00316363367850451,0.219257194974548
NMR metabolomics,X23428.Concentration of VLDL Particles,PALLD,Palladin,37056,0.00467642409564424,0.00380838285820109,-0.0027880063064299,0.0121408544977184,0.219495490203433
NMR metabolomics,X23428.Concentration of VLDL Particles,POF1B,Protein POF1B,37056,-0.00519228579869782,0.00423000002258352,-0.0134830858429615,0.00309851424556588,0.219660101738876
NMR metabolomics,X23428.Concentration of VLDL Particles,NXPE4,NXPE family member 4,37021,-0.00401088423080759,0.00326927590909061,-0.0104186650126252,0.00239689655101002,0.219904015912595
NMR metabolomics,X23428.Concentration of VLDL Particles,IL9,Interleukin-9,37169,-0.00653731383105566,0.00534766674890531,-0.0170187406589101,0.00394411299679875,0.221555006605984
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMP2,Metalloproteinase inhibitor 2,37437,-0.00287936564608036,0.0023800796173638,-0.00754432169611341,0.00178559040395269,0.226385526666671
NMR metabolomics,X23428.Concentration of VLDL Particles,MTR,Methionine synthase,37021,0.00726211626234327,0.0060251165422377,-0.00454711216044262,0.0190713446851291,0.228106407338998
NMR metabolomics,X23428.Concentration of VLDL Particles,JCHAIN,Immunoglobulin J chain,39587,-0.00677385904805817,0.00564174463742215,-0.0178316785374056,0.00428396044128925,0.22989831569175
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37411,0.00355713098455337,0.00297735391957668,-0.00227848269781693,0.00939274466692366,0.232213849598165
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37021,-0.00565716895835874,0.00474955175917407,-0.0149662904063399,0.00365195248962244,0.23363764027986
NMR metabolomics,X23428.Concentration of VLDL Particles,RGMA,Repulsive guidance molecule A,40009,-0.0034297673668676,0.00288549233931603,-0.00908533235192701,0.00222579761819182,0.234604875880631
NMR metabolomics,X23428.Concentration of VLDL Particles,KIT,Mast/stem cell growth factor receptor Kit,39908,0.00318094656714975,0.00268005871349383,-0.00207196851129815,0.00843386164559765,0.235286862066795
NMR metabolomics,X23428.Concentration of VLDL Particles,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36991,-0.00677344542524787,0.00571720809012453,-0.017979173281892,0.00443228243139622,0.23613891559774
NMR metabolomics,X23428.Concentration of VLDL Particles,PHLDB2,Pleckstrin homology-like domain family B member 2,36962,-0.0101323622931117,0.00855834173250102,-0.0269067120888137,0.00664198750259032,0.236467582199634
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39858,0.0130714640394661,0.0110538205093947,-0.00859402415894755,0.0347369522378798,0.237013414102956
NMR metabolomics,X23428.Concentration of VLDL Particles,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37021,0.00516241553752236,0.00436858836085506,-0.00340001764975356,0.0137248487247983,0.237341142393867
NMR metabolomics,X23428.Concentration of VLDL Particles,TPPP2,Tubulin polymerization-promoting protein family member 2,37169,-0.00863319302106833,0.00731499996493113,-0.0229705929523333,0.00570420691019667,0.237940138167664
NMR metabolomics,X23428.Concentration of VLDL Particles,IL36A,Interleukin-36 alpha,37056,-0.00645821410448351,0.00550196476333232,-0.0172420650406149,0.00432563683164784,0.240495755535105
NMR metabolomics,X23428.Concentration of VLDL Particles,CA3,Carbonic anhydrase 3,40017,-0.00658756321664745,0.00561574734770799,-0.0175944280181551,0.0044193015848602,0.240792278394649
NMR metabolomics,X23428.Concentration of VLDL Particles,TLR2,Toll-like receptor 2,37169,-0.00248095442193248,0.00211948275976084,-0.00663514063106373,0.00167323178719876,0.241801825637589
NMR metabolomics,X23428.Concentration of VLDL Particles,CHP1,Calcineurin B homologous protein 1,36991,0.00791238045199429,0.0067759941859724,-0.00536856815251161,0.0211933290565002,0.242945900008078
NMR metabolomics,X23428.Concentration of VLDL Particles,ZP3,Zona pellucida sperm-binding protein 3,37043,-0.028131809007678,0.0240940428433706,-0.0753561329806844,0.0190925149653284,0.242995890025566
NMR metabolomics,X23428.Concentration of VLDL Particles,ACHE,Acetylcholinesterase,37124,0.00356672578100149,0.00305574990804269,-0.00242254403876218,0.00955599560076516,0.243143394300041
NMR metabolomics,X23428.Concentration of VLDL Particles,PRND,Prion-like protein doppel,37388,-0.00547470569226763,0.0047460126837138,-0.0147768905523467,0.00382747916781141,0.24871003430804
NMR metabolomics,X23428.Concentration of VLDL Particles,ACTN4,Alpha-actinin-4,39587,0.00336733920522132,0.00292580254042429,-0.00236723377401029,0.00910191218445293,0.249786226319981
NMR metabolomics,X23428.Concentration of VLDL Particles,CTNNA1,Catenin alpha-1,36991,-0.00376823915944543,0.00327930109326963,-0.0101956693022539,0.00265919098336305,0.250536398531189
NMR metabolomics,X23428.Concentration of VLDL Particles,NOS1,"Nitric oxide synthase, brain",39489,-0.00576299072396105,0.00502835856219958,-0.0156185735058722,0.00409259205795013,0.251772231882202
NMR metabolomics,X23428.Concentration of VLDL Particles,FCAR,Immunoglobulin alpha Fc receptor,39866,0.00499254942295204,0.00435851848903974,-0.00355014681556586,0.0135352456614699,0.252031903307982
NMR metabolomics,X23428.Concentration of VLDL Particles,AIDA,"Axin interactor, dorsalization-associated protein",37039,0.00905232037875366,0.00791402338160513,-0.0064591654491924,0.0245638062066997,0.252713714825391
NMR metabolomics,X23428.Concentration of VLDL Particles,MB,Myoglobin,40052,-0.00550367963868664,0.00483315780696859,-0.0149766689403451,0.00396930966297179,0.254831092199954
NMR metabolomics,X23428.Concentration of VLDL Particles,PGR,Progesterone receptor,37056,0.0111761983102566,0.00982046632012771,-0.00807191567719368,0.0304243122977069,0.255119559808144
NMR metabolomics,X23428.Concentration of VLDL Particles,TEX101,Testis-expressed protein 101,37039,0.00517288099667893,0.00454539499266786,-0.00373609318895007,0.0140818551823079,0.255120823296556
NMR metabolomics,X23428.Concentration of VLDL Particles,CPLX2,Complexin-2,36962,-0.00319670145862701,0.00280920221448357,-0.0087027377990148,0.00230933488176078,0.255166658785261
NMR metabolomics,X23428.Concentration of VLDL Particles,EPO,Erythropoietin,39866,0.00816111312188248,0.0071902562721096,-0.00593178917145232,0.0222540154152173,0.256382277388535
NMR metabolomics,X23428.Concentration of VLDL Particles,DDX39A,ATP-dependent RNA helicase DDX39A,37056,0.00238634351042214,0.00210641679269654,-0.00174223340326308,0.00651492042410735,0.25728003810741
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC44A4,Choline transporter-like protein 4,37039,-0.0071786846775862,0.0063380350315554,-0.0196012333394348,0.00524386398426238,0.257387880395751
NMR metabolomics,X23428.Concentration of VLDL Particles,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36991,-0.00489241369138341,0.00432821283608185,-0.0133757108501038,0.00359088346733701,0.258347637678687
NMR metabolomics,X23428.Concentration of VLDL Particles,CD160,CD160 antigen,40058,0.00472233957915226,0.0041784486070296,-0.00346741969062576,0.0129120988489303,0.258423115650787
NMR metabolomics,X23428.Concentration of VLDL Particles,IMPG1,Interphotoreceptor matrix proteoglycan 1,36991,-0.00315256053895553,0.00280322119385667,-0.0086468740789146,0.00234175300100355,0.260770361713823
NMR metabolomics,X23428.Concentration of VLDL Particles,DPEP1,Dipeptidase 1,39713,-0.00495149331173936,0.00441716798438895,-0.0136091425611417,0.00370615593766298,0.262319490241292
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB2,Integrin beta-2,39731,0.00299594768622766,0.00267890959491732,-0.0022547151198103,0.00824661049226561,0.263436197491271
NMR metabolomics,X23428.Concentration of VLDL Particles,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36991,0.003318363253365,0.00297922633242468,-0.00252092035818737,0.00915764686491738,0.265370842856724
NMR metabolomics,X23428.Concentration of VLDL Particles,DOCK9,Dedicator of cytokinesis protein 9,36991,0.0120696710373387,0.0108771068400925,-0.00924945836924266,0.0333888004439201,0.267174579333467
NMR metabolomics,X23428.Concentration of VLDL Particles,AMY2B,Alpha-amylase 2B,38832,0.00497773010970235,0.00448845454996303,-0.00381964080822519,0.0137751010276299,0.267444726110569
NMR metabolomics,X23428.Concentration of VLDL Particles,HIP1,Huntingtin-interacting protein 1,37021,0.00347029428603144,0.00313801353920695,-0.00268021225081418,0.00962080082287706,0.268794831854384
NMR metabolomics,X23428.Concentration of VLDL Particles,TPRKB,EKC/KEOPS complex subunit TPRKB,36962,-0.00681857681902937,0.0061706272007811,-0.0189130061325603,0.00527585249450159,0.269177509579553
NMR metabolomics,X23428.Concentration of VLDL Particles,ERCC1,DNA excision repair protein ERCC-1,36962,0.00338831065715579,0.00308016204536345,-0.00264880695175658,0.00942542826606815,0.27133360356113
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP4,Caspase-4,37169,-0.0169076619534935,0.0153944368763867,-0.0470807582312115,0.0132654343242244,0.272094743485203
NMR metabolomics,X23428.Concentration of VLDL Particles,GAL,Galanin peptides,39931,-0.00647396547847703,0.00599874747011135,-0.0182315105198953,0.00528357956294121,0.280506068138731
NMR metabolomics,X23428.Concentration of VLDL Particles,TXNL1,Thioredoxin-like protein 1,36971,0.00982685331051364,0.00913310763507627,-0.00807403765423585,0.0277277442752631,0.281965198188651
NMR metabolomics,X23428.Concentration of VLDL Particles,RBP7,Retinoid-binding protein 7,37382,0.00604188588546705,0.00563396456936479,-0.00500068467048794,0.017084456441422,0.283557770879232
NMR metabolomics,X23428.Concentration of VLDL Particles,MAPRE3,Microtubule-associated protein RP/EB family member 3,36962,-0.0144031049802522,0.013483760516019,-0.0408312755916495,0.0120250656311452,0.285458279977152
NMR metabolomics,X23428.Concentration of VLDL Particles,LYPLA2,Acyl-protein thioesterase 2,36991,0.0104773574741128,0.00981803750905703,-0.008765996043639,0.0297207109918646,0.285921944113353
NMR metabolomics,X23428.Concentration of VLDL Particles,NRXN3,Neurexin-3,37039,0.00344311867249573,0.00327955573115849,-0.00298481056057491,0.00987104790556637,0.293795525491691
NMR metabolomics,X23428.Concentration of VLDL Particles,ZNF830,Zinc finger protein 830,37368,-0.00782461213300299,0.00752737773440907,-0.0225782724924448,0.00692904822643879,0.298596854897306
NMR metabolomics,X23428.Concentration of VLDL Particles,CA14,Carbonic anhydrase 14,40030,0.00339421250409147,0.00327198678892563,-0.00301888160220277,0.0098073066103857,0.299585861698016
NMR metabolomics,X23428.Concentration of VLDL Particles,RASA1,Ras GTPase-activating protein 1,39489,0.00315107041724695,0.00304155126083181,-0.0028103700539834,0.0091125108884773,0.300214595840429
NMR metabolomics,X23428.Concentration of VLDL Particles,PPT1,Palmitoyl-protein thioesterase 1,37039,0.00754232792681543,0.00730348412856922,-0.00677250096518024,0.0218571568188111,0.301761990294128
NMR metabolomics,X23428.Concentration of VLDL Particles,SPARCL1,SPARC-like protein 1,39871,0.00262042659097606,0.0025388266989022,-0.00235567373887226,0.00759652692082438,0.302021758543983
NMR metabolomics,X23428.Concentration of VLDL Particles,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37021,-0.00820045760749937,0.00795442896287054,-0.0237911383747256,0.0073902231597269,0.302592700308264
NMR metabolomics,X23428.Concentration of VLDL Particles,DENND2B,DENN domain-containing protein 2B,37021,-0.00492298751266162,0.00482390065053233,-0.014377832787705,0.00453185776238174,0.307490800088528
NMR metabolomics,X23428.Concentration of VLDL Particles,RAP1A,Ras-related protein Rap-1A,37056,-0.00647986341046049,0.00635732419128721,-0.0189402188253834,0.00598049200446245,0.308090981439936
NMR metabolomics,X23428.Concentration of VLDL Particles,BSND,Barttin,36962,-0.00319576137052996,0.00315777999932271,-0.00938501016920247,0.00299348742814255,0.311543416062283
NMR metabolomics,X23428.Concentration of VLDL Particles,PILRB,Paired immunoglobulin-like type 2 receptor beta,39868,0.00534273933238229,0.00529028377632321,-0.0050262168692112,0.0157116955339758,0.312551063292791
NMR metabolomics,X23428.Concentration of VLDL Particles,COL5A1,Collagen alpha-1(V) chain,37124,-0.00373282161306035,0.00369745785378889,-0.0109798390064866,0.00351419578036587,0.312722475604224
NMR metabolomics,X23428.Concentration of VLDL Particles,PLAUR,Urokinase plasminogen activator surface receptor,39757,0.00251651411578521,0.00249754757478872,-0.00237867913080069,0.00741170736237111,0.313664714922616
NMR metabolomics,X23428.Concentration of VLDL Particles,GAMT,Guanidinoacetate N-methyltransferase,37021,-0.0034689627665917,0.00344629073523399,-0.0102236926076503,0.00328576707446692,0.314155791501831
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF7,Fibroblast growth factor 7,36962,-0.00749457781577645,0.00745312395712663,-0.0221027007717446,0.00711354514019175,0.314644908270161
NMR metabolomics,X23428.Concentration of VLDL Particles,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37056,0.00332333706099918,0.00331138668098362,-0.00316698083372873,0.00981365495572708,0.31558557754443
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNL2,Interferon lambda-2,36991,-0.00580260396599379,0.00578503941428767,-0.0171412812179976,0.00553607328601004,0.315861877139828
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINT3,Kunitz-type protease inhibitor 3,37382,0.0136553466933309,0.0136179851161314,-0.0130359041342866,0.0403465975209485,0.316002556543857
NMR metabolomics,X23428.Concentration of VLDL Particles,PGLYRP1,Peptidoglycan recognition protein 1,39962,0.00391702917934835,0.00391496078867987,-0.00375629396646419,0.0115903523251609,0.31706992976344
NMR metabolomics,X23428.Concentration of VLDL Particles,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37021,-0.00604292863422084,0.00604442666380402,-0.0178900048952767,0.00580414762683504,0.317448841613001
NMR metabolomics,X23428.Concentration of VLDL Particles,TSPAN15,Tetraspanin-15,37021,-0.00460983933635625,0.00461925436656099,-0.0136635778948158,0.0044438992221033,0.318316237033181
NMR metabolomics,X23428.Concentration of VLDL Particles,EVPL,Envoplakin,37169,0.00304563391384762,0.00307381742789085,-0.00297904824481843,0.00907031607251368,0.321786072014593
NMR metabolomics,X23428.Concentration of VLDL Particles,SUSD5,Sushi domain-containing protein 5,37064,-0.00313613701242296,0.00316591783853841,-0.00934133597595824,0.00306906195111231,0.321902360595889
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTF,Ciliary neurotrophic factor,36991,0.00313788164306936,0.00316824916138693,-0.00307188671324902,0.00934764999938773,0.321989543218095
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRB3,Adhesion G protein-coupled receptor B3,39720,0.00305019113847808,0.0030798212366126,-0.00298625848528262,0.00908664076223878,0.32200387809257
NMR metabolomics,X23428.Concentration of VLDL Particles,RAC3,Ras-related C3 botulinum toxin substrate 3,37039,0.0063039412490464,0.00636791110718473,-0.00617716452103568,0.0187850470191285,0.322214610977759
NMR metabolomics,X23428.Concentration of VLDL Particles,SCN3A,Sodium channel protein type 3 subunit alpha,37039,-0.0035375339240373,0.00358663760149399,-0.0105673436229655,0.00349227577489092,0.323999477825541
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC2L,C-type lectin domain family 2 member L,37039,-0.00469294098152684,0.00477260756314225,-0.0140472518052856,0.00466136984223197,0.325474153442098
NMR metabolomics,X23428.Concentration of VLDL Particles,FOS,Proto-oncogene c-Fos,36931,-0.00323709447318923,0.00330887758224236,-0.00972249453438426,0.0032483055880058,0.327941156772534
NMR metabolomics,X23428.Concentration of VLDL Particles,NECTIN4,Nectin-4,39913,0.00268242584834737,0.00274218410838719,-0.00269225500409152,0.00805710670078625,0.327986306930403
NMR metabolomics,X23428.Concentration of VLDL Particles,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37437,-0.00232878322238282,0.00238265066151494,-0.00699877851895211,0.00234121207418646,0.32839263472438
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT19,"Keratin, type I cytoskeletal 19",39842,-0.00594647253828081,0.00608978597669082,-0.0178824530525948,0.00598950797603319,0.328848076816212
NMR metabolomics,X23428.Concentration of VLDL Particles,KIRREL1,Kin of IRRE-like protein 1,36991,0.00549094299941604,0.00562363560961376,-0.00553138279542693,0.016513268794259,0.32888204995375
NMR metabolomics,X23428.Concentration of VLDL Particles,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36991,0.00497191300305899,0.00510689224838095,-0.00503759580376768,0.0149814218098857,0.330288418997581
NMR metabolomics,X23428.Concentration of VLDL Particles,CSRP3,Cysteine and glycine-rich protein 3,37021,-0.00884677780670932,0.00911160564641194,-0.0267055248736767,0.00901196926025808,0.331598437559069
NMR metabolomics,X23428.Concentration of VLDL Particles,PAPPA,Pappalysin-1,39587,0.00428188775243887,0.00442207256557738,-0.0043853744760928,0.0129491499809705,0.332910032356514
NMR metabolomics,X23428.Concentration of VLDL Particles,CHL1,Neural cell adhesion molecule L1-like protein,39900,0.00280388776400002,0.00290445562518155,-0.0028888452613558,0.00849662078935585,0.334371759948424
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37039,-0.00499802620838562,0.00517850447130846,-0.0151478949721502,0.00515184255537897,0.334488109744598
NMR metabolomics,X23428.Concentration of VLDL Particles,TGOLN2,Trans-Golgi network integral membrane protein 2,37445,0.00223321863177161,0.00231639631921352,-0.00230691815388689,0.0067733554174301,0.335017078334504
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37021,-0.00573029103125462,0.00595586340109872,-0.0174037832974081,0.00594320123489887,0.336003991372946
NMR metabolomics,X23428.Concentration of VLDL Particles,PRAME,Melanoma antigen preferentially expressed in tumors,36962,-0.00230764410002106,0.00240011736684013,-0.00701187413902771,0.00239658593898559,0.33633296430477
NMR metabolomics,X23428.Concentration of VLDL Particles,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39477,0.011353789250061,0.011833381792435,-0.0118396390631117,0.0345472175632337,0.337336265948461
NMR metabolomics,X23428.Concentration of VLDL Particles,DCN,Decorin,39585,-0.00194115257578148,0.00202673199330207,-0.00591354728265353,0.00203124213109057,0.338191116892463
NMR metabolomics,X23428.Concentration of VLDL Particles,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37368,-0.00685262814659805,0.00716317863358013,-0.0208924582684151,0.007187201975219,0.338762944772265
NMR metabolomics,X23428.Concentration of VLDL Particles,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36962,-0.00570373057907744,0.00596543324607459,-0.0173959797413836,0.00598851858322875,0.339024125493152
NMR metabolomics,X23428.Concentration of VLDL Particles,STC2,Stanniocalcin-2,39831,-0.0023466354079493,0.00246560866144021,-0.00717922838437212,0.00248595756847351,0.341239758909496
NMR metabolomics,X23428.Concentration of VLDL Particles,NTRK3,NT-3 growth factor receptor,40009,0.00188609571219795,0.00198694463222245,-0.00200831576695805,0.00578050719135395,0.342510619736912
NMR metabolomics,X23428.Concentration of VLDL Particles,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39477,0.00308384112139273,0.00325179278967966,-0.00328967274637939,0.00945735498916486,0.342965442209175
NMR metabolomics,X23428.Concentration of VLDL Particles,NRN1,Neuritin,37411,-0.003117985237282,0.00328876628824998,-0.00956396716225195,0.00332799668768795,0.34311001660928
NMR metabolomics,X23428.Concentration of VLDL Particles,SEZ6,Seizure protein 6 homolog,37039,0.0027232070786468,0.00290630202533955,-0.00297314489101871,0.00841955904831232,0.348775359589137
NMR metabolomics,X23428.Concentration of VLDL Particles,CA8,Carbonic anhydrase-related protein,37056,0.00228514924771904,0.00243879561194461,-0.00249489015169239,0.00706518864713047,0.348776178340279
NMR metabolomics,X23428.Concentration of VLDL Particles,BRME1,Break repair meiotic recombinase recruitment factor 1,36991,-0.00355235109811278,0.00380121143400472,-0.011002725508762,0.00389802331253647,0.350047078063137
NMR metabolomics,X23428.Concentration of VLDL Particles,TOP1MT,"DNA topoisomerase I, mitochondrial",36962,-0.00426858967878609,0.00456894539424543,-0.0132237226515071,0.00468654329393495,0.350186247344157
NMR metabolomics,X23428.Concentration of VLDL Particles,KCNC4,Potassium voltage-gated channel subfamily C member 4,36991,0.00488212605869153,0.00523579791691917,-0.00538003785847005,0.0151442899758531,0.351120538589376
NMR metabolomics,X23428.Concentration of VLDL Particles,GNPDA1,Glucosamine-6-phosphate isomerase 1,37043,0.00285109852123751,0.0030631259962127,-0.00315262843133937,0.0088548254738144,0.351984065576984
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF6,Fibroblast growth factor 6,37056,0.00355622256418077,0.0038318940332026,-0.00395428974089633,0.0110667348692579,0.353394099855431
NMR metabolomics,X23428.Concentration of VLDL Particles,IL4R,Interleukin-4 receptor subunit alpha,39866,-0.00306755467089131,0.00333043965379106,-0.00959521639232179,0.00346010705053917,0.357029861210833
NMR metabolomics,X23428.Concentration of VLDL Particles,TMPRSS5,Transmembrane protease serine 5,39667,0.00326501692695252,0.00354841819136062,-0.0036898827281143,0.0102199165820193,0.357517265761017
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA10,Annexin A10,39489,0.00670948782942062,0.0072999417978071,-0.00759839809428129,0.0210173737531225,0.358049478108714
NMR metabolomics,X23428.Concentration of VLDL Particles,DOC2B,Double C2-like domain-containing protein beta,37039,0.00311417044810111,0.00339675929757985,-0.00354347777515539,0.00977181867135761,0.359260907669328
NMR metabolomics,X23428.Concentration of VLDL Particles,CSPG5,Chondroitin sulfate proteoglycan 5,36991,-0.00417561027307002,0.00456525003588671,-0.013123500343408,0.00477227979726793,0.360391698073857
NMR metabolomics,X23428.Concentration of VLDL Particles,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37368,0.00379152159403572,0.00414746165807955,-0.00433750325580021,0.0119205464438716,0.360639209892945
NMR metabolomics,X23428.Concentration of VLDL Particles,NGFR,Tumor necrosis factor receptor superfamily member 16,37437,-0.00254199816090129,0.00278561396073937,-0.00800180152395047,0.00291780520214788,0.361498082094354
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC6A,C-type lectin domain family 6 member A,39477,0.00394729501125231,0.00433213453032933,-0.00454368866819318,0.0124382786906978,0.36222181864814
NMR metabolomics,X23428.Concentration of VLDL Particles,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39904,0.00544697838443092,0.00599839875993506,-0.0063098831850418,0.0172038399539036,0.363853784448346
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP1B4,Protein ATP1B4,36962,-0.00355894663533981,0.00392212137610386,-0.0112463045325034,0.00412841126182376,0.364210151651399
NMR metabolomics,X23428.Concentration of VLDL Particles,STOML2,"Stomatin-like protein 2, mitochondrial",36962,0.00786401413631584,0.00868164309790057,-0.00915200633556928,0.024880034608201,0.365047291263211
NMR metabolomics,X23428.Concentration of VLDL Particles,IL25,Interleukin-25,36903,-0.00289968795597999,0.00321426328616016,-0.0091996439968539,0.00340026808489391,0.367003709798098
NMR metabolomics,X23428.Concentration of VLDL Particles,HRAS,GTPase Hras,37161,0.00822248396798966,0.00912715746072398,-0.00966674465502934,0.0261117125910087,0.367667833862671
NMR metabolomics,X23428.Concentration of VLDL Particles,IZUMO1,Izumo sperm-egg fusion protein 1,36962,-0.00421406710236497,0.00469430798484259,-0.0134149107526564,0.0049867765479265,0.369363501452214
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT8,"Keratin, type II cytoskeletal 8",36991,-0.00540000614715089,0.00608356405917337,-0.0173237917031307,0.00652377940882892,0.374751453333236
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL14,C-X-C motif chemokine 14,39587,0.00511059072152798,0.00575777320847432,-0.00617464476708169,0.0163958262101377,0.374770347673747
NMR metabolomics,X23428.Concentration of VLDL Particles,PLA2G2A,"Phospholipase A2, membrane associated",39826,-0.00444135582672746,0.00507885083940776,-0.0143959034719667,0.00551319181851175,0.381869809627198
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37093,0.00399849817059459,0.00458669270796316,-0.00499141953701319,0.0129884158782024,0.383354786889712
NMR metabolomics,X23428.Concentration of VLDL Particles,TPT1,Translationally-controlled tumor protein,39587,0.00529461806566342,0.0060798859882729,-0.00662195847135147,0.0172111946026783,0.38385390177979
NMR metabolomics,X23428.Concentration of VLDL Particles,CRISP2,Cysteine-rich secretory protein 2,40030,0.00454930851836574,0.00522495728017908,-0.00569160775078527,0.0147902247875167,0.383937362465906
NMR metabolomics,X23428.Concentration of VLDL Particles,YY1,Transcriptional repressor protein YY1,37056,0.00224757105673984,0.0025959767210192,-0.00284054331645779,0.00733568542993747,0.386620995706086
NMR metabolomics,X23428.Concentration of VLDL Particles,PDIA2,Protein disulfide-isomerase A2,36962,0.00320790734377168,0.00371877579260015,-0.00408089320972461,0.010496707897268,0.38835970948355
NMR metabolomics,X23428.Concentration of VLDL Particles,TSLP,Thymic stromal lymphopoietin,39585,0.00482890252586171,0.00560053996350753,-0.00614815580261305,0.0158059608543365,0.388579127203629
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF3,Fibroblast growth factor 3,37056,0.00246794793339903,0.00287797151712444,-0.00317287624016487,0.00810877210696294,0.391167420495767
NMR metabolomics,X23428.Concentration of VLDL Particles,NLGN1,Neuroligin-1,37039,-0.00538519280641653,0.00628888730424505,-0.0177114119227368,0.00694102630990376,0.391845793899203
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFBR3,Transforming growth factor beta receptor type 3,40052,-0.00251863077618045,0.00294619031196857,-0.00829316378763884,0.00325590223527794,0.392631810235615
NMR metabolomics,X23428.Concentration of VLDL Particles,CEND1,Cell cycle exit and neuronal differentiation protein 1,36991,0.0046676032544945,0.00548328192761244,-0.00607962932362589,0.0154148358326149,0.394650116869655
NMR metabolomics,X23428.Concentration of VLDL Particles,CHIT1,Chitotriosidase-1,39906,0.0118876519414309,0.0140628262468733,-0.0156754875024409,0.0394507913853026,0.397942274976586
NMR metabolomics,X23428.Concentration of VLDL Particles,ARNT,Aryl hydrocarbon receptor nuclear translocator,39587,0.00296978925975245,0.00351524835734988,-0.00392009752065331,0.00985967604015822,0.398218297519949
NMR metabolomics,X23428.Concentration of VLDL Particles,PRDX2,Peroxiredoxin-2,37249,-0.00477602916907881,0.00568497959532844,-0.0159185891759226,0.00636653083776493,0.400859647873011
NMR metabolomics,X23428.Concentration of VLDL Particles,GBP6,Guanylate-binding protein 6,37021,-0.00362877667272865,0.00432043759322562,-0.0120968343554509,0.00483928100999357,0.400974375466666
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINK5,Serine protease inhibitor Kazal-type 5,39858,-0.0025880675174199,0.00309953871304002,-0.00866316339497834,0.00348702836013855,0.403738770878546
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37437,-0.0104577213389248,0.0125561510473431,-0.0350677773917174,0.0141523347138677,0.404929115681566
NMR metabolomics,X23428.Concentration of VLDL Particles,CBX2,Chromobox protein homolog 2,37021,-0.00311380847664937,0.00378448077007444,-0.0105313907859953,0.00430377383269654,0.410646006946341
NMR metabolomics,X23428.Concentration of VLDL Particles,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37021,-0.00257477416146468,0.00312993440872961,-0.0087094456025747,0.00355989727964535,0.410734024301518
NMR metabolomics,X23428.Concentration of VLDL Particles,GAGE2A,G antigen 2A,36962,-0.00469673867511689,0.00571255228283454,-0.0158933411494726,0.00649986379923881,0.410990174686337
NMR metabolomics,X23428.Concentration of VLDL Particles,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37411,0.00332502957929076,0.00404750332735288,-0.00460807694232088,0.0112581361009024,0.411375189472193
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39866,0.00636657096153616,0.00777982886410476,-0.00888189361210918,0.0216150355351815,0.413173360706263
NMR metabolomics,X23428.Concentration of VLDL Particles,HCG22,Protein PBMUCL2,37021,-0.004125425725706,0.005069277659586,-0.0140612099384946,0.00581035848708256,0.415768881917366
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFL4,Insulin growth factor-like family member 4,37056,-0.00584176197703382,0.00718417583804081,-0.0199227466195938,0.00823922266552617,0.416150770918116
NMR metabolomics,X23428.Concentration of VLDL Particles,REST,RE1-silencing transcription factor,36962,-0.00269040970526116,0.00334247209455063,-0.0092416550105804,0.00386083560005809,0.420882685148096
NMR metabolomics,X23428.Concentration of VLDL Particles,RRP15,RRP15-like protein,36991,0.00678349645110035,0.00844137675366159,-0.00976160198607637,0.0233285948882771,0.421642152682091
NMR metabolomics,X23428.Concentration of VLDL Particles,OFD1,Oral-facial-digital syndrome 1 protein,37169,-0.00507084841014493,0.00634839198845141,-0.0175136967075097,0.00737199988721983,0.424443218391764
NMR metabolomics,X23428.Concentration of VLDL Particles,CDC25A,M-phase inducer phosphatase 1,36962,0.00311263642227246,0.00390274199495777,-0.00453673788784477,0.0107620107323897,0.425145454027954
NMR metabolomics,X23428.Concentration of VLDL Particles,IL13,Interleukin-13,39587,0.00361829841289229,0.00454239249088035,-0.0052847908692332,0.0125213876950178,0.425717329204552
NMR metabolomics,X23428.Concentration of VLDL Particles,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36962,-0.00324541128441611,0.00407514793314345,-0.0112327012333773,0.00474187866454506,0.425819216377657
NMR metabolomics,X23428.Concentration of VLDL Particles,SAP18,Histone deacetylase complex subunit SAP18,37169,0.00542476408718213,0.00682065146050453,-0.00794371277540674,0.018793240949771,0.426427620158099
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB6B,Ras-related protein Rab-6B,39489,0.00348270206282691,0.00438127716036274,-0.00510460117148406,0.0120700052971379,0.426680445745537
NMR metabolomics,X23428.Concentration of VLDL Particles,MUCL3,Mucin-like protein 3,36962,-0.00334799410158895,0.00421201718453167,-0.011603547783271,0.00490755958009313,0.426705181995909
NMR metabolomics,X23428.Concentration of VLDL Particles,LSM8,U6 snRNA-associated Sm-like protein LSm8,37169,-0.00641180983558196,0.00808013442173365,-0.0222488733021799,0.00942525363101599,0.427484630756085
NMR metabolomics,X23428.Concentration of VLDL Particles,TUBB3,Tubulin beta-3 chain,36991,-0.00208381257563203,0.00262806323296263,-0.00723481651223879,0.00306719136097474,0.427845704426461
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT6C,"Keratin, type II cytoskeletal 6C",37021,0.00298218359094275,0.00376997080047736,-0.00440695917799287,0.0103713263598784,0.428937088736587
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC12A2,Solute carrier family 12 member 2,37021,-0.00206111861749974,0.00260593118855611,-0.00716874374706971,0.00304650651207023,0.428996974234859
NMR metabolomics,X23428.Concentration of VLDL Particles,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37169,-0.00531317417166276,0.00675658639644414,-0.0185560835086933,0.00792973516536775,0.43166498627435
NMR metabolomics,X23428.Concentration of VLDL Particles,ACTA2,"Actin, aortic smooth muscle",39585,0.00316748032468555,0.00402853150278317,-0.00472844142076946,0.0110634020701406,0.431725990424042
NMR metabolomics,X23428.Concentration of VLDL Particles,PALM3,Paralemmin-3,37021,0.00555215912395129,0.00707841963806027,-0.00832154336664685,0.0194258616145494,0.432832254745911
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA11,Serpin A11,40052,0.00299083579448256,0.00381332263821824,-0.00448327657642519,0.0104649481653903,0.432868365853322
NMR metabolomics,X23428.Concentration of VLDL Particles,NOS2,"Nitric oxide synthase, inducible",37021,0.0028980599103783,0.00370187842078432,-0.00435762179435897,0.0101537416151156,0.433722245718582
NMR metabolomics,X23428.Concentration of VLDL Particles,NEB,Nebulin,37021,-0.00272812790792431,0.00351236214076327,-0.00961235770382033,0.0041561018879717,0.437336937945934
NMR metabolomics,X23428.Concentration of VLDL Particles,BLVRB,Flavin reductase,39858,0.00466457121062413,0.006008566187737,-0.00711221851734039,0.0164413609385886,0.43757143513601
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK1,Kallikrein-1,39720,0.00909225689180716,0.011718217644276,-0.0138754496909738,0.0320599634745881,0.437814975397818
NMR metabolomics,X23428.Concentration of VLDL Particles,IL4,Interleukin-4,39587,0.00649365776179903,0.00841199882387022,-0.00999385993298661,0.0229811754565847,0.440154565858209
NMR metabolomics,X23428.Concentration of VLDL Particles,TET2,Methylcytosine dioxygenase TET2,37161,-0.00710034702875384,0.00923475856186426,-0.0252004738100078,0.0109997797525001,0.441982969206419
NMR metabolomics,X23428.Concentration of VLDL Particles,CHEK2,Serine/threonine-protein kinase Chk2,39585,0.00240061535779512,0.00312421703450766,-0.00372285002983989,0.00852408074543014,0.442267394989876
NMR metabolomics,X23428.Concentration of VLDL Particles,TJP3,Tight junction protein ZO-3,36991,-0.00310665228474985,0.00405709703592952,-0.0110585624751717,0.00484525790567202,0.443849068109156
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGEF5,Rho guanine nucleotide exchange factor 5,36991,0.00530154555506777,0.00697744654870328,-0.00837424968039065,0.0189773407905262,0.447380786329063
NMR metabolomics,X23428.Concentration of VLDL Particles,IL17F,Interleukin-17F,39587,-0.00545479775445392,0.00722178757551063,-0.0196095014024548,0.00869990589354692,0.450065225821308
NMR metabolomics,X23428.Concentration of VLDL Particles,ZPR1,Zinc finger protein ZPR1,36991,0.00674950920806152,0.00896643093888273,-0.0108246954321486,0.0243237138482717,0.451611753936932
NMR metabolomics,X23428.Concentration of VLDL Particles,BCL2L15,Bcl-2-like protein 15,37056,0.00396794058060451,0.00528811548411172,-0.00639676576825446,0.0143326469294635,0.453056958496606
NMR metabolomics,X23428.Concentration of VLDL Particles,TMED1,Transmembrane emp24 domain-containing protein 1,37169,-0.0037771622243727,0.00504460469588114,-0.0136645874282997,0.00611026297955434,0.454019405406405
NMR metabolomics,X23428.Concentration of VLDL Particles,HBZ,Hemoglobin subunit zeta,37437,-0.00734639913392192,0.00984710834559862,-0.0266467314912952,0.0119539332234514,0.455652339480525
NMR metabolomics,X23428.Concentration of VLDL Particles,CD48,CD48 antigen,39908,0.00200098238880576,0.00269734471739099,-0.00328581325728059,0.00728777803489211,0.458198691543053
NMR metabolomics,X23428.Concentration of VLDL Particles,TMED4,Transmembrane emp24 domain-containing protein 4,37021,-0.00389352118107145,0.00526593759700589,-0.014214758871203,0.00642771650906009,0.459690364712081
NMR metabolomics,X23428.Concentration of VLDL Particles,INSL4,Early placenta insulin-like peptide,37368,-0.00368932884822987,0.00499329452414481,-0.0134761861155537,0.00609752841909395,0.460006887621263
NMR metabolomics,X23428.Concentration of VLDL Particles,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36962,-0.00378577238339076,0.005125245480013,-0.0138312535242162,0.00625970875743471,0.460131623087514
NMR metabolomics,X23428.Concentration of VLDL Particles,GDF15,Growth/differentiation factor 15,40052,-0.00290991489274115,0.00395317637216564,-0.0106581405821858,0.0048383107967035,0.46168331296613
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP112,Centrosomal protein of 112 kDa,37021,0.0031690653664967,0.00436512642749466,-0.00538658243139282,0.0117247131643862,0.467853986560125
NMR metabolomics,X23428.Concentration of VLDL Particles,TSPAN7,Tetraspanin-7,36991,0.00636712461307766,0.00879737882658515,-0.0108757378870292,0.0236099871131846,0.469230609948974
NMR metabolomics,X23428.Concentration of VLDL Particles,CRYBB2,Beta-crystallin B2,37388,0.00383679692548873,0.00530578037301656,-0.00656253260562373,0.0142361264566012,0.469609284133221
NMR metabolomics,X23428.Concentration of VLDL Particles,HDAC9,Histone deacetylase 9,36991,-0.00433415645792427,0.00599689655616754,-0.0160880737080126,0.0074197607921641,0.46985666359555
NMR metabolomics,X23428.Concentration of VLDL Particles,ARG1,Arginase-1,39754,0.00348126237350374,0.00482128786957995,-0.00596846185087296,0.0129309865978805,0.470267797147602
NMR metabolomics,X23428.Concentration of VLDL Particles,SOX2,Transcription factor SOX-2,37391,0.00159859373488389,0.00221933661979279,-0.00275130603990999,0.00594849350967776,0.471351202926322
NMR metabolomics,X23428.Concentration of VLDL Particles,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37021,-0.00290438249226627,0.00406256262700851,-0.010867005241203,0.00505824025667041,0.474674928173406
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP8,Neutrophil collagenase,39985,0.00476634119902532,0.00667645373959626,-0.00831950813058335,0.017852190528634,0.475297416793113
NMR metabolomics,X23428.Concentration of VLDL Particles,ARID3A,AT-rich interactive domain-containing protein 3A,36991,-0.00264300233706863,0.00371733819674207,-0.00992898520268309,0.00464298052854583,0.4771010520484
NMR metabolomics,X23428.Concentration of VLDL Particles,TNXB,Tenascin-X,39858,0.00169956871385208,0.00239641246447801,-0.00299739971652482,0.00639653714422897,0.478202166018553
NMR metabolomics,X23428.Concentration of VLDL Particles,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39788,0.00280793235353489,0.00399477756480005,-0.00502183167347321,0.010637696380543,0.482127844305567
NMR metabolomics,X23428.Concentration of VLDL Particles,TP73,Tumor protein p73,37039,-0.00227231167584154,0.00323589871467289,-0.00861467315660041,0.00407004980491732,0.482554592167305
NMR metabolomics,X23428.Concentration of VLDL Particles,BTN1A1,Butyrophilin subfamily 1 member A1,37348,0.00268681609178069,0.00383057418554857,-0.00482110931189452,0.0101947414954559,0.483057158496599
NMR metabolomics,X23428.Concentration of VLDL Particles,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37043,-0.00266540761513089,0.00380664707601517,-0.0101264358841206,0.00479562065385886,0.483815861526022
NMR metabolomics,X23428.Concentration of VLDL Particles,HLA_DRA,,39799,-0.00231103948564167,0.00330449442304424,-0.00878784855480838,0.00416576958352504,0.484335721630471
NMR metabolomics,X23428.Concentration of VLDL Particles,MFAP3,Microfibril-associated glycoprotein 3,39585,0.00318837847475556,0.00457441923359753,-0.0057774832230956,0.0121542401726067,0.485811966156449
NMR metabolomics,X23428.Concentration of VLDL Particles,GAD1,Glutamate decarboxylase 1,36962,-0.00169278544695262,0.00242877196021317,-0.00645317848897044,0.0030676075950652,0.485832838156766
NMR metabolomics,X23428.Concentration of VLDL Particles,APOH,Beta-2-glycoprotein 1,39858,0.00230276908980334,0.00330849925564252,-0.004181889451256,0.00878742763086268,0.486428793614957
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37169,0.00441073422966478,0.0063447997033754,-0.008025073188951,0.0168465416482806,0.486958949896348
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC11A,C-type lectin domain family 11 member A,39822,0.00305581657273609,0.00440946528564301,-0.00558673538712421,0.0116983685325964,0.488311503549207
NMR metabolomics,X23428.Concentration of VLDL Particles,DLGAP5,Disks large-associated protein 5,37411,-0.00338899902321447,0.00490096768144799,-0.0129948956788525,0.00621689763242358,0.48926580712935
NMR metabolomics,X23428.Concentration of VLDL Particles,PON1,Serum paraoxonase/arylesterase 1,37445,0.0016479986202249,0.00238956506459214,-0.00303554890637568,0.00633154614682549,0.490416863698495
NMR metabolomics,X23428.Concentration of VLDL Particles,TNPO1,Transportin-1,37169,-0.00223949878420759,0.00330692451984629,-0.00872107084310632,0.00424207327469113,0.498281342895332
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM171A2,Protein FAM171A2,37411,0.00992285799637968,0.014677826521746,-0.0188456819862425,0.0386913979790019,0.499024184501516
NMR metabolomics,X23428.Concentration of VLDL Particles,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37411,-0.00149372909950375,0.00223119431589859,-0.00586686995866499,0.00287941175965749,0.503203847799383
NMR metabolomics,X23428.Concentration of VLDL Particles,TMPRSS11B,Transmembrane protease serine 11B,36991,-0.00478158524990632,0.00716642549811745,-0.0188277792262165,0.00926460872640388,0.504643090331312
NMR metabolomics,X23428.Concentration of VLDL Particles,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36991,-0.00347921164009135,0.00526671383212359,-0.0138019707510536,0.00684354747087089,0.508877962861024
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNL1,Interferon lambda-1,39489,0.00275744327693364,0.00418225097474779,-0.00543976863357204,0.0109546551874393,0.509699776107252
NMR metabolomics,X23428.Concentration of VLDL Particles,PRR5,Proline-rich protein 5,37056,0.002922279187802,0.00445130863228994,-0.00580228573148628,0.0116468441070903,0.511514627427629
NMR metabolomics,X23428.Concentration of VLDL Particles,RBM25,RNA-binding protein 25,36962,-0.00279915801745679,0.00427722215468804,-0.0111825134406453,0.00558419740573176,0.512843961557474
NMR metabolomics,X23428.Concentration of VLDL Particles,IL2RB,Interleukin-2 receptor subunit beta,39587,0.00220957716530887,0.00338280125323962,-0.00442071329104078,0.00883986762165852,0.51364997318085
NMR metabolomics,X23428.Concentration of VLDL Particles,TG,Thyroglobulin,37368,0.00661671241044454,0.0101499835774992,-0.0132772554014538,0.0265106802223429,0.514480709694776
NMR metabolomics,X23428.Concentration of VLDL Particles,CRX,Cone-rod homeobox protein,39585,0.00656399327792777,0.0100897427234275,-0.0132119024599902,0.0263398890158457,0.515339407164835
NMR metabolomics,X23428.Concentration of VLDL Particles,CRTAM,Cytotoxic and regulatory T-cell molecule,39749,0.00299544989041035,0.00461222867908364,-0.00604451832059358,0.0120354181014143,0.516051622477098
NMR metabolomics,X23428.Concentration of VLDL Particles,HMCN2,Hemicentin-2,37100,-0.00344095602939497,0.0053078800601672,-0.0138444009473227,0.00696248888853273,0.516819551030463
NMR metabolomics,X23428.Concentration of VLDL Particles,NCLN,Nicalin,39587,0.00318362727031329,0.00491198381343661,-0.00644386100402245,0.012811115544649,0.516907279288978
NMR metabolomics,X23428.Concentration of VLDL Particles,PMCH,Pro-MCH,37021,0.00494673401702595,0.00775367531349982,-0.0102504695974337,0.0201439376314856,0.5234940848246
NMR metabolomics,X23428.Concentration of VLDL Particles,CORO6,Coronin-6,36991,-0.00223874266761374,0.00353894230959433,-0.00917506959441862,0.00469758425919114,0.527004469569343
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC34A3,Sodium-dependent phosphate transport protein 2C,36962,-0.00286608512513838,0.00454670290995851,-0.0117776228286571,0.00604545257838029,0.528466403565872
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRE1,Adhesion G protein-coupled receptor E1,37382,0.00314290128942774,0.00501713930078214,-0.00669069174010525,0.0129764943189607,0.531041588437882
NMR metabolomics,X23428.Concentration of VLDL Particles,GUCY2C,Heat-stable enterotoxin receptor,37169,-0.00499536276249307,0.00799727106210479,-0.0206700140442185,0.0106792885192323,0.532222388841976
NMR metabolomics,X23428.Concentration of VLDL Particles,HDDC2,5'-deoxynucleotidase HDDC2,37382,-0.00252320465188147,0.00404155475594605,-0.0104446519735357,0.00539824266977278,0.532431041077625
NMR metabolomics,X23428.Concentration of VLDL Particles,GSTM4,Glutathione S-transferase Mu 4,37021,0.00416947080254116,0.00670043701705816,-0.00896338575089282,0.0173023273559752,0.533776119300494
NMR metabolomics,X23428.Concentration of VLDL Particles,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37169,0.00366982132977434,0.00590475512414761,-0.00790349871355498,0.0152431413731037,0.534279554857469
NMR metabolomics,X23428.Concentration of VLDL Particles,TLR1,Toll-like receptor 1,37056,0.00151473811402332,0.00243989297785178,-0.00326745212256616,0.0062969283506128,0.534727771944248
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK12,Kallikrein-12,39477,-0.00796618940456566,0.0128399306336806,-0.0331324534465796,0.0172000746374483,0.534988329654387
NMR metabolomics,X23428.Concentration of VLDL Particles,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36962,0.0033285575835137,0.00539379635005596,-0.00724328326259598,0.0139003984296234,0.537173885100496
NMR metabolomics,X23428.Concentration of VLDL Particles,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37411,-0.00171479249796228,0.00278038823111949,-0.00716435343095648,0.00373476843503191,0.537412831090808
NMR metabolomics,X23428.Concentration of VLDL Particles,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37056,0.00289585446719213,0.00470794832325276,-0.00633172424638328,0.0121234331807675,0.538499926448505
NMR metabolomics,X23428.Concentration of VLDL Particles,FH,"Fumarate hydratase, mitochondrial",36991,0.00474800658000552,0.00772263368757952,-0.0103883554476503,0.0198843686076614,0.538686225655397
NMR metabolomics,X23428.Concentration of VLDL Particles,PSME2,Proteasome activator complex subunit 2,39666,0.00206611938047003,0.00337585355819811,-0.00455055359359827,0.00868279235453833,0.540527550034019
NMR metabolomics,X23428.Concentration of VLDL Particles,OSTN,Osteocrin,37039,-0.00238496371288752,0.00390943927054733,-0.0100474646831603,0.00527753725738525,0.54183746220901
NMR metabolomics,X23428.Concentration of VLDL Particles,ANK2,Ankyrin-2,37021,0.00405124109649477,0.00664546512359876,-0.00897387054575881,0.0170763527387483,0.542120828934431
NMR metabolomics,X23428.Concentration of VLDL Particles,LRP2BP,LRP2-binding protein,37039,-0.00454272682167921,0.00745384216821244,-0.0191522574713756,0.0100668038280172,0.542238247936676
NMR metabolomics,X23428.Concentration of VLDL Particles,CREB3,Cyclic AMP-responsive element-binding protein 3,36962,-0.00318548439167673,0.00526070415322307,-0.0134964645319939,0.00712549574864049,0.544841147877179
NMR metabolomics,X23428.Concentration of VLDL Particles,SCN2A,Sodium channel protein type 2 subunit alpha,36991,0.0027358852588338,0.00453194521580307,-0.00614672736414022,0.0116184978818078,0.5460608887189
NMR metabolomics,X23428.Concentration of VLDL Particles,ZNF174,Zinc finger protein 174,37056,0.00215209119398476,0.00357033453926046,-0.00484576450296574,0.00914994689093527,0.546671945134255
NMR metabolomics,X23428.Concentration of VLDL Particles,IKZF2,Zinc finger protein Helios,39477,0.0052737763013003,0.00876601160825686,-0.0119076064508831,0.0224551590534838,0.547438246043883
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36991,-0.00179498427397084,0.0030077950536874,-0.00769026257919815,0.00410029403125648,0.5506662613602
NMR metabolomics,X23428.Concentration of VLDL Particles,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36991,-0.00298309936837227,0.005033731035828,-0.0128492121985951,0.0068830134618506,0.553444408730941
NMR metabolomics,X23428.Concentration of VLDL Particles,LTBR,Tumor necrosis factor receptor superfamily member 3,39786,0.00146730484056604,0.00249522994899668,-0.00342334585946744,0.00635795554059953,0.556511140734301
NMR metabolomics,X23428.Concentration of VLDL Particles,DDX4,Probable ATP-dependent RNA helicase DDX4,37056,-0.00301158293441711,0.00515514756788651,-0.0131156721674747,0.00709250629864045,0.559102830187018
NMR metabolomics,X23428.Concentration of VLDL Particles,EVI2B,Protein EVI2B,36962,0.00225583837746227,0.00386178956778254,-0.00531326917539152,0.00982494593031605,0.559133983551057
NMR metabolomics,X23428.Concentration of VLDL Particles,FLT3,Receptor-type tyrosine-protein kinase FLT3,39477,-0.00163480177885585,0.00284018934385712,-0.00720157289281581,0.0039319693351041,0.564896542265382
NMR metabolomics,X23428.Concentration of VLDL Particles,VWA5A,von Willebrand factor A domain-containing protein 5A,36962,-0.00438755794104983,0.00762533827334876,-0.0193332209568134,0.0105581050747137,0.565036156585051
NMR metabolomics,X23428.Concentration of VLDL Particles,IL21R,Interleukin-21 receptor,37056,-0.00290932225441934,0.00508279643395346,-0.0128716032649681,0.00705295875612945,0.567070151561867
NMR metabolomics,X23428.Concentration of VLDL Particles,PPIE,Peptidyl-prolyl cis-trans isomerase E,37169,-0.00330701591007937,0.00583457360779584,-0.0147427801813592,0.00812874836120048,0.570862005969613
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMA1,Laminin subunit alpha-1,37021,-0.00286807425244488,0.00507275217507664,-0.0128106685155951,0.00707452001070533,0.571819382571198
NMR metabolomics,X23428.Concentration of VLDL Particles,PLXDC1,Plexin domain-containing protein 1,39477,0.00180070704071081,0.00320778143263564,-0.00448654456725506,0.00808795864867667,0.574562994219779
NMR metabolomics,X23428.Concentration of VLDL Particles,LYPD1,Ly6/PLAUR domain-containing protein 1,39489,0.0033438658750076,0.00601932229773899,-0.00845400582856081,0.015141737578576,0.578545627677294
NMR metabolomics,X23428.Concentration of VLDL Particles,KCNH2,Potassium voltage-gated channel subfamily H member 2,37039,0.00403743479806787,0.00728448235373594,-0.0102401506152546,0.0183150202113903,0.579416186319548
NMR metabolomics,X23428.Concentration of VLDL Particles,HTR1A,5-hydroxytryptamine receptor 1A,36991,-0.00390501107226579,0.00709239792469657,-0.0178061110046711,0.0099960888601395,0.581923387595405
NMR metabolomics,X23428.Concentration of VLDL Particles,TNNI3,"Troponin I, cardiac muscle",39585,0.00432056672546676,0.00784746077358976,-0.0110604563907692,0.0197015898417027,0.581937151975467
NMR metabolomics,X23428.Concentration of VLDL Particles,DCC,Netrin receptor DCC,37039,0.00115880558513353,0.00211402549190961,-0.00298468437900931,0.00530229554927638,0.583597379377681
NMR metabolomics,X23428.Concentration of VLDL Particles,SCG3,Secretogranin-3,39885,0.00165140386357194,0.0030201871144005,-0.00426816288065305,0.00757097060779693,0.584531593986
NMR metabolomics,X23428.Concentration of VLDL Particles,BATF,Basic leucine zipper transcriptional factor ATF-like,37039,0.00428082407942354,0.00784665093414883,-0.0110986117515082,0.0196602599103552,0.585377204408397
NMR metabolomics,X23428.Concentration of VLDL Particles,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37368,0.00311374004146294,0.00571827750138634,-0.00809408386125429,0.0143215639441802,0.586089841535384
NMR metabolomics,X23428.Concentration of VLDL Particles,PFDN6,Prefoldin subunit 6,37039,0.00335336356755167,0.00616908302683768,-0.00873803916505018,0.0154447663001535,0.586742686093269
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNW1,Interferon omega-1,37021,0.00179943128467826,0.00331304145457077,-0.00469412996628044,0.00829299253563696,0.587045531875481
NMR metabolomics,X23428.Concentration of VLDL Particles,ACRV1,Acrosomal protein SP-10,37056,0.00367983305969464,0.00682234357996265,-0.00969196035703215,0.0170516264764214,0.589634043575166
NMR metabolomics,X23428.Concentration of VLDL Particles,CASQ2,Calsequestrin-2,37021,0.00245715996472273,0.00456213741765167,-0.00648462937387454,0.01139894930332,0.590173093267967
NMR metabolomics,X23428.Concentration of VLDL Particles,SCN3B,Sodium channel subunit beta-3,36991,0.00222588816599936,0.00415298803488398,-0.00591396838237323,0.010365744714372,0.591986503945728
NMR metabolomics,X23428.Concentration of VLDL Particles,TFF1,Trefoil factor 1,39789,-0.00374044617508062,0.00701123781175048,-0.0174824722861116,0.0100015799359503,0.593699810741151
NMR metabolomics,X23428.Concentration of VLDL Particles,PLIN3,Perilipin-3,39868,0.00212978712373542,0.00400139708512376,-0.00571295116310716,0.00997252541057799,0.594552711514885
NMR metabolomics,X23428.Concentration of VLDL Particles,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37021,-0.00292625513606528,0.00550736397018629,-0.0137206885176304,0.00786817824549985,0.595195635047893
NMR metabolomics,X23428.Concentration of VLDL Particles,CCDC50,Coiled-coil domain-containing protein 50,37411,-0.00382522044648828,0.00721891942809762,-0.0179743025255596,0.0103238616325831,0.596198107842837
NMR metabolomics,X23428.Concentration of VLDL Particles,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37043,0.00102639708310588,0.00195438131510139,-0.00280419029449284,0.00485698446070461,0.599468640236687
NMR metabolomics,X23428.Concentration of VLDL Particles,GUCA2A,Guanylin,39796,-0.00157526110270923,0.00300485254034399,-0.00746477208178344,0.00431424987636499,0.600119560487054
NMR metabolomics,X23428.Concentration of VLDL Particles,THRAP3,Thyroid hormone receptor-associated protein 3,37021,-0.00562689842474156,0.010837930689157,-0.0268692425754893,0.0156154457260061,0.603639993666981
NMR metabolomics,X23428.Concentration of VLDL Particles,SEPTIN7,Septin-7,37169,0.00244293105343768,0.00479225663351227,-0.00694989194824636,0.0118357540551217,0.610223633021838
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTN4,Contactin-4,39858,-0.00112999652606617,0.00222371392043185,-0.0054884758101126,0.00322848275798026,0.611350019660092
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37124,-0.00183831495957247,0.00363587215966185,-0.00896462439250969,0.00528799447336475,0.613142407979122
NMR metabolomics,X23428.Concentration of VLDL Particles,GFRA3,GDNF family receptor alpha-3,39709,0.00129771257042112,0.00257857521798633,-0.00375629485683209,0.00635171999767433,0.61478335229704
NMR metabolomics,X23428.Concentration of VLDL Particles,GAD2,Glutamate decarboxylase 2,37056,0.00218479059336291,0.00435566096578817,-0.0063523048995819,0.0107218860863077,0.615958732589235
NMR metabolomics,X23428.Concentration of VLDL Particles,DAND5,DAN domain family member 5,37056,0.00251818160656723,0.00502057573321765,-0.00732214683053936,0.0123585100436738,0.615976791406311
NMR metabolomics,X23428.Concentration of VLDL Particles,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36931,0.00411868914919787,0.00822492881483333,-0.0120021713278755,0.0202395496262712,0.616550714029166
NMR metabolomics,X23428.Concentration of VLDL Particles,MSLNL,Mesothelin-like protein,37039,-0.00168779831689038,0.00339169817005723,-0.00833552673020255,0.00495993009642179,0.618755743578114
NMR metabolomics,X23428.Concentration of VLDL Particles,RICTOR,Rapamycin-insensitive companion of mTOR,37056,-0.00221748838165993,0.00447899376920669,-0.0109963161693051,0.00656133940598518,0.620547458430804
NMR metabolomics,X23428.Concentration of VLDL Particles,UPK3A,Uroplakin-3a,36991,0.00219655683952126,0.00445656507397222,-0.00653831070546428,0.0109314243845068,0.622104821301762
NMR metabolomics,X23428.Concentration of VLDL Particles,PDCD6,Programmed cell death protein 6,39868,-0.00319849602856162,0.00649249224028215,-0.0159237808195146,0.0095267887623914,0.622269964432244
NMR metabolomics,X23428.Concentration of VLDL Particles,KCNIP4,Kv channel-interacting protein 4,39489,0.00240550515193808,0.00488771427848224,-0.00717441483388711,0.0119854251377633,0.622617824213842
NMR metabolomics,X23428.Concentration of VLDL Particles,SHC1,SHC-transforming protein 1,36962,-0.00532558878484654,0.0108246189235301,-0.0265418418749656,0.0158906643052725,0.622735666520355
NMR metabolomics,X23428.Concentration of VLDL Particles,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39881,-0.00224239869032775,0.00458844679198355,-0.0112357544026155,0.00675095702196,0.625056974876322
NMR metabolomics,X23428.Concentration of VLDL Particles,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37039,0.00190819427459012,0.00391187926873663,-0.00575908909213368,0.00957547764131391,0.625703325990719
NMR metabolomics,X23428.Concentration of VLDL Particles,DNLZ,DNL-type zinc finger protein,36991,-0.00405287199197559,0.0083857686838032,-0.0204889786122299,0.0123832346282787,0.628888259667527
NMR metabolomics,X23428.Concentration of VLDL Particles,NENF,Neudesin,37368,0.00484250224618364,0.0102558634012527,-0.0152589900202717,0.024943994512639,0.636813689341467
NMR metabolomics,X23428.Concentration of VLDL Particles,SIRPB1,Signal-regulatory protein beta-1,39835,0.00194214942335584,0.00412609123918936,-0.0061449894054553,0.010029288252167,0.637861709260829
NMR metabolomics,X23428.Concentration of VLDL Particles,PDCL2,Phosducin-like protein 2,36962,-0.00232530678208179,0.00497409840890884,-0.0120745396635431,0.00742392609937953,0.640162078557079
NMR metabolomics,X23428.Concentration of VLDL Particles,CHRDL2,Chordin-like protein 2,39868,0.00244459279445436,0.00524777797410275,-0.00784105203478704,0.0127302376236957,0.641340747255785
NMR metabolomics,X23428.Concentration of VLDL Particles,KLHL41,Kelch-like protein 41,37411,0.00222128450154743,0.00477464860075382,-0.00713702675593006,0.0115795957590249,0.641778022240925
NMR metabolomics,X23428.Concentration of VLDL Particles,SOD3,Extracellular superoxide dismutase,37445,-0.00262445956437397,0.00568949894642637,-0.0137758774993697,0.00852695837062171,0.644604172762153
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC1A4,Neutral amino acid transporter A,37039,-0.00218682708269204,0.00479854947680831,-0.0115919840572363,0.00721832989185225,0.648594033369042
NMR metabolomics,X23428.Concentration of VLDL Particles,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37368,0.00413723757586043,0.00911591697803356,-0.0137299597010853,0.0220044348528062,0.649945769895204
NMR metabolomics,X23428.Concentration of VLDL Particles,LELP1,Late cornified envelope-like proline-rich protein 1,36991,-0.00310459910325609,0.00684415660473516,-0.016519146048537,0.0103099478420248,0.650114818395282
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC51B,Organic solute transporter subunit beta,37021,-0.00321400986870735,0.00709171719413971,-0.0171137755692212,0.0106857558318065,0.650407773677384
NMR metabolomics,X23428.Concentration of VLDL Particles,CALY,Neuron-specific vesicular protein calcyon,37021,0.00160390958843637,0.00354367190923899,-0.00534168735367206,0.0085495065305448,0.650835381335954
NMR metabolomics,X23428.Concentration of VLDL Particles,DDX1,ATP-dependent RNA helicase DDX1,37382,0.00210979959271849,0.00467872916231986,-0.00706050956542843,0.0112801087508654,0.652044111820467
NMR metabolomics,X23428.Concentration of VLDL Particles,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37056,0.00125418645687495,0.0027846601706991,-0.00420374747769529,0.00671212039144519,0.65243578290293
NMR metabolomics,X23428.Concentration of VLDL Particles,TP53BP1,TP53-binding protein 1,37056,0.00369791199962767,0.00822464590689891,-0.0124223939778942,0.0198182179771495,0.652996522224933
NMR metabolomics,X23428.Concentration of VLDL Particles,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37056,-0.00191318571351361,0.0042910757445883,-0.0103236941729067,0.00649732274587946,0.655711301451628
NMR metabolomics,X23428.Concentration of VLDL Particles,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37388,0.00149945433138322,0.00337451590248403,-0.00511459683748548,0.00811350550025192,0.656799194768479
NMR metabolomics,X23428.Concentration of VLDL Particles,GLI2,Zinc finger protein GLI2,37056,-0.00142617344712129,0.00321652604899203,-0.00773056450314568,0.0048782176089031,0.657491394912749
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTN1,Contactin-1,40052,-0.00109566276377648,0.0024836344880268,-0.00596358636030901,0.00377226083275606,0.659108138598448
NMR metabolomics,X23428.Concentration of VLDL Particles,DLL1,Delta-like protein 1,39913,0.00116776407897692,0.00264970426580473,-0.00402565628200035,0.0063611844399542,0.659425362457051
NMR metabolomics,X23428.Concentration of VLDL Particles,CYTH3,Cytohesin-3,36962,0.00294490024434888,0.0067727332588028,-0.0103296569429046,0.0162194574316024,0.663702352065989
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGAP30,Rho GTPase-activating protein 30,37169,-0.00158426415229246,0.00367342674256534,-0.00878418056772052,0.00561565226313561,0.666274019082397
NMR metabolomics,X23428.Concentration of VLDL Particles,LRP2,Low-density lipoprotein receptor-related protein 2,37039,0.00143945066521888,0.00334699275607048,-0.00512065513667926,0.00799955646711702,0.667149691392623
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP9,Matrix metalloproteinase-9,39843,-0.00242629214382039,0.00564538134762184,-0.0134912395851592,0.00863865529751842,0.667358880228656
NMR metabolomics,X23428.Concentration of VLDL Particles,DKKL1,Dickkopf-like protein 1,39788,0.00334317310164572,0.00785284665014485,-0.0120484063326382,0.0187347525359296,0.670312142668081
NMR metabolomics,X23428.Concentration of VLDL Particles,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39885,0.00131798836257603,0.00309902166712699,-0.00475609410499286,0.00739207083014492,0.670629714255123
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRV1,Adhesion G-protein coupled receptor V1,36991,-0.00269477328065309,0.00647318001340055,-0.0153822061069182,0.00999265954561199,0.677198603003142
NMR metabolomics,X23428.Concentration of VLDL Particles,THSD1,Thrombospondin type-1 domain-containing protein 1,36975,-0.00134245514651629,0.00323031177895881,-0.00767386623327555,0.00498895594024297,0.677723669871731
NMR metabolomics,X23428.Concentration of VLDL Particles,BTLA,B- and T-lymphocyte attenuator,36962,0.00331343098973741,0.00812362651841765,-0.0126088769863612,0.019235738965836,0.683371495594853
NMR metabolomics,X23428.Concentration of VLDL Particles,RETN,Resistin,39790,-0.00154956192463848,0.00380251528304747,-0.00900249187941152,0.00590336803013456,0.683639135231353
NMR metabolomics,X23428.Concentration of VLDL Particles,IL13RA2,Interleukin-13 receptor subunit alpha-2,36991,-0.00109196702198837,0.00268869673325886,-0.00636181261917574,0.004177878575199,0.684651893660957
NMR metabolomics,X23428.Concentration of VLDL Particles,DEFB118,Beta-defensin 118,36991,0.00217524374548979,0.0054242338642634,-0.00845625462846647,0.0128067421194461,0.688409551454557
NMR metabolomics,X23428.Concentration of VLDL Particles,TOP1,DNA topoisomerase 1,37382,0.00424198482788176,0.0106380070261317,-0.0166085089433363,0.0250924785990999,0.690078209760299
NMR metabolomics,X23428.Concentration of VLDL Particles,SLK,STE20-like serine/threonine-protein kinase,37169,0.0028370095626673,0.0071644487481816,-0.0112053099837686,0.0168793291091032,0.692122923057559
NMR metabolomics,X23428.Concentration of VLDL Particles,IL24,Interleukin-24,39587,-0.00172797521060587,0.00439998244480475,-0.0103519408024232,0.00689599038121143,0.694529251844575
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTNAP4,Contactin-associated protein-like 4,37039,0.00370401395785677,0.00966768370264855,-0.0152446460993344,0.0226526740150479,0.701626925777111
NMR metabolomics,X23428.Concentration of VLDL Particles,IL12RB2,Interleukin-12 receptor subunit beta-2,37056,0.00147167634583797,0.00389491485676101,-0.0061623567734136,0.00910570946508954,0.705551391904145
NMR metabolomics,X23428.Concentration of VLDL Particles,DDI2,Protein DDI1 homolog 2,37124,0.00264237577079778,0.007023831148348,-0.0111243332799643,0.0164090848215599,0.706773121837608
NMR metabolomics,X23428.Concentration of VLDL Particles,GID8,Glucose-induced degradation protein 8 homolog,37411,0.00117411834921616,0.00312788607955214,-0.00495653836670603,0.00730477506513835,0.707390296238451
NMR metabolomics,X23428.Concentration of VLDL Particles,CAPN3,Calpain-3,37368,0.00131042521574756,0.00351650621521362,-0.00558192696607114,0.00820277739756626,0.709414975616518
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT17,"Keratin, type I cytoskeletal 17",37021,0.00133719214285877,0.00364871176903858,-0.00581428292445684,0.00848866721017438,0.714010319509554
NMR metabolomics,X23428.Concentration of VLDL Particles,GJA8,Gap junction alpha-8 protein,36962,-0.00204687451938037,0.00559441450177408,-0.0130119269428576,0.00891817790409683,0.714461842863537
NMR metabolomics,X23428.Concentration of VLDL Particles,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36962,0.00114282837582881,0.0031460457477555,-0.00502342128977197,0.00730907804142958,0.7164175289282
NMR metabolomics,X23428.Concentration of VLDL Particles,MAGEA3,Melanoma-associated antigen 3,37169,0.00282108083402936,0.00782291137340722,-0.0125118254578488,0.0181539871259075,0.718390928533785
NMR metabolomics,X23428.Concentration of VLDL Particles,IL2,Interleukin-2,39587,0.00104319463491909,0.002903743253448,-0.00464814214183899,0.00673453141167717,0.719406491341358
NMR metabolomics,X23428.Concentration of VLDL Particles,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37437,-0.000862821700689077,0.00241455909346109,-0.00559535752387282,0.00386971412249466,0.720841864683748
NMR metabolomics,X23428.Concentration of VLDL Particles,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37021,-0.00122230138185516,0.00343133706033084,-0.0079477220201036,0.00550311925639327,0.721683599600493
NMR metabolomics,X23428.Concentration of VLDL Particles,EXOSC10,Exosome component 10,37021,-0.0020111153355717,0.00570338237568738,-0.013189744791919,0.00916751412077555,0.724380481490231
NMR metabolomics,X23428.Concentration of VLDL Particles,RTKN2,Rhotekin-2,37021,-0.00170775307179399,0.00486196614017974,-0.0112372067065463,0.0078217005629583,0.725408358778426
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF168,E3 ubiquitin-protein ligase RNF168,37056,0.00135397293736361,0.00387429839089904,-0.0062396519087985,0.00894759778352573,0.726737827096404
NMR metabolomics,X23428.Concentration of VLDL Particles,CD2,T-cell surface antigen CD2,37021,-0.00125387732132868,0.00359084330642014,-0.00829193020191215,0.0057841755592548,0.726954193930907
NMR metabolomics,X23428.Concentration of VLDL Particles,EPGN,Epigen,37368,-0.00161382594583788,0.00466162100871026,-0.01075060312291,0.00752295123123423,0.729202198990732
NMR metabolomics,X23428.Concentration of VLDL Particles,GUK1,Guanylate kinase,37021,-0.00133450536570307,0.00387627112723661,-0.00893199677508682,0.00626298604368068,0.730644572116702
NMR metabolomics,X23428.Concentration of VLDL Particles,CLINT1,Clathrin interactor 1,36962,-0.00157402064009723,0.00458153700893186,-0.0105538331776037,0.00740579189740921,0.731184728811216
NMR metabolomics,X23428.Concentration of VLDL Particles,LAYN,Layilin,39713,-0.00102971927107761,0.00300791471007367,-0.00692523210282201,0.00486579356066679,0.732102139167351
NMR metabolomics,X23428.Concentration of VLDL Particles,DDX53,Probable ATP-dependent RNA helicase DDX53,37039,0.00112131068837619,0.00328963445317049,-0.00532637283983797,0.00756899421659036,0.733213064593901
NMR metabolomics,X23428.Concentration of VLDL Particles,MLLT1,Protein ENL,36962,-0.00224792018162474,0.00668448305023597,-0.0153495069600872,0.0108536665968378,0.736658097107725
NMR metabolomics,X23428.Concentration of VLDL Particles,REXO2,"Oligoribonuclease, mitochondrial",37021,-0.00150278168980531,0.0044692454511497,-0.0102625027740587,0.00725693939444811,0.7366880648889
NMR metabolomics,X23428.Concentration of VLDL Particles,RUVBL1,RuvB-like 1,39477,0.00318020320312378,0.00946760234725835,-0.0153762973975026,0.0217367038037501,0.736947955993017
NMR metabolomics,X23428.Concentration of VLDL Particles,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36991,0.00223184656178919,0.00673991423669346,-0.01097838534213,0.0154420784657084,0.740544990873792
NMR metabolomics,X23428.Concentration of VLDL Particles,COMMD9,COMM domain-containing protein 9,37368,0.00121014723571563,0.00366663046786525,-0.00597644848130026,0.00839674295273151,0.741372277106882
NMR metabolomics,X23428.Concentration of VLDL Particles,MAG,Myelin-associated glycoprotein,37039,-0.00142051044695686,0.00431329003755123,-0.00987455892055727,0.00703353802664354,0.741908939514739
NMR metabolomics,X23428.Concentration of VLDL Particles,PYDC1,Pyrin domain-containing protein 1,37043,-0.00126694891747555,0.00385359525918515,-0.00881999562547844,0.00628609779052733,0.742334290864979
NMR metabolomics,X23428.Concentration of VLDL Particles,FBLN2,Fibulin-2,37437,0.000929079603146886,0.00282596357091927,-0.00460980899585489,0.00646796820214866,0.742337938370022
NMR metabolomics,X23428.Concentration of VLDL Particles,VCAN,Versican core protein,40009,0.000901339775458979,0.00275534473850633,-0.00449913591201342,0.00630181546293138,0.743578234899278
NMR metabolomics,X23428.Concentration of VLDL Particles,MORN4,MORN repeat-containing protein 4,36962,0.00242843503043518,0.00746922632592966,-0.0122112485683869,0.0170681186292573,0.745091374085989
NMR metabolomics,X23428.Concentration of VLDL Particles,UGDH,UDP-glucose 6-dehydrogenase,37021,0.00299865370451479,0.00936958092585968,-0.0153657249101702,0.0213630323191998,0.748942034944898
NMR metabolomics,X23428.Concentration of VLDL Particles,RANGAP1,Ran GTPase-activating protein 1,39477,-0.0014758127348639,0.00461559325309081,-0.0105223755109219,0.00757075004119409,0.749165942507924
NMR metabolomics,X23428.Concentration of VLDL Particles,CD164L2,CD164 sialomucin-like 2 protein,37039,0.00108948941833322,0.00344220089037803,-0.00565722432680772,0.00783620316347415,0.751620798580287
NMR metabolomics,X23428.Concentration of VLDL Particles,THY1,Thy-1 membrane glycoprotein,40009,0.000784595845680853,0.00251688100863771,-0.00414849093124905,0.00571768262261076,0.755247175294636
NMR metabolomics,X23428.Concentration of VLDL Particles,FOLR3,Folate receptor gamma,39858,-0.005453343287709,0.017635331821638,-0.0400185936581195,0.0291119070827015,0.757151911782786
NMR metabolomics,X23428.Concentration of VLDL Particles,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39477,-0.00213451793510101,0.00695745792164309,-0.0157711354615215,0.0115020995913195,0.759002997801926
NMR metabolomics,X23428.Concentration of VLDL Particles,RLN2,Prorelaxin H2,37095,-0.00405554211654068,0.0132659385785289,-0.0300567817304574,0.021945697497376,0.75982957606208
NMR metabolomics,X23428.Concentration of VLDL Particles,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37021,-0.00176602101521282,0.00578789215061937,-0.0131102896304268,0.00957824760000114,0.760277036589541
NMR metabolomics,X23428.Concentration of VLDL Particles,CGN,Cingulin,37039,0.00109549765244192,0.003633242963556,-0.00602565855612784,0.00821665386101168,0.763022289887074
NMR metabolomics,X23428.Concentration of VLDL Particles,LCN2,Neutrophil gelatinase-associated lipocalin,39372,-0.00101168359185739,0.00339642592574386,-0.00766867840631536,0.00564531122260058,0.765808576866042
NMR metabolomics,X23428.Concentration of VLDL Particles,TFAP2A,Transcription factor AP-2-alpha,36991,-0.00163823039031679,0.00553623996628323,-0.0124892607242319,0.00921279994359835,0.767303269534621
NMR metabolomics,X23428.Concentration of VLDL Particles,NPHS2,Podocin,37056,-0.00279828861522025,0.00954114614396405,-0.0214989350573898,0.0159023578269493,0.769307843111375
NMR metabolomics,X23428.Concentration of VLDL Particles,TPBGL,Trophoblast glycoprotein-like,37039,0.00109955398275697,0.0037895673890428,-0.00632799809976691,0.00852710606528085,0.77170382922637
NMR metabolomics,X23428.Concentration of VLDL Particles,KIAA2013,Uncharacterized protein KIAA2013,37368,0.00154169539637324,0.00535377065741359,-0.0089516950921574,0.0120350858849039,0.773378401577537
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39489,-0.00212777242422495,0.00740636205403232,-0.0166442420501283,0.0123886972016784,0.773894225215424
NMR metabolomics,X23428.Concentration of VLDL Particles,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39877,0.00151279388046851,0.0053328166548028,-0.00893952676294497,0.011965114523882,0.776662098991197
NMR metabolomics,X23428.Concentration of VLDL Particles,CCAR2,Cell cycle and apoptosis regulator protein 2,37388,0.00151922248528372,0.00536965229774204,-0.00900529601829068,0.0120437409888581,0.777236716054558
NMR metabolomics,X23428.Concentration of VLDL Particles,TXK,Tyrosine-protein kinase TXK,37169,-0.00193590444718067,0.00692914442051468,-0.0155170275113894,0.0116452186170281,0.77995312090381
NMR metabolomics,X23428.Concentration of VLDL Particles,CD58,Lymphocyte function-associated antigen 3,39835,0.000449276419204388,0.00162256065376039,-0.00273094246216597,0.00362949530057475,0.781865503725206
NMR metabolomics,X23428.Concentration of VLDL Particles,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37368,0.00123147443485711,0.00448458480529945,-0.00755831178352982,0.010021260653244,0.783626489743892
NMR metabolomics,X23428.Concentration of VLDL Particles,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37021,0.00133064320721184,0.0048491987583761,-0.00817378635920531,0.010835072773629,0.783777894486622
NMR metabolomics,X23428.Concentration of VLDL Particles,PITHD1,PITH domain-containing protein 1,36931,0.00201210161804579,0.00740561149491266,-0.012502896911983,0.0165271001480746,0.785857306400529
NMR metabolomics,X23428.Concentration of VLDL Particles,GPHA2,Glycoprotein hormone alpha-2,37382,0.00117717715739865,0.00434858345942588,-0.00734604642307607,0.00970040073787336,0.786623146540289
NMR metabolomics,X23428.Concentration of VLDL Particles,ISM2,Isthmin-2,37437,-0.00111855014394119,0.00415390462566154,-0.00926020321023781,0.00702310292235543,0.78772077608608
NMR metabolomics,X23428.Concentration of VLDL Particles,DPP6,Dipeptidyl aminopeptidase-like protein 6,39788,0.000830183241474403,0.0030875594701392,-0.00522143331999843,0.00688179980294724,0.788025447971712
NMR metabolomics,X23428.Concentration of VLDL Particles,ZP4,Zona pellucida sperm-binding protein 4,36962,0.000793358617667641,0.00301477735572064,-0.00511560499954481,0.0067023222348801,0.792434003257113
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMA1,Proteasome subunit alpha type-1,39477,-0.00113697343713999,0.00433230766362023,-0.00962829645783564,0.00735434958355566,0.792985234031393
NMR metabolomics,X23428.Concentration of VLDL Particles,ALMS1,Alstrom syndrome protein 1,37169,0.00109149749384156,0.00418267471272781,-0.00710654494310494,0.00928953993078807,0.794129843663912
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF20,Fibroblast growth factor 20,37056,0.00104852585057621,0.00401803067749542,-0.00682681427731481,0.00892386597846723,0.794131156326591
NMR metabolomics,X23428.Concentration of VLDL Particles,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36991,-0.00133955797173014,0.00524133596108867,-0.0116125764554639,0.00893346051200366,0.798282506974116
NMR metabolomics,X23428.Concentration of VLDL Particles,UHRF2,E3 ubiquitin-protein ligase UHRF2,37021,-0.000825428216819155,0.00323328331690996,-0.00716266351796268,0.00551180708432437,0.798502319469873
NMR metabolomics,X23428.Concentration of VLDL Particles,ERVV_1,,37021,0.00114238604256354,0.00450086430221027,-0.00767930798976859,0.00996408007489567,0.799642591912619
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINB5,Serpin B5,39585,0.00110034720962564,0.00453708512362662,-0.00779233963268253,0.00999303405193381,0.808378149013213
NMR metabolomics,X23428.Concentration of VLDL Particles,IL5,Interleukin-5,39587,0.0031868592489166,0.0134453837903614,-0.0231660929801917,0.0295398114780249,0.812642377832057
NMR metabolomics,X23428.Concentration of VLDL Particles,DBH,Dopamine beta-hydroxylase,37430,-0.00240203999138623,0.0101777781991232,-0.0223504852616677,0.0175464052788953,0.813429802020033
NMR metabolomics,X23428.Concentration of VLDL Particles,NRP2,Neuropilin-2,39858,0.00062356993698391,0.0026579653914194,-0.00458604223019812,0.00583318210416594,0.81451892469197
NMR metabolomics,X23428.Concentration of VLDL Particles,DCDC2C,Doublecortin domain-containing protein 2C,36962,-0.00138651502660329,0.00594419096163683,-0.0130371293114115,0.0102640992582049,0.815566682489247
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK3,Prostate-specific antigen,37437,0.00169430758397932,0.0073476421003027,-0.012707070932614,0.0160956861005726,0.817635247298674
NMR metabolomics,X23428.Concentration of VLDL Particles,PFDN4,Prefoldin subunit 4,36962,-0.00117031785459177,0.00509572758964898,-0.0111579439303038,0.00881730822112023,0.818354523401265
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH4,Cadherin-4,36991,0.00097353716716288,0.00436998800414645,-0.00759163932096416,0.00953871365528992,0.823711759884734
NMR metabolomics,X23428.Concentration of VLDL Particles,SPRING1,SREBP regulating gene protein,36962,0.00123687858012224,0.00560792895354674,-0.00975466216882936,0.0122284193290738,0.825439351050048
NMR metabolomics,X23428.Concentration of VLDL Particles,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36962,0.00116474303804719,0.00528103147569691,-0.00918607865431874,0.0115155647304131,0.825444570465909
NMR metabolomics,X23428.Concentration of VLDL Particles,CA11,Carbonic anhydrase-related protein 11,39477,0.000643610807280781,0.00292439095785379,-0.00508819547011265,0.00637541708467421,0.825808839125913
NMR metabolomics,X23428.Concentration of VLDL Particles,OTOA,Otoancorin,36991,-0.00108673286397896,0.00494673127823707,-0.0107823261693236,0.00860886044136569,0.826118295946616
NMR metabolomics,X23428.Concentration of VLDL Particles,CPE,Carboxypeptidase E,39906,-0.000785209100246643,0.00359719348017644,-0.00783570832139246,0.00626529012089917,0.827210763497732
NMR metabolomics,X23428.Concentration of VLDL Particles,TFRC,Transferrin receptor protein 1,39918,-0.000783666178092586,0.00364177239556954,-0.00792154007340888,0.0063542077172237,0.829623380749137
NMR metabolomics,X23428.Concentration of VLDL Particles,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37411,-0.00230228229029564,0.0108046456642954,-0.0234793877923147,0.0188748232117234,0.831265719886341
NMR metabolomics,X23428.Concentration of VLDL Particles,S100G,Protein S100-G,37411,-0.000886904111355644,0.0041972930491202,-0.00911359848763123,0.00733979026491994,0.832653369315778
NMR metabolomics,X23428.Concentration of VLDL Particles,CD82,CD82 antigen,37169,0.000831152181670404,0.00393542024901084,-0.00688227150639084,0.00854457586973165,0.832736144524207
NMR metabolomics,X23428.Concentration of VLDL Particles,IL3,Interleukin-3,36962,0.00116406437135786,0.00558404717830118,-0.00978066809811244,0.0121087968408282,0.834871109406008
NMR metabolomics,X23428.Concentration of VLDL Particles,CD3G,T-cell surface glycoprotein CD3 gamma chain,37056,0.00176403267705827,0.00850641179296285,-0.0149085344371489,0.0184365997912655,0.835718779441385
NMR metabolomics,X23428.Concentration of VLDL Particles,EFNB2,Ephrin-B2,37039,-0.0011399882377437,0.00563092039818688,-0.01217659221819,0.00989661574270259,0.8395669017292
NMR metabolomics,X23428.Concentration of VLDL Particles,GPA33,Cell surface A33 antigen,39788,0.00247620121182016,0.0122516265748624,-0.0215369868749102,0.0264893892985505,0.839831718584754
NMR metabolomics,X23428.Concentration of VLDL Particles,MRPL28,"39S ribosomal protein L28, mitochondrial",37411,0.00067602696561686,0.00336769147903583,-0.00592464833329337,0.00727670226452709,0.840905687976861
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP350,Centrosome-associated protein 350,36962,-0.000674123929167323,0.00339009484331897,-0.0073187098220725,0.00597046196373786,0.842382344351367
NMR metabolomics,X23428.Concentration of VLDL Particles,KDM3A,Lysine-specific demethylase 3A,37056,-0.00166675639282378,0.00870590643913183,-0.0187303330135222,0.0153968202278746,0.848175041373826
NMR metabolomics,X23428.Concentration of VLDL Particles,CBLN1,Cerebellin-1,36991,-0.00168892178621017,0.00897750606790585,-0.0192848336793056,0.0159069901068853,0.850779086051172
NMR metabolomics,X23428.Concentration of VLDL Particles,COL4A4,Collagen alpha-4(IV) chain,37147,-0.000898219991815655,0.00489347570721796,-0.0104894323779629,0.00869299239433155,0.854365680127555
NMR metabolomics,X23428.Concentration of VLDL Particles,DIPK1C,Divergent protein kinase domain 1C,37039,-0.000729951323594508,0.00399946958855645,-0.00856891171716515,0.00710900906997613,0.855183719623849
NMR metabolomics,X23428.Concentration of VLDL Particles,HMMR,Hyaluronan mediated motility receptor,36942,-0.000806027899780538,0.00444764159207935,-0.00952340542025606,0.00791134962069499,0.856193064741092
NMR metabolomics,X23428.Concentration of VLDL Particles,PLA2G1B,Phospholipase A2,40031,-0.000681390579010446,0.0038084885357199,-0.00814602810902145,0.00678324695100056,0.858007747174087
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGAX,Integrin alpha-X,37169,-0.000837934962036569,0.00493731928008577,-0.0105150807510047,0.00883921082693154,0.86523720355665
NMR metabolomics,X23428.Concentration of VLDL Particles,OGN,Mimecan,39858,0.000618282928625519,0.00367936081177267,-0.00659326426244891,0.00782983011969995,0.86655326428214
NMR metabolomics,X23428.Concentration of VLDL Particles,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37021,0.000316110198881492,0.00188694709243291,-0.00338230610228701,0.00401452650004999,0.866959807724205
NMR metabolomics,X23428.Concentration of VLDL Particles,EPB41L5,Band 4.1-like protein 5,37039,-0.0010043313998802,0.00600348211430269,-0.0127711563439135,0.0107624935441531,0.867143275432739
NMR metabolomics,X23428.Concentration of VLDL Particles,HNF1A,Hepatocyte nuclear factor 1-alpha,37039,0.00109256389275138,0.00663890889683601,-0.0119196975450472,0.01410482533055,0.869285129017491
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF4,E3 ubiquitin-protein ligase RNF4,37169,-0.00100695488200833,0.00612740851924336,-0.0130166755797253,0.0110027658157087,0.869469000426682
NMR metabolomics,X23428.Concentration of VLDL Particles,CTLA4,Cytotoxic T-lymphocyte protein 4,37437,0.000446669364636301,0.00276434875611521,-0.00497145419734952,0.00586479292662212,0.871637333572114
NMR metabolomics,X23428.Concentration of VLDL Particles,F3,Tissue factor,39931,-0.000398775004072761,0.00253122953127289,-0.00535998488536762,0.0045624348772221,0.874819676275728
NMR metabolomics,X23428.Concentration of VLDL Particles,UBQLN3,Ubiquilin-3,37021,-0.000679606911299716,0.00439643665214003,-0.00929662274949417,0.00793740892689474,0.877153780281549
NMR metabolomics,X23428.Concentration of VLDL Particles,PNMA2,Paraneoplastic antigen Ma2,36991,0.000601462851024396,0.00405431326384813,-0.00734499114611793,0.00854791684816672,0.882067769191977
NMR metabolomics,X23428.Concentration of VLDL Particles,ARG2,"Arginase-2, mitochondrial",37368,0.000600318206635224,0.00409692695701438,-0.00742965862911295,0.0086302950423834,0.88350606263725
NMR metabolomics,X23428.Concentration of VLDL Particles,GIPR,Gastric inhibitory polypeptide receptor,37056,0.000616869230563868,0.00427188313008766,-0.00775602170440795,0.00898976016553568,0.885185101764196
NMR metabolomics,X23428.Concentration of VLDL Particles,STEAP4,Metalloreductase STEAP4,36991,0.00100737838405441,0.00701658558200827,-0.0127451293566818,0.0147598861247906,0.885841425342317
NMR metabolomics,X23428.Concentration of VLDL Particles,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37169,-0.000664775209868843,0.0047528848900162,-0.00998042959430059,0.0086508791745629,0.888766616592694
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH22,Cadherin-22,37169,-0.000376355219255797,0.00270672707990835,-0.00568154029587617,0.00492882985736457,0.889417174326407
NMR metabolomics,X23428.Concentration of VLDL Particles,TMED10,Transmembrane emp24 domain-containing protein 10,37021,0.000656016039872928,0.00475293773895524,-0.00865974192847934,0.0099717740082252,0.890224133131252
NMR metabolomics,X23428.Concentration of VLDL Particles,IL3RA,Interleukin-3 receptor subunit alpha,39587,0.00039272063753156,0.00285759851984529,-0.0052081724613652,0.00599361373642832,0.890692437285386
NMR metabolomics,X23428.Concentration of VLDL Particles,AKR1B10,Aldo-keto reductase family 1 member B10,37039,0.000781184657753773,0.00568940487563025,-0.0103700488984815,0.0119324182139891,0.890791687929676
NMR metabolomics,X23428.Concentration of VLDL Particles,IL20RB,Interleukin-20 receptor subunit beta,37056,-0.000536326414727855,0.00403957206988553,-0.00845388767170348,0.00738123484224778,0.894378787050955
NMR metabolomics,X23428.Concentration of VLDL Particles,WFDC12,WAP four-disulfide core domain protein 12,39990,-0.000708710983803069,0.00579738228741914,-0.0120715802671446,0.0106541582995384,0.902705147611736
NMR metabolomics,X23428.Concentration of VLDL Particles,OMP,Olfactory marker protein,36991,-0.000532464104081669,0.00453900414614171,-0.00942891223051943,0.00836398402235609,0.906617324955765
NMR metabolomics,X23428.Concentration of VLDL Particles,HK2,Hexokinase-2,39585,-0.000275803616930937,0.00254976369599698,-0.00527334046108502,0.00472173322722314,0.913863566476192
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF2RB,Cytokine receptor common subunit beta,37056,0.000413142913705861,0.00405489252394788,-0.00753444643323199,0.00836073226064371,0.918847509817635
NMR metabolomics,X23428.Concentration of VLDL Particles,CDC123,Cell division cycle protein 123 homolog,36962,-0.000559361108968864,0.00595872547674429,-0.0122384630433877,0.0111197408254499,0.925211787701886
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGBL1,Integrin beta-like protein 1,37437,0.000298094419767047,0.0033351000798236,-0.0062387017366872,0.0068348905762213,0.928780479441418
NMR metabolomics,X23428.Concentration of VLDL Particles,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39489,0.000377360123076776,0.00436637976624347,-0.00818074421876042,0.00893546446491398,0.931130454659253
NMR metabolomics,X23428.Concentration of VLDL Particles,PRG3,Proteoglycan 3,37437,-0.000376717359777432,0.00466432138782608,-0.00951878727991656,0.00876535256036169,0.935629446470057
NMR metabolomics,X23428.Concentration of VLDL Particles,MED21,Mediator of RNA polymerase II transcription subunit 21,37021,0.000356944046222122,0.00459408651278523,-0.00864746551883693,0.00936135361128117,0.938070728056961
NMR metabolomics,X23428.Concentration of VLDL Particles,IL10,Interleukin-10,39587,-0.00055236418584913,0.00737658331339686,-0.015010467480107,0.0139057391084087,0.940310534971811
NMR metabolomics,X23428.Concentration of VLDL Particles,RBP1,Retinol-binding protein 1,37039,0.000471142950312563,0.00656576509291638,-0.0123977566318035,0.0133400425324287,0.942795977062163
NMR metabolomics,X23428.Concentration of VLDL Particles,ARMCX2,Armadillo repeat-containing X-linked protein 2,36991,-0.000412242292880306,0.00584328751734231,-0.0118650858268712,0.0110406012411106,0.943757203351221
NMR metabolomics,X23428.Concentration of VLDL Particles,KHDC3L,KH domain-containing protein 3,36962,-0.000423654140709756,0.00622633148557598,-0.0126272638524387,0.0117799555710192,0.945752971170051
NMR metabolomics,X23428.Concentration of VLDL Particles,SCIN,Adseverin,36991,-0.000431410042146974,0.00690237298597868,-0.0139600610946652,0.0130972410103712,0.950164259883863
NMR metabolomics,X23428.Concentration of VLDL Particles,PRC1,Protein regulator of cytokinesis 1,37368,-0.00026138202316126,0.00431054093540705,-0.00871004225655907,0.00818727821023655,0.9516485097459
NMR metabolomics,X23428.Concentration of VLDL Particles,TPSD1,Tryptase delta,37411,-0.000183842102566588,0.00341712231631807,-0.00688140184255001,0.00651371763741684,0.957095087639069
NMR metabolomics,X23428.Concentration of VLDL Particles,VSTM2B,V-set and transmembrane domain-containing protein 2B,37169,0.0001825766809153,0.00387566135163259,-0.00741371956828458,0.00777887293011518,0.962427441539953
NMR metabolomics,X23428.Concentration of VLDL Particles,ANKRA2,Ankyrin repeat family A protein 2,36962,0.000232777373471206,0.0050908547344361,-0.00974529790602354,0.010210852652966,0.963530441132643
NMR metabolomics,X23428.Concentration of VLDL Particles,CTAG1A_CTAG1B,Cancer/testis antigen 1,37135,-0.000188130231945854,0.0047314411297705,-0.00946175484629603,0.00908549438240432,0.968283693943292
NMR metabolomics,X23428.Concentration of VLDL Particles,ART3,Ecto-ADP-ribosyltransferase 3,39931,0.000113448612869912,0.00307734432205536,-0.0059181462583586,0.00614504348409842,0.9705925049279
NMR metabolomics,X23428.Concentration of VLDL Particles,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36991,0.000153711271996398,0.00449914737406671,-0.00866461758117435,0.00897204012516715,0.972746467329694
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37021,-0.000198241809309629,0.00602684785220802,-0.0120108635996373,0.0116143799810181,0.97376032076173
NMR metabolomics,X23428.Concentration of VLDL Particles,FZD10,Frizzled-10,37039,0.000174905070634626,0.00559857026789717,-0.0107982926544438,0.0111481027957131,0.975077796163147
NMR metabolomics,X23428.Concentration of VLDL Particles,BTNL10,Butyrophilin-like protein 10,36962,-0.000105833094068758,0.00369722913312626,-0.00735240219499622,0.0071407360068587,0.977164128495504
NMR metabolomics,X23428.Concentration of VLDL Particles,DUOX2,Dual oxidase 2,39585,0.000186905276058089,0.00664908695768969,-0.0128453051610137,0.0132191157131299,0.977574842062662
NMR metabolomics,X23428.Concentration of VLDL Particles,IL19,Interleukin-19,39419,-0.00017882650446638,0.00638732671779483,-0.0126979868713443,0.0123403338624115,0.977664838207356
NMR metabolomics,X23428.Concentration of VLDL Particles,KEL,Kell blood group glycoprotein,39489,8.31515067965529e-05,0.00330576440189017,-0.00639614672090818,0.00656244973450129,0.979932857152115
NMR metabolomics,X23428.Concentration of VLDL Particles,TXNDC15,Thioredoxin domain-containing protein 15,39913,5.19803258834017e-05,0.00253085349498254,-0.00490849252428238,0.00501245317604918,0.983613931887953
NMR metabolomics,X23428.Concentration of VLDL Particles,ENG,Endoglin,40052,-3.22921473811822e-05,0.00157934804658567,-0.0031278143186891,0.00306323002392673,0.983687438077757
NMR metabolomics,X23428.Concentration of VLDL Particles,BRD2,Bromodomain-containing protein 2,36991,-5.36831139309775e-05,0.00316083873036244,-0.00624892702544136,0.00614156079757941,0.986449782248346
NMR metabolomics,X23428.Concentration of VLDL Particles,MORC3,MORC family CW-type zinc finger protein 3,37388,-1.55431521273655e-05,0.00261474917494277,-0.00514045153501519,0.00510936523076046,0.99525715927029
NMR metabolomics,X23428.Concentration of VLDL Particles,RGS8,Regulator of G-protein signaling 8,39587,-2.60682655532399e-05,0.00612989238779154,-0.0120406573456247,0.0119885208145182,0.996606943161529
NMR metabolomics,X23428.Concentration of VLDL Particles,RPGR,X-linked retinitis pigmentosa GTPase regulator,37039,1.29137370062976e-05,0.00381967677169683,-0.0074736527355195,0.00749948020953209,0.997302531886527
